1	A	a	DT	DT	_	6	det	_	_
2	KATP	katp	NN	NN	_	3	compound	_	_
3	Channel	channel	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	Dependent	dependent	JJ	JJ	_	6	amod	_	_
6	Pathway	pathway	NN	NN	_	10	nsubj	_	_
7	within	within	IN	IN	sem=LOC	6	prep	_	_
8	α	α	NN	NN	_	9	compound	_	_
9	Cells	cell	NNS	NNS	_	7	pobj	_	_
10	Regulates	regulate	VBZ	VBZ	_	0	root	_	_
11	Glucagon	glucagon	NN	NN	_	12	compound	_	_
12	Release	release	NN	NN	_	10	dobj	_	_
13	from	from	IN	IN	_	12	prep	_	_
14	Both	both	DT	DT	_	18	det	_	_
15	Rodent	rodent	NN	NN	_	18	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	Human	human	JJ	JJ	_	15	conj	_	_
18	Islets	islet	NNS	NNS	_	13	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	Langerhans	langerhans	NNS	NNS	_	19	pobj	_	_

1	Abstract	abstract	NN	NN	_	0	root	_	_

1	Glucagon	glucagon	NN	NN	_	10	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	secreted	secrete	VBN	VBN	_	1	acl	_	_
4	from	from	IN	IN	_	3	prep	_	_
5	pancreatic	pancreatic	JJ	JJ	_	8	amod	_	_
6	islet	islet	NN	NN	_	8	compound	_	_
7	α	α	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	4	pobj	_	_
9	,	,	,	,	_	10	punct	_	_
10	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
11	gluconeogenesis	gluconeogenesis	NN	NN	_	10	dobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	liver	liver	NN	NN	_	14	compound	_	_
14	glycogen	glycogen	NN	NN	_	15	compound	_	_
15	breakdown	breakdown	NN	NN	_	11	conj	_	_
16	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	7	nsubjpass	_	_
3	regulating	regulate	VBG	VBG	_	2	acl	_	_
4	glucagon	glucagon	NN	NN	_	5	compound	_	_
5	release	release	NN	NN	_	3	dobj	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	debated	debate	VBN	VBN	_	0	root	_	_
8	,	,	,	,	_	7	punct	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	variously	variously	RB	RB	_	11	advmod	_	_
11	attributed	attribute	VBN	VBN	_	7	conj	_	_
12	to	to	IN	IN	_	11	prep	_	_
13	neuronal	neuronal	JJ	JJ	_	14	amod	_	_
14	control	control	NN	NN	_	12	pobj	_	_
15	,	,	,	,	_	14	punct	_	_
16	paracrine	paracrine	JJ	JJ	_	17	amod	_	_
17	control	control	NN	NN	_	14	appos	_	_
18	by	by	IN	IN	_	17	prep	_	_
19	neighbouring	neighbour	VBG	VBG	_	21	amod	_	_
20	β	β	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	18	pobj	_	_
22	,	,	,	,	_	12	punct	_	_
23	or	or	CC	CC	_	12	cc	_	_
24	to	to	IN	IN	_	12	conj	_	_
25	an	an	DT	DT	_	27	det	_	_
26	intrinsic	intrinsic	JJ	JJ	_	27	amod	_	_
27	glucose	glucose	NN	NN	_	24	pobj	_	_
28	sensing	sense	VBG	VBG	_	27	amod	_	_
29	by	by	IN	IN	_	27	prep	_	_
30	the	the	DT	DT	_	32	det	_	_
31	α	α	NN	NN	_	32	compound	_	_
32	cells	cell	NNS	NNS	_	29	pobj	_	_
33	themselves	themselves	PRP	PRP	_	32	appos	_	_
34	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	hormone	hormone	NN	NN	_	4	compound	_	_
4	secretion	secretion	NN	NN	_	2	dobj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	responses	response	NNS	NNS	_	4	conj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	α	α	NN	NN	_	12	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	β	β	NN	NN	_	9	conj	_	_
12	cells	cell	NNS	NNS	_	8	pobj	_	_
13	within	within	IN	IN	sem=LOC	2	prep	_	_
14	intact	intact	JJ	JJ	_	15	amod	_	_
15	rodent	rodent	NN	NN	_	13	pobj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	human	human	JJ	JJ	_	18	amod	_	_
18	islets	islet	NNS	NNS	_	15	conj	_	_
19	.	.	.	.	_	2	punct	_	_

1	Glucose	glucose	NN	NN	_	3	npadvmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	dependent	dependent	JJ	JJ	_	4	amod	_	_
4	suppression	suppression	NN	NN	_	8	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	glucagon	glucagon	NN	NN	_	7	compound	_	_
7	release	release	NN	NN	_	5	pobj	_	_
8	persisted	persist	VBD	VBD	_	0	root	_	_
9	when	when	WRB	WRB	_	16	advmod	_	_
10	paracrine	paracrine	JJ	JJ	_	11	amod	_	_
11	GABA	gaba	NN	NN	_	16	nsubjpass	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	Zn2+	zn0+	NN	NN	_	14	compound	_	_
14	signalling	signalling	NN	NN	_	11	conj	_	_
15	was	be	VBD	VBD	_	16	auxpass	_	_
16	blocked	block	VBN	VBN	sem=TMP	8	advcl	_	_
17	,	,	,	,	_	16	punct	_	_
18	but	but	CC	CC	_	16	cc	_	_
19	was	be	VBD	VBD	_	20	auxpass	_	_
20	reversed	reverse	VBN	VBN	_	16	conj	_	_
21	by	by	IN	IN	sem=MNR	20	prep	_	_
22	low	low	JJ	JJ	_	23	amod	_	_
23	concentrations	concentration	NNS	NNS	_	21	pobj	_	_
24	(	(	-LRB-	-LRB-	_	28	punct	_	_
25	1	0	CD	CD	_	27	quantmod	_	_
26	–	-	SYM	SYM	_	27	punct	_	_
27	20	0	CD	CD	_	28	nummod	_	_
28	μM	μm	NNS	NNS	_	23	parataxis	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	of	of	IN	IN	_	23	prep	_	_
31	the	the	DT	DT	_	40	det	_	_
32	ATP	atp	NN	NN	_	34	npadvmod	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	sensitive	sensitive	JJ	JJ	_	40	amod	_	_
35	K+	k+	NN	NN	_	40	nmod	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	KATP	katp	NN	NN	_	40	parataxis	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	channel	channel	NN	NN	_	40	compound	_	_
40	opener	opener	NN	NN	_	30	pobj	_	_
41	diazoxide	diazoxide	NN	NN	_	40	appos	_	_
42	,	,	,	,	_	16	punct	_	_
43	which	which	WDT	WDT	_	44	dep	_	_
44	had	have	VBD	VBD	syn=ADV	16	advcl	_	_
45	no	no	DT	DT	_	46	det	_	_
46	effect	effect	NN	NN	_	44	dobj	_	_
47	on	on	IN	IN	_	46	prep	_	_
48	insulin	insulin	NN	NN	_	49	compound	_	_
49	release	release	NN	NN	_	47	pobj	_	_
50	or	or	CC	CC	_	49	cc	_	_
51	β	β	NN	NN	_	52	compound	_	_
52	cell	cell	NN	NN	_	53	compound	_	_
53	responses	response	NNS	NNS	_	49	conj	_	_
54	.	.	.	.	_	8	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	prevented	prevent	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	the	the	DT	DT	_	9	det	_	_
7	KATP	katp	NN	NN	_	9	compound	_	_
8	channel	channel	NN	NN	_	9	compound	_	_
9	blocker	blocker	NN	NN	_	5	pobj	_	_
10	tolbutamide	tolbutamide	NN	NN	_	9	appos	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	100	0	CD	CD	_	13	nummod	_	_
13	μM	μm	NNS	NNS	_	9	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	.	.	.	.	_	4	punct	_	_

1	Higher	high	JJR	JJR	_	3	amod	_	_
2	diazoxide	diazoxide	NN	NN	_	3	compound	_	_
3	concentrations	concentration	NNS	NNS	_	9	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	≥	≥	SYM	SYM	_	6	punct	_	_
6	30	0	CD	CD	_	7	nummod	_	_
7	μM	μm	NNS	NNS	_	3	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	decreased	decrease	VBN	VBN	_	0	root	_	_
10	glucagon	glucagon	NN	NN	_	13	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	insulin	insulin	NN	NN	_	10	conj	_	_
13	secretion	secretion	NN	NN	_	9	dobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	and	and	CC	CC	_	13	cc	_	_
16	α	α	NN	NN	_	21	nmod	_	_
17	-	-	HYPH	HYPH	_	16	punct	_	_
18	and	and	CC	CC	_	16	cc	_	_
19	β	β	NN	NN	_	16	conj	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	cell	cell	NN	NN	_	23	compound	_	_
22	Ca2+	ca0+	NN	NN	_	23	compound	_	_
23	responses	response	NNS	NNS	_	13	conj	_	_
24	,	,	,	,	_	9	punct	_	_
25	in	in	IN	IN	_	9	prep	_	_
26	parallel	parallel	JJ	JJ	_	25	amod	_	_
27	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	16	prep	_	_
2	the	the	DT	DT	_	3	det	_	_
3	absence	absence	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	glucose	glucose	NN	NN	_	4	pobj	_	_
6	,	,	,	,	_	16	punct	_	_
7	tolbutamide	tolbutamide	NN	NN	_	16	nsubj	_	_
8	at	at	IN	IN	_	7	prep	_	_
9	low	low	JJ	JJ	_	10	amod	_	_
10	concentrations	concentration	NNS	NNS	_	8	pobj	_	_
11	(	(	-LRB-	-LRB-	_	14	punct	_	_
12	<	<	SYM	SYM	_	13	punct	_	_
13	1	0	CD	CD	_	14	nummod	_	_
14	μM	μm	NN	NN	_	10	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	stimulated	stimulate	VBN	VBN	_	0	root	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	secretion	secretion	NN	NN	_	16	dobj	_	_
19	,	,	,	,	_	16	punct	_	_
20	whereas	whereas	IN	IN	_	28	mark	_	_
21	high	high	JJ	JJ	_	22	amod	_	_
22	concentrations	concentration	NNS	NNS	_	28	nsubj	_	_
23	(	(	-LRB-	-LRB-	_	26	punct	_	_
24	>	>	SYM	SYM	_	25	punct	_	_
25	10	0	CD	CD	_	26	nummod	_	_
26	μM	μm	NNS	NNS	_	22	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	were	be	VBD	VBD	syn=ADV	16	advcl	_	_
29	inhibitory	inhibitory	JJ	JJ	syn=PRD	28	acomp	_	_
30	.	.	.	.	_	16	punct	_	_

1	In	in	IN	IN	_	17	prep	_	_
2	the	the	DT	DT	_	3	det	_	_
3	presence	presence	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	a	a	DT	DT	_	8	det	_	_
6	maximally	maximally	RB	RB	_	7	advmod	_	_
7	inhibitory	inhibitory	JJ	JJ	_	8	amod	_	_
8	concentration	concentration	NN	NN	_	4	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	tolbutamide	tolbutamide	NN	NN	_	9	pobj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	0.5	0	CD	CD	_	13	nummod	_	_
13	mM	mm	NNS	NNS	_	8	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	,	,	,	,	_	17	punct	_	_
16	glucose	glucose	NN	NN	_	17	nsubj	_	_
17	had	have	VBD	VBD	_	0	root	_	_
18	no	no	DT	DT	_	21	det	_	_
19	additional	additional	JJ	JJ	_	21	amod	_	_
20	suppressive	suppressive	JJ	JJ	_	21	amod	_	_
21	effect	effect	NN	NN	_	17	dobj	_	_
22	.	.	.	.	_	17	punct	_	_

1	Downstream	downstream	RB	RB	sem=LOC	39	advmod	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	5	det	_	_
4	KATP	katp	NN	NN	_	5	compound	_	_
5	channel	channel	NN	NN	_	2	pobj	_	_
6	,	,	,	,	_	39	punct	_	_
7	inhibition	inhibition	NN	NN	_	39	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	voltage	voltage	NN	NN	_	12	nmod	_	_
10	-	-	HYPH	HYPH	_	9	punct	_	_
11	gated	gate	VBN	VBN	_	9	amod	_	_
12	Na+	na+	NN	NN	_	21	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	TTX	ttx	NN	NN	_	12	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	N	n	NN	NN	_	19	compound	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	type	type	NN	NN	_	20	compound	_	_
20	Ca2+	ca0+	NN	NN	_	12	conj	_	_
21	channels	channel	NNS	NNS	_	8	pobj	_	_
22	(	(	-LRB-	-LRB-	_	25	punct	_	_
23	ω	ω	NN	NN	_	25	compound	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	conotoxin	conotoxin	NN	NN	_	21	parataxis	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	,	,	,	,	_	21	punct	_	_
28	but	but	CC	CC	_	21	cc	_	_
29	not	not	RB	RB	_	34	neg	_	_
30	L	l	NN	NN	_	32	compound	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	type	type	NN	NN	_	34	compound	_	_
33	Ca2+	ca0+	NN	NN	_	34	compound	_	_
34	channels	channel	NNS	NNS	_	21	conj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	nifedipine	nifedipine	NN	NN	_	34	parataxis	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	,	,	,	,	_	39	punct	_	_
39	prevented	prevent	VBD	VBD	_	0	root	_	_
40	glucagon	glucagon	NN	NN	_	41	compound	_	_
41	secretion	secretion	NN	NN	_	39	dobj	_	_
42	.	.	.	.	_	39	punct	_	_

1	Both	both	CC	CC	_	7	preconj	_	_
2	the	the	DT	DT	_	7	det	_	_
3	N	n	NN	NN	_	5	compound	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	type	type	NN	NN	_	7	compound	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	channels	channel	NNS	NNS	_	14	nsubjpass	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	α	α	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	exocytosis	exocytosis	NN	NN	_	7	conj	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	inactivated	inactivate	VBN	VBN	_	0	root	_	_
15	at	at	IN	IN	_	14	prep	_	_
16	depolarised	depolarise	VBN	VBN	_	18	amod	_	_
17	membrane	membrane	NN	NN	_	18	compound	_	_
18	potentials	potential	NNS	NNS	_	15	pobj	_	_
19	.	.	.	.	_	14	punct	_	_

1	Rodent	rodent	NN	NN	_	5	nmod	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	human	human	JJ	JJ	_	1	conj	_	_
4	glucagon	glucagon	NN	NN	_	5	compound	_	_
5	secretion	secretion	NN	NN	_	7	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	regulated	regulate	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	an	an	DT	DT	_	17	det	_	_
10	α	α	NN	NN	_	12	nmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	cell	cell	NN	NN	_	17	nmod	_	_
13	KATP	katp	NN	NN	_	14	compound	_	_
14	channel	channel	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	dependent	dependent	JJ	JJ	_	17	amod	_	_
17	mechanism	mechanism	NN	NN	_	8	pobj	_	_
18	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	6	mark	_	_
4	elevated	elevate	VBN	VBN	_	5	amod	_	_
5	glucose	glucose	NN	NN	_	6	nsubj	_	_
6	reduces	reduce	VBZ	VBZ	_	2	ccomp	_	_
7	electrical	electrical	JJ	JJ	_	8	amod	_	_
8	activity	activity	NN	NN	_	6	dobj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	exocytosis	exocytosis	NN	NN	_	8	conj	_	_
11	via	via	IN	IN	sem=MNR	6	prep	_	_
12	depolarisation	depolarisation	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	induced	induce	VBN	VBN	_	15	amod	_	_
15	inactivation	inactivation	NN	NN	_	11	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	ion	ion	NN	NN	_	18	compound	_	_
18	channels	channel	NNS	NNS	_	16	pobj	_	_
19	involved	involve	VBN	VBN	_	18	acl	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	action	action	NN	NN	_	23	compound	_	_
22	potential	potential	NN	NN	_	23	compound	_	_
23	firing	firing	NN	NN	_	20	pobj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	secretion	secretion	NN	NN	_	23	conj	_	_
26	.	.	.	.	_	2	punct	_	_

1	Author	author	NN	NN	_	2	compound	_	_
2	Summary	summary	NN	NN	_	0	root	_	_

1	Glucagon	glucagon	NN	NN	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	critical	critical	JJ	JJ	_	5	amod	_	_
5	regulator	regulator	NN	NN	syn=PRD	2	attr	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	glucose	glucose	NN	NN	_	8	compound	_	_
8	homeostasis	homeostasis	NN	NN	_	6	pobj	_	_
9	.	.	.	.	_	2	punct	_	_

1	Its	its	PRP$	PRP$	_	3	poss	_	_
2	major	major	JJ	JJ	_	3	amod	_	_
3	action	action	NN	NN	_	4	nsubj	_	_
4	is	be	VBZ	VBZ	_	0	root	_	_
5	to	to	TO	TO	_	6	aux	_	_
6	mobilize	mobilize	VB	VB	syn=PRD	4	xcomp	_	_
7	glucose	glucose	NN	NN	_	6	dobj	_	_
8	from	from	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	liver	liver	NN	NN	_	8	pobj	_	_
11	.	.	.	.	_	4	punct	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	secretion	secretion	NN	NN	_	13	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	α	α	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	pancreatic	pancreatic	JJ	JJ	_	9	amod	_	_
9	islets	islet	NNS	NNS	_	6	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	Langerhans	langerhans	NNP	NNP	_	10	pobj	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	suppressed	suppress	VBN	VBN	_	0	root	_	_
14	by	by	IN	IN	sem=MNR	13	prep	_	_
15	elevated	elevate	VBN	VBN	_	17	amod	_	_
16	blood	blood	NN	NN	_	17	compound	_	_
17	sugar	sugar	NN	NN	_	14	pobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	a	a	DT	DT	_	20	det	_	_
20	response	response	NN	NN	_	17	appos	_	_
21	that	that	WDT	WDT	_	24	dep	_	20:ref
22	is	be	VBZ	VBZ	_	24	auxpass	_	_
23	often	often	RB	RB	_	24	advmod	_	_
24	perturbed	perturb	VBN	VBN	_	20	relcl	_	_
25	in	in	IN	IN	_	24	prep	_	_
26	diabetes	diabetes	NN	NN	_	25	pobj	_	_
27	.	.	.	.	_	13	punct	_	_

1	Much	much	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	4	nsubj	_	_
3	has	have	VBZ	VBZ	_	4	aux	_	_
4	focused	focus	VBN	VBN	_	0	root	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	regulation	regulation	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	α	α	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	cell	cell	NN	NN	_	13	compound	_	_
12	glucagon	glucagon	NN	NN	_	13	compound	_	_
13	secretion	secretion	NN	NN	_	8	pobj	_	_
14	by	by	IN	IN	_	7	prep	_	_
15	neuronal	neuronal	JJ	JJ	_	16	amod	_	_
16	factors	factor	NNS	NNS	_	14	pobj	_	_
17	and	and	CC	CC	_	14	cc	_	_
18	by	by	IN	IN	_	14	conj	_	_
19	paracrine	paracrine	JJ	JJ	_	20	amod	_	_
20	factors	factor	NNS	NNS	_	18	pobj	_	_
21	from	from	IN	IN	_	20	prep	_	_
22	neighbouring	neighbour	VBG	VBG	_	23	amod	_	_
23	cells	cell	NNS	NNS	_	21	pobj	_	_
24	,	,	,	,	_	20	punct	_	_
25	including	include	VBG	VBG	_	20	prep	_	_
26	the	the	DT	DT	_	29	det	_	_
27	important	important	JJ	JJ	_	29	amod	_	_
28	islet	islet	NN	NN	_	29	compound	_	_
29	hormone	hormone	NN	NN	_	25	pobj	_	_
30	insulin	insulin	NN	NN	_	29	appos	_	_
31	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	5	prep	_	_
2	contrast	contrast	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	5	punct	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	provide	provide	VBP	VBP	_	0	root	_	_
6	evidence	evidence	NN	NN	_	5	dobj	_	_
7	in	in	IN	IN	_	6	prep	_	_
8	support	support	NN	NN	_	7	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	a	a	DT	DT	_	12	det	_	_
11	direct	direct	JJ	JJ	_	12	amod	_	_
12	effect	effect	NN	NN	_	9	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	glucose	glucose	NN	NN	_	13	pobj	_	_
15	on	on	IN	IN	_	12	prep	_	_
16	α	α	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	15	pobj	_	_
18	within	within	IN	IN	sem=LOC	12	prep	_	_
19	intact	intact	JJ	JJ	_	23	amod	_	_
20	rodent	rodent	NN	NN	_	23	nmod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	human	human	JJ	JJ	_	20	conj	_	_
23	islets	islet	NNS	NNS	_	18	pobj	_	_
24	.	.	.	.	_	5	punct	_	_

1	Notably	notably	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	our	PRP$	PRP$	_	4	poss	_	_
4	work	work	NN	NN	_	5	nsubj	_	_
5	implicates	implicate	VBZ	VBZ	_	0	root	_	_
6	an	an	DT	DT	_	13	det	_	_
7	α	α	NN	NN	_	9	nmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	cell	cell	NN	NN	_	13	nmod	_	_
10	glucose	glucose	NN	NN	_	13	nmod	_	_
11	-	-	HYPH	HYPH	_	10	punct	_	_
12	sensing	sense	VBG	VBG	_	10	amod	_	_
13	pathway	pathway	NN	NN	_	5	dobj	_	_
14	similar	similar	JJ	JJ	_	13	amod	_	_
15	to	to	IN	IN	_	14	prep	_	_
16	that	that	DT	DT	_	15	pobj	_	_
17	found	find	VBN	VBN	_	16	acl	_	_
18	in	in	IN	IN	sem=LOC	17	prep	_	_
19	insulin	insulin	NN	NN	_	21	npadvmod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	secreting	secrete	VBG	VBG	_	23	amod	_	_
22	β	β	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	18	pobj	_	_
24	,	,	,	,	_	13	punct	_	_
25	involving	involve	VBG	VBG	_	13	acl	_	_
26	closure	closure	NN	NN	_	25	dobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	ATP	atp	NN	NN	_	30	npadvmod	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	dependent	dependent	JJ	JJ	_	32	amod	_	_
31	K+	k+	NN	NN	_	32	compound	_	_
32	channels	channel	NNS	NNS	_	27	pobj	_	_
33	in	in	IN	IN	_	26	prep	_	_
34	the	the	DT	DT	_	35	det	_	_
35	presence	presence	NN	NN	_	33	pobj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	glucose	glucose	NN	NN	_	36	pobj	_	_
38	.	.	.	.	_	5	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	find	find	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	membrane	membrane	NN	NN	_	7	compound	_	_
7	depolarisation	depolarisation	NN	NN	_	8	nsubj	_	_
8	results	result	VBZ	VBZ	_	4	ccomp	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	inhibition	inhibition	NN	NN	_	9	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	Na+	na+	NN	NN	_	15	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	Ca2+	ca0+	NN	NN	_	12	conj	_	_
15	channel	channel	NN	NN	_	16	compound	_	_
16	activity	activity	NN	NN	_	11	pobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	α	α	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	exocytosis	exocytosis	NN	NN	_	16	conj	_	_
22	.	.	.	.	_	4	punct	_	_

1	Thus	thus	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	propose	propose	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	elevated	elevate	VBN	VBN	_	8	amod	_	_
7	blood	blood	NN	NN	_	8	compound	_	_
8	glucose	glucose	NN	NN	_	9	nsubj	_	_
9	reduces	reduce	VBZ	VBZ	_	4	ccomp	_	_
10	α	α	NN	NN	_	12	nmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	cell	cell	NN	NN	_	14	nmod	_	_
13	electrical	electrical	JJ	JJ	_	14	amod	_	_
14	activity	activity	NN	NN	_	9	dobj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	glucagon	glucagon	NN	NN	_	17	compound	_	_
17	secretion	secretion	NN	NN	_	14	conj	_	_
18	by	by	IN	IN	sem=MNR	9	prep	_	_
19	inactivating	inactivate	VBG	VBG	syn=NOM	18	pcomp	_	_
20	the	the	DT	DT	_	22	det	_	_
21	ion	ion	NN	NN	_	22	compound	_	_
22	channels	channel	NNS	NNS	_	19	dobj	_	_
23	involved	involve	VBN	VBN	_	22	acl	_	_
24	in	in	IN	IN	_	23	prep	_	_
25	action	action	NN	NN	_	27	compound	_	_
26	potential	potential	NN	NN	_	27	compound	_	_
27	firing	firing	NN	NN	_	24	pobj	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	secretion	secretion	NN	NN	_	27	conj	_	_
30	.	.	.	.	_	4	punct	_	_

1	Introduction	introduction	NN	NN	_	0	root	_	_

1	Blood	blood	NN	NN	_	3	compound	_	_
2	glucose	glucose	NN	NN	_	3	compound	_	_
3	levels	level	NNS	NNS	_	4	nsubj	_	_
4	are	be	VBP	VBP	_	0	root	_	_
5	under	under	IN	IN	syn=PRD	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	control	control	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	two	#crd#	CD	CD	_	10	nummod	_	_
10	hormones	hormone	NNS	NNS	_	8	pobj	_	_
11	released	release	VBN	VBN	_	10	acl	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	pancreatic	pancreatic	JJ	JJ	_	15	amod	_	_
15	islets	islet	NNS	NNS	_	12	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	Langerhans	langerhans	NNP	NNP	_	16	pobj	_	_
18	.	.	.	.	_	4	punct	_	_

1	Islet	islet	NN	NN	_	3	compound	_	_
2	β	β	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	4	nsubj	_	_
4	secrete	secrete	VBP	VBP	_	0	root	_	_
5	insulin	insulin	NN	NN	_	4	dobj	_	_
6	when	when	WRB	WRB	_	8	advmod	_	_
7	glucose	glucose	NN	NN	_	8	nsubj	_	_
8	is	be	VBZ	VBZ	sem=TMP	4	advcl	_	_
9	high	high	JJ	JJ	syn=PRD	8	acomp	_	_
10	,	,	,	,	_	4	punct	_	_
11	decreasing	decrease	VBG	VBG	syn=ADV	4	advcl	_	_
12	glucose	glucose	NN	NN	_	13	compound	_	_
13	production	production	NN	NN	_	11	dobj	_	_
14	by	by	IN	IN	_	13	prep	_	_
15	the	the	DT	DT	_	16	det	_	_
16	liver	liver	NN	NN	_	14	pobj	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	increasing	increase	VBG	VBG	_	11	conj	_	_
19	glucose	glucose	NN	NN	_	20	compound	_	_
20	storage	storage	NN	NN	_	18	dobj	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	multiple	multiple	JJ	JJ	_	23	amod	_	_
23	tissues	tissue	NNS	NNS	_	21	pobj	_	_
24	.	.	.	.	_	4	punct	_	_

1	Regulated	regulate	VBN	VBN	_	3	amod	_	_
2	insulin	insulin	NN	NN	_	3	compound	_	_
3	secretion	secretion	NN	NN	_	7	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	7	auxpass	_	_
5	relatively	relatively	RB	RB	_	6	advmod	_	_
6	well	well	RB	RB	_	7	advmod	_	_
7	understood	understand	VBN	VBN	_	0	root	_	_
8	,	,	,	,	_	7	punct	_	_
9	involving	involve	VBG	VBG	syn=ADV	7	advcl	_	_
10	the	the	DT	DT	_	12	det	_	_
11	metabolic	metabolic	JJ	JJ	_	12	amod	_	_
12	stimulation	stimulation	NN	NN	_	9	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	electrical	electrical	JJ	JJ	_	15	amod	_	_
15	activity	activity	NN	NN	_	13	pobj	_	_
16	,	,	,	,	_	15	punct	_	_
17	Ca2+	ca0+	NN	NN	_	18	compound	_	_
18	entry	entry	NN	NN	_	15	conj	_	_
19	,	,	,	,	_	18	punct	_	_
20	and	and	CC	CC	_	18	cc	_	_
21	exocytosis	exocytosis	NN	NN	_	18	conj	_	_
22	[	[	-LRB-	-LRB-	_	23	punct	_	_
23	1	0	CD	CD	_	7	parataxis	_	_
24	]	]	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	7	punct	_	_

1	Islet	islet	NN	NN	_	3	compound	_	_
2	α	α	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	4	nsubj	_	_
4	secrete	secrete	VBP	VBP	_	0	root	_	_
5	glucagon	glucagon	NN	NN	_	4	dobj	_	_
6	in	in	IN	IN	_	4	prep	_	_
7	response	response	NN	NN	_	6	pobj	_	_
8	to	to	IN	IN	_	7	prep	_	_
9	decreased	decrease	VBN	VBN	_	11	amod	_	_
10	blood	blood	NN	NN	_	11	compound	_	_
11	glucose	glucose	NN	NN	_	8	pobj	_	_
12	,	,	,	,	_	4	punct	_	_
13	whereas	whereas	IN	IN	_	17	mark	_	_
14	elevated	elevate	VBN	VBN	_	16	amod	_	_
15	glucose	glucose	NN	NN	_	16	compound	_	_
16	levels	level	NNS	NNS	_	17	nsubj	_	_
17	suppress	suppress	VBP	VBP	syn=ADV	4	advcl	_	_
18	glucagon	glucagon	NN	NN	_	19	compound	_	_
19	release	release	NN	NN	_	17	dobj	_	_
20	.	.	.	.	_	4	punct	_	_

1	Glucagon	glucagon	NN	NN	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	the	the	DT	DT	_	5	det	_	_
4	principal	principal	JJ	JJ	_	5	amod	_	_
5	factor	factor	NN	NN	syn=PRD	2	attr	_	_
6	stimulating	stimulate	VBG	VBG	_	5	acl	_	_
7	glucose	glucose	NN	NN	_	8	compound	_	_
8	production	production	NN	NN	_	6	dobj	_	_
9	by	by	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	liver	liver	NN	NN	_	9	pobj	_	_
12	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	7	prep	_	_
2	diabetes	diabetes	NN	NN	_	1	pobj	_	_
3	,	,	,	,	_	7	punct	_	_
4	baseline	baseline	NN	NN	_	6	compound	_	_
5	glucagon	glucagon	NN	NN	_	6	compound	_	_
6	release	release	NN	NN	_	7	nsubj	_	_
7	is	be	VBZ	VBZ	_	0	root	_	_
8	elevated	elevated	JJ	JJ	syn=PRD	7	acomp	_	_
9	,	,	,	,	_	7	punct	_	_
10	and	and	CC	CC	_	7	cc	_	_
11	glucagon	glucagon	NN	NN	_	12	compound	_	_
12	secretion	secretion	NN	NN	_	20	nsubjpass	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	18	det	_	_
15	low	low	JJ	JJ	_	17	amod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	glucose	glucose	NN	NN	_	18	compound	_	_
18	condition	condition	NN	NN	_	13	pobj	_	_
19	is	be	VBZ	VBZ	_	20	auxpass	_	_
20	blunted	blunt	VBN	VBN	_	7	conj	_	_
21	[	[	-LRB-	-LRB-	_	22	punct	_	_
22	2	0	CD	CD	_	20	parataxis	_	_
23	–	-	SYM	SYM	_	24	punct	_	_
24	4	0	CD	CD	_	22	prep	_	_
25	]	]	-RRB-	-RRB-	_	22	punct	_	_
26	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	effects	effect	NNS	NNS	_	3	nsubj	_	_
3	contribute	contribute	VBP	VBP	_	0	root	_	_
4	to	to	IN	IN	_	3	prep	_	_
5	chronic	chronic	JJ	JJ	_	6	amod	_	_
6	hyperglycaemia	hyperglycaemia	NN	NN	_	4	pobj	_	_
7	and	and	CC	CC	_	4	cc	_	_
8	to	to	IN	IN	_	4	conj	_	_
9	an	an	DT	DT	_	11	det	_	_
10	increased	increase	VBN	VBN	_	11	amod	_	_
11	risk	risk	NN	NN	_	8	pobj	_	_
12	for	for	IN	IN	_	11	prep	_	_
13	acute	acute	JJ	JJ	_	15	amod	_	_
14	hypoglycaemic	hypoglycaemic	JJ	JJ	_	15	amod	_	_
15	events	event	NNS	NNS	_	12	pobj	_	_
16	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	8	nsubjpass	_	_
3	regulating	regulate	VBG	VBG	_	2	acl	_	_
4	glucagon	glucagon	NN	NN	_	5	compound	_	_
5	secretion	secretion	NN	NN	_	3	dobj	_	_
6	is	be	VBZ	VBZ	_	8	auxpass	_	_
7	poorly	poorly	RB	RB	_	8	advmod	_	_
8	understood	understand	VBN	VBN	_	0	root	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	remains	remain	VBZ	VBZ	_	8	conj	_	_
11	hotly	hotly	RB	RB	_	12	advmod	_	_
12	debated	debate	VBN	VBN	syn=PRD	10	acomp	_	_
13	[	[	-LRB-	-LRB-	_	14	punct	_	_
14	5	0	CD	CD	_	10	parataxis	_	_
15	]	]	-RRB-	-RRB-	_	14	punct	_	_
16	.	.	.	.	_	8	punct	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	release	release	NN	NN	_	7	nsubjpass	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	rodents	rodent	NNS	NNS	_	3	pobj	_	_
5	may	may	MD	MD	_	7	aux	_	_
6	be	be	VB	VB	_	7	auxpass	_	_
7	regulated	regulate	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	paracrine	paracrine	JJ	JJ	_	10	amod	_	_
10	signals	signal	NNS	NNS	_	8	pobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	including	include	VBG	VBG	_	10	prep	_	_
13	γ	γ	NN	NN	_	16	nmod	_	_
14	-	-	HYPH	HYPH	_	16	punct	_	_
15	aminobutyric	aminobutyric	JJ	JJ	_	16	amod	_	_
16	acid	acid	NN	NN	_	12	pobj	_	_
17	(	(	-LRB-	-LRB-	_	16	punct	_	_
18	GABA	gaba	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	16	punct	_	_
20	[	[	-LRB-	-LRB-	_	23	punct	_	_
21	6	0	CD	CD	_	23	nummod	_	_
22	,	,	,	,	_	23	punct	_	_
23	7	0	CD	CD	_	16	parataxis	_	_
24	]	]	-RRB-	-RRB-	_	23	punct	_	_
25	,	,	,	,	_	16	punct	_	_
26	Zn2+	zn0+	NN	NN	_	16	conj	_	_
27	[	[	-LRB-	-LRB-	_	28	punct	_	_
28	8	0	CD	CD	_	26	parataxis	_	_
29	]	]	-RRB-	-RRB-	_	28	punct	_	_
30	,	,	,	,	_	26	punct	_	_
31	and	and	CC	CC	_	26	cc	_	_
32	insulin	insulin	NN	NN	_	26	conj	_	_
33	[	[	-LRB-	-LRB-	_	36	punct	_	_
34	9	0	CD	CD	_	36	nummod	_	_
35	,	,	,	,	_	36	punct	_	_
36	10	0	CD	CD	_	32	parataxis	_	_
37	]	]	-RRB-	-RRB-	_	36	punct	_	_
38	.	.	.	.	_	7	punct	_	_

1	Conversely	conversely	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	glucose	glucose	NN	NN	_	5	nsubj	_	_
4	may	may	MD	MD	_	5	aux	_	_
5	suppress	suppress	VB	VB	_	0	root	_	_
6	glucagon	glucagon	NN	NN	_	7	compound	_	_
7	secretion	secretion	NN	NN	_	5	dobj	_	_
8	through	through	IN	IN	sem=MNR	5	prep	_	_
9	a	a	DT	DT	_	11	det	_	_
10	direct	direct	JJ	JJ	_	11	amod	_	_
11	effect	effect	NN	NN	_	8	pobj	_	_
12	on	on	IN	IN	_	11	prep	_	_
13	α	α	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	activity	activity	NN	NN	_	12	pobj	_	_
17	[	[	-LRB-	-LRB-	_	18	punct	_	_
18	11	0	CD	CD	_	5	parataxis	_	_
19	–	-	SYM	SYM	_	20	punct	_	_
20	14	0	CD	CD	_	18	prep	_	_
21	]	]	-RRB-	-RRB-	_	18	punct	_	_
22	.	.	.	.	_	5	punct	_	_

1	There	there	EX	EX	_	2	expl	_	_
2	are	be	VBP	VBP	_	0	root	_	_
3	also	also	RB	RB	_	2	advmod	_	_
4	studies	study	NNS	NNS	syn=PRD	2	attr	_	_
5	suggesting	suggest	VBG	VBG	_	4	acl	_	_
6	that	that	IN	IN	_	9	mark	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	secretion	secretion	NN	NN	_	9	nsubj	_	_
9	is	be	VBZ	VBZ	_	5	ccomp	_	_
10	under	under	IN	IN	syn=PRD	9	prep	_	_
11	hypothalamic	hypothalamic	JJ	JJ	_	12	amod	_	_
12	control	control	NN	NN	_	10	pobj	_	_
13	[	[	-LRB-	-LRB-	_	16	punct	_	_
14	15	0	CD	CD	_	16	nummod	_	_
15	,	,	,	,	_	16	punct	_	_
16	16	0	CD	CD	_	2	parataxis	_	_
17	]	]	-RRB-	-RRB-	_	16	punct	_	_
18	.	.	.	.	_	2	punct	_	_

1	Human	human	JJ	JJ	_	4	amod	_	_
2	in	in	FW	FW	_	3	advmod	_	_
3	vivo	vivo	FW	FW	_	4	amod	_	_
4	studies	study	NNS	NNS	_	5	nsubj	_	_
5	provide	provide	VBP	VBP	_	0	root	_	_
6	conflicting	conflict	VBG	VBG	_	7	amod	_	_
7	evidence	evidence	NN	NN	_	5	dobj	_	_
8	regarding	regard	VBG	VBG	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	control	control	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	glucagon	glucagon	NN	NN	_	13	compound	_	_
13	secretion	secretion	NN	NN	_	11	pobj	_	_
14	by	by	IN	IN	_	10	prep	_	_
15	paracrine	paracrine	JJ	JJ	_	14	pobj	_	_
16	or	or	CC	CC	_	10	cc	_	_
17	intrinsic	intrinsic	JJ	JJ	_	18	amod	_	_
18	regulation	regulation	NN	NN	_	10	conj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	α	α	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	19	pobj	_	_
22	[	[	-LRB-	-LRB-	_	23	punct	_	_
23	17	0	CD	CD	_	5	parataxis	_	_
24	–	-	SYM	SYM	_	25	punct	_	_
25	30	0	CD	CD	_	23	prep	_	_
26	]	]	-RRB-	-RRB-	_	23	punct	_	_
27	,	,	,	,	_	5	punct	_	_
28	and	and	CC	CC	_	5	cc	_	_
29	very	very	RB	RB	_	30	advmod	_	_
30	little	little	JJ	JJ	_	31	amod	_	_
31	work	work	NN	NN	_	34	nsubjpass	_	_
32	has	have	VBZ	VBZ	_	34	aux	_	_
33	been	be	VBN	VBN	_	34	auxpass	_	_
34	done	do	VBN	VBN	_	5	conj	_	_
35	to	to	TO	TO	_	36	aux	_	_
36	examine	examine	VB	VB	sem=PRP	34	advcl	_	_
37	this	this	DT	DT	_	38	det	_	_
38	question	question	NN	NN	_	36	dobj	_	_
39	in	in	IN	IN	sem=LOC	36	prep	_	_
40	isolated	isolate	VBN	VBN	_	42	amod	_	_
41	human	human	JJ	JJ	_	42	amod	_	_
42	islets	islet	NNS	NNS	_	39	pobj	_	_
43	.	.	.	.	_	34	punct	_	_

1	Islet	islet	NN	NN	_	3	compound	_	_
2	α	α	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	4	nsubj	_	_
4	express	express	VBP	VBP	_	0	root	_	_
5	ATP	atp	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	dependent	dependent	JJ	JJ	_	8	amod	_	_
8	K+	k+	NN	NN	_	12	nmod	_	_
9	(	(	-LRB-	-LRB-	_	8	punct	_	_
10	KATP	katp	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	12	punct	_	_
12	channels	channel	NNS	NNS	_	4	dobj	_	_
13	[	[	-LRB-	-LRB-	_	22	punct	_	_
14	9	0	CD	CD	_	22	nummod	_	_
15	,	,	,	,	_	22	punct	_	_
16	13	0	CD	CD	_	22	nummod	_	_
17	,	,	,	,	_	22	punct	_	_
18	14	0	CD	CD	_	22	nummod	_	_
19	,	,	,	,	_	22	punct	_	_
20	31	0	CD	CD	_	22	nummod	_	_
21	,	,	,	,	_	22	punct	_	_
22	32	0	CD	CD	_	12	parataxis	_	_
23	]	]	-RRB-	-RRB-	_	22	punct	_	_
24	that	that	WDT	WDT	_	27	dep	_	12:ref
25	can	can	MD	MD	_	27	aux	_	_
26	be	be	VB	VB	_	27	auxpass	_	_
27	closed	close	VBN	VBN	_	12	relcl	_	_
28	by	by	IN	IN	sem=MNR	27	prep	_	_
29	ATP	atp	NN	NN	_	28	pobj	_	_
30	[	[	-LRB-	-LRB-	_	33	punct	_	_
31	9	0	CD	CD	_	33	nummod	_	_
32	,	,	,	,	_	33	punct	_	_
33	31	0	CD	CD	_	4	parataxis	_	_
34	]	]	-RRB-	-RRB-	_	33	punct	_	_
35	.	.	.	.	_	4	punct	_	_

1	Glucose	glucose	NN	NN	_	2	nsubj	_	_
2	increases	increase	VBZ	VBZ	_	0	root	_	_
3	intracellular	intracellular	JJ	JJ	_	5	amod	_	_
4	free	free	JJ	JJ	_	5	amod	_	_
5	ATP	atp	NN	NN	_	2	dobj	_	_
6	in	in	IN	IN	sem=LOC	2	prep	_	_
7	α	α	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	6	pobj	_	_
9	[	[	-LRB-	-LRB-	_	12	punct	_	_
10	8	0	CD	CD	_	12	nummod	_	_
11	,	,	,	,	_	12	punct	_	_
12	10	0	CD	CD	_	2	parataxis	_	_
13	]	]	-RRB-	-RRB-	_	12	punct	_	_
14	,	,	,	,	_	2	punct	_	_
15	although	although	IN	IN	_	17	mark	_	_
16	reports	report	NNS	NNS	_	17	nsubj	_	_
17	vary	vary	VBP	VBP	syn=ADV	2	advcl	_	_
18	as	as	IN	IN	_	17	prep	_	_
19	to	to	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	ability	ability	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	glucose	glucose	NN	NN	_	22	pobj	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	inhibit	inhibit	VB	VB	_	21	acl	_	_
26	α	α	NN	NN	_	28	compound	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	cell	cell	NN	NN	_	30	compound	_	_
29	KATP	katp	NN	NN	_	30	compound	_	_
30	channels	channel	NNS	NNS	_	25	dobj	_	_
31	[	[	-LRB-	-LRB-	_	36	punct	_	_
32	13	0	CD	CD	_	36	nummod	_	_
33	,	,	,	,	_	36	punct	_	_
34	31	0	CD	CD	_	36	nummod	_	_
35	,	,	,	,	_	36	punct	_	_
36	33	0	CD	CD	_	17	parataxis	_	_
37	]	]	-RRB-	-RRB-	_	36	punct	_	_
38	.	.	.	.	_	2	punct	_	_

1	Evidence	evidence	NN	NN	_	8	nsubj	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	SUR1	sur0	NN	NN	_	7	nmod	_	_
4	−	−	SYM	SYM	_	3	punct	_	_
5	/	/	HYPH	HYPH	_	3	punct	_	_
6	−	−	SYM	SYM	_	3	punct	_	_
7	mice	mouse	NNS	NNS	_	2	pobj	_	_
8	implicate	implicate	VBP	VBP	_	0	root	_	_
9	KATP	katp	NN	NN	_	10	compound	_	_
10	channels	channel	NNS	NNS	_	8	dobj	_	_
11	as	as	IN	IN	_	8	prep	_	_
12	regulators	regulator	NNS	NNS	_	11	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	release	release	NN	NN	_	13	pobj	_	_
16	[	[	-LRB-	-LRB-	_	21	punct	_	_
17	13	0	CD	CD	_	21	nummod	_	_
18	,	,	,	,	_	21	punct	_	_
19	34	0	CD	CD	_	21	nummod	_	_
20	,	,	,	,	_	21	punct	_	_
21	35	0	CD	CD	_	8	parataxis	_	_
22	]	]	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	8	punct	_	_

1	However	however	RB	RB	_	21	advmod	_	_
2	,	,	,	,	_	21	punct	_	_
3	because	because	IN	IN	_	9	mark	_	_
4	both	both	CC	CC	_	5	preconj	_	_
5	α	α	NN	NN	_	8	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	β	β	NN	NN	_	5	conj	_	_
8	cells	cell	NNS	NNS	_	9	nsubj	_	_
9	possess	possess	VBP	VBP	sem=PRP	21	advcl	_	_
10	molecularly	molecularly	RB	RB	_	11	advmod	_	_
11	identical	identical	JJ	JJ	_	13	amod	_	_
12	KATP	katp	NN	NN	_	13	compound	_	_
13	channels	channel	NNS	NNS	_	9	dobj	_	_
14	[	[	-LRB-	-LRB-	_	17	punct	_	_
15	36	0	CD	CD	_	17	nummod	_	_
16	,	,	,	,	_	17	punct	_	_
17	37	0	CD	CD	_	9	parataxis	_	_
18	]	]	-RRB-	-RRB-	_	17	punct	_	_
19	,	,	,	,	_	21	punct	_	_
20	it	it	PRP	PRP	_	21	nsubj	_	_
21	is	be	VBZ	VBZ	_	0	root	_	_
22	not	not	RB	RB	_	21	neg	_	_
23	clear	clear	JJ	JJ	syn=PRD	21	acomp	_	_
24	how	how	WRB	WRB	_	30	advmod	_	_
25	KATP	katp	NN	NN	_	27	npadvmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	mediated	mediate	VBN	VBN	_	28	amod	_	_
28	depolarisation	depolarisation	NN	NN	_	30	nsubj	_	_
29	would	would	MD	MD	_	30	aux	_	_
30	stimulate	stimulate	VB	VB	_	21	ccomp	_	_
31	insulin	insulin	NN	NN	_	32	compound	_	_
32	secretion	secretion	NN	NN	_	30	dobj	_	_
33	but	but	CC	CC	_	30	cc	_	_
34	suppress	suppress	VBP	VBP	_	30	conj	_	_
35	glucagon	glucagon	NN	NN	_	36	compound	_	_
36	secretion	secretion	NN	NN	_	34	dobj	_	_
37	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	answer	answer	NN	NN	_	4	nsubj	_	_
3	may	may	MD	MD	_	4	aux	_	_
4	lie	lie	VB	VB	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	downstream	downstream	JJ	JJ	_	8	amod	_	_
8	machinery	machinery	NN	NN	_	5	pobj	_	_
9	regulating	regulate	VBG	VBG	_	8	acl	_	_
10	electrical	electrical	JJ	JJ	_	11	amod	_	_
11	activity	activity	NN	NN	_	9	dobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	Ca2+	ca0+	NN	NN	_	14	compound	_	_
14	entry	entry	NN	NN	_	11	conj	_	_
15	.	.	.	.	_	4	punct	_	_

1	Unlike	unlike	IN	IN	_	7	prep	_	_
2	β	β	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	1	pobj	_	_
4	,	,	,	,	_	7	punct	_	_
5	α	α	NN	NN	_	6	compound	_	_
6	cells	cell	NNS	NNS	_	7	nsubj	_	_
7	possess	possess	VBP	VBP	_	0	root	_	_
8	a	a	DT	DT	_	14	det	_	_
9	large	large	JJ	JJ	_	14	amod	_	_
10	voltage	voltage	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	dependent	dependent	JJ	JJ	_	14	amod	_	_
13	Na+	na+	NN	NN	_	14	compound	_	_
14	current	current	NN	NN	_	7	dobj	_	_
15	that	that	WDT	WDT	_	16	dep	_	14:ref
16	is	be	VBZ	VBZ	_	14	relcl	_	_
17	essential	essential	JJ	JJ	syn=PRD	16	acomp	_	_
18	for	for	IN	IN	_	17	prep	_	_
19	glucagon	glucagon	NN	NN	_	20	compound	_	_
20	release	release	NN	NN	_	18	pobj	_	_
21	[	[	-LRB-	-LRB-	_	24	punct	_	_
22	14	0	CD	CD	_	24	nummod	_	_
23	,	,	,	,	_	24	punct	_	_
24	33	0	CD	CD	_	7	parataxis	_	_
25	]	]	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	previously	previously	RB	RB	_	4	advmod	_	_
4	proposed	propose	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	14	mark	_	_
6	the	the	DT	DT	_	10	det	_	_
7	depolarisation	depolarisation	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	induced	induce	VBN	VBN	_	10	amod	_	_
10	inactivation	inactivation	NN	NN	_	14	nsubj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	this	this	DT	DT	_	13	det	_	_
13	channel	channel	NN	NN	_	11	pobj	_	_
14	contributes	contribute	VBZ	VBZ	_	4	ccomp	_	_
15	to	to	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	cessation	cessation	NN	NN	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	action	action	NN	NN	_	21	compound	_	_
20	potential	potential	NN	NN	_	21	compound	_	_
21	firing	firing	NN	NN	_	18	pobj	_	_
22	[	[	-LRB-	-LRB-	_	23	punct	_	_
23	14	0	CD	CD	_	4	parataxis	_	_
24	]	]	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	4	punct	_	_

1	Additionally	additionally	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	activation	activation	NN	NN	_	13	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	voltage	voltage	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	dependent	dependent	JJ	JJ	_	9	amod	_	_
8	Ca2+	ca0+	NN	NN	_	9	compound	_	_
9	channels	channel	NNS	NNS	_	4	pobj	_	_
10	(	(	-LRB-	-LRB-	_	9	punct	_	_
11	VDCCs	vdccs	NNS	NNS	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	13	punct	_	_
13	is	be	VBZ	VBZ	_	0	root	_	_
14	essential	essential	JJ	JJ	syn=PRD	13	acomp	_	_
15	for	for	IN	IN	sem=PRP	14	prep	_	_
16	Ca2+	ca0+	NN	NN	_	17	compound	_	_
17	entry	entry	NN	NN	_	15	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	α	α	NN	NN	_	21	compound	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	function	function	NN	NN	_	17	conj	_	_
23	[	[	-LRB-	-LRB-	_	26	punct	_	_
24	38	0	CD	CD	_	26	nummod	_	_
25	,	,	,	,	_	26	punct	_	_
26	39	0	CD	CD	_	13	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	.	.	.	.	_	13	punct	_	_

1	Accordingly	accordingly	RB	RB	_	25	advmod	_	_
2	,	,	,	,	_	25	punct	_	_
3	the	the	DT	DT	_	15	det	_	_
4	α	α	NN	NN	_	6	nmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	cell	cell	NN	NN	_	15	nmod	_	_
7	intracellular	intracellular	JJ	JJ	_	15	amod	_	_
8	Ca2+	ca0+	NN	NN	_	15	nmod	_	_
9	(	(	-LRB-	-LRB-	_	13	punct	_	_
10	[	[	-LRB-	-LRB-	_	13	punct	_	_
11	Ca2+	ca0+	NN	NN	_	13	nmod	_	_
12	]	]	-RRB-	-RRB-	_	13	punct	_	_
13	i	i	NN	NN	_	15	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	oscillations	oscillation	NNS	NNS	_	25	nsubjpass	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	reflecting	reflect	VBG	VBG	_	15	acl	_	_
18	α	α	NN	NN	_	20	nmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	cell	cell	NN	NN	_	22	nmod	_	_
21	electrical	electrical	JJ	JJ	_	22	amod	_	_
22	activity	activity	NN	NN	_	17	dobj	_	_
23	)	)	-RRB-	-RRB-	_	25	punct	_	_
24	are	be	VBP	VBP	_	25	auxpass	_	_
25	suppressed	suppress	VBN	VBN	_	0	root	_	_
26	in	in	IN	IN	_	25	prep	_	_
27	parallel	parallel	NN	NN	_	26	pobj	_	_
28	with	with	IN	IN	_	27	prep	_	_
29	glucagon	glucagon	NN	NN	_	30	compound	_	_
30	release	release	NN	NN	_	28	pobj	_	_
31	by	by	IN	IN	_	30	prep	_	_
32	glucose	glucose	NN	NN	_	31	pobj	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	40	0	CD	CD	_	25	parataxis	_	_
35	]	]	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	25	punct	_	_

1	Multiple	multiple	JJ	JJ	_	2	amod	_	_
2	VDCCs	vdccs	NNS	NNS	_	3	nsubj	_	_
3	regulate	regulate	VBP	VBP	_	0	root	_	_
4	glucagon	glucagon	NN	NN	_	5	compound	_	_
5	release	release	NN	NN	_	3	dobj	_	_
6	[	[	-LRB-	-LRB-	_	9	punct	_	_
7	14	0	CD	CD	_	9	dep	_	_
8	,	,	,	,	_	9	punct	_	_
9	41	0	CD	CD	_	3	parataxis	_	_
10	–	-	SYM	SYM	_	11	punct	_	_
11	43	0	CD	CD	_	9	prep	_	_
12	]	]	-RRB-	-RRB-	_	9	punct	_	_
13	,	,	,	,	_	3	punct	_	_
14	although	although	IN	IN	_	20	mark	_	_
15	the	the	DT	DT	_	19	det	_	_
16	N	n	NN	NN	_	18	compound	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	type	type	NN	NN	_	19	compound	_	_
19	channels	channel	NNS	NNS	_	20	nsubj	_	_
20	appear	appear	VBP	VBP	syn=ADV	3	advcl	_	_
21	to	to	TO	TO	_	22	aux	_	_
22	be	be	VB	VB	_	20	xcomp	_	_
23	particularly	particularly	RB	RB	_	24	advmod	_	_
24	important	important	JJ	JJ	syn=PRD	22	acomp	_	_
25	for	for	IN	IN	_	24	prep	_	_
26	glucagon	glucagon	NN	NN	_	27	compound	_	_
27	release	release	NN	NN	_	25	pobj	_	_
28	evoked	evoke	VBN	VBN	_	27	acl	_	_
29	by	by	IN	IN	sem=MNR	28	prep	_	_
30	hypoglycaemia	hypoglycaemia	NN	NN	_	29	pobj	_	_
31	alone	alone	RB	RB	_	30	advmod	_	_
32	[	[	-LRB-	-LRB-	_	37	punct	_	_
33	33	0	CD	CD	_	37	nummod	_	_
34	,	,	,	,	_	37	punct	_	_
35	44	0	CD	CD	_	37	nummod	_	_
36	,	,	,	,	_	37	punct	_	_
37	45	0	CD	CD	_	22	parataxis	_	_
38	]	]	-RRB-	-RRB-	_	37	punct	_	_
39	,	,	,	,	_	22	punct	_	_
40	at	at	RB	RB	_	41	advmod	_	_
41	least	least	RBS	RBS	_	42	advmod	_	_
42	in	in	IN	IN	sem=LOC	22	prep	_	_
43	mouse	mouse	NN	NN	_	44	compound	_	_
44	islets	islet	NNS	NNS	_	42	pobj	_	_
45	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	in	in	IN	IN	syn=PRD	2	prep	_	_
4	contrast	contrast	NN	NN	_	3	pobj	_	_
5	to	to	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	β	β	NN	NN	_	8	compound	_	_
8	cell	cell	NN	NN	_	5	pobj	_	_
9	in	in	IN	IN	_	17	prep	_	_
10	which	which	WDT	WDT	_	9	pobj	_	8:ref
11	the	the	DT	DT	_	15	det	_	_
12	L	l	NN	NN	_	14	compound	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	type	type	NN	NN	_	15	compound	_	_
15	VDCC	vdcc	NN	NN	_	17	nsubj	_	_
16	functionally	functionally	RB	RB	_	17	advmod	_	_
17	predominates	predominate	VBZ	VBZ	_	8	relcl	_	_
18	[	[	-LRB-	-LRB-	_	19	punct	_	_
19	46	0	CD	CD	_	2	parataxis	_	_
20	]	]	-RRB-	-RRB-	_	19	punct	_	_
21	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	now	now	RB	RB	sem=TMP	4	advmod	_	_
4	compared	compare	VBN	VBN	_	0	root	_	_
5	insulin	insulin	NN	NN	_	8	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	glucagon	glucagon	NN	NN	_	5	conj	_	_
8	release	release	NN	NN	_	4	dobj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	α	α	NN	NN	_	15	nmod	_	_
11	-	-	HYPH	HYPH	_	10	punct	_	_
12	and	and	CC	CC	_	10	cc	_	_
13	β	β	NN	NN	_	10	conj	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	cell	cell	NN	NN	_	17	compound	_	_
16	Ca2+	ca0+	NN	NN	_	17	compound	_	_
17	responses	response	NNS	NNS	_	8	conj	_	_
18	in	in	IN	IN	sem=LOC	4	prep	_	_
19	intact	intact	JJ	JJ	_	27	amod	_	_
20	mouse	mouse	NN	NN	_	27	nmod	_	_
21	,	,	,	,	_	20	punct	_	_
22	rat	rat	NN	NN	_	20	conj	_	_
23	,	,	,	,	_	22	punct	_	_
24	and	and	CC	CC	_	22	cc	_	_
25	human	human	JJ	JJ	_	22	conj	_	_
26	pancreatic	pancreatic	JJ	JJ	_	27	amod	_	_
27	islets	islet	NNS	NNS	_	18	pobj	_	_
28	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	show	show	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	5	mark	_	_
4	glucose	glucose	NN	NN	_	5	nsubj	_	_
5	retained	retain	VBD	VBD	_	2	ccomp	_	_
6	the	the	DT	DT	_	7	det	_	_
7	ability	ability	NN	NN	_	5	dobj	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	suppress	suppress	VB	VB	_	7	acl	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	release	release	NN	NN	_	9	dobj	_	_
12	from	from	IN	IN	_	9	prep	_	_
13	isolated	isolate	VBN	VBN	_	14	amod	_	_
14	islets	islet	NNS	NNS	_	12	pobj	_	_
15	during	during	IN	IN	sem=TMP	14	prep	_	_
16	blockade	blockade	NN	NN	_	15	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	23	det	_	_
19	Zn2+	zn0+	NN	NN	_	23	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	GABA	gaba	NN	NN	_	19	conj	_	_
22	paracrine	paracrine	JJ	JJ	_	23	amod	_	_
23	pathways	pathway	NNS	NNS	_	17	pobj	_	_
24	,	,	,	,	_	12	punct	_	_
25	and	and	CC	CC	_	12	cc	_	_
26	in	in	IN	IN	_	12	conj	_	_
27	the	the	DT	DT	_	28	det	_	_
28	absence	absence	NN	NN	_	26	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	stimulated	stimulate	VBN	VBN	_	32	amod	_	_
31	insulin	insulin	NN	NN	_	32	compound	_	_
32	secretion	secretion	NN	NN	_	29	pobj	_	_
33	or	or	CC	CC	_	32	cc	_	_
34	β	β	NN	NN	_	36	compound	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	cell	cell	NN	NN	_	38	compound	_	_
37	Ca2+	ca0+	NN	NN	_	38	compound	_	_
38	responses	response	NNS	NNS	_	32	conj	_	_
39	.	.	.	.	_	2	punct	_	_

1	Thus	thus	RB	RB	_	4	advmod	_	_
2	we	we	PRP	PRP	_	4	nsubj	_	_
3	now	now	RB	RB	_	4	advmod	_	_
4	provide	provide	VBP	VBP	_	0	root	_	_
5	evidence	evidence	NN	NN	_	4	dobj	_	_
6	in	in	IN	IN	sem=LOC	5	prep	_	_
7	both	both	CC	CC	_	11	preconj	_	_
8	rodent	rodent	NN	NN	_	11	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	human	human	JJ	JJ	_	8	conj	_	_
11	islets	islet	NNS	NNS	_	6	pobj	_	_
12	supporting	support	VBG	VBG	_	5	acl	_	_
13	the	the	DT	DT	_	19	det	_	_
14	direct	direct	JJ	JJ	_	19	amod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	intrinsic	intrinsic	JJ	JJ	_	19	parataxis	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	glucose	glucose	NN	NN	_	19	compound	_	_
19	regulation	regulation	NN	NN	_	12	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	glucagon	glucagon	NN	NN	_	22	compound	_	_
22	release	release	NN	NN	_	20	pobj	_	_
23	from	from	IN	IN	_	22	prep	_	_
24	pancreatic	pancreatic	JJ	JJ	_	26	amod	_	_
25	α	α	NN	NN	_	26	compound	_	_
26	cells	cell	NNS	NNS	_	23	pobj	_	_
27	.	.	.	.	_	4	punct	_	_

1	Results	result	NNS	NNS	_	0	root	_	_

1	Glucose	glucose	NN	NN	_	3	nsubj	_	_
2	Can	can	MD	MD	_	3	aux	_	_
3	Regulate	regulate	VB	VB	_	0	root	_	_
4	Glucagon	glucagon	NN	NN	_	5	compound	_	_
5	Secretion	secretion	NN	NN	_	3	dobj	_	_
6	Directly	directly	RB	RB	_	3	advmod	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	examine	examine	VB	VB	sem=PRP	17	advcl	_	_
3	a	a	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	2	dobj	_	_
5	for	for	IN	IN	_	4	prep	_	_
6	GABA	gaba	NN	NN	_	5	pobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	Zn2+	zn0+	NN	NN	_	6	conj	_	_
9	as	as	IN	IN	_	4	prep	_	_
10	paracrine	paracrine	JJ	JJ	_	11	amod	_	_
11	mediators	mediator	NNS	NNS	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	glucagon	glucagon	NN	NN	_	14	compound	_	_
14	secretion	secretion	NN	NN	_	12	pobj	_	_
15	,	,	,	,	_	17	punct	_	_
16	we	we	PRP	PRP	_	17	nsubj	_	_
17	examined	examine	VBD	VBD	_	0	root	_	_
18	the	the	DT	DT	_	19	det	_	_
19	ability	ability	NN	NN	_	17	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	24	det	_	_
22	GABAA	gabaa	NN	NN	_	24	compound	_	_
23	receptor	receptor	NN	NN	_	24	compound	_	_
24	antagonist	antagonist	NN	NN	_	20	pobj	_	_
25	SR	sr	NN	NN	_	24	appos	_	_
26	-	-	HYPH	HYPH	_	25	punct	_	_
27	95531	0	CD	CD	_	25	nummod	_	_
28	and	and	CC	CC	_	24	cc	_	_
29	Zn2+	zn0+	NN	NN	_	30	compound	_	_
30	chelation	chelation	NN	NN	_	24	conj	_	_
31	with	with	IN	IN	_	30	prep	_	_
32	Ca2+	ca0+	NN	NN	_	34	compound	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	EDTA	edta	NN	NN	_	31	pobj	_	_
35	to	to	TO	TO	_	36	aux	_	_
36	prevent	prevent	VB	VB	_	19	acl	_	_
37	the	the	DT	DT	_	41	det	_	_
38	glucose	glucose	NN	NN	_	40	npadvmod	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	dependent	dependent	JJ	JJ	_	41	amod	_	_
41	suppression	suppression	NN	NN	_	36	dobj	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	glucagon	glucagon	NN	NN	_	44	compound	_	_
44	release	release	NN	NN	_	42	pobj	_	_
45	.	.	.	.	_	17	punct	_	_

1	Glucose	glucose	NN	NN	_	23	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	at	at	IN	IN	_	1	prep	_	_
4	concentrations	concentration	NNS	NNS	_	3	pobj	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	7	0	CD	CD	_	9	nummod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	8.3	0	CD	CD	_	6	conj	_	_
9	mM	mm	NN	NN	_	4	parataxis	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	just	just	RB	RB	_	12	advmod	_	_
12	above	above	IN	IN	_	4	prep	_	_
13	the	the	DT	DT	_	14	det	_	_
14	threshold	threshold	NN	NN	_	12	pobj	_	_
15	for	for	IN	IN	_	14	prep	_	_
16	insulin	insulin	NN	NN	_	17	compound	_	_
17	release	release	NN	NN	_	15	pobj	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	see	see	VB	VB	_	1	parataxis	_	_
20	below	below	RB	RB	_	19	advmod	_	_
21	)	)	-RRB-	-RRB-	_	19	punct	_	_
22	,	,	,	,	_	23	punct	_	_
23	suppressed	suppress	VBN	VBN	_	0	root	_	_
24	glucagon	glucagon	NN	NN	_	25	compound	_	_
25	secretion	secretion	NN	NN	_	23	dobj	_	_
26	from	from	IN	IN	_	23	prep	_	_
27	isolated	isolate	VBN	VBN	_	35	amod	_	_
28	mouse	mouse	NN	NN	_	35	nmod	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	Figure	figure	NN	NN	_	31	compound	_	_
31	1A	0a	NN	NN	_	28	parataxis	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	and	and	CC	CC	_	28	cc	_	_
34	rat	rat	NN	NN	_	28	conj	_	_
35	islets	islet	NNS	NNS	_	26	pobj	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	Figure	figure	NN	NN	_	38	compound	_	_
38	1B	0b	NN	NN	_	35	parataxis	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	by	by	IN	IN	_	23	prep	_	_
41	60	0	CD	CD	_	42	nummod	_	_
42	%	%	NN	NN	_	40	pobj	_	_
43	(	(	-LRB-	-LRB-	_	50	punct	_	_
44	n	n	NN	NN	_	46	nsubj	_	_
45	=	=	SYM	SYM	_	46	punct	_	_
46	15	0	CD	CD	_	50	ccomp	_	_
47	,	,	,	,	_	50	punct	_	_
48	p	p	NN	NN	_	50	nsubj	_	_
49	<	<	SYM	SYM	_	50	punct	_	_
50	0.001	0	CD	CD	_	42	parataxis	_	_
51	)	)	-RRB-	-RRB-	_	50	punct	_	_
52	and	and	CC	CC	_	42	cc	_	_
53	57	0	CD	CD	_	54	nummod	_	_
54	%	%	NN	NN	_	42	conj	_	_
55	(	(	-LRB-	-LRB-	_	62	punct	_	_
56	n	n	NN	NN	_	58	nsubj	_	_
57	=	=	SYM	SYM	_	58	punct	_	_
58	10	0	CD	CD	_	62	ccomp	_	_
59	,	,	,	,	_	62	punct	_	_
60	p	p	NN	NN	_	62	nsubj	_	_
61	<	<	SYM	SYM	_	62	punct	_	_
62	0.001	0	CD	CD	_	54	parataxis	_	_
63	)	)	-RRB-	-RRB-	_	62	punct	_	_
64	,	,	,	,	_	23	punct	_	_
65	respectively	respectively	RB	RB	_	23	advmod	_	_
66	.	.	.	.	_	23	punct	_	_

1	In	in	IN	IN	sem=LOC	16	prep	_	_
2	both	both	CC	CC	_	6	preconj	_	_
3	mouse	mouse	NN	NN	_	6	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	rat	rat	NN	NN	_	3	conj	_	_
6	islets	islet	NNS	NNS	_	1	pobj	_	_
7	,	,	,	,	_	16	punct	_	_
8	the	the	DT	DT	_	9	det	_	_
9	ability	ability	NN	NN	_	16	nsubj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	glucose	glucose	NN	NN	_	10	pobj	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	inhibit	inhibit	VB	VB	_	9	acl	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	13	dobj	_	_
16	persisted	persist	VBD	VBD	_	0	root	_	_
17	in	in	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	19	det	_	_
19	presence	presence	NN	NN	_	17	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	Ca2+	ca0+	NN	NN	_	23	compound	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	EDTA	edta	NN	NN	_	20	pobj	_	_
24	(	(	-LRB-	-LRB-	_	26	punct	_	_
25	43	0	CD	CD	_	26	nummod	_	_
26	%	%	NN	NN	_	23	parataxis	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	48	0	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	26	conj	_	_
30	,	,	,	,	_	26	punct	_	_
31	n	n	NN	NN	_	33	nsubj	_	_
32	=	=	SYM	SYM	_	33	punct	_	_
33	10	0	CD	CD	_	26	ccomp	_	_
34	,	,	,	,	_	26	punct	_	_
35	p	p	NN	NN	_	37	nsubj	_	_
36	<	<	SYM	SYM	_	37	punct	_	_
37	0.001	0	CD	CD	_	26	ccomp	_	_
38	,	,	,	,	_	26	punct	_	_
39	respectively	respectively	RB	RB	_	26	advmod	_	_
40	)	)	-RRB-	-RRB-	_	26	punct	_	_
41	and	and	CC	CC	_	23	cc	_	_
42	SR	sr	NN	NN	_	23	conj	_	_
43	-	-	HYPH	HYPH	_	42	punct	_	_
44	95531	0	CD	CD	_	42	nummod	_	_
45	(	(	-LRB-	-LRB-	_	47	punct	_	_
46	31	0	CD	CD	_	47	nummod	_	_
47	%	%	NN	NN	_	42	parataxis	_	_
48	and	and	CC	CC	_	47	cc	_	_
49	46	0	CD	CD	_	50	nummod	_	_
50	%	%	NN	NN	_	47	conj	_	_
51	,	,	,	,	_	47	punct	_	_
52	n	n	NN	NN	_	54	nsubj	_	_
53	=	=	SYM	SYM	_	54	punct	_	_
54	8	0	CD	CD	_	47	ccomp	_	_
55	and	and	CC	CC	_	54	cc	_	_
56	10	0	CD	CD	_	54	conj	_	_
57	,	,	,	,	_	47	punct	_	_
58	p	p	NN	NN	_	60	nsubj	_	_
59	<	<	SYM	SYM	_	60	punct	_	_
60	0.01	0	CD	CD	_	47	ccomp	_	_
61	and	and	CC	CC	_	60	cc	_	_
62	p	p	NN	NN	_	64	nsubj	_	_
63	<	<	SYM	SYM	_	64	punct	_	_
64	0.001	0	CD	CD	_	60	conj	_	_
65	,	,	,	,	_	64	punct	_	_
66	respectively	respectively	RB	RB	_	64	conj	_	_
67	)	)	-RRB-	-RRB-	_	47	punct	_	_
68	(	(	-LRB-	-LRB-	_	69	punct	_	_
69	Figure	figure	NN	NN	_	16	parataxis	_	_
70	1	0	CD	CD	_	69	nummod	_	_
71	)	)	-RRB-	-RRB-	_	69	punct	_	_
72	.	.	.	.	_	16	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	worth	worth	JJ	JJ	syn=PRD	2	acomp	_	_
4	noting	note	VBG	VBG	_	3	advcl	_	_
5	that	that	IN	IN	_	17	mark	_	_
6	in	in	IN	IN	_	17	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	presence	presence	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	12	det	_	_
11	GABAA	gabaa	NN	NN	_	12	compound	_	_
12	antagonist	antagonist	NN	NN	_	9	pobj	_	_
13	,	,	,	,	_	17	punct	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	increased	increase	VBN	VBN	_	2	ccomp	_	_
18	under	under	IN	IN	_	17	prep	_	_
19	both	both	CC	CC	_	20	preconj	_	_
20	low	low	JJ	JJ	_	26	amod	_	_
21	-	-	HYPH	HYPH	_	20	punct	_	_
22	and	and	CC	CC	_	20	cc	_	_
23	high	high	JJ	JJ	_	20	conj	_	_
24	-	-	HYPH	HYPH	_	26	punct	_	_
25	glucose	glucose	NN	NN	_	26	compound	_	_
26	conditions	condition	NNS	NNS	_	18	pobj	_	_
27	,	,	,	,	_	17	punct	_	_
28	and	and	CC	CC	_	17	cc	_	_
29	furthermore	furthermore	RB	RB	_	32	advmod	_	_
30	,	,	,	,	_	32	punct	_	_
31	glucose	glucose	NN	NN	_	32	nsubj	_	_
32	was	be	VBD	VBD	_	17	conj	_	_
33	approximately	approximately	RB	RB	_	34	advmod	_	_
34	50	0	CD	CD	_	35	nummod	_	_
35	%	%	NN	NN	_	37	npadvmod	_	_
36	less	less	RBR	RBR	_	37	advmod	_	_
37	effective	effective	JJ	JJ	syn=PRD	32	acomp	_	_
38	in	in	IN	IN	_	37	prep	_	_
39	suppressing	suppress	VBG	VBG	syn=NOM	38	pcomp	_	_
40	glucagon	glucagon	NN	NN	_	41	compound	_	_
41	release	release	NN	NN	_	39	dobj	_	_
42	from	from	IN	IN	_	41	prep	_	_
43	mouse	mouse	NN	NN	_	44	compound	_	_
44	islets	islet	NNS	NNS	_	42	pobj	_	_
45	(	(	-LRB-	-LRB-	_	47	punct	_	_
46	31	0	CD	CD	_	47	nummod	_	_
47	%	%	NN	NN	_	32	parataxis	_	_
48	versus	versus	CC	CC	_	47	cc	_	_
49	60	0	CD	CD	_	50	nummod	_	_
50	%	%	NN	NN	_	47	conj	_	_
51	,	,	,	,	_	47	punct	_	_
52	respectively	respectively	RB	RB	_	47	advmod	_	_
53	)	)	-RRB-	-RRB-	_	47	punct	_	_
54	(	(	-LRB-	-LRB-	_	56	punct	_	_
55	Figure	figure	NN	NN	_	56	compound	_	_
56	1A	0a	NN	NN	_	2	parataxis	_	_
57	)	)	-RRB-	-RRB-	_	56	punct	_	_
58	.	.	.	.	_	2	punct	_	_

1	Additionally	additionally	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	somatostatin	somatostatin	NN	NN	_	10	nsubjpass	_	_
4	released	release	VBN	VBN	_	3	acl	_	_
5	from	from	IN	IN	_	4	prep	_	_
6	pancreatic	pancreatic	JJ	JJ	_	8	amod	_	_
7	δ	δ	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	5	pobj	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	suggested	suggest	VBN	VBN	_	0	root	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	be	be	VB	VB	_	10	xcomp	_	_
13	a	a	DT	DT	_	16	det	_	_
14	potential	potential	JJ	JJ	_	16	amod	_	_
15	paracrine	paracrine	JJ	JJ	_	16	amod	_	_
16	regulator	regulator	NN	NN	syn=PRD	12	attr	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	glucagon	glucagon	NN	NN	_	19	compound	_	_
19	secretion	secretion	NN	NN	_	17	pobj	_	_
20	.	.	.	.	_	10	punct	_	_

1	However	however	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	the	the	DT	DT	_	12	det	_	_
4	somatostatin	somatostatin	NN	NN	_	5	nmod	_	_
5	receptor	receptor	NN	NN	_	12	nmod	_	_
6	2	0	CD	CD	_	5	nummod	_	_
7	(	(	-LRB-	-LRB-	_	5	punct	_	_
8	SSTR	sstr	NN	NN	_	5	appos	_	_
9	-	-	HYPH	HYPH	_	8	punct	_	_
10	2	0	CD	CD	_	8	nummod	_	_
11	)	)	-RRB-	-RRB-	_	12	punct	_	_
12	antagonist	antagonist	NN	NN	_	18	nsubj	_	_
13	PRL	prl	NN	NN	_	12	appos	_	_
14	-	-	HYPH	HYPH	_	13	punct	_	_
15	2903	0	CD	CD	_	13	nummod	_	_
16	does	do	VBZ	VBZ	_	18	aux	_	_
17	not	not	RB	RB	_	18	neg	_	_
18	interfere	interfere	VB	VB	_	0	root	_	_
19	with	with	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	ability	ability	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	glucose	glucose	NN	NN	_	22	pobj	_	_
24	(	(	-LRB-	-LRB-	_	23	punct	_	_
25	at	at	IN	IN	_	23	prep	_	_
26	3	0	CD	CD	_	29	nummod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	7	0	CD	CD	_	26	conj	_	_
29	mM	mm	NNS	NNS	_	25	pobj	_	_
30	)	)	-RRB-	-RRB-	_	21	punct	_	_
31	to	to	TO	TO	_	32	aux	_	_
32	inhibit	inhibit	VB	VB	_	21	acl	_	_
33	glucagon	glucagon	NN	NN	_	34	compound	_	_
34	secretion	secretion	NN	NN	_	32	dobj	_	_
35	from	from	IN	IN	_	32	prep	_	_
36	mouse	mouse	NN	NN	_	37	compound	_	_
37	islets	islet	NNS	NNS	_	35	pobj	_	_
38	[	[	-LRB-	-LRB-	_	39	punct	_	_
39	47	0	CD	CD	_	18	parataxis	_	_
40	]	]	-RRB-	-RRB-	_	39	punct	_	_
41	.	.	.	.	_	18	punct	_	_

1	Like	like	IN	IN	_	12	prep	_	_
2	the	the	DT	DT	_	5	det	_	_
3	GABAA	gabaa	NN	NN	_	5	compound	_	_
4	receptor	receptor	NN	NN	_	5	compound	_	_
5	antagonist	antagonist	NN	NN	_	1	pobj	_	_
6	,	,	,	,	_	12	punct	_	_
7	however	however	RB	RB	_	12	advmod	_	_
8	,	,	,	,	_	12	punct	_	_
9	PRL	prl	NN	NN	_	12	nsubj	_	_
10	-	-	HYPH	HYPH	_	9	punct	_	_
11	2903	0	CD	CD	_	9	nummod	_	_
12	increased	increase	VBD	VBD	_	0	root	_	_
13	glucagon	glucagon	NN	NN	_	14	compound	_	_
14	secretion	secretion	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	_	12	prep	_	_
16	low	low	JJ	JJ	_	18	amod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	glucose	glucose	NN	NN	_	19	compound	_	_
19	conditions	condition	NNS	NNS	_	15	pobj	_	_
20	[	[	-LRB-	-LRB-	_	21	punct	_	_
21	47	0	CD	CD	_	12	parataxis	_	_
22	]	]	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	12	punct	_	_

1	Thus	thus	RB	RB	_	21	advmod	_	_
2	,	,	,	,	_	21	punct	_	_
3	although	although	IN	IN	_	10	mark	_	_
4	the	the	DT	DT	_	6	det	_	_
5	present	present	JJ	JJ	_	6	amod	_	_
6	data	datum	NNS	NNS	_	10	nsubj	_	_
7	do	do	VBP	VBP	_	10	aux	_	_
8	not	not	RB	RB	_	10	neg	_	_
9	entirely	entirely	RB	RB	_	10	advmod	_	_
10	rule	rule	VB	VB	syn=ADV	21	advcl	_	_
11	out	out	RP	RP	_	10	prt	_	_
12	these	these	DT	DT	_	13	det	_	_
13	pathways	pathway	NNS	NNS	_	10	dobj	_	_
14	as	as	IN	IN	_	10	prep	_	_
15	modulators	modulator	NNS	NNS	_	14	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	secretion	secretion	NN	NN	_	16	pobj	_	_
19	,	,	,	,	_	21	punct	_	_
20	glucose	glucose	NN	NN	_	21	nsubj	_	_
21	is	be	VBZ	VBZ	_	0	root	_	_
22	clearly	clearly	RB	RB	_	21	advmod	_	_
23	able	able	JJ	JJ	syn=PRD	21	acomp	_	_
24	to	to	TO	TO	_	25	aux	_	_
25	suppress	suppress	VB	VB	_	23	xcomp	_	_
26	glucagon	glucagon	NN	NN	_	27	compound	_	_
27	secretion	secretion	NN	NN	_	25	dobj	_	_
28	independently	independently	RB	RB	_	25	advmod	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	these	these	DT	DT	_	29	pobj	_	_
31	.	.	.	.	_	21	punct	_	_

1	α	α	NN	NN	_	3	compound	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	Cell	cell	NN	NN	_	5	compound	_	_
4	KATP	katp	NN	NN	_	5	compound	_	_
5	Channels	channel	NNS	NNS	_	6	nsubj	_	_
6	Regulate	regulate	VBP	VBP	_	0	root	_	_
7	Glucagon	glucagon	NN	NN	_	8	compound	_	_
8	Secretion	secretion	NN	NN	_	6	dobj	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	next	next	RB	RB	_	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	glucagon	glucagon	NN	NN	_	7	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	insulin	insulin	NN	NN	_	4	conj	_	_
7	secretion	secretion	NN	NN	_	3	dobj	_	_
8	during	during	IN	IN	sem=TMP	3	prep	_	_
9	pharmacological	pharmacological	JJ	JJ	_	10	amod	_	_
10	manipulation	manipulation	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	KATP	katp	NN	NN	_	14	compound	_	_
13	channel	channel	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	11	pobj	_	_
15	.	.	.	.	_	3	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	we	we	PRP	PRP	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	examined	examine	VBN	VBN	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	role	role	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	KATP	katp	NN	NN	_	9	compound	_	_
9	channels	channel	NNS	NNS	_	7	pobj	_	_
10	in	in	IN	IN	sem=LOC	6	prep	_	_
11	intact	intact	JJ	JJ	_	12	amod	_	_
12	islets	islet	NNS	NNS	_	10	pobj	_	_
13	by	by	IN	IN	sem=MNR	4	prep	_	_
14	applying	apply	VBG	VBG	syn=NOM	13	pcomp	_	_
15	an	an	DT	DT	_	22	det	_	_
16	indirect	indirect	JJ	JJ	_	22	amod	_	_
17	,	,	,	,	_	16	punct	_	_
18	but	but	CC	CC	_	16	cc	_	_
19	minimally	minimally	RB	RB	_	20	advmod	_	_
20	invasive	invasive	JJ	JJ	_	16	conj	_	_
21	,	,	,	,	_	22	punct	_	_
22	technique	technique	NN	NN	_	14	dobj	_	_
23	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	4	nsubj	_	_
2	would	would	MD	MD	_	4	aux	_	_
3	have	have	VB	VB	_	4	aux	_	_
4	been	be	VBN	VBN	_	0	root	_	_
5	difficult	difficult	JJ	JJ	syn=PRD	4	acomp	_	_
6	(	(	-LRB-	-LRB-	_	9	punct	_	_
7	if	if	IN	IN	_	9	mark	_	_
8	not	not	RB	RB	_	9	neg	_	_
9	impossible	impossible	JJ	JJ	syn=PRD	4	parataxis	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	study	study	VB	VB	_	4	xcomp	_	_
13	the	the	DT	DT	_	14	det	_	_
14	effects	effect	NNS	NNS	_	12	dobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	glucose	glucose	NN	NN	_	15	pobj	_	_
17	on	on	IN	IN	_	14	prep	_	_
18	α	α	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	cell	cell	NN	NN	_	23	compound	_	_
21	KATP	katp	NN	NN	_	22	compound	_	_
22	channel	channel	NN	NN	_	23	compound	_	_
23	activity	activity	NN	NN	_	17	pobj	_	_
24	using	use	VBG	VBG	sem=MNR	12	advcl	_	_
25	the	the	DT	DT	_	29	det	_	_
26	patch	patch	NN	NN	_	28	compound	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	clamp	clamp	NN	NN	_	29	compound	_	_
29	technique	technique	NN	NN	_	24	dobj	_	_
30	because	because	IN	IN	sem=PRP	4	prep	_	_
31	of	of	IN	IN	_	30	pcomp	_	_
32	the	the	DT	DT	_	33	det	_	_
33	smallness	smallness	NN	NN	_	30	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	the	the	DT	DT	_	40	det	_	_
36	α	α	NN	NN	_	38	compound	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	cell	cell	NN	NN	_	40	compound	_	_
39	resting	resting	NN	NN	_	40	compound	_	_
40	conductance	conductance	NN	NN	_	34	pobj	_	_
41	(	(	-LRB-	-LRB-	_	33	punct	_	_
42	0.15	0	CD	CD	_	43	nummod	_	_
43	nS	n	NNS	NNS	_	33	appos	_	_
44	/	/	SYM	SYM	_	45	punct	_	_
45	pF	pf	NN	NN	_	43	prep	_	_
46	in	in	IN	IN	_	43	prep	_	_
47	the	the	DT	DT	_	48	det	_	_
48	absence	absence	NN	NN	_	46	pobj	_	_
49	of	of	IN	IN	_	48	prep	_	_
50	glucose	glucose	NN	NN	_	49	pobj	_	_
51	,	,	,	,	_	43	punct	_	_
52	of	of	IN	IN	_	56	prep	_	_
53	which	which	WDT	WDT	_	52	pobj	_	43:ref
54	two	#crd#	CD	CD	_	55	nummod	_	_
55	thirds	#ord#	NNS	NNS	_	56	nsubj	_	_
56	is	be	VBZ	VBZ	_	43	relcl	_	_
57	attributable	attributable	JJ	JJ	syn=PRD	56	acomp	_	_
58	to	to	IN	IN	_	57	prep	_	_
59	KATP	katp	NN	NN	_	60	compound	_	_
60	channels	channel	NNS	NNS	_	58	pobj	_	_
61	)	)	-RRB-	-RRB-	_	33	punct	_	_
62	[	[	-LRB-	-LRB-	_	63	punct	_	_
63	13	0	CD	CD	_	4	parataxis	_	_
64	]	]	-RRB-	-RRB-	_	63	punct	_	_
65	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	instead	instead	RB	RB	_	4	advmod	_	_
4	used	use	VBN	VBN	_	0	root	_	_
5	increasing	increase	VBG	VBG	_	6	amod	_	_
6	concentrations	concentration	NNS	NNS	_	4	dobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	diazoxide	diazoxide	NN	NN	_	7	pobj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	tolbutamide	tolbutamide	NN	NN	_	8	conj	_	_
11	to	to	TO	TO	_	13	aux	_	_
12	“	"	``	``	_	13	punct	_	_
13	titrate	titrate	VB	VB	sem=PRP	4	advcl	_	_
14	”	"	''	''	_	13	punct	_	_
15	the	the	DT	DT	_	16	det	_	_
16	influence	influence	NN	NN	_	13	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	KATP	katp	NN	NN	_	19	compound	_	_
19	channel	channel	NN	NN	_	20	compound	_	_
20	activity	activity	NN	NN	_	17	pobj	_	_
21	on	on	IN	IN	_	16	prep	_	_
22	α	α	NN	NN	_	24	nmod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	cell	cell	NN	NN	_	28	nmod	_	_
25	[	[	-LRB-	-LRB-	_	28	punct	_	_
26	Ca2+	ca0+	NN	NN	_	28	nmod	_	_
27	]	]	-RRB-	-RRB-	_	28	punct	_	_
28	i	i	NN	NN	_	21	pobj	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	glucagon	glucagon	NN	NN	_	31	compound	_	_
31	secretion	secretion	NN	NN	_	28	conj	_	_
32	.	.	.	.	_	4	punct	_	_

1	Increasing	increase	VBG	VBG	_	2	amod	_	_
2	concentrations	concentration	NNS	NNS	_	9	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	8	det	_	_
5	KATP	katp	NN	NN	_	6	compound	_	_
6	channel	channel	NN	NN	_	8	compound	_	_
7	activator	activator	NN	NN	_	8	compound	_	_
8	diazoxide	diazoxide	NN	NN	_	3	pobj	_	_
9	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	23	mark	_	_
11	moderate	moderate	JJ	JJ	_	12	amod	_	_
12	activation	activation	NN	NN	_	23	nsubj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	KATP	katp	NN	NN	_	15	compound	_	_
15	channels	channel	NNS	NNS	_	13	pobj	_	_
16	(	(	-LRB-	-LRB-	_	21	punct	_	_
17	0.3	0	CD	CD	_	19	quantmod	_	_
18	–	-	SYM	SYM	_	19	punct	_	_
19	10	0	CD	CD	_	20	nummod	_	_
20	μM	μm	NNS	NNS	_	21	compound	_	_
21	diazoxide	diazoxide	NN	NN	_	12	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	relieved	relieve	VBD	VBD	_	9	ccomp	_	_
24	the	the	DT	DT	_	25	det	_	_
25	suppression	suppression	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	glucagon	glucagon	NN	NN	_	28	compound	_	_
28	secretion	secretion	NN	NN	_	26	pobj	_	_
29	from	from	IN	IN	_	28	prep	_	_
30	both	both	CC	CC	_	31	preconj	_	_
31	mouse	mouse	NN	NN	_	42	nmod	_	_
32	(	(	-LRB-	-LRB-	_	34	punct	_	_
33	Figure	figure	NN	NN	_	34	compound	_	_
34	2A	0a	NN	NN	_	31	parataxis	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	and	and	CC	CC	_	31	cc	_	_
37	rat	rat	NN	NN	_	31	conj	_	_
38	(	(	-LRB-	-LRB-	_	40	punct	_	_
39	Figure	figure	NN	NN	_	40	compound	_	_
40	2B	0b	NN	NN	_	37	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	islets	islet	NNS	NNS	_	29	pobj	_	_
43	.	.	.	.	_	9	punct	_	_

1	Stimulation	stimulation	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	glucagon	glucagon	NN	NN	_	4	compound	_	_
4	release	release	NN	NN	_	2	pobj	_	_
5	was	be	VBD	VBD	_	0	root	_	_
6	half	half	RB	RB	_	8	advmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	maximal	maximal	JJ	JJ	syn=PRD	5	acomp	_	_
9	at	at	IN	IN	_	8	prep	_	_
10	approximately	approximately	RB	RB	_	11	advmod	_	_
11	1	0	CD	CD	_	12	nummod	_	_
12	μM	μm	NN	NN	_	13	compound	_	_
13	diazoxide	diazoxide	NN	NN	_	9	pobj	_	_
14	,	,	,	,	_	5	punct	_	_
15	which	which	WDT	WDT	_	16	dep	_	_
16	is	be	VBZ	VBZ	syn=ADV	5	advcl	_	_
17	well	well	RB	RB	_	18	advmod	_	_
18	below	below	IN	IN	syn=PRD|sem=LOC	16	prep	_	_
19	that	that	DT	DT	_	18	pobj	_	_
20	required	require	VBN	VBN	_	19	acl	_	_
21	to	to	TO	TO	_	22	aux	_	_
22	inhibit	inhibit	VB	VB	sem=PRP	20	advcl	_	_
23	insulin	insulin	NN	NN	_	24	compound	_	_
24	release	release	NN	NN	_	22	dobj	_	_
25	,	,	,	,	_	5	punct	_	_
26	suggesting	suggest	VBG	VBG	syn=ADV	5	advcl	_	_
27	that	that	IN	IN	_	34	mark	_	_
28	“	"	``	``	_	29	punct	_	_
29	re-activation	re-activation	NN	NN	_	34	nsubj	_	_
30	”	"	''	''	_	29	punct	_	_
31	of	of	IN	IN	_	29	prep	_	_
32	glucagon	glucagon	NN	NN	_	33	compound	_	_
33	release	release	NN	NN	_	31	pobj	_	_
34	was	be	VBD	VBD	_	26	ccomp	_	_
35	not	not	RB	RB	_	34	neg	_	_
36	secondary	secondary	JJ	JJ	syn=PRD	34	acomp	_	_
37	to	to	IN	IN	_	36	prep	_	_
38	reduced	reduce	VBN	VBN	_	42	amod	_	_
39	β	β	NN	NN	_	41	compound	_	_
40	-	-	HYPH	HYPH	_	41	punct	_	_
41	cell	cell	NN	NN	_	42	compound	_	_
42	secretion	secretion	NN	NN	_	37	pobj	_	_
43	.	.	.	.	_	5	punct	_	_

1	Increasing	increase	VBG	VBG	syn=NOM	9	csubj	_	_
2	the	the	DT	DT	_	3	det	_	_
3	concentration	concentration	NN	NN	_	1	dobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	diazoxide	diazoxide	NN	NN	_	4	pobj	_	_
6	beyond	beyond	IN	IN	_	1	prep	_	_
7	10	0	CD	CD	_	8	nummod	_	_
8	μM	μm	NNS	NNS	_	6	pobj	_	_
9	inhibited	inhibit	VBD	VBD	_	0	root	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	9	dobj	_	_
12	in	in	IN	IN	_	9	prep	_	_
13	parallel	parallel	NN	NN	_	12	pobj	_	_
14	with	with	IN	IN	_	13	prep	_	_
15	an	an	DT	DT	_	16	det	_	_
16	inhibition	inhibition	NN	NN	_	14	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	insulin	insulin	NN	NN	_	19	compound	_	_
19	release	release	NN	NN	_	17	pobj	_	_
20	from	from	IN	IN	_	16	prep	_	_
21	both	both	CC	CC	_	25	preconj	_	_
22	mouse	mouse	NN	NN	_	25	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	rat	rat	NN	NN	_	22	conj	_	_
25	islets	islet	NNS	NNS	_	20	pobj	_	_
26	(	(	-LRB-	-LRB-	_	28	punct	_	_
27	Figure	figure	NN	NN	_	28	compound	_	_
28	2A	0a	NN	NN	_	9	parataxis	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	2B	0b	NN	NN	_	28	conj	_	_
31	)	)	-RRB-	-RRB-	_	28	punct	_	_
32	.	.	.	.	_	9	punct	_	_

1	When	when	WRB	WRB	_	3	advmod	_	_
2	instead	instead	RB	RB	_	3	advmod	_	_
3	applied	apply	VBN	VBN	sem=TMP	23	advcl	_	_
4	in	in	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	presence	presence	NN	NN	_	4	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	1	0	CD	CD	_	9	nummod	_	_
9	mM	mm	NN	NN	_	10	compound	_	_
10	glucose	glucose	NN	NN	_	7	pobj	_	_
11	(	(	-LRB-	-LRB-	_	10	punct	_	_
12	at	at	IN	IN	_	18	prep	_	_
13	which	which	WDT	WDT	_	14	det	_	10:ref
14	concentration	concentration	NN	NN	_	12	pcomp	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	18	nsubjpass	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	stimulated	stimulate	VBN	VBN	_	10	relcl	_	_
19	)	)	-RRB-	-RRB-	_	23	punct	_	_
20	,	,	,	,	_	23	punct	_	_
21	increasing	increase	VBG	VBG	_	22	amod	_	_
22	diazoxide	diazoxide	NN	NN	_	23	nsubj	_	_
23	produced	produce	VBD	VBD	_	0	root	_	_
24	a	a	DT	DT	_	26	det	_	_
25	monotonic	monotonic	JJ	JJ	_	26	amod	_	_
26	inhibition	inhibition	NN	NN	_	23	dobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	secretion	secretion	NN	NN	_	27	pobj	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	Figure	figure	NN	NN	_	32	compound	_	_
32	2C	0c	NN	NN	_	26	parataxis	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	with	with	IN	IN	_	26	prep	_	_
35	a	a	DT	DT	_	40	det	_	_
36	half	half	RB	RB	_	38	advmod	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	maximal	maximal	JJ	JJ	_	40	amod	_	_
39	inhibitory	inhibitory	JJ	JJ	_	40	amod	_	_
40	concentration	concentration	NN	NN	_	34	pobj	_	_
41	(	(	-LRB-	-LRB-	_	42	punct	_	_
42	IC50	ic0	NN	NN	_	40	parataxis	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	that	that	WDT	WDT	_	45	dep	_	40:ref
45	is	be	VBZ	VBZ	_	40	relcl	_	_
46	much	much	RB	RB	_	47	advmod	_	_
47	lower	low	JJR	JJR	syn=PRD	45	acomp	_	_
48	than	than	IN	IN	_	47	prep	_	_
49	what	what	WP	WP	_	51	dep	_	_
50	is	be	VBZ	VBZ	_	51	auxpass	_	_
51	seen	see	VBN	VBN	syn=NOM	48	pcomp	_	_
52	under	under	IN	IN	_	51	prep	_	_
53	high	high	JJ	JJ	_	55	amod	_	_
54	-	-	HYPH	HYPH	_	55	punct	_	_
55	glucose	glucose	NN	NN	_	56	compound	_	_
56	conditions	condition	NNS	NNS	_	52	pobj	_	_
57	(	(	-LRB-	-LRB-	_	60	punct	_	_
58	∼	∼	SYM	SYM	_	59	punct	_	_
59	2	0	CD	CD	_	60	nummod	_	_
60	μM	μm	NNS	NNS	_	51	parataxis	_	_
61	versus	versus	CC	CC	_	60	cc	_	_
62	∼	∼	SYM	SYM	_	63	punct	_	_
63	50	0	CD	CD	_	64	nummod	_	_
64	μM	μm	NNS	NNS	_	60	conj	_	_
65	)	)	-RRB-	-RRB-	_	60	punct	_	_
66	.	.	.	.	_	23	punct	_	_

1	In	in	IN	IN	_	23	prep	_	_
2	the	the	DT	DT	_	4	det	_	_
3	complete	complete	JJ	JJ	_	4	amod	_	_
4	absence	absence	NN	NN	_	1	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	glucose	glucose	NN	NN	_	5	pobj	_	_
7	,	,	,	,	_	23	punct	_	_
8	when	when	WRB	WRB	_	12	advmod	_	_
9	KATP	katp	NN	NN	_	10	compound	_	_
10	channels	channel	NNS	NNS	_	12	nsubjpass	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	expected	expect	VBN	VBN	sem=TMP	23	advcl	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	be	be	VB	VB	_	12	xcomp	_	_
15	open	open	JJ	JJ	syn=PRD	14	acomp	_	_
16	,	,	,	,	_	23	punct	_	_
17	the	the	DT	DT	_	20	det	_	_
18	KATP	katp	NN	NN	_	19	compound	_	_
19	channel	channel	NN	NN	_	20	compound	_	_
20	antagonist	antagonist	NN	NN	_	23	nsubj	_	_
21	tolbutamide	tolbutamide	NN	NN	_	20	appos	_	_
22	also	also	RB	RB	_	23	advmod	_	_
23	produced	produce	VBD	VBD	_	0	root	_	_
24	a	a	DT	DT	_	26	det	_	_
25	biphasic	biphasic	JJ	JJ	_	26	amod	_	_
26	effect	effect	NN	NN	_	23	dobj	_	_
27	on	on	IN	IN	_	26	prep	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	release	release	NN	NN	_	27	pobj	_	_
30	.	.	.	.	_	23	punct	_	_

1	Augmentation	augmentation	NN	NN	_	6	nsubjpass	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	glucagon	glucagon	NN	NN	_	4	compound	_	_
4	secretion	secretion	NN	NN	_	2	pobj	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	seen	see	VBN	VBN	_	0	root	_	_
7	at	at	IN	IN	_	6	prep	_	_
8	tolbutamide	tolbutamide	NN	NN	_	9	compound	_	_
9	concentrations	concentration	NNS	NNS	_	7	pobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	up	up	IN	IN	_	13	quantmod	_	_
12	to	to	IN	IN	_	13	quantmod	_	_
13	1	0	CD	CD	_	14	nummod	_	_
14	μM	μm	NN	NN	_	10	pobj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	stimulation	stimulation	NN	NN	_	9	parataxis	_	_
17	being	be	VBG	VBG	_	16	acl	_	_
18	half	half	RB	RB	_	20	advmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	maximal	maximal	JJ	JJ	syn=PRD	17	acomp	_	_
21	at	at	IN	IN	_	17	prep	_	_
22	0.1	0	CD	CD	_	23	nummod	_	_
23	μM	μm	NNS	NNS	_	21	pobj	_	_
24	)	)	-RRB-	-RRB-	_	16	punct	_	_
25	,	,	,	,	_	6	punct	_	_
26	whereas	whereas	IN	IN	_	29	mark	_	_
27	inhibition	inhibition	NN	NN	_	29	nsubjpass	_	_
28	was	be	VBD	VBD	_	29	auxpass	_	_
29	observed	observe	VBN	VBN	syn=ADV	6	advcl	_	_
30	at	at	IN	IN	_	29	prep	_	_
31	higher	high	JJR	JJR	_	32	amod	_	_
32	concentrations	concentration	NNS	NNS	_	30	pobj	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	Figure	figure	NN	NN	_	35	compound	_	_
35	2D	0d	NN	NN	_	29	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	6	punct	_	_

1	Importantly	importantly	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	in	in	IN	IN	_	18	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	presence	presence	NN	NN	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	a	a	DT	DT	_	11	det	_	_
8	maximally	maximally	RB	RB	_	9	advmod	_	_
9	inhibitory	inhibitory	JJ	JJ	_	11	amod	_	_
10	tolbutamide	tolbutamide	NN	NN	_	11	compound	_	_
11	concentration	concentration	NN	NN	_	6	pobj	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	0.5	0	CD	CD	_	14	nummod	_	_
14	mM	mm	NNS	NNS	_	5	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	,	,	,	,	_	18	punct	_	_
17	glucose	glucose	NN	NN	_	18	nsubj	_	_
18	was	be	VBD	VBD	_	0	root	_	_
19	unable	unable	JJ	JJ	syn=PRD	18	acomp	_	_
20	to	to	TO	TO	_	21	aux	_	_
21	produce	produce	VB	VB	_	19	xcomp	_	_
22	any	any	DT	DT	_	24	det	_	_
23	further	far	JJ	JJ	_	24	amod	_	_
24	inhibition	inhibition	NN	NN	_	21	dobj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	glucagon	glucagon	NN	NN	_	27	compound	_	_
27	release	release	NN	NN	_	25	pobj	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	Figure	figure	NN	NN	_	30	compound	_	_
30	3A	0a	NN	NN	_	18	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	.	.	.	.	_	18	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	are	be	VBP	VBP	_	0	root	_	_
4	inconsistent	inconsistent	JJ	JJ	syn=PRD	3	acomp	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	idea	idea	NN	NN	_	5	pobj	_	_
8	that	that	IN	IN	_	13	mark	_	_
9	β	β	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	secretion	secretion	NN	NN	_	13	nsubj	_	_
13	is	be	VBZ	VBZ	_	7	acl	_	_
14	the	the	DT	DT	_	16	det	_	_
15	primary	primary	JJ	JJ	_	16	amod	_	_
16	inhibitor	inhibitor	NN	NN	syn=PRD	13	attr	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	α	α	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	cell	cell	NN	NN	_	22	compound	_	_
21	glucagon	glucagon	NN	NN	_	22	compound	_	_
22	release	release	NN	NN	_	17	pobj	_	_
23	.	.	.	.	_	3	punct	_	_

1	They	they	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	glucagon	glucagon	NN	NN	_	6	compound	_	_
6	secretion	secretion	NN	NN	_	7	nsubj	_	_
7	is	be	VBZ	VBZ	_	3	ccomp	_	_
8	maximal	maximal	JJ	JJ	syn=PRD	7	acomp	_	_
9	within	within	IN	IN	_	7	prep	_	_
10	a	a	DT	DT	_	12	det	_	_
11	“	"	``	``	_	12	punct	_	_
12	window	window	NN	NN	_	9	pobj	_	_
13	”	"	''	''	_	12	punct	_	_
14	of	of	IN	IN	_	12	prep	_	_
15	intermediate	intermediate	JJ	JJ	_	18	amod	_	_
16	KATP	katp	NN	NN	_	17	compound	_	_
17	channel	channel	NN	NN	_	18	compound	_	_
18	activity	activity	NN	NN	_	14	pobj	_	_
19	.	.	.	.	_	3	punct	_	_

1	To	to	TO	TO	_	3	aux	_	_
2	further	far	RB	RB	_	3	advmod	_	_
3	investigate	investigate	VB	VB	sem=PRP	19	advcl	_	_
4	the	the	DT	DT	_	5	det	_	_
5	role	role	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	α	α	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	cell	cell	NN	NN	_	11	compound	_	_
10	KATP	katp	NN	NN	_	11	compound	_	_
11	channels	channel	NNS	NNS	_	6	pobj	_	_
12	as	as	IN	IN	_	5	prep	_	_
13	regulators	regulator	NNS	NNS	_	12	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	14	pobj	_	_
17	,	,	,	,	_	19	punct	_	_
18	we	we	PRP	PRP	_	19	nsubj	_	_
19	studied	study	VBD	VBD	_	0	root	_	_
20	islets	islet	NNS	NNS	_	19	dobj	_	_
21	from	from	IN	IN	_	20	prep	_	_
22	Kir6.2Y12X	kir0y0x	NN	NN	_	23	compound	_	_
23	mice	mouse	NNS	NNS	_	21	pobj	_	_
24	,	,	,	,	_	23	punct	_	_
25	which	which	WDT	WDT	_	26	dep	_	23:ref
26	posses	poss	VBZ	VBZ	_	23	relcl	_	_
27	a	a	DT	DT	_	29	det	_	_
28	Tyr12STOP	tyr0stop	NN	NN	_	29	compound	_	_
29	mutation	mutation	NN	NN	_	26	dobj	_	_
30	in	in	IN	IN	sem=LOC	29	prep	_	_
31	the	the	DT	DT	_	33	det	_	_
32	Kcnj11	kcnj0	NN	NN	_	33	compound	_	_
33	gene	gene	NN	NN	_	30	pobj	_	_
34	,	,	,	,	_	26	punct	_	_
35	leading	lead	VBG	VBG	syn=ADV	26	advcl	_	_
36	to	to	IN	IN	_	35	prep	_	_
37	premature	premature	JJ	JJ	_	38	amod	_	_
38	termination	termination	NN	NN	_	36	pobj	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	the	the	DT	DT	_	46	det	_	_
41	KATP	katp	NN	NN	_	42	nmod	_	_
42	channel	channel	NN	NN	_	46	nmod	_	_
43	pore	pore	NN	NN	_	46	nmod	_	_
44	-	-	HYPH	HYPH	_	43	punct	_	_
45	forming	form	VBG	VBG	_	43	amod	_	_
46	subunit	subunit	NN	NN	_	39	pobj	_	_
47	[	[	-LRB-	-LRB-	_	48	punct	_	_
48	48	0	CD	CD	_	19	parataxis	_	_
49	]	]	-RRB-	-RRB-	_	48	punct	_	_
50	.	.	.	.	_	19	punct	_	_

1	At	at	IN	IN	_	15	prep	_	_
2	low	low	JJ	JJ	_	4	amod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	glucose	glucose	NN	NN	_	5	compound	_	_
5	concentrations	concentration	NNS	NNS	_	1	pobj	_	_
6	,	,	,	,	_	15	punct	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	secretion	secretion	NN	NN	_	15	nsubjpass	_	_
9	from	from	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	12	det	_	_
11	Kir6.2Y12X	kir0y0x	NN	NN	_	12	compound	_	_
12	islets	islet	NNS	NNS	_	9	pobj	_	_
13	was	be	VBD	VBD	_	15	auxpass	_	_
14	already	already	RB	RB	_	15	advmod	_	_
15	suppressed	suppress	VBN	VBN	_	0	root	_	_
16	compared	compare	VBN	VBN	_	15	prep	_	_
17	with	with	IN	IN	_	16	prep	_	_
18	that	that	DT	DT	_	17	pobj	_	_
19	from	from	IN	IN	_	18	prep	_	_
20	wild	wild	JJ	JJ	_	22	amod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	type	type	NN	NN	_	23	compound	_	_
23	islets	islet	NNS	NNS	_	19	pobj	_	_
24	(	(	-LRB-	-LRB-	_	26	punct	_	_
25	Figure	figure	NN	NN	_	26	compound	_	_
26	3B	0b	NN	NN	_	15	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	,	,	,	,	_	15	punct	_	_
29	similar	similar	JJ	JJ	syn=PRD	15	advcl	_	_
30	to	to	IN	IN	_	29	prep	_	_
31	the	the	DT	DT	_	32	det	_	_
32	effect	effect	NN	NN	_	30	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	glucose	glucose	NN	NN	_	35	compound	_	_
35	stimulation	stimulation	NN	NN	_	33	pobj	_	_
36	or	or	CC	CC	_	35	cc	_	_
37	pharmacological	pharmacological	JJ	JJ	_	40	amod	_	_
38	KATP	katp	NN	NN	_	39	compound	_	_
39	channel	channel	NN	NN	_	40	compound	_	_
40	inhibition	inhibition	NN	NN	_	35	conj	_	_
41	observed	observe	VBN	VBN	_	32	acl	_	_
42	in	in	IN	IN	_	41	prep	_	_
43	Figures	figure	NNS	NNS	_	44	compound	_	_
44	2D	0d	NN	NN	_	42	pobj	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	3A	0a	NN	NN	_	44	conj	_	_
47	.	.	.	.	_	15	punct	_	_

1	Consistent	consistent	JJ	JJ	syn=PRD	13	advcl	_	_
2	with	with	IN	IN	_	1	prep	_	_
3	a	a	DT	DT	_	5	det	_	_
4	recent	recent	JJ	JJ	_	5	amod	_	_
5	report	report	NN	NN	_	2	pobj	_	_
6	[	[	-LRB-	-LRB-	_	7	punct	_	_
7	49	0	CD	CD	_	1	parataxis	_	_
8	]	]	-RRB-	-RRB-	_	7	punct	_	_
9	,	,	,	,	_	13	punct	_	_
10	higher	high	JJR	JJR	_	12	amod	_	_
11	glucose	glucose	NN	NN	_	12	compound	_	_
12	levels	level	NNS	NNS	_	13	nsubj	_	_
13	stimulated	stimulate	VBD	VBD	_	0	root	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	13	dobj	_	_
16	,	,	,	,	_	13	punct	_	_
17	perhaps	perhaps	RB	RB	_	18	advmod	_	_
18	due	due	IN	IN	sem=PRP	13	prep	_	_
19	to	to	IN	IN	_	18	pcomp	_	_
20	a	a	DT	DT	_	22	det	_	_
21	direct	direct	JJ	JJ	_	22	amod	_	_
22	effect	effect	NN	NN	_	18	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	metabolism	metabolism	NN	NN	_	23	pobj	_	_
25	on	on	IN	IN	_	22	prep	_	_
26	secretion	secretion	NN	NN	_	25	pobj	_	_
27	[	[	-LRB-	-LRB-	_	28	punct	_	_
28	33	0	CD	CD	_	13	parataxis	_	_
29	]	]	-RRB-	-RRB-	_	28	punct	_	_
30	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	sem=LOC	9	prep	_	_
2	wild	wild	JJ	JJ	_	4	amod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	type	type	NN	NN	_	5	compound	_	_
5	islets	islet	NNS	NNS	_	1	pobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	secretion	secretion	NN	NN	_	9	nsubj	_	_
9	exhibited	exhibit	VBD	VBD	_	0	root	_	_
10	a	a	DT	DT	_	11	det	_	_
11	nadir	nadir	NN	NN	_	9	dobj	_	_
12	at	at	IN	IN	_	9	prep	_	_
13	5	0	CD	CD	_	14	nummod	_	_
14	mM	mm	NNS	NNS	_	15	compound	_	_
15	glucose	glucose	NN	NN	_	12	pobj	_	_
16	,	,	,	,	_	9	punct	_	_
17	and	and	CC	CC	_	9	cc	_	_
18	glucagon	glucagon	NN	NN	_	19	compound	_	_
19	secretion	secretion	NN	NN	_	24	nsubj	_	_
20	at	at	IN	IN	_	19	prep	_	_
21	20	0	CD	CD	_	22	nummod	_	_
22	mM	mm	NNS	NNS	_	23	compound	_	_
23	glucose	glucose	NN	NN	_	20	pobj	_	_
24	was	be	VBD	VBD	_	9	conj	_	_
25	40	0	CD	CD	_	26	nummod	_	_
26	%	%	NN	NN	_	27	npadvmod	_	_
27	higher	high	JJR	JJR	syn=PRD	24	acomp	_	_
28	than	than	IN	IN	_	27	prep	_	_
29	at	at	IN	IN	_	28	prep	_	_
30	5	0	CD	CD	_	31	nummod	_	_
31	mM	mm	NNS	NNS	_	32	compound	_	_
32	glucose	glucose	NN	NN	_	29	pobj	_	_
33	.	.	.	.	_	9	punct	_	_

1	Insulin	insulin	NN	NN	_	2	compound	_	_
2	secretion	secretion	NN	NN	_	8	nsubjpass	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	the	the	DT	DT	_	6	det	_	_
5	Kir6.2Y12X	kir0y0x	NN	NN	_	6	compound	_	_
6	islets	islet	NNS	NNS	_	3	pobj	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	elevated	elevate	VBN	VBN	_	0	root	_	_
9	at	at	IN	IN	_	8	prep	_	_
10	low	low	JJ	JJ	_	12	amod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	glucose	glucose	NN	NN	_	13	compound	_	_
13	concentrations	concentration	NNS	NNS	_	9	pobj	_	_
14	(	(	-LRB-	-LRB-	_	16	punct	_	_
15	Figure	figure	NN	NN	_	16	compound	_	_
16	3C	0c	NN	NN	_	8	parataxis	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	,	,	,	,	_	8	punct	_	_
19	whereas	whereas	IN	IN	_	26	mark	_	_
20	glucose	glucose	NN	NN	_	22	npadvmod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	stimulated	stimulate	VBN	VBN	_	24	amod	_	_
23	insulin	insulin	NN	NN	_	24	compound	_	_
24	secretion	secretion	NN	NN	_	26	nsubjpass	_	_
25	was	be	VBD	VBD	_	26	auxpass	_	_
26	blunted	blunt	VBN	VBN	syn=ADV	8	advcl	_	_
27	.	.	.	.	_	8	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	notable	notable	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	increase	increase	NN	NN	_	14	nsubj	_	_
7	in	in	IN	IN	_	6	prep	_	_
8	glucagon	glucagon	NN	NN	_	9	compound	_	_
9	release	release	NN	NN	_	7	pobj	_	_
10	from	from	IN	IN	_	6	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	Kir6.2Y12X	kir0y0x	NN	NN	_	13	compound	_	_
13	islets	islet	NNS	NNS	_	10	pobj	_	_
14	was	be	VBD	VBD	_	2	ccomp	_	_
15	coincident	coincident	JJ	JJ	syn=PRD	14	acomp	_	_
16	with	with	IN	IN	_	15	prep	_	_
17	increased	increase	VBN	VBN	_	19	amod	_	_
18	insulin	insulin	NN	NN	_	19	compound	_	_
19	secretion	secretion	NN	NN	_	16	pobj	_	_
20	,	,	,	,	_	14	punct	_	_
21	reinforcing	reinforce	VBG	VBG	syn=ADV	14	advcl	_	_
22	the	the	DT	DT	_	23	det	_	_
23	view	view	NN	NN	_	21	dobj	_	_
24	that	that	IN	IN	_	30	mark	_	_
25	inhibition	inhibition	NN	NN	_	30	nsubjpass	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	glucagon	glucagon	NN	NN	_	26	pobj	_	_
28	is	be	VBZ	VBZ	_	30	auxpass	_	_
29	not	not	RB	RB	_	30	neg	_	_
30	mediated	mediate	VBN	VBN	_	23	acl	_	_
31	by	by	IN	IN	sem=MNR	30	prep	_	_
32	a	a	DT	DT	_	33	det	_	_
33	factor	factor	NN	NN	_	31	pobj	_	_
34	released	release	VBN	VBN	_	33	acl	_	_
35	by	by	IN	IN	sem=MNR	34	prep	_	_
36	the	the	DT	DT	_	38	det	_	_
37	β	β	NN	NN	_	38	compound	_	_
38	cells	cell	NNS	NNS	_	35	pobj	_	_
39	.	.	.	.	_	2	punct	_	_

1	Furthermore	furthermore	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	in	in	IN	IN	sem=LOC	12	prep	_	_
4	control	control	NN	NN	_	5	compound	_	_
5	islets	islet	NNS	NNS	_	3	pobj	_	_
6	,	,	,	,	_	12	punct	_	_
7	the	the	DT	DT	_	8	det	_	_
8	inhibition	inhibition	NN	NN	_	12	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	9	pobj	_	_
12	is	be	VBZ	VBZ	_	0	root	_	_
13	maximal	maximal	JJ	JJ	syn=PRD	12	acomp	_	_
14	at	at	IN	IN	_	12	prep	_	_
15	a	a	DT	DT	_	16	det	_	_
16	concentration	concentration	NN	NN	_	14	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	glucose	glucose	NN	NN	_	17	pobj	_	_
19	(	(	-LRB-	-LRB-	_	16	punct	_	_
20	5	0	CD	CD	_	21	nummod	_	_
21	mM	mm	NNS	NNS	_	16	appos	_	_
22	)	)	-RRB-	-RRB-	_	16	punct	_	_
23	that	that	WDT	WDT	_	24	dep	_	16:ref
24	is	be	VBZ	VBZ	_	16	relcl	_	_
25	without	without	IN	IN	syn=PRD	24	prep	_	_
26	stimulatory	stimulatory	JJ	JJ	_	27	amod	_	_
27	action	action	NN	NN	_	25	pobj	_	_
28	on	on	IN	IN	_	27	prep	_	_
29	insulin	insulin	NN	NN	_	30	compound	_	_
30	secretion	secretion	NN	NN	_	28	pobj	_	_
31	.	.	.	.	_	12	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	next	next	RB	RB	sem=TMP	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	function	function	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	α	α	NN	NN	_	10	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	β	β	NN	NN	_	7	conj	_	_
10	cells	cell	NNS	NNS	_	6	pobj	_	_
11	in	in	FW	FW	_	12	advmod	_	_
12	situ	situ	FW	FW	_	3	advmod	_	_
13	by	by	IN	IN	sem=MNR	3	prep	_	_
14	monitoring	monitor	VBG	VBG	syn=NOM	13	pcomp	_	_
15	the	the	DT	DT	_	20	det	_	_
16	[	[	-LRB-	-LRB-	_	19	punct	_	_
17	Ca2+	ca0+	NN	NN	_	19	nmod	_	_
18	]	]	-RRB-	-RRB-	_	19	punct	_	_
19	i	i	NN	NN	_	20	compound	_	_
20	responses	response	NNS	NNS	_	14	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	single	single	JJ	JJ	_	23	amod	_	_
23	cells	cell	NNS	NNS	_	21	pobj	_	_
24	within	within	IN	IN	sem=LOC	20	prep	_	_
25	intact	intact	JJ	JJ	_	27	amod	_	_
26	mouse	mouse	NN	NN	_	27	compound	_	_
27	islets	islet	NNS	NNS	_	24	pobj	_	_
28	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	4	nsubjpass	_	_
2	were	be	VBD	VBD	_	4	auxpass	_	_
3	functionally	functionally	RB	RB	_	4	advmod	_	_
4	identified	identify	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	their	their	PRP$	PRP$	_	11	poss	_	_
7	[	[	-LRB-	-LRB-	_	10	punct	_	_
8	Ca2+	ca0+	NN	NN	_	10	nmod	_	_
9	]	]	-RRB-	-RRB-	_	10	punct	_	_
10	i	i	NN	NN	_	11	compound	_	_
11	response	response	NN	NN	_	5	pobj	_	_
12	to	to	IN	IN	_	11	prep	_	_
13	0.5	0	CD	CD	_	19	nummod	_	_
14	,	,	,	,	_	13	punct	_	_
15	2	0	CD	CD	_	13	conj	_	_
16	,	,	,	,	_	15	punct	_	_
17	and	and	CC	CC	_	15	cc	_	_
18	11	0	CD	CD	_	15	conj	_	_
19	mM	mm	NNS	NNS	_	20	compound	_	_
20	glucose	glucose	NN	NN	_	12	pobj	_	_
21	[	[	-LRB-	-LRB-	_	22	punct	_	_
22	50	0	CD	CD	_	4	parataxis	_	_
23	]	]	-RRB-	-RRB-	_	22	punct	_	_
24	.	.	.	.	_	4	punct	_	_

1	Glucose	glucose	NN	NN	_	2	compound	_	_
2	stimulation	stimulation	NN	NN	_	3	nsubj	_	_
3	suppressed	suppress	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	9	det	_	_
5	[	[	-LRB-	-LRB-	_	8	punct	_	_
6	Ca2+	ca0+	NN	NN	_	8	nmod	_	_
7	]	]	-RRB-	-RRB-	_	8	punct	_	_
8	i	i	NN	NN	_	9	compound	_	_
9	response	response	NN	NN	_	3	dobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	α	α	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	10	pobj	_	_
13	by	by	IN	IN	_	3	prep	_	_
14	51	0	CD	CD	_	16	quantmod	_	_
15	±	±	SYM	SYM	_	16	punct	_	_
16	3	0	CD	CD	_	17	nummod	_	_
17	%	%	NN	NN	_	13	pobj	_	_
18	(	(	-LRB-	-LRB-	_	29	punct	_	_
19	n	n	NN	NN	_	22	nsubj	_	_
20	=	=	SYM	SYM	_	22	punct	_	_
21	63	0	CD	CD	_	22	nummod	_	_
22	cells	cell	NNS	NNS	_	29	ccomp	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	15	0	CD	CD	_	25	nummod	_	_
25	islets	islet	NNS	NNS	_	23	pobj	_	_
26	,	,	,	,	_	29	punct	_	_
27	p	p	NN	NN	_	29	nsubj	_	_
28	<	<	SYM	SYM	_	29	punct	_	_
29	0.001	0	CD	CD	_	17	parataxis	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	(	(	-LRB-	-LRB-	_	33	punct	_	_
32	Figure	figure	NN	NN	_	33	compound	_	_
33	4A	0a	NN	NN	_	3	parataxis	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	4B	0b	NN	NN	_	33	conj	_	_
36	)	)	-RRB-	-RRB-	_	33	punct	_	_
37	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	suppressive	suppressive	JJ	JJ	_	3	amod	_	_
3	effect	effect	NN	NN	_	7	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	glucose	glucose	NN	NN	_	4	pobj	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	alleviated	alleviate	VBN	VBN	_	0	root	_	_
8	(	(	-LRB-	-LRB-	_	7	punct	_	_
9	to	to	IN	IN	_	7	prep	_	_
10	101	0	CD	CD	_	12	quantmod	_	_
11	±	±	SYM	SYM	_	12	punct	_	_
12	11	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	9	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	initial	initial	JJ	JJ	_	16	amod	_	_
16	values	value	NNS	NNS	_	14	pobj	_	_
17	)	)	-RRB-	-RRB-	_	7	punct	_	_
18	by	by	IN	IN	sem=MNR	7	prep	_	_
19	application	application	NN	NN	_	18	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	2	0	CD	CD	_	22	nummod	_	_
22	μM	μm	NN	NN	_	23	compound	_	_
23	diazoxide	diazoxide	NN	NN	_	20	pobj	_	_
24	(	(	-LRB-	-LRB-	_	26	punct	_	_
25	Figure	figure	NN	NN	_	26	compound	_	_
26	4A	0a	NN	NN	_	7	parataxis	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	4B	0b	NN	NN	_	26	conj	_	_
29	)	)	-RRB-	-RRB-	_	26	punct	_	_
30	.	.	.	.	_	7	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	concentration	concentration	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	diazoxide	diazoxide	NN	NN	_	3	pobj	_	_
5	was	be	VBD	VBD	_	0	root	_	_
6	similar	similar	JJ	JJ	syn=PRD	5	acomp	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	that	that	DT	DT	_	7	pobj	_	_
9	which	which	WDT	WDT	_	10	dep	_	8:ref
10	produced	produce	VBD	VBD	_	8	relcl	_	_
11	maximal	maximal	JJ	JJ	_	12	amod	_	_
12	stimulation	stimulation	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	13	pobj	_	_
16	and	and	CC	CC	_	6	cc	_	_
17	much	much	JJ	JJ	_	22	amod	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	∼	∼	SYM	SYM	_	20	punct	_	_
20	15-fold	0-fold	RB	RB	_	22	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	lower	low	JJR	JJR	_	6	conj	_	_
23	than	than	IN	IN	_	22	prep	_	_
24	necessary	necessary	JJ	JJ	_	23	amod	_	_
25	to	to	TO	TO	_	26	aux	_	_
26	inhibit	inhibit	VB	VB	_	24	xcomp	_	_
27	insulin	insulin	NN	NN	_	28	compound	_	_
28	secretion	secretion	NN	NN	_	26	dobj	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	Figure	figure	NN	NN	_	31	compound	_	_
31	2B	0b	NN	NN	_	28	parataxis	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	or	or	CC	CC	_	28	cc	_	_
34	β	β	NN	NN	_	36	nmod	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	cell	cell	NN	NN	_	41	nmod	_	_
37	[	[	-LRB-	-LRB-	_	40	punct	_	_
38	Ca2+	ca0+	NN	NN	_	40	nmod	_	_
39	]	]	-RRB-	-RRB-	_	40	punct	_	_
40	i	i	NN	NN	_	41	compound	_	_
41	responses	response	NNS	NNS	_	28	conj	_	_
42	to	to	IN	IN	_	41	prep	_	_
43	glucose	glucose	NN	NN	_	42	pobj	_	_
44	(	(	-LRB-	-LRB-	_	46	punct	_	_
45	Figure	figure	NN	NN	_	46	compound	_	_
46	4A	0a	NN	NN	_	22	parataxis	_	_
47	)	)	-RRB-	-RRB-	_	46	punct	_	_
48	.	.	.	.	_	5	punct	_	_

1	KATP	katp	NN	NN	_	2	compound	_	_
2	Channels	channel	NNS	NNS	_	3	nsubj	_	_
3	Regulate	regulate	VBP	VBP	_	0	root	_	_
4	Human	human	JJ	JJ	_	8	amod	_	_
5	α	α	NN	NN	_	7	compound	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	Cell	cell	NN	NN	_	8	compound	_	_
8	Activity	activity	NN	NN	_	3	dobj	_	_

1	Little	little	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	5	nsubjpass	_	_
3	has	have	VBZ	VBZ	_	5	aux	_	_
4	been	be	VBN	VBN	_	5	auxpass	_	_
5	done	do	VBN	VBN	_	0	root	_	_
6	to	to	TO	TO	_	7	aux	_	_
7	examine	examine	VB	VB	sem=PRP	5	advcl	_	_
8	the	the	DT	DT	_	9	det	_	_
9	mechanism	mechanism	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	glucose	glucose	NN	NN	_	13	npadvmod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	regulated	regulate	VBN	VBN	_	15	amod	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	10	pobj	_	_
16	from	from	IN	IN	_	15	prep	_	_
17	isolated	isolate	VBN	VBN	_	19	amod	_	_
18	human	human	JJ	JJ	_	19	amod	_	_
19	islets	islet	NNS	NNS	_	16	pobj	_	_
20	[	[	-LRB-	-LRB-	_	21	punct	_	_
21	51	0	CD	CD	_	5	parataxis	_	_
22	]	]	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	5	punct	_	_

1	Glucagon	glucagon	NN	NN	_	4	nmod	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	insulin	insulin	NN	NN	_	1	conj	_	_
4	secretion	secretion	NN	NN	_	12	nsubjpass	_	_
5	from	from	IN	IN	_	4	prep	_	_
6	islets	islet	NNS	NNS	_	5	pobj	_	_
7	isolated	isolate	VBN	VBN	_	6	acl	_	_
8	from	from	IN	IN	_	7	prep	_	_
9	healthy	healthy	JJ	JJ	_	10	amod	_	_
10	donors	donor	NNS	NNS	_	8	pobj	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	examined	examine	VBN	VBN	_	0	root	_	_
13	.	.	.	.	_	12	punct	_	_

1	Similar	similar	JJ	JJ	syn=PRD	11	advcl	_	_
2	to	to	IN	IN	_	1	prep	_	_
3	above	above	RB	RB	_	2	pcomp	_	_
4	,	,	,	,	_	11	punct	_	_
5	glucagon	glucagon	NN	NN	_	6	compound	_	_
6	secretion	secretion	NN	NN	_	11	nsubjpass	_	_
7	from	from	IN	IN	_	6	prep	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	islets	islet	NNS	NNS	_	7	pobj	_	_
10	was	be	VBD	VBD	_	11	auxpass	_	_
11	suppressed	suppress	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	sem=EXT	11	prep	_	_
13	58	0	CD	CD	_	15	quantmod	_	_
14	±	±	SYM	SYM	_	15	punct	_	_
15	3	0	CD	CD	_	16	nummod	_	_
16	%	%	NN	NN	_	12	pobj	_	_
17	(	(	-LRB-	-LRB-	_	24	punct	_	_
18	n	n	NN	NN	_	20	nsubj	_	_
19	=	=	SYM	SYM	_	20	punct	_	_
20	9	0	CD	CD	_	24	ccomp	_	_
21	,	,	,	,	_	24	punct	_	_
22	p	p	NN	NN	_	24	nsubj	_	_
23	<	<	SYM	SYM	_	24	punct	_	_
24	0.05	0	CD	CD	_	11	parataxis	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	upon	upon	IN	IN	sem=TMP	11	prep	_	_
27	raising	raise	VBG	VBG	syn=NOM	26	pcomp	_	_
28	the	the	DT	DT	_	30	det	_	_
29	glucose	glucose	NN	NN	_	30	compound	_	_
30	concentration	concentration	NN	NN	_	27	dobj	_	_
31	from	from	IN	IN	_	27	prep	_	_
32	0	0	CD	CD	_	31	pobj	_	_
33	to	to	IN	IN	_	31	prep	_	_
34	10	0	CD	CD	_	33	pobj	_	_
35	mM	mm	NNS	NNS	_	31	pobj	_	_
36	.	.	.	.	_	11	punct	_	_

1	Tolbutamide	tolbutamide	NN	NN	_	6	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	4	punct	_	_
3	200	0	CD	CD	_	4	nummod	_	_
4	μM	μm	NNS	NNS	_	1	parataxis	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	inhibited	inhibit	VBD	VBD	_	0	root	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	release	release	NN	NN	_	6	dobj	_	_
9	by	by	IN	IN	_	6	prep	_	_
10	43	0	CD	CD	_	12	quantmod	_	_
11	±	±	SYM	SYM	_	12	punct	_	_
12	14	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	_	9	pobj	_	_
14	(	(	-LRB-	-LRB-	_	21	punct	_	_
15	n	n	NN	NN	_	17	nsubj	_	_
16	=	=	SYM	SYM	_	17	punct	_	_
17	7	0	CD	CD	_	21	ccomp	_	_
18	,	,	,	,	_	21	punct	_	_
19	p	p	NN	NN	_	21	nsubj	_	_
20	<	<	SYM	SYM	_	21	punct	_	_
21	0.05	0	CD	CD	_	6	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	6	punct	_	_

1	At	at	IN	IN	sem=TMP	9	prep	_	_
2	the	the	DT	DT	_	4	det	_	_
3	same	same	JJ	JJ	_	4	amod	_	_
4	time	time	NN	NN	_	1	pobj	_	_
5	,	,	,	,	_	9	punct	_	_
6	insulin	insulin	NN	NN	_	7	compound	_	_
7	secretion	secretion	NN	NN	_	9	nsubjpass	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	increased	increase	VBN	VBN	_	0	root	_	_
10	6.4	0	CD	CD	sem=EXT	9	advmod	_	_
11	-	-	HYPH	HYPH	_	10	punct	_	_
12	and	and	CC	CC	_	10	cc	_	_
13	4.4-fold	0-fold	RB	RB	_	10	conj	_	_
14	by	by	IN	IN	sem=MNR	9	prep	_	_
15	glucose	glucose	NN	NN	_	18	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	tolbutamide	tolbutamide	NN	NN	_	15	conj	_	_
18	stimulation	stimulation	NN	NN	_	14	pobj	_	_
19	,	,	,	,	_	9	punct	_	_
20	respectively	respectively	RB	RB	_	9	advmod	_	_
21	(	(	-LRB-	-LRB-	_	23	punct	_	_
22	Figure	figure	NN	NN	_	23	compound	_	_
23	5A	0a	NN	NN	_	9	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	9	punct	_	_

1	Moderate	moderate	JJ	JJ	_	2	amod	_	_
2	re-activation	re-activation	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	KATP	katp	NN	NN	_	5	compound	_	_
5	channels	channel	NNS	NNS	_	3	pobj	_	_
6	with	with	IN	IN	_	2	prep	_	_
7	2	0	CD	CD	_	8	nummod	_	_
8	μM	μm	NNS	NNS	_	9	compound	_	_
9	diazoxide	diazoxide	NN	NN	_	6	pobj	_	_
10	antagonized	antagonize	VBD	VBD	_	0	root	_	_
11	the	the	DT	DT	_	15	det	_	_
12	glucose	glucose	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	induced	induce	VBN	VBN	_	15	amod	_	_
15	suppression	suppression	NN	NN	_	10	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	release	release	NN	NN	_	16	pobj	_	_
19	(	(	-LRB-	-LRB-	_	26	punct	_	_
20	n	n	NN	NN	_	22	nsubj	_	_
21	=	=	SYM	SYM	_	22	punct	_	_
22	7	0	CD	CD	_	26	ccomp	_	_
23	,	,	,	,	_	26	punct	_	_
24	p	p	NN	NN	_	26	nsubj	_	_
25	<	<	SYM	SYM	_	26	punct	_	_
26	0.01	0	CD	CD	_	10	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	Figure	figure	NN	NN	_	30	compound	_	_
30	5B	0b	NN	NN	_	10	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	.	.	.	.	_	10	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	10-fold	0-fold	RB	RB	_	3	advmod	_	_
3	higher	high	JJR	JJR	_	4	amod	_	_
4	concentration	concentration	NN	NN	_	7	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	diazoxide	diazoxide	NN	NN	_	5	pobj	_	_
7	had	have	VBD	VBD	_	0	root	_	_
8	significantly	significantly	RB	RB	_	9	advmod	_	_
9	less	less	JJR	JJR	_	11	amod	_	_
10	stimulatory	stimulatory	JJ	JJ	_	11	amod	_	_
11	effect	effect	NN	NN	_	7	dobj	_	_
12	(	(	-LRB-	-LRB-	_	15	punct	_	_
13	p	p	NN	NN	_	15	nsubj	_	_
14	<	<	SYM	SYM	_	15	punct	_	_
15	0.001	0	CD	CD	_	7	parataxis	_	_
16	versus	versus	CC	CC	_	15	cc	_	_
17	2	0	CD	CD	_	18	nummod	_	_
18	μM	μm	NNS	NNS	_	19	compound	_	_
19	diazoxide	diazoxide	NN	NN	_	15	conj	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	,	,	,	,	_	7	punct	_	_
22	and	and	CC	CC	_	7	cc	_	_
23	in	in	IN	IN	_	33	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	presence	presence	NN	NN	_	23	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	200	0	CD	CD	_	28	nummod	_	_
28	μM	μm	NNS	NNS	_	29	compound	_	_
29	diazoxide	diazoxide	NN	NN	_	26	pobj	_	_
30	,	,	,	,	_	33	punct	_	_
31	glucagon	glucagon	NN	NN	_	32	compound	_	_
32	secretion	secretion	NN	NN	_	33	nsubj	_	_
33	was	be	VBD	VBD	_	7	conj	_	_
34	not	not	RB	RB	_	33	neg	_	_
35	different	different	JJ	JJ	syn=PRD	33	acomp	_	_
36	from	from	IN	IN	_	35	prep	_	_
37	that	that	DT	DT	_	36	pobj	_	_
38	observed	observe	VBN	VBN	_	37	acl	_	_
39	in	in	IN	IN	_	38	prep	_	_
40	the	the	DT	DT	_	41	det	_	_
41	absence	absence	NN	NN	_	39	pobj	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	the	the	DT	DT	_	46	det	_	_
44	KATP	katp	NN	NN	_	45	compound	_	_
45	channel	channel	NN	NN	_	46	compound	_	_
46	activator	activator	NN	NN	_	42	pobj	_	_
47	.	.	.	.	_	33	punct	_	_

1	Importantly	importantly	RB	RB	_	22	advmod	_	_
2	,	,	,	,	_	22	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	lowest	low	JJS	JJS	_	5	amod	_	_
5	concentration	concentration	NN	NN	_	22	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	diazoxide	diazoxide	NN	NN	_	6	pobj	_	_
8	(	(	-LRB-	-LRB-	_	10	punct	_	_
9	2	0	CD	CD	_	10	nummod	_	_
10	μM	μm	NNS	NNS	_	5	parataxis	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	,	,	,	,	_	5	punct	_	_
13	which	which	WDT	WDT	_	14	dep	_	5:ref
14	produced	produce	VBD	VBD	_	5	relcl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	strongest	strong	JJS	JJS	_	17	amod	_	_
17	stimulation	stimulation	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	glucagon	glucagon	NN	NN	_	20	compound	_	_
20	secretion	secretion	NN	NN	_	18	pobj	_	_
21	,	,	,	,	_	22	punct	_	_
22	had	have	VBD	VBD	_	0	root	_	_
23	no	no	DT	DT	_	25	det	_	_
24	inhibitory	inhibitory	JJ	JJ	_	25	amod	_	_
25	effect	effect	NN	NN	_	22	dobj	_	_
26	on	on	IN	IN	_	25	prep	_	_
27	glucose	glucose	NN	NN	_	29	npadvmod	_	_
28	-	-	HYPH	HYPH	_	29	punct	_	_
29	stimulated	stimulate	VBN	VBN	_	31	amod	_	_
30	insulin	insulin	NN	NN	_	31	compound	_	_
31	secretion	secretion	NN	NN	_	26	pobj	_	_
32	(	(	-LRB-	-LRB-	_	35	punct	_	_
33	n	n	NN	NN	_	35	nsubj	_	_
34	=	=	SYM	SYM	_	35	punct	_	_
35	5	0	CD	CD	_	25	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	,	,	,	,	_	22	punct	_	_
38	whereas	whereas	IN	IN	_	43	mark	_	_
39	20	0	CD	CD	_	42	nummod	_	_
40	and	and	CC	CC	_	39	cc	_	_
41	200	0	CD	CD	_	39	conj	_	_
42	μM	μm	NNS	NNS	_	43	nsubj	_	_
43	produced	produce	VBD	VBD	syn=ADV	22	advcl	_	_
44	partial	partial	JJ	JJ	_	47	amod	_	_
45	or	or	CC	CC	_	44	cc	_	_
46	complete	complete	JJ	JJ	_	44	conj	_	_
47	inhibition	inhibition	NN	NN	_	43	dobj	_	_
48	of	of	IN	IN	_	47	prep	_	_
49	insulin	insulin	NN	NN	_	50	compound	_	_
50	secretion	secretion	NN	NN	_	48	pobj	_	_
51	.	.	.	.	_	22	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	GABAA	gabaa	NN	NN	_	4	compound	_	_
3	receptor	receptor	NN	NN	_	4	compound	_	_
4	antagonist	antagonist	NN	NN	_	6	nsubj	_	_
5	SR95531	sr0	NN	NN	_	4	appos	_	_
6	had	have	VBD	VBD	_	0	root	_	_
7	no	no	DT	DT	_	8	det	_	_
8	effect	effect	NN	NN	_	6	dobj	_	_
9	on	on	IN	IN	_	8	prep	_	_
10	glucose	glucose	NN	NN	_	12	npadvmod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	induced	induce	VBN	VBN	_	13	amod	_	_
13	inhibition	inhibition	NN	NN	_	9	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	14	pobj	_	_
17	from	from	IN	IN	_	13	prep	_	_
18	human	human	JJ	JJ	_	19	amod	_	_
19	islets	islet	NNS	NNS	_	17	pobj	_	_
20	,	,	,	,	_	6	punct	_	_
21	and	and	CC	CC	_	6	cc	_	_
22	whole	whole	JJ	JJ	_	24	amod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	cell	cell	NN	NN	_	28	compound	_	_
25	voltage	voltage	NN	NN	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	clamp	clamp	NN	NN	_	28	compound	_	_
28	measurements	measurement	NNS	NNS	_	29	nsubj	_	_
29	indicate	indicate	VBP	VBP	_	6	conj	_	_
30	that	that	IN	IN	_	42	mark	_	_
31	human	human	JJ	JJ	_	33	amod	_	_
32	α	α	NN	NN	_	33	compound	_	_
33	cells	cell	NNS	NNS	_	42	nsubj	_	_
34	,	,	,	,	_	42	punct	_	_
35	unlike	unlike	IN	IN	_	42	prep	_	_
36	human	human	JJ	JJ	_	40	amod	_	_
37	β	β	NN	NN	_	40	nmod	_	_
38	and	and	CC	CC	_	37	cc	_	_
39	δ	δ	NN	NN	_	37	conj	_	_
40	cells	cell	NNS	NNS	_	35	pobj	_	_
41	,	,	,	,	_	42	punct	_	_
42	express	express	VBP	VBP	_	29	ccomp	_	_
43	few	few	JJ	JJ	_	50	amod	_	_
44	if	if	IN	IN	_	45	mark	_	_
45	any	any	DT	DT	_	43	parataxis	_	_
46	GABAA	gabaa	NN	NN	_	47	nmod	_	_
47	receptor	receptor	NN	NN	_	50	nmod	_	_
48	Cl	cl	NN	NN	_	50	nmod	_	_
49	−	−	SYM	SYM	_	48	punct	_	_
50	channels	channel	NNS	NNS	_	42	dobj	_	_
51	(	(	-LRB-	-LRB-	_	52	punct	_	_
52	M.	m.	NNP	NNP	_	29	meta	_	_
53	Braun	braun	NNP	NNP	_	52	nmod	_	_
54	,	,	,	,	_	52	punct	_	_
55	R.	r.	NNP	NNP	_	52	conj	_	_
56	Ramracheya	ramracheya	NNP	NNP	_	55	nmod	_	_
57	,	,	,	,	_	55	punct	_	_
58	and	and	CC	CC	_	55	cc	_	_
59	P.	p.	NNP	NNP	_	55	conj	_	_
60	Rorsman	rorsman	NNP	NNP	_	59	nmod	_	_
61	,	,	,	,	_	59	punct	_	_
62	unpublished	unpublished	JJ	JJ	_	63	amod	_	_
63	data	datum	NNS	NNS	_	59	conj	_	_
64	)	)	-RRB-	-RRB-	_	63	punct	_	_
65	.	.	.	.	_	29	punct	_	_

1	Examination	examination	NN	NN	_	16	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	5	det	_	_
4	Ca2+	ca0+	NN	NN	_	5	compound	_	_
5	responses	response	NNS	NNS	_	2	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	single	single	JJ	JJ	_	11	amod	_	_
8	α	α	NN	NN	_	11	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	β	β	NN	NN	_	8	conj	_	_
11	cells	cell	NNS	NNS	_	6	pobj	_	_
12	within	within	IN	IN	sem=LOC	5	prep	_	_
13	intact	intact	JJ	JJ	_	15	amod	_	_
14	human	human	JJ	JJ	_	15	amod	_	_
15	islets	islet	NNS	NNS	_	12	pobj	_	_
16	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
17	that	that	IN	IN	_	19	mark	_	_
18	glucose	glucose	NN	NN	_	19	nsubj	_	_
19	decreased	decrease	VBD	VBD	_	16	advcl	_	_
20	[	[	-LRB-	-LRB-	_	23	punct	_	_
21	Ca2+	ca0+	NN	NN	_	23	nmod	_	_
22	]	]	-RRB-	-RRB-	_	23	punct	_	_
23	i	i	NN	NN	_	19	dobj	_	_
24	by	by	IN	IN	sem=EXT	19	prep	_	_
25	62	0	CD	CD	_	27	quantmod	_	_
26	±	±	SYM	SYM	_	27	punct	_	_
27	3	0	CD	CD	_	28	nummod	_	_
28	%	%	NN	NN	_	24	pobj	_	_
29	(	(	-LRB-	-LRB-	_	40	punct	_	_
30	n	n	NN	NN	_	33	nsubj	_	_
31	=	=	SYM	SYM	_	33	punct	_	_
32	42	0	CD	CD	_	33	nummod	_	_
33	cells	cell	NNS	NNS	_	40	ccomp	_	_
34	in	in	IN	IN	sem=LOC	33	prep	_	_
35	7	0	CD	CD	_	36	nummod	_	_
36	islets	islet	NNS	NNS	_	34	pobj	_	_
37	,	,	,	,	_	40	punct	_	_
38	p	p	NN	NN	_	40	nsubj	_	_
39	<	<	SYM	SYM	_	40	punct	_	_
40	0.001	0	CD	CD	_	19	parataxis	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	in	in	IN	IN	sem=LOC	19	prep	_	_
43	α	α	NN	NN	_	44	compound	_	_
44	cells	cell	NNS	NNS	_	42	pobj	_	_
45	,	,	,	,	_	19	punct	_	_
46	and	and	CC	CC	_	19	cc	_	_
47	that	that	IN	IN	_	53	mark	_	_
48	this	this	DT	DT	_	49	det	_	_
49	effect	effect	NN	NN	_	53	nsubjpass	_	_
50	could	could	MD	MD	_	53	aux	_	_
51	be	be	VB	VB	_	53	auxpass	_	_
52	completely	completely	RB	RB	_	53	advmod	_	_
53	reversed	reverse	VBN	VBN	_	19	conj	_	_
54	by	by	IN	IN	sem=MNR	53	prep	_	_
55	2	0	CD	CD	_	56	nummod	_	_
56	μM	μm	NNS	NNS	_	57	compound	_	_
57	diazoxide	diazoxide	NN	NN	_	54	pobj	_	_
58	(	(	-LRB-	-LRB-	_	60	punct	_	_
59	Figure	figure	NN	NN	_	60	compound	_	_
60	6A	0a	NN	NN	_	16	parataxis	_	_
61	and	and	CC	CC	_	60	cc	_	_
62	6B	0b	NN	NN	_	60	conj	_	_
63	)	)	-RRB-	-RRB-	_	60	punct	_	_
64	.	.	.	.	_	16	punct	_	_

1	Furthermore	furthermore	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	re-activation	re-activation	NN	NN	_	18	nsubjpass	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	α	α	NN	NN	_	8	nmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	cell	cell	NN	NN	_	13	nmod	_	_
9	[	[	-LRB-	-LRB-	_	12	punct	_	_
10	Ca2+	ca0+	NN	NN	_	12	nmod	_	_
11	]	]	-RRB-	-RRB-	_	12	punct	_	_
12	i	i	NN	NN	_	13	compound	_	_
13	responses	response	NNS	NNS	_	5	pobj	_	_
14	by	by	IN	IN	_	4	prep	_	_
15	diazoxide	diazoxide	NN	NN	_	14	pobj	_	_
16	could	could	MD	MD	_	18	aux	_	_
17	be	be	VB	VB	_	18	auxpass	_	_
18	prevented	prevent	VBN	VBN	_	0	root	_	_
19	by	by	IN	IN	sem=MNR	18	prep	_	_
20	application	application	NN	NN	_	19	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	100	0	CD	CD	_	23	nummod	_	_
23	μM	μm	NNS	NNS	_	24	compound	_	_
24	tolbutamide	tolbutamide	NN	NN	_	21	pobj	_	_
25	,	,	,	,	_	18	punct	_	_
26	confirming	confirm	VBG	VBG	syn=ADV	18	advcl	_	_
27	the	the	DT	DT	_	28	det	_	_
28	role	role	NN	NN	_	26	dobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	KATP	katp	NN	NN	_	31	compound	_	_
31	channels	channel	NNS	NNS	_	29	pobj	_	_
32	(	(	-LRB-	-LRB-	_	34	punct	_	_
33	Figure	figure	NN	NN	_	34	compound	_	_
34	6C	0c	NN	NN	_	18	parataxis	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	18	punct	_	_

1	An	an	DT	DT	_	2	det	_	_
2	analysis	analysis	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	8	det	_	_
5	dose	dose	NN	NN	_	7	compound	_	_
6	–	-	HYPH	HYPH	_	7	punct	_	_
7	response	response	NN	NN	_	8	compound	_	_
8	relationship	relationship	NN	NN	_	3	pobj	_	_
9	to	to	IN	IN	_	8	prep	_	_
10	diazoxide	diazoxide	NN	NN	_	9	pobj	_	_
11	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
12	a	a	DT	DT	_	15	det	_	_
13	maximally	maximally	RB	RB	_	14	advmod	_	_
14	effective	effective	JJ	JJ	_	15	amod	_	_
15	concentration	concentration	NN	NN	_	11	dobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	1.7	0	CD	CD	_	18	nummod	_	_
18	μM	μm	NNS	NNS	_	16	pobj	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	Figure	figure	NN	NN	_	21	compound	_	_
21	6D	0d	NN	NN	_	15	parataxis	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	6E	0e	NN	NN	_	21	conj	_	_
24	;	;	:	:	_	21	punct	_	_
25	n	n	NN	NN	_	28	nsubj	_	_
26	=	=	SYM	SYM	_	28	punct	_	_
27	38	0	CD	CD	_	28	nummod	_	_
28	cells	cell	NNS	NNS	_	21	ccomp	_	_
29	in	in	IN	IN	sem=LOC	28	prep	_	_
30	9	0	CD	CD	_	31	nummod	_	_
31	islets	islet	NNS	NNS	_	29	pobj	_	_
32	)	)	-RRB-	-RRB-	_	21	punct	_	_
33	,	,	,	,	_	15	punct	_	_
34	far	far	RB	RB	_	35	advmod	_	_
35	below	below	IN	IN	_	15	prep	_	_
36	the	the	DT	DT	_	37	det	_	_
37	concentration	concentration	NN	NN	_	35	pobj	_	_
38	necessary	necessary	JJ	JJ	_	37	amod	_	_
39	to	to	TO	TO	_	40	aux	_	_
40	block	block	VB	VB	_	38	xcomp	_	_
41	β	β	NN	NN	_	43	compound	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	cell	cell	NN	NN	_	44	compound	_	_
44	responses	response	NNS	NNS	_	40	dobj	_	_
45	(	(	-LRB-	-LRB-	_	47	punct	_	_
46	Figure	figure	NN	NN	_	47	compound	_	_
47	6D	0d	NN	NN	_	11	parataxis	_	_
48	)	)	-RRB-	-RRB-	_	47	punct	_	_
49	.	.	.	.	_	11	punct	_	_

1	Increases	increase	NNS	NNS	_	7	nsubj	_	_
2	in	in	IN	IN	_	1	prep	_	_
3	diazoxide	diazoxide	NN	NN	_	2	pobj	_	_
4	above	above	IN	IN	_	1	prep	_	_
5	20	0	CD	CD	_	6	nummod	_	_
6	μM	μm	NNS	NNS	_	4	pobj	_	_
7	blocked	block	VBD	VBD	_	0	root	_	_
8	the	the	DT	DT	_	13	det	_	_
9	[	[	-LRB-	-LRB-	_	12	punct	_	_
10	Ca2+	ca0+	NN	NN	_	12	nmod	_	_
11	]	]	-RRB-	-RRB-	_	12	punct	_	_
12	i	i	NN	NN	_	13	compound	_	_
13	responses	response	NNS	NNS	_	7	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	α	α	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	14	pobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	β	β	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	conj	_	_
20	in	in	IN	IN	_	7	prep	_	_
21	parallel	parallel	JJ	JJ	_	20	pobj	_	_
22	,	,	,	,	_	7	punct	_	_
23	consistent	consistent	JJ	JJ	syn=PRD	7	advcl	_	_
24	with	with	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	26	det	_	_
26	effect	effect	NN	NN	_	24	pobj	_	_
27	on	on	IN	IN	_	26	prep	_	_
28	glucagon	glucagon	NN	NN	_	31	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	insulin	insulin	NN	NN	_	28	conj	_	_
31	release	release	NN	NN	_	27	pobj	_	_
32	.	.	.	.	_	7	punct	_	_

1	Na+	na+	NN	NN	_	2	compound	_	_
2	Channels	channel	NNS	NNS	_	3	nsubj	_	_
3	Regulate	regulate	VBP	VBP	_	0	root	_	_
4	Low	low	JJ	JJ	_	6	amod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	Glucose	glucose	NN	NN	_	8	npadvmod	_	_
7	–	-	HYPH	HYPH	_	8	punct	_	_
8	Stimulated	stimulate	VBN	VBN	_	10	amod	_	_
9	Glucagon	glucagon	NN	NN	_	10	compound	_	_
10	Secretion	secretion	NN	NN	_	3	dobj	_	_

1	The	the	DT	DT	_	3	det	_	_
2	above	above	JJ	JJ	_	3	amod	_	_
3	data	datum	NNS	NNS	_	4	nsubj	_	_
4	suggest	suggest	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	17	mark	_	_
6	glucose	glucose	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	dependent	dependent	JJ	JJ	_	9	amod	_	_
9	inhibition	inhibition	NN	NN	_	17	nsubjpass	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	α	α	NN	NN	_	13	compound	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	KATP	katp	NN	NN	_	15	compound	_	_
15	channels	channel	NNS	NNS	_	10	pobj	_	_
16	is	be	VBZ	VBZ	_	17	auxpass	_	_
17	involved	involve	VBN	VBN	_	4	ccomp	_	_
18	in	in	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	20	det	_	_
20	suppression	suppression	NN	NN	_	18	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	glucagon	glucagon	NN	NN	_	23	compound	_	_
23	secretion	secretion	NN	NN	_	21	pobj	_	_
24	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	not	not	RB	RB	_	2	neg	_	_
4	clear	clear	JJ	JJ	syn=PRD	2	acomp	_	_
5	however	however	RB	RB	_	2	advmod	_	_
6	,	,	,	,	_	2	punct	_	_
7	how	how	WRB	WRB	_	14	advmod	_	_
8	KATP	katp	NN	NN	_	9	compound	_	_
9	channel	channel	NN	NN	_	10	compound	_	_
10	inhibition	inhibition	NN	NN	_	14	nsubj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	membrane	membrane	NN	NN	_	13	compound	_	_
13	depolarisation	depolarisation	NN	NN	_	10	conj	_	_
14	result	result	VBP	VBP	_	2	ccomp	_	_
15	in	in	IN	IN	_	14	prep	_	_
16	suppression	suppression	NN	NN	_	15	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	secretion	secretion	NN	NN	_	17	pobj	_	_
19	.	.	.	.	_	2	punct	_	_

1	Unlike	unlike	IN	IN	_	11	prep	_	_
2	in	in	IN	IN	sem=LOC	1	prep	_	_
3	β	β	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	2	pobj	_	_
5	,	,	,	,	_	11	punct	_	_
6	α	α	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	cell	cell	NN	NN	_	10	compound	_	_
9	Na+	na+	NN	NN	_	10	compound	_	_
10	channels	channel	NNS	NNS	_	11	nsubj	_	_
11	are	be	VBP	VBP	_	0	root	_	_
12	active	active	JJ	JJ	syn=PRD	11	acomp	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	16	det	_	_
15	physiological	physiological	JJ	JJ	_	16	amod	_	_
16	range	range	NN	NN	_	13	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	membrane	membrane	NN	NN	_	19	compound	_	_
19	potentials	potential	NNS	NNS	_	17	pobj	_	_
20	.	.	.	.	_	11	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	6	nsubj	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	our	our	PRP$	PRP$	_	5	poss	_	_
5	group	group	NN	NN	_	3	pobj	_	_
6	suggested	suggest	VBD	VBD	_	0	root	_	_
7	that	that	IN	IN	_	34	mark	_	_
8	the	the	DT	DT	_	12	det	_	_
9	voltage	voltage	NN	NN	_	11	npadvmod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	dependent	dependent	JJ	JJ	_	12	amod	_	_
12	inactivation	inactivation	NN	NN	_	34	nsubj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	Na+	na+	NN	NN	_	15	compound	_	_
15	channels	channel	NNS	NNS	_	13	pobj	_	_
16	,	,	,	,	_	12	punct	_	_
17	which	which	WDT	WDT	_	22	dep	_	12:ref
18	in	in	IN	IN	sem=LOC	22	prep	_	_
19	mouse	mouse	NN	NN	_	21	compound	_	_
20	α	α	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	18	pobj	_	_
22	is	be	VBZ	VBZ	_	12	relcl	_	_
23	half	half	RB	RB	_	25	advmod	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	maximal	maximal	JJ	JJ	syn=PRD	22	acomp	_	_
26	at	at	IN	IN	_	22	prep	_	_
27	−	−	SYM	SYM	_	28	punct	_	_
28	42	0	CD	CD	_	29	nummod	_	_
29	mV	mv	NNS	NNS	_	26	pobj	_	_
30	[	[	-LRB-	-LRB-	_	31	punct	_	_
31	43	0	CD	CD	_	12	parataxis	_	_
32	]	]	-RRB-	-RRB-	_	31	punct	_	_
33	,	,	,	,	_	34	punct	_	_
34	contributes	contribute	VBZ	VBZ	_	6	ccomp	_	_
35	to	to	IN	IN	_	34	prep	_	_
36	cessation	cessation	NN	NN	_	35	pobj	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	electrical	electrical	JJ	JJ	_	39	amod	_	_
39	activity	activity	NN	NN	_	37	pobj	_	_
40	upon	upon	IN	IN	sem=MNR	34	prep	_	_
41	α	α	NN	NN	_	43	compound	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	cell	cell	NN	NN	_	44	compound	_	_
44	depolarisation	depolarisation	NN	NN	_	40	pobj	_	_
45	[	[	-LRB-	-LRB-	_	46	punct	_	_
46	14	0	CD	CD	_	6	parataxis	_	_
47	]	]	-RRB-	-RRB-	_	46	punct	_	_
48	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	thus	thus	RB	RB	_	3	advmod	_	_
3	used	use	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	10	det	_	_
5	voltage	voltage	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	dependent	dependent	JJ	JJ	_	10	amod	_	_
8	Na+	na+	NN	NN	_	9	compound	_	_
9	channel	channel	NN	NN	_	10	compound	_	_
10	antagonist	antagonist	NN	NN	_	3	dobj	_	_
11	tetrodotoxin	tetrodotoxin	NN	NN	_	10	appos	_	_
12	(	(	-LRB-	-LRB-	_	11	punct	_	_
13	TTX	ttx	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	3	punct	_	_
15	to	to	TO	TO	_	16	aux	_	_
16	test	test	VB	VB	sem=PRP	3	advcl	_	_
17	a	a	DT	DT	_	18	det	_	_
18	role	role	NN	NN	_	16	dobj	_	_
19	for	for	IN	IN	_	18	prep	_	_
20	these	these	DT	DT	_	21	det	_	_
21	channels	channel	NNS	NNS	_	19	pobj	_	_
22	in	in	IN	IN	_	18	prep	_	_
23	α	α	NN	NN	_	25	compound	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	cell	cell	NN	NN	_	26	compound	_	_
26	function	function	NN	NN	_	22	pobj	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	secretion	secretion	NN	NN	_	26	conj	_	_
30	.	.	.	.	_	3	punct	_	_

1	TTX	ttx	NN	NN	_	8	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	4	punct	_	_
3	0.1	0	CD	CD	_	4	nummod	_	_
4	μg	μg	NNS	NNS	_	1	parataxis	_	_
5	/	/	SYM	SYM	_	6	punct	_	_
6	ml	ml	NN	NN	_	4	prep	_	_
7	)	)	-RRB-	-RRB-	_	4	punct	_	_
8	suppressed	suppress	VBD	VBD	_	0	root	_	_
9	glucagon	glucagon	NN	NN	_	10	compound	_	_
10	release	release	NN	NN	_	8	dobj	_	_
11	from	from	IN	IN	_	8	prep	_	_
12	mouse	mouse	NN	NN	_	13	compound	_	_
13	islets	islet	NNS	NNS	_	11	pobj	_	_
14	by	by	IN	IN	sem=EXT	8	prep	_	_
15	56	0	CD	CD	_	17	quantmod	_	_
16	±	±	SYM	SYM	_	17	punct	_	_
17	5	0	CD	CD	_	18	nummod	_	_
18	%	%	NN	NN	_	14	pobj	_	_
19	(	(	-LRB-	-LRB-	_	26	punct	_	_
20	n	n	NN	NN	_	22	nsubj	_	_
21	=	=	SYM	SYM	_	22	punct	_	_
22	10	0	CD	CD	_	26	ccomp	_	_
23	,	,	,	,	_	26	punct	_	_
24	p	p	NN	NN	_	26	nsubj	_	_
25	<	<	SYM	SYM	_	26	punct	_	_
26	0.001	0	CD	CD	_	8	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	under	under	IN	IN	_	8	prep	_	_
29	low	low	JJ	JJ	_	31	amod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	glucose	glucose	NN	NN	_	32	compound	_	_
32	conditions	condition	NNS	NNS	_	28	pobj	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	Figure	figure	NN	NN	_	35	compound	_	_
35	7A	0a	NN	NN	_	8	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	8	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	TTX	ttx	NN	NN	_	3	pobj	_	_
5	in	in	IN	IN	_	2	prep	_	_
6	the	the	DT	DT	_	10	det	_	_
7	low	low	JJ	JJ	_	9	amod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	glucose	glucose	NN	NN	_	10	compound	_	_
10	condition	condition	NN	NN	_	5	pobj	_	_
11	was	be	VBD	VBD	_	0	root	_	_
12	similar	similar	JJ	JJ	syn=PRD	11	acomp	_	_
13	to	to	IN	IN	_	12	prep	_	_
14	what	what	WP	WP	_	16	dep	_	_
15	we	we	PRP	PRP	_	16	nsubj	_	_
16	observed	observe	VBD	VBD	syn=NOM	13	pcomp	_	_
17	with	with	IN	IN	_	16	prep	_	_
18	high	high	JJ	JJ	_	20	amod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	glucose	glucose	NN	NN	_	21	compound	_	_
21	stimulation	stimulation	NN	NN	_	17	pobj	_	_
22	alone	alone	RB	RB	_	21	advmod	_	_
23	.	.	.	.	_	11	punct	_	_

1	With	with	IN	IN	_	3	mark	_	_
2	TTX	ttx	NN	NN	_	3	nsubj	_	_
3	present	present	NN	NN	syn=PRD	6	advcl	_	_
4	,	,	,	,	_	6	punct	_	_
5	glucose	glucose	NN	NN	_	6	nsubj	_	_
6	was	be	VBD	VBD	_	0	root	_	_
7	without	without	IN	IN	syn=PRD	6	prep	_	_
8	further	far	JJ	JJ	_	10	amod	_	_
9	inhibitory	inhibitory	JJ	JJ	_	10	amod	_	_
10	action	action	NN	NN	_	7	pobj	_	_
11	,	,	,	,	_	6	punct	_	_
12	suggesting	suggest	VBG	VBG	syn=ADV	6	advcl	_	_
13	that	that	IN	IN	_	15	mark	_	_
14	glucose	glucose	NN	NN	_	15	nsubj	_	_
15	inhibits	inhibit	VBZ	VBZ	_	12	ccomp	_	_
16	glucagon	glucagon	NN	NN	_	17	compound	_	_
17	secretion	secretion	NN	NN	_	15	dobj	_	_
18	through	through	IN	IN	sem=MNR	15	prep	_	_
19	a	a	DT	DT	_	24	det	_	_
20	Na+	na+	NN	NN	_	21	compound	_	_
21	channel	channel	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	dependent	dependent	JJ	JJ	_	24	amod	_	_
24	mechanism	mechanism	NN	NN	_	18	pobj	_	_
25	.	.	.	.	_	6	punct	_	_

1	TTX	ttx	NN	NN	_	2	nsubj	_	_
2	has	have	VBZ	VBZ	_	0	root	_	_
3	no	no	DT	DT	_	4	det	_	_
4	effect	effect	NN	NN	_	2	dobj	_	_
5	on	on	IN	IN	_	4	prep	_	_
6	glucose	glucose	NN	NN	_	8	npadvmod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	stimulated	stimulate	VBN	VBN	_	10	amod	_	_
9	insulin	insulin	NN	NN	_	10	compound	_	_
10	secretion	secretion	NN	NN	_	5	pobj	_	_
11	in	in	IN	IN	sem=LOC	2	prep	_	_
12	mouse	mouse	NN	NN	_	13	compound	_	_
13	islets	islet	NNS	NNS	_	11	pobj	_	_
14	(	(	-LRB-	-LRB-	_	16	punct	_	_
15	Figure	figure	NN	NN	_	16	compound	_	_
16	7A	0a	NN	NN	_	2	parataxis	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	;	;	:	:	_	2	punct	_	_
19	again	again	RB	RB	_	20	advmod	_	_
20	suggestive	suggestive	JJ	JJ	syn=PRD	2	advcl	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	a	a	DT	DT	_	27	det	_	_
23	direct	direct	JJ	JJ	_	27	amod	_	_
24	rather	rather	RB	RB	_	25	advmod	_	_
25	than	than	IN	IN	_	23	cc	_	_
26	indirect	indirect	JJ	JJ	_	23	conj	_	_
27	effect	effect	NN	NN	_	21	pobj	_	_
28	on	on	IN	IN	_	27	prep	_	_
29	α	α	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	28	pobj	_	_
31	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	17	prep	_	_
2	accordance	accordance	NN	NN	_	1	pobj	_	_
3	with	with	IN	IN	_	2	prep	_	_
4	this	this	DT	DT	_	3	pobj	_	_
5	,	,	,	,	_	17	punct	_	_
6	application	application	NN	NN	_	17	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	0.1	0	CD	CD	_	9	nummod	_	_
9	μg	μg	NNS	NNS	_	12	nmod	_	_
10	/	/	SYM	SYM	_	11	punct	_	_
11	ml	ml	NN	NN	_	9	prep	_	_
12	TTX	ttx	NN	NN	_	7	pobj	_	_
13	to	to	IN	IN	_	6	prep	_	_
14	mouse	mouse	NN	NN	_	15	compound	_	_
15	islets	islet	NNS	NNS	_	13	pobj	_	_
16	reversibly	reversibly	RB	RB	_	17	advmod	_	_
17	abolished	abolish	VBD	VBD	_	0	root	_	_
18	the	the	DT	DT	_	26	det	_	_
19	α	α	NN	NN	_	21	nmod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	cell	cell	NN	NN	_	26	nmod	_	_
22	[	[	-LRB-	-LRB-	_	25	punct	_	_
23	Ca2+	ca0+	NN	NN	_	25	nmod	_	_
24	]	]	-RRB-	-RRB-	_	25	punct	_	_
25	i	i	NN	NN	_	26	compound	_	_
26	response	response	NN	NN	_	17	dobj	_	_
27	evoked	evoke	VBN	VBN	_	26	acl	_	_
28	by	by	IN	IN	sem=MNR	27	prep	_	_
29	low	low	JJ	JJ	_	31	amod	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	glucose	glucose	NN	NN	_	32	compound	_	_
32	concentrations	concentration	NNS	NNS	_	28	pobj	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	Figure	figure	NN	NN	_	35	compound	_	_
35	7B	0b	NN	NN	_	17	parataxis	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	7C	0c	NN	NN	_	35	conj	_	_
38	;	;	:	:	_	35	punct	_	_
39	n	n	NN	NN	_	42	nsubj	_	_
40	=	=	SYM	SYM	_	42	punct	_	_
41	18	0	CD	CD	_	42	nummod	_	_
42	cells	cell	NNS	NNS	_	35	ccomp	_	_
43	in	in	IN	IN	sem=LOC	42	prep	_	_
44	4	0	CD	CD	_	45	nummod	_	_
45	islets	islet	NNS	NNS	_	43	pobj	_	_
46	)	)	-RRB-	-RRB-	_	35	punct	_	_
47	,	,	,	,	_	17	punct	_	_
48	but	but	CC	CC	_	17	cc	_	_
49	had	have	VBD	VBD	_	17	conj	_	_
50	no	no	DT	DT	_	51	det	_	_
51	effect	effect	NN	NN	_	49	dobj	_	_
52	on	on	IN	IN	_	51	prep	_	_
53	β	β	NN	NN	_	55	nmod	_	_
54	-	-	HYPH	HYPH	_	55	punct	_	_
55	cell	cell	NN	NN	_	59	nmod	_	_
56	[	[	-LRB-	-LRB-	_	59	punct	_	_
57	Ca2+	ca0+	NN	NN	_	59	nmod	_	_
58	]	]	-RRB-	-RRB-	_	59	punct	_	_
59	i	i	NN	NN	_	52	pobj	_	_
60	(	(	-LRB-	-LRB-	_	62	punct	_	_
61	unpublished	unpublished	JJ	JJ	_	62	amod	_	_
62	data	datum	NNS	NNS	_	49	meta	_	_
63	)	)	-RRB-	-RRB-	_	62	punct	_	_
64	.	.	.	.	_	17	punct	_	_

1	N	n	NN	NN	_	3	compound	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	Type	type	NN	NN	_	5	compound	_	_
4	Ca2+	ca0+	NN	NN	_	5	compound	_	_
5	Channels	channel	NNS	NNS	_	6	nsubj	_	_
6	Mediate	mediate	VBP	VBP	_	0	root	_	_
7	the	the	DT	DT	_	9	det	_	_
8	Ca2+	ca0+	NN	NN	_	9	compound	_	_
9	Influx	influx	NN	NN	_	6	dobj	_	_
10	That	that	WDT	WDT	_	11	dep	_	9:ref
11	Triggers	trigger	VBZ	VBZ	_	9	relcl	_	_
12	Glucagon	glucagon	NN	NN	_	13	compound	_	_
13	Secretion	secretion	NN	NN	_	11	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	α	α	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	Cell	cell	NN	NN	_	18	compound	_	_
18	Exocytosis	exocytosis	NN	NN	_	13	conj	_	_

1	Downstream	downstream	RB	RB	_	11	advmod	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	Na+	na+	NN	NN	_	4	compound	_	_
4	channel	channel	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	2	pobj	_	_
6	,	,	,	,	_	11	punct	_	_
7	the	the	DT	DT	_	8	det	_	_
8	opening	opening	NN	NN	_	11	nsubj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	VDCCs	vdccs	NNS	NNS	_	9	pobj	_	_
11	allows	allow	VBZ	VBZ	_	0	root	_	_
12	Ca2+	ca0+	NN	NN	_	11	dobj	_	_
13	into	into	IN	IN	_	11	prep	_	_
14	α	α	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	13	pobj	_	_
16	,	,	,	,	_	11	punct	_	_
17	triggering	trigger	VBG	VBG	syn=ADV	11	advcl	_	_
18	the	the	DT	DT	_	19	det	_	_
19	exocytosis	exocytosis	NN	NN	_	17	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	glucagon	glucagon	NN	NN	_	23	npadvmod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	containing	contain	VBG	VBG	_	24	amod	_	_
24	vesicles	vesicle	NNS	NNS	_	20	pobj	_	_
25	.	.	.	.	_	11	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	applied	apply	VBD	VBD	_	0	root	_	_
3	whole	whole	JJ	JJ	_	5	amod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	cell	cell	NN	NN	_	9	compound	_	_
6	patch	patch	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	clamp	clamp	NN	NN	_	9	compound	_	_
9	recordings	recording	NNS	NNS	_	2	dobj	_	_
10	to	to	TO	TO	_	11	aux	_	_
11	establish	establish	VB	VB	sem=PRP	2	advcl	_	_
12	the	the	DT	DT	_	18	det	_	_
13	α	α	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	cell	cell	NN	NN	_	18	compound	_	_
16	Ca2+	ca0+	NN	NN	_	17	compound	_	_
17	channel	channel	NN	NN	_	18	compound	_	_
18	complement	complement	NN	NN	_	11	dobj	_	_
19	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	7	det	_	_
2	integrated	integrated	JJ	JJ	_	7	amod	_	_
3	whole	whole	JJ	JJ	_	5	amod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	cell	cell	NN	NN	_	7	compound	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	current	current	NN	NN	_	21	nsubj	_	_
8	measured	measure	VBN	VBN	_	7	acl	_	_
9	during	during	IN	IN	sem=TMP	8	prep	_	_
10	50	0	CD	CD	_	12	nummod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	ms	ms	NN	NN	_	13	compound	_	_
13	depolarisations	depolarisation	NNS	NNS	_	9	pobj	_	_
14	from	from	IN	IN	_	13	prep	_	_
15	−	−	SYM	SYM	_	16	punct	_	_
16	70	0	CD	CD	_	17	nummod	_	_
17	mV	mv	NNS	NNS	_	14	pobj	_	_
18	to	to	IN	IN	_	14	prep	_	_
19	0	0	CD	CD	_	20	nummod	_	_
20	mV	mv	NNS	NNS	_	18	pobj	_	_
21	amounted	amount	VBD	VBD	_	0	root	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	6.2	0	CD	CD	_	25	quantmod	_	_
24	±	±	SYM	SYM	_	25	punct	_	_
25	0.8	0	CD	CD	_	26	nummod	_	_
26	pC	pc	NN	NN	_	22	pobj	_	26:gap
27	(	(	-LRB-	-LRB-	_	30	punct	_	_
28	n	n	NN	NN	_	30	nsubj	_	_
29	=	=	SYM	SYM	_	30	punct	_	_
30	15	0	CD	CD	_	26	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	under	under	IN	IN	_	22	prep	_	32:gap
33	control	control	NN	NN	_	34	compound	_	_
34	conditions	condition	NNS	NNS	_	32	pobj	_	_
35	,	,	,	,	_	21	punct	_	_
36	2.6	0	CD	CD	_	38	quantmod	_	_
37	±	±	SYM	SYM	_	38	punct	_	_
38	0.8	0	CD	CD	_	39	nummod	_	_
39	pC	pc	NN	NN	_	21	conj	_	26:gap
40	(	(	-LRB-	-LRB-	_	47	punct	_	_
41	n	n	NN	NN	_	43	nsubj	_	_
42	=	=	SYM	SYM	_	43	punct	_	_
43	10	0	CD	CD	_	47	ccomp	_	_
44	;	;	:	:	_	47	punct	_	_
45	p	p	NN	NN	_	47	nsubj	_	_
46	<	<	SYM	SYM	_	47	punct	_	_
47	0.05	0	CD	CD	_	39	parataxis	_	_
48	)	)	-RRB-	-RRB-	_	47	punct	_	_
49	in	in	IN	IN	_	39	prep	_	32:gap
50	the	the	DT	DT	_	51	det	_	_
51	presence	presence	NN	NN	_	49	pobj	_	_
52	of	of	IN	IN	_	51	prep	_	_
53	50	0	CD	CD	_	54	nummod	_	_
54	μM	μm	NNS	NNS	_	55	compound	_	_
55	nifedipine	nifedipine	NN	NN	_	52	pobj	_	_
56	,	,	,	,	_	39	punct	_	_
57	and	and	CC	CC	_	39	cc	_	_
58	4.1	0	CD	CD	_	60	quantmod	_	_
59	±	±	SYM	SYM	_	60	punct	_	_
60	0.5	0	CD	CD	_	61	nummod	_	_
61	pC	pc	NN	NN	_	39	conj	_	26:gap
62	(	(	-LRB-	-LRB-	_	69	punct	_	_
63	n	n	NN	NN	_	65	nsubj	_	_
64	=	=	SYM	SYM	_	65	punct	_	_
65	12	0	CD	CD	_	69	ccomp	_	_
66	;	;	:	:	_	69	punct	_	_
67	p	p	NN	NN	_	69	nsubj	_	_
68	<	<	SYM	SYM	_	69	punct	_	_
69	0.01	0	CD	CD	_	61	parataxis	_	_
70	)	)	-RRB-	-RRB-	_	69	punct	_	_
71	in	in	IN	IN	_	61	prep	_	32:gap
72	the	the	DT	DT	_	73	det	_	_
73	presence	presence	NN	NN	_	71	pobj	_	_
74	of	of	IN	IN	_	73	prep	_	_
75	1	0	CD	CD	_	76	nummod	_	_
76	μM	μm	NN	NN	_	79	compound	_	_
77	ω	ω	NN	NN	_	79	compound	_	_
78	-	-	HYPH	HYPH	_	79	punct	_	_
79	conotoxin	conotoxin	NN	NN	_	74	pobj	_	_
80	.	.	.	.	_	61	punct	_	_

1	Thus	thus	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	L	l	NN	NN	_	8	nmod	_	_
4	-	-	HYPH	HYPH	_	3	punct	_	_
5	and	and	CC	CC	_	3	cc	_	_
6	N	n	NN	NN	_	3	conj	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	type	type	NN	NN	_	10	compound	_	_
9	Ca2+	ca0+	NN	NN	_	10	compound	_	_
10	channels	channel	NNS	NNS	_	11	nsubj	_	_
11	account	account	VBP	VBP	_	0	root	_	_
12	for	for	IN	IN	_	11	prep	_	_
13	58	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	12	pobj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	34	0	CD	CD	_	17	nummod	_	_
17	%	%	NN	NN	_	14	conj	_	_
18	of	of	IN	IN	_	14	prep	_	_
19	the	the	DT	DT	_	24	det	_	_
20	α	α	NN	NN	_	22	compound	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	cell	cell	NN	NN	_	24	compound	_	_
23	Ca2+	ca0+	NN	NN	_	24	compound	_	_
24	current	current	NN	NN	_	18	pobj	_	_
25	,	,	,	,	_	11	punct	_	_
26	respectively	respectively	RB	RB	_	11	advmod	_	_
27	.	.	.	.	_	11	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	8A	0a	NN	NN	_	3	nsubj	_	_
3	compares	compare	VBZ	VBZ	_	0	root	_	_
4	glucagon	glucagon	NN	NN	_	5	compound	_	_
5	secretion	secretion	NN	NN	_	3	dobj	_	_
6	at	at	IN	IN	_	3	prep	_	_
7	1	0	CD	CD	_	10	nummod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	20	0	CD	CD	_	7	conj	_	_
10	mM	mm	NNS	NNS	_	11	compound	_	_
11	glucose	glucose	NN	NN	_	6	pobj	_	_
12	under	under	IN	IN	_	3	prep	_	_
13	control	control	NN	NN	_	14	compound	_	_
14	conditions	condition	NNS	NNS	_	12	pobj	_	_
15	and	and	CC	CC	_	12	cc	_	_
16	in	in	IN	IN	_	12	conj	_	_
17	the	the	DT	DT	_	18	det	_	_
18	presence	presence	NN	NN	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	100	0	CD	CD	_	21	nummod	_	_
21	nM	nm	NNS	NNS	_	24	compound	_	_
22	ω	ω	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	conotoxin	conotoxin	NN	NN	_	19	pobj	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	20	0	CD	CD	_	27	nummod	_	_
27	μM	μm	NNS	NNS	_	28	compound	_	_
28	nifedipine	nifedipine	NN	NN	_	24	conj	_	_
29	,	,	,	,	_	3	punct	_	_
30	respectively	respectively	RB	RB	_	3	advmod	_	_
31	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	35	mark	_	_
4	whereas	whereas	IN	IN	_	12	mark	_	_
5	the	the	DT	DT	_	10	det	_	_
6	L	l	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	type	type	NN	NN	_	10	compound	_	_
9	channel	channel	NN	NN	_	10	compound	_	_
10	blocker	blocker	NN	NN	_	12	nsubj	_	_
11	nifedipine	nifedipine	NN	NN	_	10	appos	_	_
12	had	have	VBD	VBD	syn=ADV	35	advcl	_	_
13	no	no	DT	DT	_	14	det	_	_
14	effect	effect	NN	NN	_	12	dobj	_	_
15	on	on	IN	IN	_	14	prep	_	_
16	glucagon	glucagon	NN	NN	_	17	compound	_	_
17	release	release	NN	NN	_	15	pobj	_	_
18	at	at	IN	IN	_	12	prep	_	_
19	1	0	CD	CD	_	22	nummod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	20	0	CD	CD	_	19	conj	_	_
22	mM	mm	NNS	NNS	_	23	compound	_	_
23	glucose	glucose	NN	NN	_	18	pobj	_	_
24	,	,	,	,	_	35	punct	_	_
25	the	the	DT	DT	_	31	det	_	_
26	N	n	NN	NN	_	28	compound	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	type	type	NN	NN	_	31	compound	_	_
29	Ca2+	ca0+	NN	NN	_	30	compound	_	_
30	channel	channel	NN	NN	_	31	compound	_	_
31	blocker	blocker	NN	NN	_	35	nsubj	_	_
32	ω	ω	NN	NN	_	34	compound	_	_
33	-	-	HYPH	HYPH	_	34	punct	_	_
34	conotoxin	conotoxin	NN	NN	_	31	appos	_	_
35	inhibited	inhibit	VBD	VBD	_	2	ccomp	_	_
36	the	the	DT	DT	_	37	det	_	_
37	release	release	NN	NN	_	35	dobj	_	_
38	of	of	IN	IN	_	37	prep	_	_
39	the	the	DT	DT	_	40	det	_	_
40	hormone	hormone	NN	NN	_	38	pobj	_	_
41	to	to	IN	IN	_	35	prep	_	_
42	a	a	DT	DT	_	43	det	_	_
43	level	level	NN	NN	_	41	pobj	_	_
44	similar	similar	JJ	JJ	_	43	amod	_	_
45	to	to	IN	IN	_	44	prep	_	_
46	that	that	DT	DT	_	45	pobj	_	_
47	of	of	IN	IN	_	46	prep	_	_
48	high	high	JJ	JJ	_	49	amod	_	_
49	glucose	glucose	NN	NN	_	47	pobj	_	_
50	,	,	,	,	_	49	punct	_	_
51	tolbutamide	tolbutamide	NN	NN	_	49	conj	_	_
52	,	,	,	,	_	51	punct	_	_
53	and	and	CC	CC	_	51	cc	_	_
54	TTX	ttx	NN	NN	_	51	conj	_	_
55	.	.	.	.	_	2	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	glucose	glucose	NN	NN	_	4	nsubj	_	_
4	exerted	exert	VBD	VBD	_	0	root	_	_
5	no	no	DT	DT	_	8	det	_	_
6	additional	additional	JJ	JJ	_	8	amod	_	_
7	inhibitory	inhibitory	JJ	JJ	_	8	amod	_	_
8	action	action	NN	NN	_	4	dobj	_	_
9	in	in	IN	IN	_	4	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	presence	presence	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	ω	ω	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	conotoxin	conotoxin	NN	NN	_	12	pobj	_	_
16	.	.	.	.	_	4	punct	_	_

1	Thus	thus	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	glucagon	glucagon	NN	NN	_	4	compound	_	_
4	secretion	secretion	NN	NN	_	11	nsubj	_	_
5	stimulated	stimulate	VBN	VBN	_	4	acl	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	low	low	JJ	JJ	_	9	amod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	glucose	glucose	NN	NN	_	10	compound	_	_
10	levels	level	NNS	NNS	_	6	pobj	_	_
11	depends	depend	VBZ	VBZ	_	0	root	_	_
12	principally	principally	RB	RB	_	11	advmod	_	_
13	on	on	IN	IN	_	11	prep	_	_
14	Ca2+	ca0+	NN	NN	_	15	compound	_	_
15	influx	influx	NN	NN	_	13	pobj	_	_
16	through	through	IN	IN	_	11	prep	_	_
17	N	n	NN	NN	_	19	compound	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	type	type	NN	NN	_	20	compound	_	_
20	channels	channel	NNS	NNS	_	16	pobj	_	_
21	,	,	,	,	_	11	punct	_	_
22	although	although	IN	IN	_	25	mark	_	_
23	these	these	DT	DT	_	25	nsubj	_	_
24	only	only	RB	RB	_	25	advmod	_	_
25	account	account	VBP	VBP	syn=ADV	11	advcl	_	_
26	for	for	IN	IN	_	25	prep	_	_
27	one	#crd#	CD	CD	_	28	nummod	_	_
28	third	#ord#	NN	NN	_	26	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	the	the	DT	DT	_	32	det	_	_
31	Ca2+	ca0+	NN	NN	_	32	compound	_	_
32	current	current	NN	NN	_	29	pobj	_	_
33	.	.	.	.	_	11	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	confirmed	confirm	VBD	VBD	_	0	root	_	_
3	this	this	DT	DT	_	6	det	_	_
4	Ca2+	ca0+	NN	NN	_	5	compound	_	_
5	channel	channel	NN	NN	_	6	compound	_	_
6	dependence	dependence	NN	NN	_	2	dobj	_	_
7	by	by	IN	IN	sem=MNR	2	prep	_	_
8	conducting	conduct	VBG	VBG	syn=NOM	7	pcomp	_	_
9	high	high	JJ	JJ	_	11	amod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	resolution	resolution	NN	NN	_	16	nmod	_	_
12	single	single	JJ	JJ	_	14	amod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	cell	cell	NN	NN	_	16	compound	_	_
15	capacitance	capacitance	NN	NN	_	16	compound	_	_
16	measurements	measurement	NNS	NNS	_	8	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	exocytosis	exocytosis	NN	NN	_	17	pobj	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	Figure	figure	NN	NN	_	21	compound	_	_
21	8B	0b	NN	NN	_	2	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	2	punct	_	_

1	Exocytosis	exocytosis	NN	NN	_	15	nsubj	_	_
2	elicited	elicit	VBN	VBN	_	1	acl	_	_
3	by	by	IN	IN	sem=MNR	2	prep	_	_
4	500	0	CD	CD	_	6	nummod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	ms	ms	NN	NN	_	8	compound	_	_
7	step	step	NN	NN	_	8	compound	_	_
8	depolarisations	depolarisation	NNS	NNS	_	3	pobj	_	_
9	from	from	IN	IN	_	8	prep	_	_
10	−	−	SYM	SYM	_	11	punct	_	_
11	70	0	CD	CD	_	9	pobj	_	_
12	to	to	IN	IN	_	9	prep	_	_
13	0	0	CD	CD	_	12	pobj	_	_
14	mV	mv	NNS	NNS	_	9	pobj	_	_
15	averaged	average	VBD	VBD	_	0	root	_	_
16	approximately	approximately	RB	RB	_	17	advmod	_	_
17	150	0	CD	CD	_	18	nummod	_	_
18	fF	ff	NNS	NNS	_	15	dobj	_	_
19	(	(	-LRB-	-LRB-	_	15	punct	_	_
20	corresponding	correspond	VBG	VBG	syn=ADV	15	advcl	_	_
21	to	to	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	23	det	_	_
23	fusion	fusion	NN	NN	_	21	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	∼	∼	SYM	SYM	_	26	punct	_	_
26	75	0	CD	CD	_	28	nummod	_	_
27	secretory	secretory	JJ	JJ	_	28	amod	_	_
28	granules	granule	NNS	NNS	_	24	pobj	_	_
29	with	with	IN	IN	_	23	prep	_	_
30	the	the	DT	DT	_	32	det	_	_
31	plasma	plasma	NN	NN	_	32	compound	_	_
32	membrane	membrane	NN	NN	_	29	pobj	_	_
33	[	[	-LRB-	-LRB-	_	34	punct	_	_
34	43	0	CD	CD	_	23	parataxis	_	_
35	]	]	-RRB-	-RRB-	_	34	punct	_	_
36	)	)	-RRB-	-RRB-	_	23	punct	_	_
37	under	under	IN	IN	_	23	prep	_	_
38	control	control	NN	NN	_	39	compound	_	_
39	conditions	condition	NNS	NNS	_	37	pobj	_	_
40	(	(	-LRB-	-LRB-	_	39	punct	_	_
41	Ctrl	ctrl	NN	NN	_	39	appos	_	_
42	)	)	-RRB-	-RRB-	_	15	punct	_	_
43	.	.	.	.	_	15	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	response	response	NN	NN	_	6	nsubjpass	_	_
3	was	be	VBD	VBD	_	6	auxpass	_	_
4	not	not	RB	RB	_	6	neg	_	_
5	significantly	significantly	RB	RB	_	6	advmod	_	_
6	affected	affect	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	sem=MNR	6	prep	_	_
8	50	0	CD	CD	_	9	nummod	_	_
9	μM	μm	NN	NN	_	10	compound	_	_
10	nifedipine	nifedipine	NN	NN	_	7	pobj	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	nif	nif	NN	NN	_	10	parataxis	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	,	,	,	,	_	6	punct	_	_
15	but	but	CC	CC	_	6	cc	_	_
16	was	be	VBD	VBD	_	18	auxpass	_	_
17	nearly	nearly	RB	RB	_	18	advmod	_	_
18	abolished	abolish	VBN	VBN	_	6	conj	_	_
19	by	by	IN	IN	sem=MNR	18	prep	_	_
20	1	0	CD	CD	_	21	nummod	_	_
21	μM	μm	NN	NN	_	24	compound	_	_
22	ω	ω	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	conotoxin	conotoxin	NN	NN	_	19	pobj	_	_
25	(	(	-LRB-	-LRB-	_	31	punct	_	_
26	ω	ω	NN	NN	_	28	compound	_	_
27	-	-	HYPH	HYPH	_	28	punct	_	_
28	con	con	NN	NN	_	31	dep	_	_
29	;	;	:	:	_	31	punct	_	_
30	Figure	figure	NN	NN	_	31	compound	_	_
31	8C	0c	NN	NN	_	19	parataxis	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	.	.	.	.	_	6	punct	_	_

1	Inactivation	inactivation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	N	n	NN	NN	_	5	compound	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	Type	type	NN	NN	_	7	compound	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	Channels	channel	NNS	NNS	_	2	pobj	_	_
8	Underlie	underlie	VBP	VBP	_	0	root	_	_
9	Glucose	glucose	NN	NN	_	10	compound	_	_
10	Inhibition	inhibition	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	Glucagon	glucagon	NN	NN	_	13	compound	_	_
13	Secretion	secretion	NN	NN	_	11	pobj	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	next	next	RB	RB	_	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	mechanism	mechanism	NN	NN	_	3	dobj	_	_
6	by	by	IN	IN	_	12	prep	_	_
7	which	which	WDT	WDT	_	6	pobj	_	5:ref
8	N	n	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	type	type	NN	NN	_	11	compound	_	_
11	channels	channel	NNS	NNS	_	12	nsubj	_	_
12	regulate	regulate	VBP	VBP	_	5	relcl	_	_
13	glucagon	glucagon	NN	NN	_	14	compound	_	_
14	release	release	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	_	12	prep	_	_
16	response	response	NN	NN	_	15	pobj	_	_
17	to	to	IN	IN	_	16	prep	_	_
18	membrane	membrane	NN	NN	_	21	compound	_	_
19	depolarisation	depolarisation	NN	NN	_	21	compound	_	_
20	/	/	HYPH	HYPH	_	21	punct	_	_
21	hyperpolarisation	hyperpolarisation	NN	NN	_	17	pobj	_	_
22	in	in	IN	IN	sem=LOC	12	prep	_	_
23	mouse	mouse	NN	NN	_	25	compound	_	_
24	α	α	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	22	pobj	_	_
26	.	.	.	.	_	3	punct	_	_

1	Non–L	non–l	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	type	type	NN	NN	_	10	nmod	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	isradipine	isradipine	NN	NN	_	7	npadvmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	resistant	resistant	JJ	JJ	_	10	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	Ca2+	ca0+	NN	NN	_	10	compound	_	_
10	currents	current	NNS	NNS	_	12	nsubjpass	_	_
11	were	be	VBD	VBD	_	12	auxpass	_	_
12	elicited	elicit	VBN	VBN	_	0	root	_	_
13	by	by	IN	IN	sem=MNR	12	prep	_	_
14	step	step	NN	NN	_	15	compound	_	_
15	depolarization	depolarization	NN	NN	_	13	pobj	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	0	0	CD	CD	_	18	nummod	_	_
18	mV	mv	NNS	NNS	_	16	pobj	_	_
19	in	in	IN	IN	_	12	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	absence	absence	NN	NN	_	19	pobj	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	black	black	JJ	JJ	_	21	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	or	or	CC	CC	_	21	cc	_	_
26	presence	presence	NN	NN	_	21	conj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	red	red	JJ	JJ	_	26	parataxis	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	of	of	IN	IN	_	21	prep	_	_
31	1	0	CD	CD	_	32	nummod	_	_
32	μM	μm	NN	NN	_	35	compound	_	_
33	ω	ω	NN	NN	_	35	compound	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	conotoxin	conotoxin	NN	NN	_	30	pobj	_	_
36	following	following	IN	IN	_	12	prep	_	_
37	a	a	DT	DT	_	42	det	_	_
38	200	0	CD	CD	_	40	nummod	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	ms	ms	NN	NN	_	42	compound	_	_
41	conditioning	conditioning	NN	NN	_	42	compound	_	_
42	pulse	pulse	NN	NN	_	36	pobj	_	_
43	to	to	IN	IN	_	42	prep	_	_
44	−	−	SYM	SYM	_	45	punct	_	_
45	70	0	CD	CD	_	46	nummod	_	_
46	mV	mv	NNS	NNS	_	43	pobj	_	_
47	(	(	-LRB-	-LRB-	_	49	punct	_	_
48	Figure	figure	NN	NN	_	49	compound	_	_
49	9A	0a	NN	NN	_	46	parataxis	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	or	or	CC	CC	_	46	cc	_	_
52	+	+	SYM	SYM	_	53	punct	_	_
53	10	0	CD	CD	_	54	nummod	_	_
54	mV	mv	NNS	NNS	_	46	conj	_	_
55	(	(	-LRB-	-LRB-	_	57	punct	_	_
56	Figure	figure	NN	NN	_	57	compound	_	_
57	9B	0b	NN	NN	_	54	parataxis	_	_
58	)	)	-RRB-	-RRB-	_	57	punct	_	_
59	.	.	.	.	_	12	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	evident	evident	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	the	the	DT	DT	_	11	det	_	_
6	ω	ω	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	conotoxin	conotoxin	NN	NN	_	10	npadvmod	_	_
9	–	-	HYPH	HYPH	_	10	punct	_	_
10	sensitive	sensitive	JJ	JJ	_	11	amod	_	_
11	component	component	NN	NN	_	13	nsubjpass	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	abolished	abolish	VBN	VBN	_	2	ccomp	_	_
14	by	by	IN	IN	sem=MNR	13	prep	_	_
15	the	the	DT	DT	_	20	det	_	_
16	+	+	SYM	SYM	_	17	punct	_	_
17	10	0	CD	CD	_	18	nummod	_	_
18	mV	mv	NN	NN	_	20	compound	_	_
19	conditioning	conditioning	NN	NN	_	20	compound	_	_
20	pulse	pulse	NN	NN	_	14	pobj	_	_
21	.	.	.	.	_	2	punct	_	_

1	Figure	figure	NN	NN	_	2	compound	_	_
2	9C	0c	NN	NN	_	3	nsubj	_	_
3	summarizes	summarize	VBZ	VBZ	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	relationship	relationship	NN	NN	_	3	dobj	_	_
6	between	between	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	conditioning	conditioning	NN	NN	_	9	compound	_	_
9	voltage	voltage	NN	NN	_	6	pobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	the	the	DT	DT	_	14	det	_	_
12	Ca2+	ca0+	NN	NN	_	14	compound	_	_
13	current	current	NN	NN	_	14	compound	_	_
14	amplitude	amplitude	NN	NN	_	9	conj	_	_
15	in	in	IN	IN	_	5	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	absence	absence	NN	NN	_	15	pobj	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	open	open	JJ	JJ	_	20	amod	_	_
20	squares	square	NNS	NNS	_	17	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	and	and	CC	CC	_	17	cc	_	_
23	presence	presence	NN	NN	_	17	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	circles	circle	NNS	NNS	_	23	parataxis	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	of	of	IN	IN	_	17	prep	_	_
28	ω	ω	NN	NN	_	30	compound	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	conotoxin	conotoxin	NN	NN	_	27	pobj	_	_
31	(	(	-LRB-	-LRB-	_	33	punct	_	_
32	upper	upper	JJ	JJ	_	33	amod	_	_
33	panel	panel	NN	NN	_	3	parataxis	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	12	det	_	_
2	ω	ω	NN	NN	_	4	compound	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	conotoxin	conotoxin	NN	NN	_	6	npadvmod	_	_
5	–	-	HYPH	HYPH	_	6	punct	_	_
6	sensitive	sensitive	JJ	JJ	_	12	amod	_	_
7	N	n	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	type	type	NN	NN	_	12	compound	_	_
10	Ca2+	ca0+	NN	NN	_	12	compound	_	_
11	current	current	NN	NN	_	12	compound	_	_
12	component	component	NN	NN	_	14	nsubjpass	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	shown	show	VBN	VBN	_	0	root	_	_
15	in	in	IN	IN	sem=LOC	14	prep	_	_
16	the	the	DT	DT	_	18	det	_	_
17	lower	low	JJR	JJR	_	18	amod	_	_
18	panel	panel	NN	NN	_	15	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	Figure	figure	NN	NN	_	21	compound	_	_
21	9C	0c	NN	NN	_	19	pobj	_	_
22	,	,	,	,	_	14	punct	_	_
23	and	and	CC	CC	_	14	cc	_	_
24	underwent	undergo	VBD	VBD	_	14	conj	_	_
25	voltage	voltage	NN	NN	_	27	npadvmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	dependent	dependent	JJ	JJ	_	28	amod	_	_
28	inactivation	inactivation	NN	NN	_	24	dobj	_	_
29	that	that	WDT	WDT	_	30	dep	_	28:ref
30	was	be	VBD	VBD	_	28	relcl	_	_
31	half	half	RB	RB	_	33	advmod	_	_
32	-	-	HYPH	HYPH	_	33	punct	_	_
33	maximal	maximal	JJ	JJ	syn=PRD	30	acomp	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	V0.5	v0	NN	NN	_	33	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	at	at	IN	IN	_	30	prep	_	_
38	−	−	SYM	SYM	_	41	punct	_	_
39	31	0	CD	CD	_	41	quantmod	_	_
40	±	±	SYM	SYM	_	41	punct	_	_
41	6	0	CD	CD	_	42	nummod	_	_
42	mV	mv	NNS	NNS	_	37	pobj	_	_
43	(	(	-LRB-	-LRB-	_	46	punct	_	_
44	n	n	NN	NN	_	46	nsubj	_	_
45	=	=	SYM	SYM	_	46	punct	_	_
46	6	0	CD	CD	_	30	parataxis	_	_
47	)	)	-RRB-	-RRB-	_	46	punct	_	_
48	.	.	.	.	_	14	punct	_	_

1	A	a	DT	DT	_	10	det	_	_
2	residual	residual	JJ	JJ	_	10	amod	_	_
3	,	,	,	,	_	10	punct	_	_
4	ω	ω	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	conotoxin	conotoxin	NN	NN	_	8	npadvmod	_	_
7	–	-	HYPH	HYPH	_	8	punct	_	_
8	insensitive	insensitive	JJ	JJ	_	10	amod	_	_
9	Ca2+	ca0+	NN	NN	_	10	compound	_	_
10	current	current	NN	NN	_	12	nsubj	_	_
11	also	also	RB	RB	_	12	advmod	_	_
12	appears	appear	VBZ	VBZ	_	0	root	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	undergo	undergo	VB	VB	_	12	xcomp	_	_
15	voltage	voltage	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	dependent	dependent	JJ	JJ	_	18	amod	_	_
18	inactivation	inactivation	NN	NN	_	14	dobj	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	Figure	figure	NN	NN	_	21	compound	_	_
21	9C	0c	NN	NN	_	12	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	12	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	accounts	account	VBZ	VBZ	_	0	root	_	_
3	for	for	IN	IN	_	2	prep	_	_
4	less	less	JJR	JJR	_	6	amod	_	_
5	than	than	IN	IN	_	6	quantmod	_	_
6	15	0	CD	CD	_	7	nummod	_	_
7	%	%	NN	NN	_	3	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	11	det	_	_
10	inactivating	inactivate	VBG	VBG	_	11	amod	_	_
11	current	current	NN	NN	_	8	pobj	_	_
12	,	,	,	,	_	2	punct	_	_
13	and	and	CC	CC	_	2	cc	_	_
14	may	may	MD	MD	_	15	aux	_	_
15	be	be	VB	VB	_	2	conj	_	_
16	attributable	attributable	JJ	JJ	syn=PRD	15	acomp	_	_
17	to	to	IN	IN	_	16	prep	_	_
18	T	t	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	type	type	NN	NN	_	22	compound	_	_
21	Ca2+	ca0+	NN	NN	_	22	compound	_	_
22	channels	channel	NNS	NNS	_	17	pobj	_	_
23	that	that	WDT	WDT	_	26	dep	_	22:ref
24	have	have	VBP	VBP	_	26	aux	_	_
25	been	be	VBN	VBN	_	26	auxpass	_	_
26	reported	report	VBN	VBN	_	22	relcl	_	_
27	in	in	IN	IN	sem=LOC	26	prep	_	_
28	α	α	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	27	pobj	_	_
30	[	[	-LRB-	-LRB-	_	31	punct	_	_
31	14	0	CD	CD	_	15	parataxis	_	_
32	]	]	-RRB-	-RRB-	_	31	punct	_	_
33	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	6	prep	_	_
2	Figure	figure	NN	NN	_	3	compound	_	_
3	9D	0d	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	examined	examine	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	11	det	_	_
8	voltage	voltage	NN	NN	_	10	npadvmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	dependent	dependent	JJ	JJ	_	11	amod	_	_
11	activation	activation	NN	NN	_	6	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	α	α	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	exocytosis	exocytosis	NN	NN	_	12	pobj	_	_
17	using	use	VBG	VBG	sem=MNR	6	advcl	_	_
18	step	step	NN	NN	_	20	npadvmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	wise	wise	JJ	JJ	_	21	amod	_	_
21	depolarisations	depolarisation	NNS	NNS	_	17	dobj	_	_
22	(	(	-LRB-	-LRB-	_	24	punct	_	_
23	500	0	CD	CD	_	24	nummod	_	_
24	ms	m	NNS	NNS	_	21	parataxis	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	from	from	IN	IN	_	21	prep	_	_
27	−	−	SYM	SYM	_	28	punct	_	_
28	70	0	CD	CD	_	29	nummod	_	_
29	mV	mv	NNS	NNS	_	26	pobj	_	_
30	to	to	IN	IN	_	26	prep	_	_
31	between	between	IN	IN	_	33	quantmod	_	_
32	−	−	SYM	SYM	_	33	punct	_	_
33	50	0	CD	CD	_	36	nummod	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	20	0	CD	CD	_	33	conj	_	_
36	mV	mv	NNS	NNS	_	30	pobj	_	_
37	(	(	-LRB-	-LRB-	_	39	punct	_	_
38	Figure	figure	NN	NN	_	39	compound	_	_
39	9D	0d	NN	NN	_	6	parataxis	_	_
40	)	)	-RRB-	-RRB-	_	39	punct	_	_
41	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	capacitance	capacitance	NN	NN	_	3	nmod	_	_
3	response	response	NN	NN	_	6	nmod	_	_
4	versus	versus	CC	CC	_	3	cc	_	_
5	voltage	voltage	NN	NN	_	3	conj	_	_
6	relationship	relationship	NN	NN	_	11	nsubj	_	_
7	(	(	-LRB-	-LRB-	_	9	punct	_	_
8	Figure	figure	NN	NN	_	9	compound	_	_
9	9E	0e	NN	NN	_	6	parataxis	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
12	a	a	DT	DT	_	14	det	_	_
13	marked	marked	JJ	JJ	_	14	amod	_	_
14	increase	increase	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	18	det	_	_
17	capacitance	capacitance	NN	NN	_	18	compound	_	_
18	response	response	NN	NN	_	15	pobj	_	_
19	between	between	IN	IN	_	18	prep	_	_
20	−	−	SYM	SYM	_	21	punct	_	_
21	10	0	CD	CD	_	24	nummod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	10	0	CD	CD	_	21	conj	_	_
24	mV	mv	NNS	NNS	_	19	pobj	_	_
25	.	.	.	.	_	11	punct	_	_

1	Thus	thus	RB	RB	_	13	advmod	_	_
2	any	any	DT	DT	_	3	det	_	_
3	reduction	reduction	NN	NN	_	13	nsubj	_	_
4	in	in	IN	IN	_	3	prep	_	_
5	action	action	NN	NN	_	7	compound	_	_
6	potential	potential	NN	NN	_	7	compound	_	_
7	amplitude	amplitude	NN	NN	_	4	pobj	_	_
8	within	within	IN	IN	_	3	prep	_	_
9	this	this	DT	DT	_	10	det	_	_
10	range	range	NN	NN	_	8	pobj	_	_
11	would	would	MD	MD	_	13	aux	_	_
12	severely	severely	RB	RB	_	13	advmod	_	_
13	attenuate	attenuate	VB	VB	_	0	root	_	_
14	α	α	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	exocytosis	exocytosis	NN	NN	_	13	dobj	_	_
18	.	.	.	.	_	13	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	voltage	voltage	NN	NN	_	4	npadvmod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	dependent	dependent	JJ	JJ	_	5	amod	_	_
5	inactivation	inactivation	NN	NN	_	12	nsubjpass	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	α	α	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	cell	cell	NN	NN	_	10	compound	_	_
10	exocytosis	exocytosis	NN	NN	_	6	pobj	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	examined	examine	VBN	VBN	_	0	root	_	_
13	next	next	RB	RB	_	12	advmod	_	_
14	(	(	-LRB-	-LRB-	_	16	punct	_	_
15	Figure	figure	NN	NN	_	16	compound	_	_
16	9F	0f	NN	NN	_	12	parataxis	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	.	.	.	.	_	12	punct	_	_

1	Cells	cell	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	held	hold	VBN	VBN	_	0	root	_	_
4	at	at	IN	IN	_	3	prep	_	_
5	conditioning	conditioning	NN	NN	_	6	compound	_	_
6	potentials	potential	NNS	NNS	_	4	pobj	_	_
7	between	between	IN	IN	_	6	prep	_	_
8	−	−	SYM	SYM	_	9	punct	_	_
9	70	0	CD	CD	_	13	nummod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	−	−	SYM	SYM	_	12	punct	_	_
12	30	0	CD	CD	_	9	conj	_	_
13	mV	mv	NNS	NNS	_	7	pobj	_	_
14	,	,	,	,	_	3	punct	_	_
15	after	after	IN	IN	_	19	prep	_	_
16	which	which	WDT	WDT	_	15	pobj	_	_
17	exocytosis	exocytosis	NN	NN	_	19	nsubjpass	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	elicited	elicit	VBN	VBN	sem=TMP	3	advcl	_	_
20	by	by	IN	IN	sem=MNR	19	prep	_	_
21	depolarisation	depolarisation	NN	NN	_	20	pobj	_	_
22	to	to	IN	IN	_	21	prep	_	_
23	0	0	CD	CD	_	24	nummod	_	_
24	mV	mv	NNS	NNS	_	22	pobj	_	_
25	.	.	.	.	_	3	punct	_	_

1	Exocytosis	exocytosis	NN	NN	_	10	nsubj	_	_
2	stimulated	stimulate	VBN	VBN	_	1	acl	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	9	det	_	_
5	−	−	SYM	SYM	_	6	punct	_	_
6	30	0	CD	CD	_	7	nummod	_	_
7	mV	mv	NN	NN	_	9	compound	_	_
8	conditioning	conditioning	NN	NN	_	9	compound	_	_
9	potential	potential	NN	NN	_	3	pobj	_	_
10	was	be	VBD	VBD	_	0	root	_	_
11	only	only	RB	RB	_	13	advmod	_	_
12	25	0	CD	CD	_	13	nummod	_	_
13	%	%	NN	NN	syn=PRD	10	attr	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	that	that	DT	DT	_	14	pobj	_	_
16	elicited	elicit	VBN	VBN	_	15	acl	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	−	−	SYM	SYM	_	19	punct	_	_
19	70	0	CD	CD	_	20	nummod	_	_
20	mV	mv	NN	NN	_	17	pobj	_	_
21	(	(	-LRB-	-LRB-	_	23	punct	_	_
22	Figure	figure	NN	NN	_	23	compound	_	_
23	9G	0g	NN	NN	_	10	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	10	punct	_	_

1	This	this	DT	DT	_	5	det	_	_
2	voltage	voltage	NN	NN	_	4	npadvmod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	dependent	dependent	JJ	JJ	_	5	amod	_	_
5	decline	decline	NN	NN	_	8	nsubj	_	_
6	in	in	IN	IN	sem=TMP	5	prep	_	_
7	exocytosis	exocytosis	NN	NN	_	6	pobj	_	_
8	is	be	VBZ	VBZ	_	0	root	_	_
9	attributable	attributable	JJ	JJ	syn=PRD	8	acomp	_	_
10	to	to	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	15	det	_	_
12	voltage	voltage	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	dependent	dependent	JJ	JJ	_	15	amod	_	_
15	inactivation	inactivation	NN	NN	_	10	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	22	det	_	_
18	N	n	NN	NN	_	20	compound	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	type	type	NN	NN	_	22	compound	_	_
21	Ca2+	ca0+	NN	NN	_	22	compound	_	_
22	channels	channel	NNS	NNS	_	16	pobj	_	_
23	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	fact	fact	NN	NN	_	30	nsubjpass	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	inhibition	inhibition	NN	NN	_	7	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	exocytosis	exocytosis	NN	NN	_	5	pobj	_	_
7	appears	appear	VBZ	VBZ	_	2	acl	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	occur	occur	VB	VB	_	7	xcomp	_	_
10	at	at	IN	IN	_	9	prep	_	_
11	more	more	RB	RB	_	13	advmod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	negative	negative	JJ	JJ	_	14	amod	_	_
14	voltages	voltage	NNS	NNS	_	10	pobj	_	_
15	than	than	IN	IN	_	14	prep	_	_
16	that	that	DT	DT	_	15	pobj	_	_
17	documented	document	VBN	VBN	_	16	acl	_	_
18	for	for	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	20	det	_	_
20	inactivation	inactivation	NN	NN	_	18	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	27	det	_	_
23	N	n	NN	NN	_	25	compound	_	_
24	-	-	HYPH	HYPH	_	25	punct	_	_
25	type	type	NN	NN	_	27	compound	_	_
26	Ca2+	ca0+	NN	NN	_	27	compound	_	_
27	channels	channel	NNS	NNS	_	21	pobj	_	_
28	can	can	MD	MD	_	30	aux	_	_
29	be	be	VB	VB	_	30	auxpass	_	_
30	attributed	attribute	VBN	VBN	_	0	root	_	_
31	to	to	IN	IN	_	30	prep	_	_
32	the	the	DT	DT	_	33	det	_	_
33	brevity	brevity	NN	NN	_	31	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	the	the	DT	DT	_	37	det	_	_
36	conditioning	conditioning	NN	NN	_	37	compound	_	_
37	pulses	pulse	NNS	NNS	_	34	pobj	_	_
38	in	in	IN	IN	_	33	prep	_	_
39	Figure	figure	NN	NN	_	40	compound	_	_
40	9A	0a	NN	NN	_	38	pobj	_	_
41	–	-	SYM	SYM	_	42	punct	_	_
42	9C	0c	NN	NN	_	40	prep	_	_
43	(	(	-LRB-	-LRB-	_	33	punct	_	_
44	200	0	CD	CD	_	45	nummod	_	_
45	ms	m	NNS	NNS	_	33	appos	_	_
46	)	)	-RRB-	-RRB-	_	33	punct	_	_
47	,	,	,	,	_	30	punct	_	_
48	whereas	whereas	IN	IN	_	55	mark	_	_
49	in	in	IN	IN	_	55	prep	_	_
50	Figure	figure	NN	NN	_	51	compound	_	_
51	9G	0g	NN	NN	_	49	pobj	_	_
52	the	the	DT	DT	_	54	det	_	_
53	holding	holding	NN	NN	_	54	compound	_	_
54	potential	potential	NN	NN	_	55	nsubj	_	_
55	was	be	VBD	VBD	syn=ADV	30	advcl	_	_
56	varied	varied	JJ	JJ	syn=PRD	55	acomp	_	_
57	.	.	.	.	_	30	punct	_	_

1	Discussion	discussion	NN	NN	_	0	root	_	_

1	Regulated	regulate	VBN	VBN	_	3	amod	_	_
2	glucagon	glucagon	NN	NN	_	3	compound	_	_
3	secretion	secretion	NN	NN	_	8	nsubj	_	_
4	from	from	IN	IN	_	3	prep	_	_
5	pancreatic	pancreatic	JJ	JJ	_	7	amod	_	_
6	α	α	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	4	pobj	_	_
8	is	be	VBZ	VBZ	_	0	root	_	_
9	a	a	DT	DT	_	11	det	_	_
10	major	major	JJ	JJ	_	11	amod	_	_
11	component	component	NN	NN	syn=PRD	8	attr	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	counter-regulatory	counter-regulatory	JJ	JJ	_	15	amod	_	_
15	response	response	NN	NN	_	12	pobj	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	hypoglycaemia	hypoglycaemia	NN	NN	_	16	pobj	_	_
18	.	.	.	.	_	8	punct	_	_

1	Diabetes	diabetes	NN	NN	_	2	compound	_	_
2	mellitus	mellitus	NN	NN	_	3	nsubj	_	_
3	is	be	VBZ	VBZ	_	0	root	_	_
4	associated	associated	JJ	JJ	syn=PRD	3	acomp	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	defects	defect	NNS	NNS	_	5	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	glucagon	glucagon	NN	NN	_	9	compound	_	_
9	secretion	secretion	NN	NN	_	7	pobj	_	_
10	that	that	WDT	WDT	_	11	dep	_	6:ref
11	exacerbate	exacerbate	VBP	VBP	_	6	relcl	_	_
12	the	the	DT	DT	_	13	det	_	_
13	consequences	consequence	NNS	NNS	_	11	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	impaired	impaired	JJ	JJ	_	17	amod	_	_
16	insulin	insulin	NN	NN	_	17	compound	_	_
17	secretion	secretion	NN	NN	_	14	pobj	_	_
18	[	[	-LRB-	-LRB-	_	19	punct	_	_
19	2	0	CD	CD	_	3	parataxis	_	_
20	–	-	SYM	SYM	_	21	punct	_	_
21	4	0	CD	CD	_	19	prep	_	_
22	]	]	-RRB-	-RRB-	_	19	punct	_	_
23	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	10	nsubj	_	_
3	regulating	regulate	VBG	VBG	_	2	acl	_	_
4	the	the	DT	DT	_	5	det	_	_
5	release	release	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	this	this	DT	DT	_	9	det	_	_
8	important	important	JJ	JJ	_	9	amod	_	_
9	hormone	hormone	NN	NN	_	6	pobj	_	_
10	is	be	VBZ	VBZ	_	0	root	_	_
11	incompletely	incompletely	RB	RB	_	12	advmod	_	_
12	understood	understand	VBN	VBN	syn=PRD	10	dep	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	currently	currently	RB	RB	sem=TMP	16	advmod	_	_
15	the	the	DT	DT	_	16	det	_	_
16	source	source	NN	NN	_	12	conj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	much	much	JJ	JJ	_	19	amod	_	_
19	debate	debate	NN	NN	_	17	pobj	_	_
20	.	.	.	.	_	10	punct	_	_

1	In	in	IN	IN	_	6	prep	_	_
2	the	the	DT	DT	_	4	det	_	_
3	present	present	JJ	JJ	_	4	amod	_	_
4	study	study	NN	NN	_	1	pobj	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	examined	examine	VBD	VBD	_	0	root	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	secretion	secretion	NN	NN	_	6	dobj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	the	the	DT	DT	_	15	det	_	_
11	[	[	-LRB-	-LRB-	_	14	punct	_	_
12	Ca2+	ca0+	NN	NN	_	14	nmod	_	_
13	]	]	-RRB-	-RRB-	_	14	punct	_	_
14	i	i	NN	NN	_	15	compound	_	_
15	response	response	NN	NN	_	8	conj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	in	in	FW	FW	_	18	advmod	_	_
18	situ	situ	FW	FW	_	20	amod	_	_
19	α	α	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	16	pobj	_	_
21	of	of	IN	IN	_	8	prep	_	_
22	isolated	isolate	VBN	VBN	_	26	amod	_	_
23	rodent	rodent	NN	NN	_	26	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	human	human	JJ	JJ	_	23	conj	_	_
26	islets	islet	NNS	NNS	_	21	pobj	_	_
27	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	far	RB	RB	_	3	advmod	_	_
3	characterised	characterise	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	Ca2+	ca0+	NN	NN	_	6	compound	_	_
6	currents	current	NNS	NNS	_	3	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	capacitance	capacitance	NN	NN	_	9	compound	_	_
9	changes	change	NNS	NNS	_	6	conj	_	_
10	of	of	IN	IN	_	6	prep	_	_
11	single	single	JJ	JJ	_	14	amod	_	_
12	isolated	isolated	JJ	JJ	_	14	amod	_	_
13	α	α	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	10	pobj	_	_
15	,	,	,	,	_	3	punct	_	_
16	to	to	TO	TO	_	17	aux	_	_
17	dissect	dissect	VB	VB	sem=PRP	3	advcl	_	_
18	the	the	DT	DT	_	19	det	_	_
19	mechanism	mechanism	NN	NN	_	17	dobj	_	_
20	regulating	regulate	VBG	VBG	_	19	acl	_	_
21	downstream	downstream	JJ	JJ	_	22	amod	_	_
22	control	control	NN	NN	_	20	dobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	glucagon	glucagon	NN	NN	_	25	compound	_	_
25	release	release	NN	NN	_	23	pobj	_	_
26	.	.	.	.	_	3	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	30	nsubj	_	_
3	with	with	IN	IN	_	2	prep	_	_
4	genetic	genetic	JJ	JJ	_	6	amod	_	_
5	mouse	mouse	NN	NN	_	6	compound	_	_
6	models	model	NNS	NNS	_	3	pobj	_	_
7	,	,	,	,	_	2	punct	_	_
8	including	include	VBG	VBG	_	2	prep	_	_
9	SUR1	sur0	NN	NN	_	28	nmod	_	_
10	−	−	SYM	SYM	_	9	punct	_	_
11	/	/	HYPH	HYPH	_	9	punct	_	_
12	−	−	SYM	SYM	_	9	punct	_	_
13	[	[	-LRB-	-LRB-	_	18	punct	_	_
14	13	0	CD	CD	_	18	nummod	_	_
15	,	,	,	,	_	18	punct	_	_
16	34	0	CD	CD	_	18	nummod	_	_
17	,	,	,	,	_	18	punct	_	_
18	35	0	CD	CD	_	9	parataxis	_	_
19	]	]	-RRB-	-RRB-	_	18	punct	_	_
20	and	and	CC	CC	_	9	cc	_	_
21	Kir6.2	kir0	NN	NN	_	9	conj	_	_
22	−	−	SYM	SYM	_	21	punct	_	_
23	/	/	HYPH	HYPH	_	21	punct	_	_
24	−	−	SYM	SYM	_	21	punct	_	_
25	[	[	-LRB-	-LRB-	_	26	punct	_	_
26	16	0	CD	CD	_	21	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	mice	mouse	NNS	NNS	_	8	pobj	_	_
29	,	,	,	,	_	30	punct	_	_
30	suggests	suggest	VBZ	VBZ	_	0	root	_	_
31	an	an	DT	DT	_	33	det	_	_
32	important	important	JJ	JJ	_	33	amod	_	_
33	role	role	NN	NN	_	30	dobj	_	_
34	for	for	IN	IN	_	33	prep	_	_
35	KATP	katp	NN	NN	_	36	compound	_	_
36	channels	channel	NNS	NNS	_	34	pobj	_	_
37	in	in	IN	IN	_	33	prep	_	_
38	glucagon	glucagon	NN	NN	_	39	compound	_	_
39	secretion	secretion	NN	NN	_	37	pobj	_	_
40	.	.	.	.	_	30	punct	_	_

1	Three	#crd#	CD	CD	_	2	nummod	_	_
2	pieces	piece	NNS	NNS	_	5	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	evidence	evidence	NN	NN	_	3	pobj	_	_
5	argue	argue	VBP	VBP	_	0	root	_	_
6	for	for	IN	IN	sem=PRP	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	importance	importance	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	islet	islet	NN	NN	_	12	compound	_	_
11	KATP	katp	NN	NN	_	12	compound	_	_
12	channels	channel	NNS	NNS	_	9	pobj	_	_
13	in	in	IN	IN	_	8	prep	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	13	pobj	_	_
16	.	.	.	.	_	5	punct	_	_

1	First	#ord#	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	introduction	introduction	NN	NN	_	17	nsubj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	7	det	_	_
6	Tyr12STOP	tyr0stop	NN	NN	_	7	compound	_	_
7	mutation	mutation	NN	NN	_	4	pobj	_	_
8	into	into	IN	IN	sem=LOC	3	prep	_	_
9	the	the	DT	DT	_	12	det	_	_
10	KATP	katp	NN	NN	_	11	compound	_	_
11	channel	channel	NN	NN	_	12	compound	_	_
12	subunits	subunit	NNS	NNS	_	8	pobj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	the	the	DT	DT	_	16	det	_	_
15	Kir6.2Y12X	kir0y0x	NN	NN	_	16	compound	_	_
16	islets	islet	NNS	NNS	_	13	pobj	_	_
17	results	result	VBZ	VBZ	_	0	root	_	_
18	in	in	IN	IN	_	17	prep	_	_
19	suppression	suppression	NN	NN	_	18	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	glucagon	glucagon	NN	NN	_	22	compound	_	_
22	secretion	secretion	NN	NN	_	20	pobj	_	_
23	at	at	IN	IN	_	19	prep	_	_
24	low	low	JJ	JJ	_	26	amod	_	_
25	-	-	HYPH	HYPH	_	26	punct	_	_
26	glucose	glucose	NN	NN	_	27	compound	_	_
27	levels	level	NNS	NNS	_	23	pobj	_	_
28	and	and	CC	CC	_	17	cc	_	_
29	causes	cause	VBZ	VBZ	_	17	conj	_	_
30	loss	loss	NN	NN	_	29	dobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	glucose	glucose	NN	NN	_	35	nmod	_	_
33	-	-	HYPH	HYPH	_	32	punct	_	_
34	induced	induce	VBN	VBN	_	32	amod	_	_
35	inhibition	inhibition	NN	NN	_	31	pobj	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	secretion	secretion	NN	NN	_	36	pobj	_	_
38	.	.	.	.	_	17	punct	_	_

1	Second	#ord#	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	KATP	katp	NN	NN	_	5	compound	_	_
5	channel	channel	NN	NN	_	6	compound	_	_
6	inhibitor	inhibitor	NN	NN	_	14	nsubj	_	_
7	tolbutamide	tolbutamide	NN	NN	_	6	appos	_	_
8	when	when	WRB	WRB	_	9	advmod	_	6:ref
9	applied	apply	VBN	VBN	sem=TMP	6	advcl	_	_
10	at	at	IN	IN	_	9	prep	_	_
11	maximally	maximally	RB	RB	_	12	advmod	_	_
12	effective	effective	JJ	JJ	_	13	amod	_	_
13	concentrations	concentration	NNS	NNS	_	10	pobj	_	_
14	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	14	dobj	_	_
17	from	from	IN	IN	_	14	prep	_	_
18	isolated	isolate	VBN	VBN	_	19	amod	_	_
19	islets	islet	NNS	NNS	_	17	pobj	_	_
20	.	.	.	.	_	14	punct	_	_

1	Third	#ord#	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	a	a	DT	DT	_	5	det	_	_
4	low	low	JJ	JJ	_	5	amod	_	_
5	dose	dose	NN	NN	_	12	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	10	det	_	_
8	KATP	katp	NN	NN	_	9	compound	_	_
9	channel	channel	NN	NN	_	10	compound	_	_
10	activator	activator	NN	NN	_	6	pobj	_	_
11	diazoxide	diazoxide	NN	NN	_	10	appos	_	_
12	restores	restore	VBZ	VBZ	_	0	root	_	_
13	α	α	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	cell	cell	NN	NN	_	17	compound	_	_
16	Ca2+	ca0+	NN	NN	_	17	compound	_	_
17	responses	response	NNS	NNS	_	12	dobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	glucagon	glucagon	NN	NN	_	20	compound	_	_
20	secretion	secretion	NN	NN	_	17	conj	_	_
21	in	in	IN	IN	_	12	prep	_	_
22	high	high	JJ	JJ	_	24	amod	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	glucose	glucose	NN	NN	_	25	compound	_	_
25	conditions	condition	NNS	NNS	_	21	pobj	_	_
26	.	.	.	.	_	12	punct	_	_

1	What	what	WDT	WDT	_	2	dep	_	_
2	is	be	VBZ	VBZ	syn=NOM	21	csubj	_	_
3	not	not	RB	RB	_	2	neg	_	_
4	immediately	immediately	RB	RB	_	2	advmod	_	_
5	clear	clear	JJ	JJ	syn=PRD	2	acomp	_	_
6	from	from	IN	IN	_	5	prep	_	_
7	these	these	DT	DT	_	8	det	_	_
8	arguments	argument	NNS	NNS	_	6	pobj	_	_
9	,	,	,	,	_	6	punct	_	_
10	and	and	CC	CC	_	6	cc	_	_
11	from	from	IN	IN	_	6	conj	_	_
12	the	the	DT	DT	_	19	det	_	_
13	previous	previous	JJ	JJ	_	19	amod	_	_
14	SUR1	sur0	NN	NN	_	19	nmod	_	_
15	−	−	SYM	SYM	_	14	punct	_	_
16	/	/	HYPH	HYPH	_	14	punct	_	_
17	−	−	SYM	SYM	_	14	punct	_	_
18	genetic	genetic	JJ	JJ	_	19	amod	_	_
19	studies	study	NNS	NNS	_	11	pobj	_	_
20	,	,	,	,	_	21	punct	_	_
21	is	be	VBZ	VBZ	_	0	root	_	_
22	whether	whether	IN	IN	_	26	mark	_	_
23	glucagon	glucagon	NN	NN	_	26	nsubjpass	_	_
24	is	be	VBZ	VBZ	_	26	aux	_	_
25	being	be	VBG	VBG	_	26	auxpass	_	_
26	controlled	control	VBN	VBN	syn=NOM,PRD	21	ccomp	_	_
27	by	by	IN	IN	sem=MNR	26	prep	_	_
28	the	the	DT	DT	_	31	det	_	_
29	α	α	NN	NN	_	31	compound	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	cell	cell	NN	NN	_	27	pobj	_	_
32	or	or	CC	CC	_	31	cc	_	_
33	the	the	DT	DT	_	36	det	_	_
34	β	β	NN	NN	_	36	compound	_	_
35	-	-	HYPH	HYPH	_	36	punct	_	_
36	cell	cell	NN	NN	_	38	compound	_	_
37	KATP	katp	NN	NN	_	38	compound	_	_
38	channels	channel	NNS	NNS	_	31	conj	_	_
39	,	,	,	,	_	26	punct	_	_
40	as	as	IN	IN	_	44	mark	_	_
41	the	the	DT	DT	_	42	det	_	_
42	latter	latter	JJ	JJ	_	44	nsubj	_	_
43	may	may	MD	MD	_	44	aux	_	_
44	regulate	regulate	VB	VB	syn=ADV	26	advcl	_	_
45	α	α	NN	NN	_	47	compound	_	_
46	-	-	HYPH	HYPH	_	47	punct	_	_
47	cell	cell	NN	NN	_	48	compound	_	_
48	function	function	NN	NN	_	44	dobj	_	_
49	indirectly	indirectly	RB	RB	_	44	advmod	_	_
50	via	via	IN	IN	sem=MNR	44	prep	_	_
51	paracrine	paracrine	JJ	JJ	_	52	amod	_	_
52	pathways	pathway	NNS	NNS	_	50	pobj	_	_
53	.	.	.	.	_	21	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	therefore	therefore	RB	RB	_	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	insulin	insulin	NN	NN	_	7	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	glucagon	glucagon	NN	NN	_	4	conj	_	_
7	secretion	secretion	NN	NN	_	3	dobj	_	_
8	,	,	,	,	_	7	punct	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	the	the	DT	DT	_	12	det	_	_
11	Ca2+	ca0+	NN	NN	_	12	compound	_	_
12	responses	response	NNS	NNS	_	7	conj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	α	α	NN	NN	_	17	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	β	β	NN	NN	_	14	conj	_	_
17	cells	cell	NNS	NNS	_	13	pobj	_	_
18	in	in	FW	FW	_	19	advmod	_	_
19	situ	situ	FW	FW	_	3	advmod	_	_
20	in	in	IN	IN	_	3	prep	_	_
21	parallel	parallel	NN	NN	_	20	pobj	_	_
22	to	to	TO	TO	_	23	aux	_	_
23	determine	determine	VB	VB	sem=PRP	3	advcl	_	_
24	the	the	DT	DT	_	26	det	_	_
25	functional	functional	JJ	JJ	_	26	amod	_	_
26	relationship	relationship	NN	NN	_	23	dobj	_	_
27	between	between	IN	IN	_	26	prep	_	_
28	these	these	DT	DT	_	29	det	_	_
29	cells	cell	NNS	NNS	_	27	pobj	_	_
30	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	measured	measure	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	7	det	_	_
6	glucagon	glucagon	NN	NN	_	7	compound	_	_
7	response	response	NN	NN	_	4	dobj	_	_
8	to	to	IN	IN	_	7	prep	_	_
9	glucose	glucose	NN	NN	_	8	pobj	_	_
10	during	during	IN	IN	sem=TMP	4	prep	_	_
11	blockade	blockade	NN	NN	_	10	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	putative	putative	JJ	JJ	_	16	amod	_	_
14	paracrine	paracrine	JJ	JJ	_	16	amod	_	_
15	signalling	signalling	NN	NN	_	16	compound	_	_
16	pathways	pathway	NNS	NNS	_	12	pobj	_	_
17	.	.	.	.	_	4	punct	_	_

1	Studies	study	NNS	NNS	_	5	nsubj	_	_
2	on	on	IN	IN	_	1	prep	_	_
3	rat	rat	NN	NN	_	4	compound	_	_
4	islets	islet	NNS	NNS	_	2	pobj	_	_
5	support	support	VBP	VBP	_	0	root	_	_
6	an	an	DT	DT	_	8	det	_	_
7	important	important	JJ	JJ	_	8	amod	_	_
8	role	role	NN	NN	_	5	dobj	_	_
9	for	for	IN	IN	_	8	prep	_	_
10	paracrine	paracrine	JJ	JJ	_	11	amod	_	_
11	signals	signal	NNS	NNS	_	9	pobj	_	_
12	as	as	IN	IN	_	11	prep	_	_
13	regulators	regulator	NNS	NNS	_	12	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	release	release	NN	NN	_	14	pobj	_	_
17	[	[	-LRB-	-LRB-	_	22	punct	_	_
18	33	0	CD	CD	_	22	dep	_	_
19	,	,	,	,	_	22	punct	_	_
20	52	0	CD	CD	_	22	dep	_	_
21	,	,	,	,	_	22	punct	_	_
22	53	0	CD	CD	_	8	parataxis	_	_
23	]	]	-RRB-	-RRB-	_	22	punct	_	_
24	,	,	,	,	_	5	punct	_	_
25	whereas	whereas	IN	IN	_	40	mark	_	_
26	the	the	DT	DT	_	27	det	_	_
27	case	case	NN	NN	_	40	nsubj	_	_
28	for	for	IN	IN	_	27	prep	_	_
29	paracrine	paracrine	JJ	JJ	_	30	amod	_	_
30	regulation	regulation	NN	NN	_	28	pobj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	glucagon	glucagon	NN	NN	_	33	compound	_	_
33	secretion	secretion	NN	NN	_	31	pobj	_	_
34	from	from	IN	IN	_	33	prep	_	_
35	mouse	mouse	NN	NN	_	39	nmod	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	human	human	JJ	JJ	_	35	conj	_	_
38	α	α	NN	NN	_	39	compound	_	_
39	cells	cell	NNS	NNS	_	34	pobj	_	_
40	is	be	VBZ	VBZ	syn=ADV	5	advcl	_	_
41	less	less	RBR	RBR	_	42	advmod	_	_
42	clear	clear	JJ	JJ	syn=PRD	40	acomp	_	_
43	[	[	-LRB-	-LRB-	_	44	punct	_	_
44	9	0	CD	CD	_	5	parataxis	_	_
45	,	,	,	,	_	44	punct	_	_
46	10	0	CD	CD	_	44	appos	_	_
47	,	,	,	,	_	44	punct	_	_
48	14	0	CD	CD	_	44	appos	_	_
49	,	,	,	,	_	44	punct	_	_
50	17	0	CD	CD	_	44	appos	_	_
51	–	-	SYM	SYM	_	52	punct	_	_
52	21	0	CD	CD	_	50	prep	_	_
53	,	,	,	,	_	44	punct	_	_
54	27	0	CD	CD	_	44	appos	_	_
55	]	]	-RRB-	-RRB-	_	44	punct	_	_
56	.	.	.	.	_	5	punct	_	_

1	Although	although	IN	IN	_	3	mark	_	_
2	it	it	PRP	PRP	_	3	nsubj	_	_
3	is	be	VBZ	VBZ	syn=ADV	29	advcl	_	_
4	clear	clear	JJ	JJ	syn=PRD	3	acomp	_	_
5	that	that	IN	IN	_	13	mark	_	_
6	Zn2+	zn0+	NN	NN	_	13	nsubj	_	_
7	,	,	,	,	_	6	punct	_	_
8	GABA	gaba	NN	NN	_	6	conj	_	_
9	,	,	,	,	_	8	punct	_	_
10	and	and	CC	CC	_	8	cc	_	_
11	somatostatin	somatostatin	NN	NN	_	8	conj	_	_
12	can	can	MD	MD	_	13	aux	_	_
13	exert	exert	VB	VB	_	3	ccomp	_	_
14	a	a	DT	DT	_	16	det	_	_
15	paracrine	paracrine	JJ	JJ	_	16	amod	_	_
16	control	control	NN	NN	_	13	dobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	glucagon	glucagon	NN	NN	_	19	compound	_	_
19	secretion	secretion	NN	NN	_	17	pobj	_	_
20	under	under	IN	IN	_	13	prep	_	_
21	certain	certain	JJ	JJ	_	22	amod	_	_
22	conditions	condition	NNS	NNS	_	20	pobj	_	_
23	,	,	,	,	_	29	punct	_	_
24	the	the	DT	DT	_	25	det	_	_
25	data	datum	NNS	NNS	_	29	nsubj	_	_
26	shown	show	VBN	VBN	_	25	acl	_	_
27	here	here	RB	RB	_	26	advmod	_	_
28	firmly	firmly	RB	RB	_	29	advmod	_	_
29	establish	establish	VB	VB	_	0	root	_	_
30	that	that	DT	DT	_	33	mark	_	_
31	glucose	glucose	NN	NN	_	33	nsubj	_	_
32	can	can	MD	MD	_	33	aux	_	_
33	suppress	suppress	VB	VB	_	29	ccomp	_	_
34	glucagon	glucagon	NN	NN	_	35	compound	_	_
35	secretion	secretion	NN	NN	_	33	dobj	_	_
36	independently	independently	RB	RB	_	33	advmod	_	_
37	of	of	IN	IN	_	36	prep	_	_
38	these	these	DT	DT	_	39	det	_	_
39	pathways	pathway	NNS	NNS	_	37	pobj	_	_
40	as	as	IN	IN	_	41	mark	_	_
41	demonstrated	demonstrate	VBN	VBN	syn=ADV	33	advcl	_	_
42	in	in	IN	IN	_	41	prep	_	_
43	Figure	figure	NN	NN	_	42	pobj	_	_
44	1	0	CD	CD	_	43	nummod	_	_
45	(	(	-LRB-	-LRB-	_	42	punct	_	_
46	and	and	CC	CC	_	42	cc	_	_
47	in	in	IN	IN	_	42	conj	_	_
48	[	[	-LRB-	-LRB-	_	47	punct	_	_
49	47	0	CD	CD	_	47	pobj	_	_
50	]	]	-RRB-	-RRB-	_	29	punct	_	_
51	)	)	-RRB-	-RRB-	_	29	punct	_	_
52	.	.	.	.	_	29	punct	_	_

1	Furthermore	furthermore	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	and	and	CC	CC	_	11	cc	_	_
4	in	in	IN	IN	_	11	prep	_	_
5	agreement	agreement	NN	NN	_	4	pobj	_	_
6	with	with	IN	IN	_	5	prep	_	_
7	recently	recently	RB	RB	_	8	advmod	_	_
8	published	publish	VBN	VBN	_	9	amod	_	_
9	results	result	NNS	NNS	_	6	pobj	_	_
10	[	[	-LRB-	-LRB-	_	11	punct	_	_
11	47	0	CD	CD	_	19	parataxis	_	_
12	]	]	-RRB-	-RRB-	_	11	punct	_	_
13	,	,	,	,	_	19	punct	_	_
14	maximal	maximal	JJ	JJ	_	15	amod	_	_
15	inhibition	inhibition	NN	NN	_	19	nsubj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	release	release	NN	NN	_	16	pobj	_	_
19	occurs	occur	VBZ	VBZ	_	0	root	_	_
20	at	at	IN	IN	_	19	prep	_	_
21	levels	level	NNS	NNS	_	20	pobj	_	_
22	equal	equal	JJ	JJ	_	21	amod	_	_
23	to	to	IN	IN	_	22	prep	_	_
24	or	or	CC	CC	_	22	cc	_	_
25	lower	low	JJR	JJR	_	22	conj	_	_
26	than	than	IN	IN	_	25	prep	_	_
27	5	0	CD	CD	_	28	nummod	_	_
28	mM	mm	NN	NN	_	29	compound	_	_
29	glucose	glucose	NN	NN	_	25	npadvmod	_	_
30	,	,	,	,	_	19	punct	_	_
31	whereas	whereas	IN	IN	_	37	mark	_	_
32	the	the	DT	DT	_	33	det	_	_
33	stimulation	stimulation	NN	NN	_	37	nsubj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	insulin	insulin	NN	NN	_	36	compound	_	_
36	release	release	NN	NN	_	34	pobj	_	_
37	requires	require	VBZ	VBZ	syn=ADV	19	advcl	_	_
38	glucose	glucose	NN	NN	_	39	compound	_	_
39	levels	level	NNS	NNS	_	37	dobj	_	_
40	greater	great	JJR	JJR	_	39	amod	_	_
41	than	than	IN	IN	_	40	prep	_	_
42	5	0	CD	CD	_	43	nummod	_	_
43	mM	mm	NNS	NNS	_	41	pobj	_	_
44	(	(	-LRB-	-LRB-	_	45	punct	_	_
45	Figure	figure	NN	NN	_	40	parataxis	_	_
46	3	0	CD	CD	_	45	nummod	_	_
47	)	)	-RRB-	-RRB-	_	45	punct	_	_
48	,	,	,	,	_	19	punct	_	_
49	suggesting	suggest	VBG	VBG	syn=ADV	19	advcl	_	_
50	that	that	IN	IN	_	59	mark	_	_
51	products	product	NNS	NNS	_	59	nsubjpass	_	_
52	of	of	IN	IN	_	51	prep	_	_
53	β	β	NN	NN	_	55	compound	_	_
54	-	-	HYPH	HYPH	_	55	punct	_	_
55	cell	cell	NN	NN	_	56	compound	_	_
56	secretion	secretion	NN	NN	_	52	pobj	_	_
57	are	be	VBP	VBP	_	59	auxpass	_	_
58	not	not	RB	RB	_	59	neg	_	_
59	required	require	VBN	VBN	_	49	ccomp	_	_
60	for	for	IN	IN	sem=PRP	59	prep	_	_
61	suppression	suppression	NN	NN	_	60	pobj	_	_
62	of	of	IN	IN	_	61	prep	_	_
63	glucagon	glucagon	NN	NN	_	64	compound	_	_
64	release	release	NN	NN	_	62	pobj	_	_
65	.	.	.	.	_	19	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	conclusion	conclusion	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	further	far	RB	RB	_	5	advmod	_	_
5	underpinned	underpin	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	significant	significant	JJ	JJ	_	9	amod	_	_
9	discordance	discordance	NN	NN	_	6	pobj	_	_
10	between	between	IN	IN	_	9	prep	_	_
11	insulin	insulin	NN	NN	_	14	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	glucagon	glucagon	NN	NN	_	11	conj	_	_
14	release	release	NN	NN	_	10	pobj	_	_
15	,	,	,	,	_	9	punct	_	_
16	and	and	CC	CC	_	9	cc	_	_
17	the	the	DT	DT	_	25	det	_	_
18	β	β	NN	NN	_	23	nmod	_	_
19	-	-	HYPH	HYPH	_	18	punct	_	_
20	and	and	CC	CC	_	18	cc	_	_
21	α	α	NN	NN	_	18	conj	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	cell	cell	NN	NN	_	25	compound	_	_
24	Ca2+	ca0+	NN	NN	_	25	compound	_	_
25	responses	response	NNS	NNS	_	9	conj	_	_
26	,	,	,	,	_	5	punct	_	_
27	under	under	IN	IN	_	5	prep	_	_
28	several	several	JJ	JJ	_	29	amod	_	_
29	conditions	condition	NNS	NNS	_	27	pobj	_	_
30	:	:	:	:	_	29	punct	_	_
31	(	(	-LRB-	-LRB-	_	32	punct	_	_
32	1	0	LS	LS	_	35	meta	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	low	low	JJ	JJ	_	35	amod	_	_
35	doses	dose	NNS	NNS	_	29	nmod	_	_
36	of	of	IN	IN	_	35	prep	_	_
37	the	the	DT	DT	_	40	det	_	_
38	KATP	katp	NN	NN	_	39	compound	_	_
39	channel	channel	NN	NN	_	40	compound	_	_
40	opener	opener	NN	NN	_	36	pobj	_	_
41	diazoxide	diazoxide	NN	NN	_	40	appos	_	_
42	that	that	WDT	WDT	_	43	dep	_	35:ref
43	stimulate	stimulate	VBP	VBP	_	35	relcl	_	_
44	glucagon	glucagon	NN	NN	_	45	compound	_	_
45	secretion	secretion	NN	NN	_	43	dobj	_	_
46	while	while	IN	IN	_	48	mark	_	_
47	not	not	RB	RB	_	48	neg	_	_
48	affecting	affect	VBG	VBG	syn=ADV	43	advcl	_	_
49	insulin	insulin	NN	NN	_	50	compound	_	_
50	release	release	NN	NN	_	48	dobj	_	_
51	;	;	:	:	_	35	punct	_	_
52	(	(	-LRB-	-LRB-	_	53	punct	_	_
53	2	0	LS	LS	_	56	meta	_	_
54	)	)	-RRB-	-RRB-	_	53	punct	_	_
55	high	high	JJ	JJ	_	56	amod	_	_
56	doses	dose	NNS	NNS	_	35	conj	_	_
57	of	of	IN	IN	_	56	prep	_	_
58	diazoxide	diazoxide	NN	NN	_	57	pobj	_	_
59	at	at	IN	IN	_	69	prep	_	_
60	which	which	WDT	WDT	_	59	pobj	_	56:ref
61	suppression	suppression	NN	NN	_	69	nsubjpass	_	_
62	of	of	IN	IN	_	61	prep	_	_
63	β	β	NN	NN	_	65	compound	_	_
64	-	-	HYPH	HYPH	_	65	punct	_	_
65	cell	cell	NN	NN	_	66	compound	_	_
66	secretion	secretion	NN	NN	_	62	pobj	_	_
67	would	would	MD	MD	_	69	aux	_	_
68	be	be	VB	VB	_	69	auxpass	_	_
69	expected	expect	VBN	VBN	_	56	relcl	_	_
70	to	to	TO	TO	_	71	aux	_	_
71	elevate	elevate	VB	VB	sem=PRP	69	advcl	_	_
72	glucagon	glucagon	NN	NN	_	73	compound	_	_
73	release	release	NN	NN	_	71	dobj	_	_
74	;	;	:	:	_	56	punct	_	_
75	(	(	-LRB-	-LRB-	_	76	punct	_	_
76	3	0	LS	LS	_	78	meta	_	_
77	)	)	-RRB-	-RRB-	_	76	punct	_	_
78	in	in	IN	IN	sem=LOC	56	conj	_	_
79	the	the	DT	DT	_	81	det	_	_
80	Kir6.2Y12X	kir0y0x	NN	NN	_	81	compound	_	_
81	islets	islet	NNS	NNS	_	78	pobj	_	_
82	;	;	:	:	_	78	punct	_	_
83	and	and	CC	CC	_	78	cc	_	_
84	(	(	-LRB-	-LRB-	_	85	punct	_	_
85	4	0	LS	LS	_	87	meta	_	_
86	)	)	-RRB-	-RRB-	_	85	punct	_	_
87	in	in	IN	IN	_	78	conj	_	_
88	response	response	NN	NN	_	87	pobj	_	_
89	to	to	IN	IN	_	88	prep	_	_
90	the	the	DT	DT	_	93	det	_	_
91	Na+	na+	NN	NN	_	92	compound	_	_
92	channel	channel	NN	NN	_	93	compound	_	_
93	blocker	blocker	NN	NN	_	89	pobj	_	_
94	TTX	ttx	NN	NN	_	93	appos	_	_
95	.	.	.	.	_	5	punct	_	_

1	Therefore	therefore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	our	PRP$	PRP$	_	4	poss	_	_
4	data	datum	NNS	NNS	_	5	nsubj	_	_
5	argue	argue	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	12	mark	_	_
7	glucagon	glucagon	NN	NN	_	9	npadvmod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	producing	produce	VBG	VBG	_	11	amod	_	_
10	α	α	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	12	nsubj	_	_
12	possess	possess	VBP	VBP	_	5	ccomp	_	_
13	an	an	DT	DT	_	15	det	_	_
14	intrinsic	intrinsic	JJ	JJ	_	15	amod	_	_
15	mechanism	mechanism	NN	NN	_	12	dobj	_	_
16	for	for	IN	IN	_	15	prep	_	_
17	regulation	regulation	NN	NN	_	16	pobj	_	_
18	by	by	IN	IN	_	17	prep	_	_
19	glucose	glucose	NN	NN	_	18	pobj	_	_
20	and	and	CC	CC	_	16	cc	_	_
21	that	that	WDT	WDT	_	22	dep	_	15:ref
22	involves	involve	VBZ	VBZ	_	16	conj	_	_
23	KATP	katp	NN	NN	_	24	compound	_	_
24	channels	channel	NNS	NNS	_	22	dobj	_	_
25	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	at	at	IN	IN	syn=PRD	2	prep	_	_
4	variance	variance	NN	NN	_	3	pobj	_	_
5	with	with	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	data	datum	NNS	NNS	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	Liu	liu	NNP	NNP	_	8	pobj	_	_
10	et	et	FW	FW	_	11	advmod	_	_
11	al.	al.	FW	FW	_	9	advmod	_	_
12	[	[	-LRB-	-LRB-	_	13	punct	_	_
13	12	0	CD	CD	_	9	parataxis	_	_
14	]	]	-RRB-	-RRB-	_	13	punct	_	_
15	who	who	WP	WP	_	16	dep	_	9:ref
16	report	report	VBP	VBP	_	9	relcl	_	_
17	that	that	IN	IN	_	19	mark	_	_
18	tolbutamide	tolbutamide	NN	NN	_	19	nsubj	_	_
19	has	have	VBZ	VBZ	_	16	ccomp	_	_
20	no	no	DT	DT	_	21	det	_	_
21	effect	effect	NN	NN	_	19	dobj	_	_
22	on	on	IN	IN	_	21	prep	_	_
23	[	[	-LRB-	-LRB-	_	26	punct	_	_
24	Ca2+	ca0+	NN	NN	_	26	nmod	_	_
25	]	]	-RRB-	-RRB-	_	26	punct	_	_
26	i	i	NN	NN	_	22	pobj	_	_
27	in	in	IN	IN	sem=LOC	19	prep	_	_
28	single	single	JJ	JJ	_	32	amod	_	_
29	,	,	,	,	_	32	punct	_	_
30	isolated	isolate	VBN	VBN	_	32	amod	_	_
31	α	α	NN	NN	_	32	compound	_	_
32	cells	cell	NNS	NNS	_	27	pobj	_	_
33	,	,	,	,	_	3	punct	_	_
34	but	but	CC	CC	_	3	cc	_	_
35	in	in	IN	IN	_	3	conj	_	_
36	agreement	agreement	NN	NN	_	35	pobj	_	_
37	with	with	IN	IN	_	36	prep	_	_
38	the	the	DT	DT	_	39	det	_	_
39	conclusion	conclusion	NN	NN	_	37	pobj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	Ostenson	ostenson	NNP	NNP	_	40	pobj	_	_
42	et	et	FW	FW	_	43	advmod	_	_
43	al.	al.	FW	FW	_	41	advmod	_	_
44	[	[	-LRB-	-LRB-	_	45	punct	_	_
45	54	0	CD	CD	_	40	parataxis	_	_
46	]	]	-RRB-	-RRB-	_	45	punct	_	_
47	,	,	,	,	_	39	punct	_	_
48	that	that	IN	IN	_	51	mark	_	_
49	sulfonylureas	sulfonylurea	NNS	NNS	_	51	nsubj	_	_
50	can	can	MD	MD	_	51	aux	_	_
51	inhibit	inhibit	VB	VB	_	39	acl	_	_
52	glucagon	glucagon	NN	NN	_	53	compound	_	_
53	secretion	secretion	NN	NN	_	51	dobj	_	_
54	by	by	IN	IN	sem=MNR	51	prep	_	_
55	a	a	DT	DT	_	59	det	_	_
56	direct	direct	JJ	JJ	_	59	amod	_	_
57	,	,	,	,	_	59	punct	_	_
58	non-paracrine	non-paracrine	JJ	JJ	_	59	amod	_	_
59	mechanism	mechanism	NN	NN	_	54	pobj	_	_
60	.	.	.	.	_	2	punct	_	_

1	On	on	IN	IN	_	9	prep	_	_
2	the	the	DT	DT	_	3	det	_	_
3	basis	basis	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	our	our	PRP$	PRP$	_	6	poss	_	_
6	findings	finding	NNS	NNS	_	4	pobj	_	_
7	,	,	,	,	_	9	punct	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	propose	propose	VBP	VBP	_	0	root	_	_
10	that	that	IN	IN	_	16	mark	_	_
11	α	α	NN	NN	_	13	compound	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	16	nsubj	_	_
16	occurs	occur	VBZ	VBZ	_	9	ccomp	_	_
17	within	within	IN	IN	_	16	prep	_	_
18	a	a	DT	DT	_	20	det	_	_
19	narrow	narrow	JJ	JJ	_	20	amod	_	_
20	window	window	NN	NN	_	17	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	intermediate	intermediate	JJ	JJ	_	25	amod	_	_
23	KATP	katp	NN	NN	_	24	compound	_	_
24	channel	channel	NN	NN	_	25	compound	_	_
25	activity	activity	NN	NN	_	21	pobj	_	_
26	(	(	-LRB-	-LRB-	_	25	punct	_	_
27	and	and	CC	CC	_	25	cc	_	_
28	thus	thus	RB	RB	_	30	advmod	_	_
29	membrane	membrane	NN	NN	_	30	compound	_	_
30	potential	potential	NN	NN	_	25	conj	_	_
31	)	)	-RRB-	-RRB-	_	9	punct	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	Figure	figure	NN	NN	_	9	parataxis	_	_
34	10	0	CD	CD	_	33	nummod	_	_
35	)	)	-RRB-	-RRB-	_	33	punct	_	_
36	.	.	.	.	_	9	punct	_	_

1	That	that	RB	RB	_	2	advmod	_	_
2	is	is	RB	RB	_	30	advmod	_	_
3	,	,	,	,	_	30	punct	_	_
4	if	if	IN	IN	_	8	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	α	α	NN	NN	_	7	compound	_	_
7	cell	cell	NN	NN	_	8	nsubj	_	_
8	is	be	VBZ	VBZ	syn=ADV	30	advcl	_	_
9	either	either	DT	DT	_	11	advmod	_	_
10	too	too	RB	RB	_	11	advmod	_	_
11	hyperpolarised	hyperpolarised	VBN	VBN	syn=PRD	8	acomp	_	_
12	(	(	-LRB-	-LRB-	_	15	punct	_	_
13	maximal	maximal	JJ	JJ	_	15	amod	_	_
14	KATP	katp	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	11	parataxis	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	or	or	CC	CC	_	11	cc	_	_
18	too	too	RB	RB	_	19	advmod	_	_
19	depolarised	depolarise	VBN	VBN	_	11	conj	_	_
20	(	(	-LRB-	-LRB-	_	23	punct	_	_
21	maximal	maximal	JJ	JJ	_	23	amod	_	_
22	KATP	katp	NN	NN	_	23	compound	_	_
23	inhibition	inhibition	NN	NN	_	19	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	,	,	,	,	_	30	punct	_	_
26	then	then	RB	RB	_	30	advmod	_	_
27	glucagon	glucagon	NN	NN	_	28	compound	_	_
28	secretion	secretion	NN	NN	_	30	nsubjpass	_	_
29	is	be	VBZ	VBZ	_	30	auxpass	_	_
30	suppressed	suppress	VBN	VBN	_	0	root	_	_
31	.	.	.	.	_	30	punct	_	_

1	This	this	DT	DT	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	supported	support	VBN	VBN	_	0	root	_	_
4	by	by	IN	IN	sem=MNR	3	prep	_	_
5	the	the	DT	DT	_	7	det	_	_
6	biphasic	biphasic	JJ	JJ	_	7	amod	_	_
7	effects	effect	NNS	NNS	_	4	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	both	both	CC	CC	_	10	preconj	_	_
10	diazoxide	diazoxide	NN	NN	_	8	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	tolbutamide	tolbutamide	NN	NN	_	10	conj	_	_
13	.	.	.	.	_	3	punct	_	_

1	Whereas	whereas	IN	IN	_	9	mark	_	_
2	the	the	DT	DT	_	3	det	_	_
3	former	former	JJ	JJ	_	9	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	in	in	IN	IN	_	3	parataxis	_	_
6	high	high	JJ	JJ	_	7	amod	_	_
7	glucose	glucose	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	5	punct	_	_
9	brings	bring	VBZ	VBZ	syn=ADV	53	advcl	_	_
10	the	the	DT	DT	_	12	det	_	_
11	α	α	NN	NN	_	12	compound	_	_
12	cell	cell	NN	NN	_	9	dobj	_	_
13	in	in	IN	IN	sem=MNR	9	prep	_	_
14	a	a	DT	DT	_	18	det	_	_
15	dose	dose	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	dependent	dependent	JJ	JJ	_	18	amod	_	_
18	manner	manner	NN	NN	_	13	pobj	_	_
19	through	through	IN	IN	_	9	prep	_	_
20	the	the	DT	DT	_	23	det	_	_
21	membrane	membrane	NN	NN	_	23	compound	_	_
22	potential	potential	NN	NN	_	23	compound	_	_
23	window	window	NN	NN	_	19	pobj	_	_
24	supporting	support	VBG	VBG	_	23	acl	_	_
25	glucagon	glucagon	NN	NN	_	26	compound	_	_
26	secretion	secretion	NN	NN	_	24	dobj	_	_
27	in	in	IN	IN	_	24	prep	_	_
28	the	the	DT	DT	_	40	det	_	_
29	depolarised	depolarise	VBN	VBN	_	40	nmod	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	low	low	JJ	JJ	_	32	amod	_	_
32	KATP	katp	NN	NN	_	29	parataxis	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	to	to	IN	IN	_	29	prep	_	_
35	hyperpolarised	hyperpolarised	VBN	VBN	_	34	pobj	_	_
36	(	(	-LRB-	-LRB-	_	38	punct	_	_
37	high	high	JJ	JJ	_	38	amod	_	_
38	KATP	katp	NN	NN	_	35	parataxis	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	direction	direction	NN	NN	_	27	pobj	_	_
41	(	(	-LRB-	-LRB-	_	43	punct	_	_
42	Figure	figure	NN	NN	_	43	compound	_	_
43	10C	0c	NN	NN	_	24	parataxis	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	,	,	,	,	_	53	punct	_	_
46	the	the	DT	DT	_	47	det	_	_
47	latter	latter	JJ	JJ	_	53	nsubj	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	in	in	IN	IN	_	47	parataxis	_	_
50	zero	#crd#	CD	CD	_	51	nummod	_	_
51	glucose	glucose	NN	NN	_	49	pobj	_	_
52	)	)	-RRB-	-RRB-	_	49	punct	_	_
53	brings	bring	VBZ	VBZ	_	0	root	_	_
54	the	the	DT	DT	_	56	det	_	_
55	α	α	NN	NN	_	56	compound	_	_
56	cell	cell	NN	NN	_	53	dobj	_	_
57	through	through	IN	IN	_	53	prep	_	_
58	the	the	DT	DT	_	59	det	_	_
59	window	window	NN	NN	_	57	pobj	_	_
60	in	in	IN	IN	_	53	prep	_	_
61	the	the	DT	DT	_	63	det	_	_
62	opposite	opposite	JJ	JJ	_	63	amod	_	_
63	direction	direction	NN	NN	_	60	pobj	_	_
64	(	(	-LRB-	-LRB-	_	65	punct	_	_
65	from	from	IN	IN	_	60	parataxis	_	_
66	hyperpolarised	hyperpolarised	VBN	VBN	_	65	amod	_	_
67	to	to	IN	IN	_	65	prep	_	_
68	depolarised	depolarise	VBN	VBN	_	67	amod	_	_
69	)	)	-RRB-	-RRB-	_	65	punct	_	_
70	(	(	-LRB-	-LRB-	_	72	punct	_	_
71	Figure	figure	NN	NN	_	72	compound	_	_
72	10B	0b	NN	NN	_	53	parataxis	_	_
73	)	)	-RRB-	-RRB-	_	72	punct	_	_
74	.	.	.	.	_	53	punct	_	_

1	Thus	thus	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	glucose	glucose	NN	NN	_	5	nsubj	_	_
4	likely	likely	RB	RB	_	5	advmod	_	_
5	leads	lead	VBZ	VBZ	_	0	root	_	_
6	to	to	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	suppression	suppression	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	9	pobj	_	_
12	by	by	IN	IN	sem=MNR	5	prep	_	_
13	depolarising	depolarise	VBG	VBG	syn=NOM	12	pcomp	_	_
14	the	the	DT	DT	_	19	det	_	_
15	α	α	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	membrane	membrane	NN	NN	_	19	compound	_	_
19	potential	potential	NN	NN	_	13	dobj	_	_
20	above	above	IN	IN	_	13	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	range	range	NN	NN	_	20	pobj	_	_
23	that	that	WDT	WDT	_	24	dep	_	22:ref
24	supports	support	VBZ	VBZ	_	22	relcl	_	_
25	glucagon	glucagon	NN	NN	_	26	compound	_	_
26	secretion	secretion	NN	NN	_	24	dobj	_	_
27	(	(	-LRB-	-LRB-	_	29	punct	_	_
28	Figure	figure	NN	NN	_	29	compound	_	_
29	10A	0a	NN	NN	_	5	parataxis	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	5	punct	_	_

1	Indeed	indeed	RB	RB	_	19	advmod	_	_
2	,	,	,	,	_	19	punct	_	_
3	in	in	IN	IN	_	19	prep	_	_
4	some	some	DT	DT	_	3	pobj	_	_
5	(	(	-LRB-	-LRB-	_	4	punct	_	_
6	but	but	CC	CC	_	4	cc	_	_
7	not	not	RB	RB	_	6	neg	_	_
8	all	all	DT	DT	_	4	conj	_	_
9	,	,	,	,	_	8	punct	_	_
10	see	see	VBP	VBP	_	15	parataxis	_	_
11	[	[	-LRB-	-LRB-	_	10	punct	_	_
12	55	0	CD	CD	_	10	dobj	_	_
13	]	]	-RRB-	-RRB-	_	10	punct	_	_
14	)	)	-RRB-	-RRB-	_	10	punct	_	_
15	studies	study	NNS	NNS	_	8	conj	_	_
16	,	,	,	,	_	19	punct	_	_
17	glucose	glucose	NN	NN	_	19	nsubjpass	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	found	find	VBN	VBN	_	0	root	_	_
20	to	to	TO	TO	_	21	aux	_	_
21	depolarize	depolarize	VB	VB	_	19	xcomp	_	_
22	mouse	mouse	NN	NN	_	26	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	rat	rat	NN	NN	_	22	conj	_	_
25	α	α	NN	NN	_	26	compound	_	_
26	cells	cell	NNS	NNS	_	21	dobj	_	_
27	and	and	CC	CC	_	21	cc	_	_
28	reduce	reduce	VB	VB	_	21	conj	_	_
29	action	action	NN	NN	_	31	nmod	_	_
30	potential	potential	JJ	JJ	_	31	amod	_	_
31	amplitudes	amplitude	NNS	NNS	_	28	dobj	_	_
32	[	[	-LRB-	-LRB-	_	35	punct	_	_
33	13	0	CD	CD	_	35	nummod	_	_
34	,	,	,	,	_	35	punct	_	_
35	52	0	CD	CD	_	19	parataxis	_	_
36	]	]	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	19	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	interesting	interesting	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	22	mark	_	_
5	whereas	whereas	IN	IN	_	10	mark	_	_
6	low	low	JJ	JJ	_	7	amod	_	_
7	concentrations	concentration	NNS	NNS	_	10	nsubj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	glucose	glucose	NN	NN	_	8	pobj	_	_
10	were	be	VBD	VBD	syn=ADV	22	advcl	_	_
11	without	without	IN	IN	syn=PRD	10	prep	_	_
12	stimulatory	stimulatory	JJ	JJ	_	13	amod	_	_
13	effect	effect	NN	NN	_	11	pobj	_	_
14	,	,	,	,	_	22	punct	_	_
15	tolbutamide	tolbutamide	NN	NN	_	22	nsubj	_	_
16	(	(	-LRB-	-LRB-	_	20	punct	_	_
17	0.1	0	CD	CD	_	19	quantmod	_	_
18	–	-	SYM	SYM	_	19	punct	_	_
19	1	0	CD	CD	_	20	nummod	_	_
20	μM	μm	NNS	NNS	_	15	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	stimulated	stimulate	VBD	VBD	_	2	ccomp	_	_
23	glucagon	glucagon	NN	NN	_	24	compound	_	_
24	release	release	NN	NN	_	22	dobj	_	_
25	beyond	beyond	IN	IN	_	22	prep	_	_
26	that	that	DT	DT	_	25	pobj	_	_
27	observed	observe	VBN	VBN	_	26	acl	_	_
28	at	at	IN	IN	_	27	prep	_	_
29	zero	#crd#	CD	CD	_	30	nummod	_	_
30	glucose	glucose	NN	NN	_	28	pobj	_	_
31	.	.	.	.	_	2	punct	_	_

1	Thus	thus	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	small	small	JJ	JJ	_	4	amod	_	_
4	depolarisations	depolarisation	NNS	NNS	_	15	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	8	punct	_	_
6	as	as	IN	IN	_	8	mark	_	_
7	previously	previously	RB	RB	_	8	advmod	_	_
8	documented	document	VBN	VBN	syn=ADV	4	parataxis	_	_
9	for	for	IN	IN	_	8	prep	_	_
10	arginine	arginine	NN	NN	_	9	pobj	_	_
11	[	[	-LRB-	-LRB-	_	10	punct	_	_
12	13	0	CD	CD	_	10	nummod	_	_
13	]	]	-RRB-	-RRB-	_	8	punct	_	_
14	)	)	-RRB-	-RRB-	_	8	punct	_	_
15	exert	exert	VBP	VBP	_	0	root	_	_
16	a	a	DT	DT	_	21	det	_	_
17	positive	positive	JJ	JJ	_	21	amod	_	_
18	“	"	``	``	_	21	punct	_	_
19	chronotropic	chronotropic	JJ	JJ	_	21	amod	_	_
20	”	"	''	''	_	21	punct	_	_
21	effect	effect	NN	NN	_	15	dobj	_	_
22	in	in	IN	IN	sem=LOC	15	prep	_	_
23	α	α	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	22	pobj	_	_
25	and	and	CC	CC	_	15	cc	_	_
26	thus	thus	RB	RB	_	27	advmod	_	_
27	stimulate	stimulate	VBP	VBP	_	15	conj	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	release	release	NN	NN	_	27	dobj	_	_
30	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	fact	fact	NN	NN	_	10	nsubj	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	glucose	glucose	NN	NN	_	7	nsubj	_	_
5	did	do	VBD	VBD	_	7	aux	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	share	share	VB	VB	_	2	acl	_	_
8	this	this	DT	DT	_	9	det	_	_
9	ability	ability	NN	NN	_	7	dobj	_	_
10	indicates	indicate	VBZ	VBZ	_	0	root	_	_
11	that	that	IN	IN	_	19	mark	_	_
12	the	the	DT	DT	_	13	det	_	_
13	depolarisation	depolarisation	NN	NN	_	19	nsubj	_	_
14	produced	produce	VBN	VBN	_	13	acl	_	_
15	by	by	IN	IN	sem=MNR	14	prep	_	_
16	1	0	CD	CD	_	17	nummod	_	_
17	mM	mm	NN	NN	_	18	compound	_	_
18	glucose	glucose	NN	NN	_	15	pobj	_	_
19	results	result	VBZ	VBZ	_	10	ccomp	_	_
20	in	in	IN	IN	_	19	prep	_	_
21	sufficient	sufficient	JJ	JJ	_	22	amod	_	_
22	inactivation	inactivation	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	currents	current	NNS	NNS	_	23	pobj	_	_
26	to	to	TO	TO	_	27	aux	_	_
27	balance	balance	VB	VB	_	22	advcl	_	_
28	any	any	DT	DT	_	29	det	_	_
29	increase	increase	NN	NN	_	27	dobj	_	_
30	in	in	IN	IN	_	29	prep	_	_
31	action	action	NN	NN	_	33	compound	_	_
32	potential	potential	NN	NN	_	33	compound	_	_
33	frequency	frequency	NN	NN	_	30	pobj	_	_
34	.	.	.	.	_	10	punct	_	_

1	Previous	previous	JJ	JJ	_	3	amod	_	_
2	human	human	JJ	JJ	_	3	amod	_	_
3	studies	study	NNS	NNS	_	5	nsubj	_	_
4	have	have	VBP	VBP	_	5	aux	_	_
5	employed	employ	VBN	VBN	_	0	root	_	_
6	pharmacological	pharmacological	JJ	JJ	_	8	amod	_	_
7	KATP	katp	NN	NN	_	8	compound	_	_
8	channel	channel	NN	NN	_	5	dobj	_	_
9	antagonists	antagonist	NNS	NNS	_	8	appos	_	_
10	[	[	-LRB-	-LRB-	_	13	punct	_	_
11	23	0	CD	CD	_	13	nummod	_	_
12	,	,	,	,	_	13	punct	_	_
13	24	0	CD	CD	_	9	parataxis	_	_
14	]	]	-RRB-	-RRB-	_	13	punct	_	_
15	or	or	CC	CC	_	9	cc	_	_
16	agonists	agonist	NNS	NNS	_	9	conj	_	_
17	[	[	-LRB-	-LRB-	_	20	punct	_	_
18	25	0	CD	CD	_	20	nummod	_	_
19	,	,	,	,	_	20	punct	_	_
20	26	0	CD	CD	_	8	parataxis	_	_
21	]	]	-RRB-	-RRB-	_	20	punct	_	_
22	to	to	TO	TO	_	23	aux	_	_
23	examine	examine	VB	VB	sem=PRP	5	advcl	_	_
24	the	the	DT	DT	_	25	det	_	_
25	regulation	regulation	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	glucagon	glucagon	NN	NN	_	28	compound	_	_
28	release	release	NN	NN	_	26	pobj	_	_
29	in	in	FW	FW	_	30	advmod	_	_
30	vivo	vivo	FW	FW	_	23	advmod	_	_
31	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	interpreted	interpret	VBN	VBN	_	0	root	_	_
4	with	with	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	assumption	assumption	NN	NN	_	4	pobj	_	_
7	that	that	IN	IN	_	12	mark	_	_
8	pharmacological	pharmacological	JJ	JJ	_	10	amod	_	_
9	KATP	katp	NN	NN	_	10	compound	_	_
10	modulation	modulation	NN	NN	_	12	nsubj	_	_
11	only	only	RB	RB	_	12	advmod	_	_
12	affects	affect	VBZ	VBZ	_	6	advcl	_	_
13	the	the	DT	DT	_	15	det	_	_
14	β	β	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	dobj	_	_
16	,	,	,	,	_	12	punct	_	_
17	and	and	CC	CC	_	12	cc	_	_
18	that	that	IN	IN	_	24	mark	_	_
19	any	any	DT	DT	_	20	det	_	_
20	change	change	NN	NN	_	24	nsubj	_	_
21	in	in	IN	IN	_	20	prep	_	_
22	glucagon	glucagon	NN	NN	_	23	compound	_	_
23	release	release	NN	NN	_	21	pobj	_	_
24	was	be	VBD	VBD	_	12	conj	_	_
25	therefore	therefore	RB	RB	_	24	advmod	_	_
26	secondary	secondary	JJ	JJ	syn=PRD	24	acomp	_	_
27	to	to	IN	IN	_	26	prep	_	_
28	altered	altered	JJ	JJ	_	32	amod	_	_
29	β	β	NN	NN	_	31	compound	_	_
30	-	-	HYPH	HYPH	_	31	punct	_	_
31	cell	cell	NN	NN	_	32	compound	_	_
32	function	function	NN	NN	_	27	pobj	_	_
33	.	.	.	.	_	3	punct	_	_

1	Our	our	PRP$	PRP$	_	2	poss	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	establish	establish	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	KATP	katp	NN	NN	_	6	compound	_	_
6	channel	channel	NN	NN	_	7	compound	_	_
7	modulation	modulation	NN	NN	_	8	nsubj	_	_
8	has	have	VBZ	VBZ	_	3	ccomp	_	_
9	dramatic	dramatic	JJ	JJ	_	12	amod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	direct	direct	JJ	JJ	_	9	conj	_	_
12	effects	effect	NNS	NNS	_	8	dobj	_	_
13	on	on	IN	IN	_	12	prep	_	_
14	glucagon	glucagon	NN	NN	_	15	compound	_	_
15	secretion	secretion	NN	NN	_	13	pobj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	Ca2+	ca0+	NN	NN	_	18	compound	_	_
18	signalling	signalling	NN	NN	_	15	conj	_	_
19	in	in	IN	IN	sem=LOC	15	prep	_	_
20	human	human	JJ	JJ	_	22	amod	_	_
21	α	α	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	19	pobj	_	_
23	under	under	IN	IN	_	8	prep	_	_
24	conditions	condition	NNS	NNS	_	23	pobj	_	_
25	in	in	IN	IN	_	29	prep	_	_
26	which	which	WDT	WDT	_	25	pobj	_	24:ref
27	insulin	insulin	NN	NN	_	28	compound	_	_
28	secretion	secretion	NN	NN	_	29	nsubj	_	_
29	is	be	VBZ	VBZ	_	24	relcl	_	_
30	unaffected	unaffected	JJ	JJ	syn=PRD	29	acomp	_	_
31	.	.	.	.	_	3	punct	_	_

1	Thus	thus	RB	RB	_	21	advmod	_	_
2	,	,	,	,	_	21	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	in	in	FW	FW	_	5	advmod	_	_
5	vivo	vivo	FW	FW	_	6	amod	_	_
6	manipulation	manipulation	NN	NN	_	21	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	α	α	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	cell	cell	NN	NN	_	13	compound	_	_
11	KATP	katp	NN	NN	_	12	compound	_	_
12	channel	channel	NN	NN	_	13	compound	_	_
13	activity	activity	NN	NN	_	7	pobj	_	_
14	in	in	IN	IN	_	6	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	above	above	JJ	JJ	_	17	amod	_	_
17	studies	study	NNS	NNS	_	14	pobj	_	_
18	may	may	MD	MD	_	21	aux	_	_
19	well	well	RB	RB	_	21	advmod	_	_
20	have	have	VB	VB	_	21	aux	_	_
21	involved	involve	VBN	VBN	_	0	root	_	_
22	direct	direct	JJ	JJ	_	23	amod	_	_
23	effects	effect	NNS	NNS	_	21	dobj	_	_
24	on	on	IN	IN	_	23	prep	_	_
25	α	α	NN	NN	_	27	compound	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	function	function	NN	NN	_	24	pobj	_	_
29	that	that	WDT	WDT	_	30	dep	_	23:ref
30	contributed	contribute	VBD	VBD	_	23	relcl	_	_
31	to	to	IN	IN	_	30	prep	_	_
32	the	the	DT	DT	_	34	det	_	_
33	observed	observe	VBN	VBN	_	34	amod	_	_
34	changes	change	NNS	NNS	_	31	pobj	_	_
35	in	in	IN	IN	_	34	prep	_	_
36	glucagon	glucagon	NN	NN	_	37	compound	_	_
37	release	release	NN	NN	_	35	pobj	_	_
38	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	importance	importance	NN	NN	_	14	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	8	det	_	_
5	human	human	JJ	JJ	_	8	amod	_	_
6	KATP	katp	NN	NN	_	7	compound	_	_
7	channel	channel	NN	NN	_	8	compound	_	_
8	pathway	pathway	NN	NN	_	3	pobj	_	_
9	for	for	IN	IN	_	2	prep	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	release	release	NN	NN	_	9	pobj	_	_
12	is	be	VBZ	VBZ	_	14	auxpass	_	_
13	nicely	nicely	RB	RB	_	14	advmod	_	_
14	highlighted	highlight	VBN	VBN	_	0	root	_	_
15	by	by	IN	IN	sem=MNR	14	prep	_	_
16	a	a	DT	DT	_	17	det	_	_
17	study	study	NN	NN	_	15	pobj	_	_
18	investigating	investigate	VBG	VBG	_	17	acl	_	_
19	the	the	DT	DT	_	20	det	_	_
20	effects	effect	NNS	NNS	_	18	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	28	det	_	_
23	common	common	JJ	JJ	_	28	amod	_	_
24	Glu23Lys	glu0lys	NN	NN	_	28	nmod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	E23K	e0k	NN	NN	_	28	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	polymorphism	polymorphism	NN	NN	_	21	pobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	the	the	DT	DT	_	32	det	_	_
31	Kir6.2	kir0	NN	NN	_	32	compound	_	_
32	subunit	subunit	NN	NN	_	29	pobj	_	_
33	of	of	IN	IN	_	32	prep	_	_
34	the	the	DT	DT	_	36	det	_	_
35	KATP	katp	NN	NN	_	36	compound	_	_
36	channel	channel	NN	NN	_	33	pobj	_	_
37	on	on	IN	IN	_	20	prep	_	_
38	insulin	insulin	NN	NN	_	41	nmod	_	_
39	and	and	CC	CC	_	38	cc	_	_
40	glucagon	glucagon	NN	NN	_	38	conj	_	_
41	secretion	secretion	NN	NN	_	37	pobj	_	_
42	in	in	IN	IN	sem=LOC	41	prep	_	_
43	non-diabetic	non-diabetic	JJ	JJ	_	45	amod	_	_
44	human	human	JJ	JJ	_	45	amod	_	_
45	patients	patient	NNS	NNS	_	42	pobj	_	_
46	[	[	-LRB-	-LRB-	_	47	punct	_	_
47	29	0	CD	CD	_	14	parataxis	_	_
48	]	]	-RRB-	-RRB-	_	47	punct	_	_
49	.	.	.	.	_	14	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	variant	variant	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	channel	channel	NN	NN	_	3	pobj	_	_
6	leads	lead	VBZ	VBZ	_	0	root	_	_
7	to	to	IN	IN	_	6	prep	_	_
8	a	a	DT	DT	_	10	det	_	_
9	slight	slight	JJ	JJ	_	10	amod	_	_
10	decrease	decrease	NN	NN	_	7	pobj	_	_
11	in	in	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	ATP	atp	NN	NN	_	14	compound	_	_
14	sensitivity	sensitivity	NN	NN	_	11	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	the	the	DT	DT	_	17	det	_	_
17	channel	channel	NN	NN	_	15	pobj	_	_
18	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	functional	functional	JJ	JJ	_	3	amod	_	_
3	significance	significance	NN	NN	_	7	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	this	this	DT	DT	_	4	pobj	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	examined	examine	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	comparing	compare	VBG	VBG	syn=NOM	8	pcomp	_	_
10	hormone	hormone	NN	NN	_	11	compound	_	_
11	release	release	NN	NN	_	9	dobj	_	_
12	during	during	IN	IN	sem=TMP	9	prep	_	_
13	hyperglycaemic	hyperglycaemic	JJ	JJ	_	14	amod	_	_
14	clamps	clamp	NNS	NNS	_	12	pobj	_	_
15	in	in	IN	IN	sem=LOC	14	prep	_	_
16	individuals	individual	NNS	NNS	_	15	pobj	_	_
17	carrying	carry	VBG	VBG	_	16	acl	_	_
18	the	the	DT	DT	_	19	det	_	_
19	polymorphism	polymorphism	NN	NN	_	17	dobj	_	_
20	or	or	CC	CC	_	17	cc	_	_
21	not	not	RB	RB	_	17	conj	_	_
22	.	.	.	.	_	7	punct	_	_

1	Although	although	IN	IN	_	8	mark	_	_
2	insulin	insulin	NN	NN	_	3	compound	_	_
3	secretion	secretion	NN	NN	_	8	nsubj	_	_
4	in	in	IN	IN	sem=LOC	3	prep	_	_
5	homozygous	homozygous	JJ	JJ	_	7	amod	_	_
6	Glu23Lys	glu0lys	NN	NN	_	7	compound	_	_
7	individuals	individual	NNS	NNS	_	4	pobj	_	_
8	was	be	VBD	VBD	syn=ADV	22	advcl	_	_
9	not	not	RB	RB	_	8	neg	_	_
10	different	different	JJ	JJ	syn=PRD	8	acomp	_	_
11	from	from	IN	IN	_	10	prep	_	_
12	controls	control	NNS	NNS	_	11	pobj	_	_
13	,	,	,	,	_	22	punct	_	_
14	glucose	glucose	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	induced	induce	VBN	VBN	_	17	amod	_	_
17	suppression	suppression	NN	NN	_	22	nsubjpass	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	glucagon	glucagon	NN	NN	_	20	compound	_	_
20	release	release	NN	NN	_	18	pobj	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	blunted	blunt	VBN	VBN	_	0	root	_	_
23	[	[	-LRB-	-LRB-	_	24	punct	_	_
24	29	0	CD	CD	_	22	parataxis	_	_
25	]	]	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	22	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	becomes	become	VBZ	VBZ	_	0	root	_	_
3	understandable	understandable	JJ	JJ	syn=PRD	2	acomp	_	_
4	in	in	IN	IN	_	2	prep	_	_
5	light	light	NN	NN	_	4	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	effect	effect	NN	NN	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	diazoxide	diazoxide	NN	NN	_	9	pobj	_	_
11	on	on	IN	IN	_	8	prep	_	_
12	isolated	isolate	VBN	VBN	_	14	amod	_	_
13	human	human	JJ	JJ	_	14	amod	_	_
14	islets	islet	NNS	NNS	_	11	pobj	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	Figures	figure	NNS	NNS	_	17	nmod	_	_
17	4	0	CD	CD	_	2	parataxis	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	5	0	CD	CD	_	17	conj	_	_
20	)	)	-RRB-	-RRB-	_	17	punct	_	_
21	.	.	.	.	_	2	punct	_	_

1	Half	half	RB	RB	_	3	advmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	maximal	maximal	JJ	JJ	_	4	amod	_	_
4	activation	activation	NN	NN	_	8	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	KATP	katp	NN	NN	_	7	compound	_	_
7	channels	channel	NNS	NNS	_	5	pobj	_	_
8	occurs	occur	VBZ	VBZ	_	0	root	_	_
9	at	at	IN	IN	_	8	prep	_	_
10	diazoxide	diazoxide	NN	NN	_	11	compound	_	_
11	concentrations	concentration	NNS	NNS	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	20	0	CD	CD	_	15	quantmod	_	_
14	–	-	SYM	SYM	_	15	punct	_	_
15	100	0	CD	CD	_	16	nummod	_	_
16	μM	μm	NNS	NNS	_	12	pobj	_	_
17	(	(	-LRB-	-LRB-	_	8	punct	_	_
18	depending	depending	IN	IN	_	8	prep	_	_
19	on	on	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	23	det	_	_
21	intracellular	intracellular	JJ	JJ	_	23	amod	_	_
22	ATP	atp	NN	NN	_	23	compound	_	_
23	level	level	NN	NN	_	19	pobj	_	_
24	)	)	-RRB-	-RRB-	_	8	punct	_	_
25	[	[	-LRB-	-LRB-	_	26	punct	_	_
26	56	0	CD	CD	_	8	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	.	.	.	.	_	8	punct	_	_

1	If	if	IN	IN	_	5	mark	_	_
2	the	the	DT	DT	_	4	det	_	_
3	Glu23Lys	glu0lys	NN	NN	_	4	compound	_	_
4	polymorphism	polymorphism	NN	NN	_	5	nsubj	_	_
5	increases	increase	VBZ	VBZ	sem=PRP	37	advcl	_	_
6	KATP	katp	NN	NN	_	7	compound	_	_
7	channel	channel	NN	NN	_	8	compound	_	_
8	activity	activity	NN	NN	_	5	dobj	_	_
9	to	to	IN	IN	_	5	prep	_	_
10	the	the	DT	DT	_	12	det	_	_
11	same	same	JJ	JJ	_	12	amod	_	_
12	extent	extent	NN	NN	_	9	pobj	_	_
13	as	as	IN	IN	_	12	prep	_	_
14	0.3	0	CD	CD	_	16	compound	_	_
15	–	-	HYPH	HYPH	_	16	punct	_	_
16	1.5	0	CD	CD	_	17	nummod	_	_
17	μM	μm	NNS	NNS	_	18	compound	_	_
18	diazoxide	diazoxide	NN	NN	_	13	pobj	_	_
19	,	,	,	,	_	18	punct	_	_
20	the	the	DT	DT	_	21	det	_	_
21	concentration	concentration	NN	NN	_	18	appos	_	_
22	at	at	IN	IN	_	31	prep	_	_
23	which	which	WDT	WDT	_	22	pobj	_	21:ref
24	an	an	DT	DT	_	25	det	_	_
25	effect	effect	NN	NN	_	31	nsubjpass	_	_
26	on	on	IN	IN	_	25	prep	_	_
27	glucagon	glucagon	NN	NN	_	28	compound	_	_
28	release	release	NN	NN	_	26	pobj	_	_
29	is	be	VBZ	VBZ	_	31	auxpass	_	_
30	first	#ord#	RB	RB	_	31	advmod	_	_
31	seen	see	VBN	VBN	_	21	relcl	_	_
32	,	,	,	,	_	37	punct	_	_
33	then	then	RB	RB	_	37	advmod	_	_
34	the	the	DT	DT	_	35	det	_	_
35	effect	effect	NN	NN	_	37	nsubj	_	_
36	will	will	MD	MD	_	37	aux	_	_
37	be	be	VB	VB	_	0	root	_	_
38	very	very	RB	RB	_	39	advmod	_	_
39	difficult	difficult	JJ	JJ	syn=PRD	37	acomp	_	_
40	to	to	TO	TO	_	41	aux	_	_
41	detect	detect	VB	VB	_	39	advcl	_	_
42	with	with	IN	IN	sem=MNR	41	prep	_	_
43	electrophysiology	electrophysiology	NN	NN	_	42	pobj	_	_
44	,	,	,	,	_	37	punct	_	_
45	perhaps	perhaps	RB	RB	_	46	advmod	_	_
46	explaining	explain	VBG	VBG	syn=ADV	37	advcl	_	_
47	why	why	WRB	WRB	_	51	advmod	_	_
48	some	some	DT	DT	_	49	det	_	_
49	studies	study	NNS	NNS	_	51	nsubj	_	_
50	have	have	VBP	VBP	_	51	aux	_	_
51	failed	fail	VBN	VBN	sem=PRP	46	advcl	_	_
52	to	to	TO	TO	_	53	aux	_	_
53	detect	detect	VB	VB	_	51	xcomp	_	_
54	a	a	DT	DT	_	56	det	_	_
55	functional	functional	JJ	JJ	_	56	amod	_	_
56	effect	effect	NN	NN	_	53	dobj	_	_
57	of	of	IN	IN	_	56	prep	_	_
58	the	the	DT	DT	_	59	det	_	_
59	polymorphism	polymorphism	NN	NN	_	57	pobj	_	_
60	(	(	-LRB-	-LRB-	_	61	punct	_	_
61	reviewed	review	VBN	VBN	_	37	parataxis	_	_
62	in	in	IN	IN	_	61	prep	_	_
63	[	[	-LRB-	-LRB-	_	64	punct	_	_
64	57	0	CD	CD	_	62	pobj	_	_
65	]	]	-RRB-	-RRB-	_	61	punct	_	_
66	)	)	-RRB-	-RRB-	_	61	punct	_	_
67	.	.	.	.	_	37	punct	_	_

1	Nevertheless	nevertheless	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	such	such	JJ	JJ	_	5	amod	_	_
4	small	small	JJ	JJ	_	5	amod	_	_
5	changes	change	NNS	NNS	_	7	nsubj	_	_
6	can	can	MD	MD	_	7	aux	_	_
7	have	have	VB	VB	_	0	root	_	_
8	significant	significant	JJ	JJ	_	10	amod	_	_
9	biological	biological	JJ	JJ	_	10	amod	_	_
10	effects	effect	NNS	NNS	_	7	dobj	_	_
11	,	,	,	,	_	7	punct	_	_
12	as	as	IN	IN	_	13	mark	_	_
13	illustrated	illustrate	VBN	VBN	syn=ADV	7	advcl	_	_
14	by	by	IN	IN	sem=MNR	13	prep	_	_
15	the	the	DT	DT	_	18	det	_	_
16	glucagon	glucagon	NN	NN	_	17	compound	_	_
17	release	release	NN	NN	_	18	compound	_	_
18	data	datum	NNS	NNS	_	14	pobj	_	_
19	,	,	,	,	_	7	punct	_	_
20	and	and	CC	CC	_	7	cc	_	_
21	may	may	MD	MD	_	22	aux	_	_
22	contribute	contribute	VB	VB	_	7	conj	_	_
23	to	to	IN	IN	_	22	prep	_	_
24	pathological	pathological	JJ	JJ	_	25	amod	_	_
25	states	state	NNS	NNS	_	23	pobj	_	_
26	such	such	JJ	JJ	_	27	amod	_	_
27	as	as	IN	IN	_	25	prep	_	_
28	impaired	impair	VBN	VBN	_	30	amod	_	_
29	glucose	glucose	NN	NN	_	30	compound	_	_
30	tolerance	tolerance	NN	NN	_	27	pobj	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	diabetes	diabetes	NN	NN	_	30	conj	_	_
33	.	.	.	.	_	7	punct	_	_

1	Thus	thus	RB	RB	_	23	advmod	_	_
2	,	,	,	,	_	23	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	reduced	reduce	VBN	VBN	_	5	amod	_	_
5	ability	ability	NN	NN	_	23	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	glucose	glucose	NN	NN	_	6	pobj	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	inhibit	inhibit	VB	VB	_	5	acl	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	9	dobj	_	_
12	in	in	IN	IN	sem=LOC	9	prep	_	_
13	individuals	individual	NNS	NNS	_	12	pobj	_	_
14	carrying	carry	VBG	VBG	_	13	acl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	Glu23Lys	glu0lys	NN	NN	_	17	compound	_	_
17	variant	variant	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	21	det	_	_
20	KATP	katp	NN	NN	_	21	compound	_	_
21	channel	channel	NN	NN	_	18	pobj	_	_
22	likely	likely	RB	RB	_	23	advmod	_	_
23	results	result	VBZ	VBZ	_	0	root	_	_
24	from	from	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	26	det	_	_
26	failure	failure	NN	NN	_	24	pobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	these	these	DT	DT	_	29	det	_	_
29	channels	channel	NNS	NNS	_	27	pobj	_	_
30	to	to	TO	TO	_	31	aux	_	_
31	undergo	undergo	VB	VB	_	26	acl	_	_
32	complete	complete	JJ	JJ	_	33	amod	_	_
33	inhibition	inhibition	NN	NN	_	31	dobj	_	_
34	in	in	IN	IN	_	31	prep	_	_
35	response	response	NN	NN	_	34	pobj	_	_
36	to	to	IN	IN	_	35	prep	_	_
37	glucose	glucose	NN	NN	_	36	pobj	_	_
38	.	.	.	.	_	23	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	proposed	propose	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	glucagon	glucagon	NN	NN	_	6	compound	_	_
6	secretion	secretion	NN	NN	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	stimulated	stimulate	VBN	VBN	_	3	advcl	_	_
9	within	within	IN	IN	_	8	prep	_	_
10	a	a	DT	DT	_	11	det	_	_
11	window	window	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	intermediate	intermediate	JJ	JJ	_	19	amod	_	_
14	α	α	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	cell	cell	NN	NN	_	19	compound	_	_
17	KATP	katp	NN	NN	_	18	compound	_	_
18	channel	channel	NN	NN	_	19	compound	_	_
19	activity	activity	NN	NN	_	12	pobj	_	_
20	,	,	,	,	_	8	punct	_	_
21	and	and	CC	CC	_	8	cc	_	_
22	that	that	IN	IN	_	26	mark	_	_
23	glucagon	glucagon	NN	NN	_	24	compound	_	_
24	release	release	NN	NN	_	26	nsubjpass	_	_
25	is	be	VBZ	VBZ	_	26	auxpass	_	_
26	suppressed	suppress	VBN	VBN	_	8	conj	_	_
27	by	by	IN	IN	sem=MNR	26	prep	_	_
28	either	either	CC	CC	_	29	preconj	_	_
29	increases	increase	NNS	NNS	_	27	pobj	_	_
30	or	or	CC	CC	_	29	cc	_	_
31	decreases	decrease	NNS	NNS	_	29	conj	_	_
32	in	in	IN	IN	_	29	prep	_	_
33	KATP	katp	NN	NN	_	34	compound	_	_
34	channel	channel	NN	NN	_	35	compound	_	_
35	activity	activity	NN	NN	_	32	pobj	_	_
36	.	.	.	.	_	3	punct	_	_

1	How	how	WRB	WRB	_	4	advmod	_	_
2	is	be	VBZ	VBZ	_	4	auxpass	_	_
3	this	this	DT	DT	_	4	nsubjpass	_	_
4	accomplished	accomplish	VBN	VBN	_	0	root	_	_
5	?	?	.	.	_	4	punct	_	_

1	Briefly	briefly	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	suggest	suggest	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	this	this	DT	DT	_	7	det	_	_
7	window	window	NN	NN	_	8	nsubj	_	_
8	is	be	VBZ	VBZ	_	4	ccomp	_	_
9	the	the	DT	DT	_	10	det	_	_
10	result	result	NN	NN	syn=PRD	8	attr	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	1	0	LS	LS	_	16	meta	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	the	the	DT	DT	_	16	det	_	_
16	ability	ability	NN	NN	_	11	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	intermediate	intermediate	JJ	JJ	_	21	amod	_	_
19	KATP	katp	NN	NN	_	20	compound	_	_
20	channel	channel	NN	NN	_	21	compound	_	_
21	activity	activity	NN	NN	_	17	pobj	_	_
22	to	to	TO	TO	_	23	aux	_	_
23	support	support	VB	VB	_	16	acl	_	_
24	regenerative	regenerative	JJ	JJ	_	26	amod	_	_
25	electrical	electrical	JJ	JJ	_	26	amod	_	_
26	responses	response	NNS	NNS	_	23	dobj	_	_
27	through	through	IN	IN	sem=MNR	23	prep	_	_
28	the	the	DT	DT	_	29	det	_	_
29	activation	activation	NN	NN	_	27	pobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	voltage	voltage	NN	NN	_	33	npadvmod	_	_
32	-	-	HYPH	HYPH	_	33	punct	_	_
33	dependent	dependent	JJ	JJ	_	34	amod	_	_
34	Na+	na+	NN	NN	_	40	nmod	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	N	n	NN	NN	_	38	compound	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	type	type	NN	NN	_	39	compound	_	_
39	Ca2+	ca0+	NN	NN	_	34	conj	_	_
40	channels	channel	NNS	NNS	_	30	pobj	_	_
41	(	(	-LRB-	-LRB-	_	43	punct	_	_
42	grey	grey	JJ	JJ	_	43	amod	_	_
43	in	in	IN	IN	_	23	parataxis	_	_
44	Figure	figure	NN	NN	_	43	pobj	_	_
45	10	0	CD	CD	_	44	nummod	_	_
46	)	)	-RRB-	-RRB-	_	43	punct	_	_
47	;	;	:	:	_	16	punct	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	2	0	LS	LS	_	52	meta	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	the	the	DT	DT	_	52	det	_	_
52	failure	failure	NN	NN	_	16	conj	_	_
53	of	of	IN	IN	_	52	prep	_	_
54	the	the	DT	DT	_	58	det	_	_
55	Na+	na+	NN	NN	_	58	nmod	_	_
56	and	and	CC	CC	_	55	cc	_	_
57	Ca2+	ca0+	NN	NN	_	55	conj	_	_
58	channels	channel	NNS	NNS	_	53	pobj	_	_
59	to	to	TO	TO	_	60	aux	_	_
60	activate	activate	VB	VB	_	52	acl	_	_
61	when	when	WRB	WRB	_	65	advmod	_	_
62	α	α	NN	NN	_	63	compound	_	_
63	cells	cell	NNS	NNS	_	65	nsubjpass	_	_
64	are	be	VBP	VBP	_	65	auxpass	_	_
65	hyperpolarised	hyperpolarised	VBN	VBN	sem=TMP	60	advcl	_	_
66	by	by	IN	IN	sem=MNR	65	prep	_	_
67	the	the	DT	DT	_	68	det	_	_
68	opening	opening	NN	NN	_	66	pobj	_	_
69	of	of	IN	IN	_	68	prep	_	_
70	a	a	DT	DT	_	72	det	_	_
71	major	major	JJ	JJ	_	72	amod	_	_
72	fraction	fraction	NN	NN	_	69	pobj	_	_
73	of	of	IN	IN	_	72	prep	_	_
74	KATP	katp	NN	NN	_	75	compound	_	_
75	channels	channel	NNS	NNS	_	73	pobj	_	_
76	(	(	-LRB-	-LRB-	_	77	punct	_	_
77	above	above	IN	IN	_	65	parataxis	_	_
78	the	the	DT	DT	_	79	det	_	_
79	grey	grey	NN	NN	_	77	pobj	_	_
80	in	in	IN	IN	_	79	prep	_	_
81	Figure	figure	NN	NN	_	80	pobj	_	_
82	10	0	CD	CD	_	81	nummod	_	_
83	)	)	-RRB-	-RRB-	_	77	punct	_	_
84	;	;	:	:	_	52	punct	_	_
85	and	and	CC	CC	_	52	cc	_	_
86	(	(	-LRB-	-LRB-	_	87	punct	_	_
87	3	0	LS	LS	_	93	meta	_	_
88	)	)	-RRB-	-RRB-	_	87	punct	_	_
89	the	the	DT	DT	_	93	det	_	_
90	voltage	voltage	NN	NN	_	92	npadvmod	_	_
91	-	-	HYPH	HYPH	_	92	punct	_	_
92	dependent	dependent	JJ	JJ	_	93	amod	_	_
93	inactivation	inactivation	NN	NN	_	52	conj	_	_
94	of	of	IN	IN	_	93	prep	_	_
95	the	the	DT	DT	_	105	det	_	_
96	Na+	na+	NN	NN	_	105	nmod	_	_
97	[	[	-LRB-	-LRB-	_	98	punct	_	_
98	14	0	CD	CD	_	96	parataxis	_	_
99	]	]	-RRB-	-RRB-	_	98	punct	_	_
100	and	and	CC	CC	_	96	cc	_	_
101	N	n	NN	NN	_	103	compound	_	_
102	-	-	HYPH	HYPH	_	103	punct	_	_
103	type	type	NN	NN	_	96	conj	_	_
104	Ca2+	ca0+	NN	NN	_	105	compound	_	_
105	channels	channel	NNS	NNS	_	94	pobj	_	_
106	when	when	WRB	WRB	_	110	advmod	_	93:ref
107	KATP	katp	NN	NN	_	108	compound	_	_
108	channels	channel	NNS	NNS	_	110	nsubjpass	_	_
109	are	be	VBP	VBP	_	110	auxpass	_	_
110	closed	close	VBN	VBN	_	93	relcl	_	_
111	and	and	CC	CC	_	110	cc	_	_
112	the	the	DT	DT	_	117	det	_	_
113	α	α	NN	NN	_	115	compound	_	_
114	-	-	HYPH	HYPH	_	115	punct	_	_
115	cell	cell	NN	NN	_	117	compound	_	_
116	membrane	membrane	NN	NN	_	117	compound	_	_
117	potential	potential	NN	NN	_	119	nsubjpass	_	_
118	is	be	VBZ	VBZ	_	119	auxpass	_	_
119	depolarised	depolarise	VBN	VBN	_	110	conj	_	_
120	(	(	-LRB-	-LRB-	_	121	punct	_	_
121	below	below	IN	IN	_	110	parataxis	_	_
122	the	the	DT	DT	_	123	det	_	_
123	grey	grey	NN	NN	_	121	pobj	_	_
124	in	in	IN	IN	_	123	prep	_	_
125	Figure	figure	NN	NN	_	124	pobj	_	_
126	10	0	CD	CD	_	125	nummod	_	_
127	)	)	-RRB-	-RRB-	_	121	punct	_	_
128	.	.	.	.	_	4	punct	_	_

1	Thus	thus	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	differential	differential	JJ	JJ	_	5	amod	_	_
5	responsiveness	responsiveness	NN	NN	_	15	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	α	α	NN	NN	_	10	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	β	β	NN	NN	_	7	conj	_	_
10	cells	cell	NNS	NNS	_	6	pobj	_	_
11	to	to	IN	IN	_	5	prep	_	_
12	diazoxide	diazoxide	NN	NN	_	11	pobj	_	_
13	does	do	VBZ	VBZ	_	15	aux	_	_
14	not	not	RB	RB	_	15	neg	_	_
15	result	result	VB	VB	_	0	root	_	_
16	from	from	IN	IN	_	15	prep	_	_
17	differential	differential	JJ	JJ	_	18	amod	_	_
18	sensitivities	sensitivity	NNS	NNS	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	22	det	_	_
21	KATP	katp	NN	NN	_	22	compound	_	_
22	channels	channel	NNS	NNS	_	19	pobj	_	_
23	in	in	IN	IN	sem=LOC	22	prep	_	_
24	these	these	DT	DT	_	25	det	_	_
25	cells	cell	NNS	NNS	_	23	pobj	_	_
26	,	,	,	,	_	16	punct	_	_
27	but	but	CC	CC	_	16	cc	_	_
28	to	to	IN	IN	_	16	conj	_	_
29	the	the	DT	DT	_	31	det	_	_
30	downstream	downstream	JJ	JJ	_	31	amod	_	_
31	responses	response	NNS	NNS	_	28	pobj	_	_
32	to	to	IN	IN	_	31	prep	_	_
33	titrated	titrate	VBN	VBN	_	36	amod	_	_
34	KATP	katp	NN	NN	_	35	compound	_	_
35	channel	channel	NN	NN	_	36	compound	_	_
36	activity	activity	NN	NN	_	32	pobj	_	_
37	.	.	.	.	_	15	punct	_	_

1	One	#crd#	CD	CD	_	3	nummod	_	_
2	important	important	JJ	JJ	_	3	amod	_	_
3	difference	difference	NN	NN	_	10	nsubj	_	_
4	between	between	IN	IN	_	3	prep	_	_
5	mouse	mouse	NN	NN	_	9	nmod	_	_
6	α	α	NN	NN	_	9	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	β	β	NN	NN	_	6	conj	_	_
9	cells	cell	NNS	NNS	_	4	pobj	_	_
10	is	be	VBZ	VBZ	_	0	root	_	_
11	that	that	IN	IN	_	37	mark	_	_
12	whereas	whereas	IN	IN	_	15	mark	_	_
13	the	the	DT	DT	_	14	det	_	_
14	latter	latter	JJ	JJ	_	15	nsubj	_	_
15	rely	rely	VBP	VBP	syn=ADV	37	advcl	_	_
16	exclusively	exclusively	RB	RB	_	15	advmod	_	_
17	on	on	IN	IN	_	15	prep	_	_
18	voltage	voltage	NN	NN	_	20	npadvmod	_	_
19	-	-	HYPH	HYPH	_	20	punct	_	_
20	gated	gate	VBN	VBN	_	22	amod	_	_
21	Ca2+	ca0+	NN	NN	_	22	compound	_	_
22	channels	channel	NNS	NNS	_	17	pobj	_	_
23	for	for	IN	IN	sem=PRP	15	prep	_	_
24	the	the	DT	DT	_	25	det	_	_
25	upstroke	upstroke	NN	NN	_	23	pobj	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	the	the	DT	DT	_	29	det	_	_
28	action	action	NN	NN	_	29	compound	_	_
29	potentials	potential	NNS	NNS	_	26	pobj	_	_
30	,	,	,	,	_	37	punct	_	_
31	glucagon	glucagon	NN	NN	_	35	nmod	_	_
32	-	-	HYPH	HYPH	_	31	punct	_	_
33	producing	produce	VBG	VBG	_	31	amod	_	_
34	α	α	NN	NN	_	35	compound	_	_
35	cells	cell	NNS	NNS	_	37	nsubjpass	_	_
36	are	be	VBP	VBP	_	37	auxpass	_	_
37	equipped	equip	VBN	VBN	syn=PRD	10	ccomp	_	_
38	with	with	IN	IN	_	37	prep	_	_
39	voltage	voltage	NN	NN	_	41	npadvmod	_	_
40	-	-	HYPH	HYPH	_	41	punct	_	_
41	gated	gate	VBN	VBN	_	43	amod	_	_
42	Na+	na+	NN	NN	_	43	compound	_	_
43	channels	channel	NNS	NNS	_	38	pobj	_	_
44	.	.	.	.	_	10	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	channels	channel	NNS	NNS	_	3	nsubj	_	_
3	undergo	undergo	VBP	VBP	_	0	root	_	_
4	voltage	voltage	NN	NN	_	6	npadvmod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	dependent	dependent	JJ	JJ	_	7	amod	_	_
7	inactivation	inactivation	NN	NN	_	3	dobj	_	_
8	at	at	IN	IN	_	3	prep	_	_
9	voltages	voltage	NNS	NNS	_	8	pobj	_	_
10	more	more	RBR	RBR	_	11	advmod	_	_
11	positive	positive	JJ	JJ	_	9	amod	_	_
12	than	than	IN	IN	_	11	prep	_	_
13	−	−	SYM	SYM	_	14	punct	_	_
14	50	0	CD	CD	_	15	nummod	_	_
15	mV	mv	NNS	NNS	_	12	pobj	_	_
16	[	[	-LRB-	-LRB-	_	17	punct	_	_
17	14	0	CD	CD	_	3	parataxis	_	_
18	]	]	-RRB-	-RRB-	_	17	punct	_	_
19	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	3	nsubj	_	_
2	will	will	MD	MD	_	3	aux	_	_
3	reduce	reduce	VB	VB	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	action	action	NN	NN	_	6	compound	_	_
6	potential	potential	NN	NN	_	7	compound	_	_
7	amplitude	amplitude	NN	NN	_	3	dobj	_	_
8	,	,	,	,	_	3	punct	_	_
9	and	and	CC	CC	_	3	cc	_	_
10	indeed	indeed	RB	RB	_	13	advmod	_	_
11	it	it	PRP	PRP	_	13	nsubjpass	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	reported	report	VBN	VBN	_	3	conj	_	_
14	that	that	IN	IN	_	16	mark	_	_
15	glucose	glucose	NN	NN	_	16	nsubj	_	_
16	reduces	reduce	VBZ	VBZ	_	13	ccomp	_	_
17	the	the	DT	DT	_	19	det	_	_
18	peak	peak	JJ	JJ	_	19	amod	_	_
19	voltage	voltage	NN	NN	_	16	dobj	_	_
20	in	in	IN	IN	sem=LOC	16	prep	_	_
21	α	α	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	20	pobj	_	_
23	from	from	IN	IN	_	16	prep	_	_
24	+	+	SYM	SYM	_	25	punct	_	_
25	11	0	CD	CD	_	26	nummod	_	_
26	mV	mv	NNS	NNS	_	23	pobj	_	_
27	to	to	IN	IN	_	23	prep	_	_
28	−	−	SYM	SYM	_	29	punct	_	_
29	1	0	CD	CD	_	30	nummod	_	_
30	mV	mv	NNS	NNS	_	27	pobj	_	_
31	[	[	-LRB-	-LRB-	_	32	punct	_	_
32	13	0	CD	CD	_	13	parataxis	_	_
33	]	]	-RRB-	-RRB-	_	32	punct	_	_
34	.	.	.	.	_	13	punct	_	_

1	This	this	DT	DT	_	5	nsubj	_	_
2	will	will	MD	MD	_	5	aux	_	_
3	in	in	IN	IN	_	5	prep	_	_
4	itself	itself	PRP	PRP	_	3	pobj	_	_
5	result	result	VB	VB	_	0	root	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	an	an	DT	DT	_	11	det	_	_
8	approximately	approximately	RB	RB	_	9	advmod	_	_
9	35	0	CD	CD	_	10	nummod	_	_
10	%	%	NN	NN	_	11	compound	_	_
11	reduction	reduction	NN	NN	_	6	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	exocytosis	exocytosis	NN	NN	_	12	pobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	which	which	WDT	WDT	_	16	dep	_	13:ref
16	is	be	VBZ	VBZ	_	13	relcl	_	_
17	steeply	steeply	RB	RB	_	18	advmod	_	_
18	dependent	dependent	JJ	JJ	syn=PRD	16	acomp	_	_
19	on	on	IN	IN	_	18	prep	_	_
20	voltage	voltage	NN	NN	_	19	pobj	_	_
21	between	between	IN	IN	_	20	prep	_	_
22	−	−	SYM	SYM	_	23	punct	_	_
23	10	0	CD	CD	_	27	nummod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	+	+	SYM	SYM	_	26	punct	_	_
26	10	0	CD	CD	_	23	conj	_	_
27	mV	mv	NNS	NNS	_	21	pobj	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	Figure	figure	NN	NN	_	30	compound	_	_
30	9E	0e	NN	NN	_	5	parataxis	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	functional	functional	JJ	JJ	_	3	amod	_	_
3	significance	significance	NN	NN	_	7	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	this	this	DT	DT	_	4	pobj	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	illustrated	illustrate	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	observations	observation	NNS	NNS	_	8	pobj	_	_
11	that	that	IN	IN	_	26	mark	_	_
12	glucagon	glucagon	NN	NN	_	13	compound	_	_
13	secretion	secretion	NN	NN	_	26	nsubjpass	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	α	α	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	Ca2+	ca0+	NN	NN	_	19	compound	_	_
19	responses	response	NNS	NNS	_	13	conj	_	_
20	at	at	IN	IN	_	13	prep	_	_
21	low	low	JJ	JJ	_	23	amod	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	glucose	glucose	NN	NN	_	24	compound	_	_
24	concentrations	concentration	NNS	NNS	_	20	pobj	_	_
25	are	be	VBP	VBP	_	26	auxpass	_	_
26	suppressed	suppress	VBN	VBN	_	10	acl	_	_
27	by	by	IN	IN	sem=MNR	26	prep	_	_
28	the	the	DT	DT	_	31	det	_	_
29	Na+	na+	NN	NN	_	30	compound	_	_
30	channel	channel	NN	NN	_	31	compound	_	_
31	blocker	blocker	NN	NN	_	27	pobj	_	_
32	TTX	ttx	NN	NN	_	31	appos	_	_
33	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	exact	exact	JJ	JJ	_	5	amod	_	_
3	ion	ion	NN	NN	_	4	compound	_	_
4	channel	channel	NN	NN	_	5	compound	_	_
5	complement	complement	NN	NN	_	10	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	α	α	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	6	pobj	_	_
10	remains	remain	VBZ	VBZ	_	0	root	_	_
11	to	to	TO	TO	_	13	aux	_	_
12	be	be	VB	VB	_	13	auxpass	_	_
13	established	establish	VBN	VBN	_	10	xcomp	_	_
14	.	.	.	.	_	10	punct	_	_

1	However	however	RB	RB	_	24	advmod	_	_
2	,	,	,	,	_	24	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	fact	fact	NN	NN	_	24	nsubj	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	glucagon	glucagon	NN	NN	_	7	compound	_	_
7	secretion	secretion	NN	NN	_	11	nsubj	_	_
8	from	from	IN	IN	_	7	prep	_	_
9	human	human	JJ	JJ	_	10	amod	_	_
10	islets	islet	NNS	NNS	_	8	pobj	_	_
11	shows	show	VBZ	VBZ	_	4	acl	_	_
12	the	the	DT	DT	_	19	det	_	_
13	same	same	JJ	JJ	_	19	amod	_	_
14	bell	bell	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	shaped	shape	VBN	VBN	_	19	amod	_	_
17	diazoxide	diazoxide	NN	NN	_	18	compound	_	_
18	concentration	concentration	NN	NN	_	19	compound	_	_
19	dependence	dependence	NN	NN	_	11	dobj	_	_
20	as	as	IN	IN	_	19	prep	_	_
21	in	in	IN	IN	sem=LOC	20	prep	_	_
22	mouse	mouse	NN	NN	_	23	compound	_	_
23	islets	islet	NNS	NNS	_	21	pobj	_	_
24	suggests	suggest	VBZ	VBZ	_	0	root	_	_
25	that	that	IN	IN	_	42	mark	_	_
26	the	the	DT	DT	_	30	det	_	_
27	depolarization	depolarization	NN	NN	_	29	npadvmod	_	_
28	-	-	HYPH	HYPH	_	29	punct	_	_
29	induced	induce	VBN	VBN	_	30	amod	_	_
30	inactivation	inactivation	NN	NN	_	42	nsubj	_	_
31	of	of	IN	IN	_	30	prep	_	_
32	ion	ion	NN	NN	_	33	compound	_	_
33	channels	channel	NNS	NNS	_	31	pobj	_	_
34	involved	involve	VBN	VBN	_	33	acl	_	_
35	in	in	IN	IN	_	34	prep	_	_
36	α	α	NN	NN	_	38	nmod	_	_
37	-	-	HYPH	HYPH	_	38	punct	_	_
38	cell	cell	NN	NN	_	41	nmod	_	_
39	regenerative	regenerative	JJ	JJ	_	41	amod	_	_
40	electrical	electrical	JJ	JJ	_	41	amod	_	_
41	activity	activity	NN	NN	_	35	pobj	_	_
42	underlies	underly	VBZ	VBZ	_	24	ccomp	_	_
43	glucose	glucose	NN	NN	_	45	npadvmod	_	_
44	-	-	HYPH	HYPH	_	45	punct	_	_
45	induced	induce	VBN	VBN	_	46	amod	_	_
46	suppression	suppression	NN	NN	_	42	dobj	_	_
47	of	of	IN	IN	_	46	prep	_	_
48	glucagon	glucagon	NN	NN	_	49	compound	_	_
49	secretion	secretion	NN	NN	_	47	pobj	_	_
50	in	in	IN	IN	sem=LOC	42	prep	_	_
51	man	man	NN	NN	_	50	pobj	_	_
52	as	as	RB	RB	_	53	advmod	_	_
53	well	well	RB	RB	_	42	advmod	_	_
54	.	.	.	.	_	24	punct	_	_

1	Although	although	IN	IN	_	6	mark	_	_
2	L	l	NN	NN	_	4	compound	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	type	type	NN	NN	_	5	compound	_	_
5	VDCCs	vdccs	NNS	NNS	_	6	nsubj	_	_
6	mediate	mediate	VBP	VBP	syn=ADV	28	advcl	_	_
7	the	the	DT	DT	_	8	det	_	_
8	majority	majority	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	Ca2+	ca0+	NN	NN	_	11	compound	_	_
11	current	current	NN	NN	_	9	pobj	_	_
12	in	in	IN	IN	sem=LOC	6	prep	_	_
13	α	α	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	12	pobj	_	_
15	,	,	,	,	_	28	punct	_	_
16	this	this	DT	DT	_	17	det	_	_
17	work	work	NN	NN	_	28	nsubj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	previous	previous	JJ	JJ	_	20	amod	_	_
20	studies	study	NNS	NNS	_	17	conj	_	_
21	[	[	-LRB-	-LRB-	_	26	punct	_	_
22	33	0	CD	CD	_	26	nummod	_	_
23	,	,	,	,	_	26	punct	_	_
24	44	0	CD	CD	_	26	nummod	_	_
25	,	,	,	,	_	26	punct	_	_
26	45	0	CD	CD	_	20	parataxis	_	_
27	]	]	-RRB-	-RRB-	_	26	punct	_	_
28	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
29	that	that	IN	IN	_	31	mark	_	_
30	it	it	PRP	PRP	_	31	nsubj	_	_
31	is	be	VBZ	VBZ	_	28	ccomp	_	_
32	the	the	DT	DT	_	43	det	_	_
33	N	n	NN	NN	_	35	nmod	_	_
34	-	-	HYPH	HYPH	_	35	punct	_	_
35	type	type	NN	NN	_	43	nmod	_	_
36	(	(	-LRB-	-LRB-	_	41	punct	_	_
37	ω	ω	NN	NN	_	39	compound	_	_
38	-	-	HYPH	HYPH	_	39	punct	_	_
39	conotoxin	conotoxin	NN	NN	_	41	npadvmod	_	_
40	–	-	HYPH	HYPH	_	41	punct	_	_
41	sensitive	sensitive	JJ	JJ	_	35	parataxis	_	_
42	)	)	-RRB-	-RRB-	_	41	punct	_	_
43	VDCCs	vdccs	NNS	NNS	syn=PRD	31	attr	_	_
44	that	that	WDT	WDT	_	45	dep	_	43:ref
45	mediate	mediate	VBP	VBP	_	43	relcl	_	_
46	the	the	DT	DT	_	48	det	_	_
47	Ca2+	ca0+	NN	NN	_	48	compound	_	_
48	influx	influx	NN	NN	_	45	dobj	_	_
49	necessary	necessary	JJ	JJ	_	48	amod	_	_
50	for	for	IN	IN	_	49	prep	_	_
51	α	α	NN	NN	_	53	compound	_	_
52	-	-	HYPH	HYPH	_	53	punct	_	_
53	cell	cell	NN	NN	_	54	compound	_	_
54	exocytosis	exocytosis	NN	NN	_	50	pobj	_	_
55	and	and	CC	CC	_	54	cc	_	_
56	glucagon	glucagon	NN	NN	_	57	compound	_	_
57	secretion	secretion	NN	NN	_	54	conj	_	_
58	under	under	IN	IN	_	54	prep	_	_
59	hypoglycaemic	hypoglycaemic	JJ	JJ	_	60	amod	_	_
60	conditions	condition	NNS	NNS	_	58	pobj	_	_
61	.	.	.	.	_	28	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	now	now	RB	RB	_	3	advmod	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	the	the	DT	DT	_	12	det	_	_
6	α	α	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	cell	cell	NN	NN	_	12	compound	_	_
9	N	n	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	type	type	NN	NN	_	12	compound	_	_
12	VDCCs	vdccs	NNS	NNS	_	13	nsubj	_	_
13	are	be	VBP	VBP	_	3	advcl	_	_
14	also	also	RB	RB	_	13	advmod	_	_
15	subject	subject	JJ	JJ	syn=PRD	13	acomp	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	voltage	voltage	NN	NN	_	19	npadvmod	_	_
18	-	-	HYPH	HYPH	_	19	punct	_	_
19	dependent	dependent	JJ	JJ	_	20	amod	_	_
20	inactivation	inactivation	NN	NN	_	16	pobj	_	_
21	at	at	IN	IN	_	20	prep	_	_
22	voltages	voltage	NNS	NNS	_	21	pobj	_	_
23	more	more	RBR	RBR	_	24	advmod	_	_
24	positive	positive	JJ	JJ	_	22	amod	_	_
25	than	than	IN	IN	_	24	prep	_	_
26	−	−	SYM	SYM	_	27	punct	_	_
27	50	0	CD	CD	_	28	nummod	_	_
28	mV	mv	NNS	NNS	_	25	pobj	_	_
29	and	and	CC	CC	_	13	cc	_	_
30	furthermore	furthermore	RB	RB	_	34	advmod	_	_
31	that	that	IN	IN	_	34	mark	_	_
32	this	this	DT	DT	_	34	nsubjpass	_	_
33	is	be	VBZ	VBZ	_	34	auxpass	_	_
34	associated	associate	VBN	VBN	_	13	conj	_	_
35	with	with	IN	IN	_	34	prep	_	_
36	reduced	reduce	VBN	VBN	_	38	amod	_	_
37	exocytotic	exocytotic	JJ	JJ	_	38	amod	_	_
38	capacity	capacity	NN	NN	_	35	pobj	_	_
39	.	.	.	.	_	3	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	pertinent	pertinent	JJ	JJ	syn=PRD	2	acomp	_	_
4	that	that	IN	IN	_	12	mark	_	_
5	N	n	NN	NN	_	7	nmod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	type	type	NN	NN	_	11	nmod	_	_
8	VDCC	vdcc	NN	NN	_	10	npadvmod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	deficient	deficient	JJ	JJ	_	11	amod	_	_
11	mice	mouse	NNS	NNS	_	12	nsubj	_	_
12	exhibit	exhibit	VBP	VBP	_	2	ccomp	_	_
13	reduced	reduce	VBN	VBN	_	16	amod	_	_
14	serum	serum	NN	NN	_	16	compound	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	levels	level	NNS	NNS	_	12	dobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	improved	improve	VBN	VBN	_	20	amod	_	_
19	glucose	glucose	NN	NN	_	20	compound	_	_
20	tolerance	tolerance	NN	NN	_	16	conj	_	_
21	despite	despite	IN	IN	_	12	prep	_	_
22	a	a	DT	DT	_	24	det	_	_
23	parallel	parallel	JJ	JJ	_	24	amod	_	_
24	reduction	reduction	NN	NN	_	21	pobj	_	_
25	in	in	IN	IN	_	24	prep	_	_
26	plasma	plasma	NN	NN	_	27	compound	_	_
27	insulin	insulin	NN	NN	_	25	pobj	_	_
28	[	[	-LRB-	-LRB-	_	29	punct	_	_
29	44	0	CD	CD	_	2	parataxis	_	_
30	]	]	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	2	punct	_	_

1	Although	although	IN	IN	_	12	mark	_	_
2	Ca2+	ca0+	NN	NN	_	3	compound	_	_
3	influx	influx	NN	NN	_	12	nsubj	_	_
4	through	through	IN	IN	_	3	prep	_	_
5	L	l	NN	NN	_	7	compound	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	type	type	NN	NN	_	9	compound	_	_
8	Ca2+	ca0+	NN	NN	_	9	compound	_	_
9	channels	channel	NNS	NNS	_	4	pobj	_	_
10	does	do	VBZ	VBZ	_	12	aux	_	_
11	not	not	RB	RB	_	12	neg	_	_
12	appear	appear	VB	VB	syn=ADV	30	advcl	_	_
13	to	to	TO	TO	_	14	aux	_	_
14	contribute	contribute	VB	VB	_	12	xcomp	_	_
15	much	much	RB	RB	_	14	dobj	_	_
16	to	to	IN	IN	_	14	prep	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	secretion	secretion	NN	NN	_	16	pobj	_	_
19	under	under	IN	IN	_	14	prep	_	_
20	the	the	DT	DT	_	22	det	_	_
21	experimental	experimental	JJ	JJ	_	22	amod	_	_
22	conditions	condition	NNS	NNS	_	19	pobj	_	_
23	used	use	VBN	VBN	_	22	acl	_	_
24	in	in	IN	IN	_	23	prep	_	_
25	this	this	DT	DT	_	26	det	_	_
26	study	study	NN	NN	_	24	pobj	_	_
27	,	,	,	,	_	30	punct	_	_
28	these	these	DT	DT	_	29	det	_	_
29	channels	channel	NNS	NNS	_	30	nsubj	_	_
30	become	become	VBP	VBP	_	0	root	_	_
31	the	the	DT	DT	_	33	det	_	_
32	predominant	predominant	JJ	JJ	_	33	amod	_	_
33	conduit	conduit	NN	NN	syn=PRD	30	attr	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	Ca2+	ca0+	NN	NN	_	36	compound	_	_
36	entry	entry	NN	NN	_	34	pobj	_	_
37	in	in	IN	IN	_	33	prep	_	_
38	the	the	DT	DT	_	39	det	_	_
39	presence	presence	NN	NN	_	37	pobj	_	_
40	of	of	IN	IN	_	39	prep	_	_
41	agents	agent	NNS	NNS	_	40	pobj	_	_
42	increasing	increase	VBG	VBG	_	41	acl	_	_
43	cAMP	camp	NN	NN	_	42	dobj	_	_
44	[	[	-LRB-	-LRB-	_	45	punct	_	_
45	41	0	CD	CD	_	30	parataxis	_	_
46	]	]	-RRB-	-RRB-	_	45	punct	_	_
47	(	(	-LRB-	-LRB-	_	49	punct	_	_
48	unpublished	unpublished	JJ	JJ	_	49	amod	_	_
49	data	datum	NNS	NNS	_	30	meta	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	.	.	.	.	_	30	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	10	nsubj	_	_
3	underlying	underlie	VBG	VBG	_	2	acl	_	_
4	this	this	DT	DT	_	5	det	_	_
5	switch	switch	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	Ca2+	ca0+	NN	NN	_	8	compound	_	_
8	channel	channel	NN	NN	_	9	compound	_	_
9	dependence	dependence	NN	NN	_	6	pobj	_	_
10	remains	remain	VBZ	VBZ	_	0	root	_	_
11	obscure	obscure	JJ	JJ	syn=PRD	10	acomp	_	_
12	,	,	,	,	_	10	punct	_	_
13	but	but	CC	CC	_	10	cc	_	_
14	may	may	MD	MD	_	15	aux	_	_
15	depend	depend	VB	VB	_	10	conj	_	_
16	on	on	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	strength	strength	NN	NN	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	depolarisation	depolarisation	NN	NN	_	19	pobj	_	_
21	because	because	IN	IN	_	39	mark	_	_
22	glucagon	glucagon	NN	NN	_	23	compound	_	_
23	secretion	secretion	NN	NN	_	39	nsubjpass	_	_
24	stimulated	stimulate	VBN	VBN	_	23	acl	_	_
25	by	by	IN	IN	sem=MNR	24	prep	_	_
26	strong	strong	JJ	JJ	_	27	amod	_	_
27	depolarisation	depolarisation	NN	NN	_	25	pobj	_	_
28	with	with	IN	IN	_	27	prep	_	_
29	increased	increase	VBN	VBN	_	30	amod	_	_
30	K+	k+	NN	NN	_	28	pobj	_	_
31	in	in	IN	IN	_	27	prep	_	_
32	combination	combination	NN	NN	_	31	pobj	_	_
33	with	with	IN	IN	_	32	prep	_	_
34	KATP	katp	NN	NN	_	35	compound	_	_
35	channel	channel	NN	NN	_	36	compound	_	_
36	block	block	NN	NN	_	33	pobj	_	_
37	can	can	MD	MD	_	39	aux	_	_
38	be	be	VB	VB	_	39	auxpass	_	_
39	prevented	prevent	VBN	VBN	sem=PRP	15	advcl	_	_
40	by	by	IN	IN	sem=MNR	39	prep	_	_
41	inhibition	inhibition	NN	NN	_	40	pobj	_	_
42	of	of	IN	IN	_	41	prep	_	_
43	L	l	NN	NN	_	45	compound	_	_
44	-	-	HYPH	HYPH	_	45	punct	_	_
45	type	type	NN	NN	_	47	compound	_	_
46	Ca2+	ca0+	NN	NN	_	47	compound	_	_
47	channels	channel	NNS	NNS	_	42	pobj	_	_
48	[	[	-LRB-	-LRB-	_	49	punct	_	_
49	47	0	CD	CD	_	15	parataxis	_	_
50	]	]	-RRB-	-RRB-	_	49	punct	_	_
51	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	finally	finally	RB	RB	_	3	advmod	_	_
3	point	point	VBP	VBP	_	0	root	_	_
4	out	out	RP	RP	_	3	prt	_	_
5	that	that	IN	IN	_	17	mark	_	_
6	the	the	DT	DT	_	7	det	_	_
7	model	model	NN	NN	_	17	nsubj	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	propose	propose	VBP	VBP	_	7	advcl	_	_
10	here	here	RB	RB	_	9	advmod	_	_
11	for	for	IN	IN	sem=PRP	9	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	control	control	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	14	pobj	_	_
17	shares	share	VBZ	VBZ	_	3	ccomp	_	_
18	many	many	JJ	JJ	_	19	amod	_	_
19	features	feature	NNS	NNS	_	17	dobj	_	_
20	with	with	IN	IN	_	17	prep	_	_
21	what	what	WP	WP	_	23	dep	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	known	know	VBN	VBN	syn=NOM	20	pcomp	_	_
24	about	about	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	27	det	_	_
26	metabolic	metabolic	JJ	JJ	_	27	amod	_	_
27	control	control	NN	NN	_	24	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	insulin	insulin	NN	NN	_	30	compound	_	_
30	secretion	secretion	NN	NN	_	28	pobj	_	_
31	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	4	nsubj	_	_
2	in	in	IN	IN	_	4	prep	_	_
3	turn	turn	NN	NN	_	2	pobj	_	_
4	means	mean	VBZ	VBZ	_	0	root	_	_
5	that	that	IN	IN	_	23	mark	_	_
6	processes	process	NNS	NNS	_	23	nsubj	_	_
7	that	that	WDT	WDT	_	8	dep	_	6:ref
8	interfere	interfere	VBP	VBP	_	6	relcl	_	_
9	with	with	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	ability	ability	NN	NN	_	9	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	,	,	,	,	_	14	punct	_	_
14	for	for	IN	IN	_	12	parataxis	_	_
15	example	example	NN	NN	_	14	pobj	_	_
16	,	,	,	,	_	14	punct	_	_
17	glucose	glucose	NN	NN	_	12	pobj	_	_
18	to	to	TO	TO	_	19	aux	_	_
19	stimulate	stimulate	VB	VB	_	11	acl	_	_
20	insulin	insulin	NN	NN	_	21	compound	_	_
21	secretion	secretion	NN	NN	_	19	dobj	_	_
22	will	will	MD	MD	_	23	aux	_	_
23	have	have	VB	VB	_	4	ccomp	_	_
24	the	the	DT	DT	_	26	det	_	_
25	opposite	opposite	JJ	JJ	_	26	amod	_	_
26	effect	effect	NN	NN	_	23	dobj	_	_
27	on	on	IN	IN	_	26	prep	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	secretion	secretion	NN	NN	_	27	pobj	_	_
30	.	.	.	.	_	4	punct	_	_

1	This	this	DT	DT	_	3	nsubj	_	_
2	would	would	MD	MD	_	3	aux	_	_
3	provide	provide	VB	VB	_	0	root	_	_
4	a	a	DT	DT	_	6	det	_	_
5	simple	simple	JJ	JJ	_	6	amod	_	_
6	explanation	explanation	NN	NN	_	3	dobj	_	_
7	for	for	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	9	det	_	_
9	fact	fact	NN	NN	_	7	pobj	_	_
10	that	that	IN	IN	_	16	mark	_	_
11	both	both	CC	CC	_	15	preconj	_	_
12	insulin	insulin	NN	NN	_	15	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	glucagon	glucagon	NN	NN	_	12	conj	_	_
15	secretion	secretion	NN	NN	_	16	nsubj	_	_
16	become	become	VBD	VBD	_	9	acl	_	_
17	perturbed	perturb	VBN	VBN	syn=PRD	16	acomp	_	_
18	in	in	IN	IN	_	16	prep	_	_
19	diabetes	diabetes	NN	NN	_	18	pobj	_	_
20	and	and	CC	CC	_	9	cc	_	_
21	why	why	WRB	WRB	_	25	advmod	_	_
22	oversecretion	oversecretion	NN	NN	_	25	nsubj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	glucagon	glucagon	NN	NN	_	23	pobj	_	_
25	exacerbates	exacerbate	VBZ	VBZ	syn=NOM	9	conj	_	_
26	the	the	DT	DT	_	28	det	_	_
27	hyperglycaemic	hyperglycaemic	JJ	JJ	_	28	amod	_	_
28	effects	effect	NNS	NNS	_	25	dobj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	insufficient	insufficient	JJ	JJ	_	32	amod	_	_
31	insulin	insulin	NN	NN	_	32	compound	_	_
32	secretion	secretion	NN	NN	_	29	pobj	_	_
33	.	.	.	.	_	3	punct	_	_

1	Materials	material	NNS	NNS	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Methods	method	NNS	NNS	_	1	conj	_	_

1	Islet	islet	NN	NN	_	2	compound	_	_
2	isolation	isolation	NN	NN	_	0	root	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	culture	culture	NN	NN	_	2	conj	_	_
5	.	.	.	.	_	2	punct	_	_

1	Islets	islet	NNS	NNS	_	7	nsubjpass	_	_
2	from	from	IN	IN	_	1	prep	_	_
3	female	female	JJ	JJ	_	5	amod	_	_
4	NMRI	nmri	NN	NN	_	5	compound	_	_
5	mice	mouse	NNS	NNS	_	2	pobj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	isolated	isolate	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	sem=MNR	7	prep	_	_
9	collagenase	collagenase	NN	NN	_	10	compound	_	_
10	digestion	digestion	NN	NN	_	8	pobj	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	cultured	culture	VBN	VBN	_	7	conj	_	_
13	in	in	IN	IN	sem=LOC	12	prep	_	_
14	RPMI	rpmi	NN	NN	_	17	nmod	_	_
15	-	-	HYPH	HYPH	_	14	punct	_	_
16	1640	0	CD	CD	_	14	nummod	_	_
17	media	medium	NNS	NNS	_	13	pobj	_	_
18	(	(	-LRB-	-LRB-	_	21	punct	_	_
19	5	0	CD	CD	_	20	nummod	_	_
20	mM	mm	NNS	NNS	_	21	compound	_	_
21	glucose	glucose	NN	NN	_	17	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	at	at	IN	IN	_	12	prep	_	_
24	37	0	CD	CD	_	26	nummod	_	_
25	°	°	SYM	SYM	_	24	punct	_	_
26	C	c	NNP	NNP	_	23	pobj	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	5	0	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	30	compound	_	_
30	CO2	co0	NN	NN	_	26	conj	_	_
31	for	for	IN	IN	sem=TMP	12	prep	_	_
32	2	0	CD	CD	_	34	quantmod	_	_
33	−	−	SYM	SYM	_	34	punct	_	_
34	24	0	CD	CD	_	35	nummod	_	_
35	h	h	NNS	NNS	_	31	pobj	_	_
36	prior	prior	IN	IN	sem=TMP	12	prep	_	_
37	to	to	IN	IN	_	36	prep	_	_
38	secretion	secretion	NN	NN	_	37	pobj	_	_
39	or	or	CC	CC	_	38	cc	_	_
40	intracellular	intracellular	JJ	JJ	_	42	amod	_	_
41	Ca2+	ca0+	NN	NN	_	42	compound	_	_
42	assays	assay	NNS	NNS	_	38	conj	_	_
43	.	.	.	.	_	7	punct	_	_

1	For	for	IN	IN	sem=PRP	9	prep	_	_
2	single	single	JJ	JJ	_	4	amod	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	cell	cell	NN	NN	_	5	compound	_	_
5	studies	study	NNS	NNS	_	1	pobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	islets	islet	NNS	NNS	_	9	nsubjpass	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	dispersed	disperse	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	sem=LOC	9	prep	_	_
11	a	a	DT	DT	_	15	det	_	_
12	Ca2+	ca0+	NN	NN	_	14	npadvmod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	free	free	JJ	JJ	_	15	amod	_	_
15	buffer	buffer	NN	NN	_	10	pobj	_	_
16	and	and	CC	CC	_	9	cc	_	_
17	plated	plate	VBN	VBN	_	9	conj	_	_
18	in	in	IN	IN	sem=LOC	17	prep	_	_
19	35	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	mm	mm	NN	NN	_	23	compound	_	_
22	plastic	plastic	NN	NN	_	23	compound	_	_
23	dishes	dish	NNS	NNS	_	18	pobj	_	_
24	.	.	.	.	_	9	punct	_	_

1	Generation	generation	NN	NN	_	25	nsubjpass	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	5	det	_	_
4	Kir6.2Y12X	kir0y0x	NN	NN	_	5	compound	_	_
5	mice	mouse	NNS	NNS	_	2	pobj	_	_
6	,	,	,	,	_	5	punct	_	_
7	which	which	WDT	WDT	_	8	dep	_	5:ref
8	possess	possess	VBP	VBP	_	5	relcl	_	_
9	a	a	DT	DT	_	11	det	_	_
10	Tyr12STOP	tyr0stop	NN	NN	_	11	compound	_	_
11	mutation	mutation	NN	NN	_	8	dobj	_	_
12	in	in	IN	IN	sem=LOC	8	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	Kcnj11	kcnj0	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	12	pobj	_	_
16	on	on	IN	IN	_	8	prep	_	_
17	a	a	DT	DT	_	21	det	_	_
18	BALB	balb	NN	NN	_	20	compound	_	_
19	/	/	HYPH	HYPH	_	20	punct	_	_
20	c	c	NN	NN	_	21	compound	_	_
21	background	background	NN	NN	_	16	pobj	_	_
22	,	,	,	,	_	25	punct	_	_
23	has	have	VBZ	VBZ	_	25	aux	_	_
24	been	be	VBN	VBN	_	25	auxpass	_	_
25	described	describe	VBN	VBN	_	0	root	_	_
26	previously	previously	RB	RB	_	25	advmod	_	_
27	[	[	-LRB-	-LRB-	_	28	punct	_	_
28	48	0	CD	CD	_	25	parataxis	_	_
29	]	]	-RRB-	-RRB-	_	28	punct	_	_
30	.	.	.	.	_	25	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	results	result	VBZ	VBZ	_	0	root	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	nonfunctional	nonfunctional	JJ	JJ	_	6	amod	_	_
5	KATP	katp	NN	NN	_	6	compound	_	_
6	channels	channel	NNS	NNS	_	3	pobj	_	_
7	in	in	IN	IN	sem=LOC	2	prep	_	_
8	both	both	CC	CC	_	9	preconj	_	_
9	α	α	NN	NN	_	12	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	β	β	NN	NN	_	9	conj	_	_
12	cells	cell	NNS	NNS	_	7	pobj	_	_
13	.	.	.	.	_	2	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	animals	animal	NNS	NNS	_	3	nsubj	_	_
3	are	be	VBP	VBP	_	0	root	_	_
4	not	not	RB	RB	_	3	neg	_	_
5	overtly	overtly	RB	RB	_	6	advmod	_	_
6	diabetic	diabetic	JJ	JJ	syn=PRD	3	acomp	_	_
7	,	,	,	,	_	3	punct	_	_
8	exhibiting	exhibit	VBG	VBG	syn=ADV	3	advcl	_	_
9	normal	normal	JJ	JJ	_	11	amod	_	_
10	fasting	fasting	NN	NN	_	11	compound	_	_
11	glucose	glucose	NN	NN	_	8	dobj	_	_
12	,	,	,	,	_	3	punct	_	_
13	but	but	CC	CC	_	3	cc	_	_
14	are	be	VBP	VBP	_	3	conj	_	_
15	glucose	glucose	NN	NN	syn=PRD	14	attr	_	_
16	intolerant	intolerant	JJ	JJ	_	15	amod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	R.	r.	NNP	NNP	_	14	meta	_	_
19	Cox	cox	NNP	NNP	_	18	nmod	_	_
20	,	,	,	,	_	18	punct	_	_
21	unpublished	unpublished	JJ	JJ	_	18	amod	_	_
22	data	datum	NNS	NNS	_	18	nmod	_	_
23	)	)	-RRB-	-RRB-	_	18	punct	_	_
24	.	.	.	.	_	3	punct	_	_

1	For	for	IN	IN	sem=PRP	17	prep	_	_
2	these	these	DT	DT	_	3	det	_	_
3	experiments	experiment	NNS	NNS	_	1	pobj	_	_
4	,	,	,	,	_	17	punct	_	_
5	age	age	NN	NN	_	10	npadvmod	_	_
6	-	-	HYPH	HYPH	_	5	punct	_	_
7	and	and	CC	CC	_	5	cc	_	_
8	weight	weight	NN	NN	_	5	conj	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	matched	match	VBN	VBN	_	15	amod	_	_
11	wild	wild	JJ	JJ	_	13	amod	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	type	type	NN	NN	_	15	compound	_	_
14	C3HB	c0hb	NN	NN	_	15	compound	_	_
15	mice	mouse	NNS	NNS	_	17	nsubjpass	_	_
16	were	be	VBD	VBD	_	17	auxpass	_	_
17	used	use	VBN	VBN	_	0	root	_	_
18	as	as	IN	IN	_	17	prep	_	_
19	controls	control	NNS	NNS	_	18	pobj	_	_
20	because	because	IN	IN	_	27	mark	_	_
21	the	the	DT	DT	_	23	det	_	_
22	Kir6.2Y12X	kir0y0x	NN	NN	_	23	compound	_	_
23	mice	mouse	NNS	NNS	_	27	nsubjpass	_	_
24	were	be	VBD	VBD	_	27	auxpass	_	_
25	back	back	RB	RB	_	27	advmod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	crossed	cross	VBN	VBN	sem=PRP	17	advcl	_	_
28	into	into	IN	IN	_	27	prep	_	_
29	this	this	DT	DT	_	30	det	_	_
30	background	background	NN	NN	_	28	pobj	_	_
31	over	over	IN	IN	sem=TMP	27	prep	_	_
32	several	several	JJ	JJ	_	33	amod	_	_
33	generations	generation	NNS	NNS	_	31	pobj	_	_
34	.	.	.	.	_	17	punct	_	_

1	Human	human	JJ	JJ	_	2	amod	_	_
2	islets	islet	NNS	NNS	_	8	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	four	#crd#	CD	CD	_	6	nummod	_	_
5	healthy	healthy	JJ	JJ	_	6	amod	_	_
6	donors	donor	NNS	NNS	_	3	pobj	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	obtained	obtain	VBN	VBN	_	0	root	_	_
9	from	from	IN	IN	_	8	prep	_	_
10	the	the	DT	DT	_	16	det	_	_
11	Oxford	oxford	NNP	NNP	_	16	compound	_	_
12	DRWF	drwf	NNP	NNP	_	16	compound	_	_
13	Human	human	NNP	NNP	_	14	compound	_	_
14	Islet	islet	NNP	NNP	_	15	compound	_	_
15	Isolation	isolation	NNP	NNP	_	16	compound	_	_
16	Facility	facility	NNP	NNP	_	9	pobj	_	_
17	.	.	.	.	_	8	punct	_	_

1	Experiments	experiment	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	performed	performed	VBN	VBN	_	0	root	_	_
4	in	in	IN	IN	sem=MNR	3	prep	_	_
5	duplicate	duplicate	NN	NN	_	4	pobj	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	triplicate	triplicate	NN	NN	_	5	conj	_	_
8	using	use	VBG	VBG	sem=MNR	3	advcl	_	_
9	islets	islet	NNS	NNS	_	8	dobj	_	_
10	from	from	IN	IN	_	9	prep	_	_
11	each	each	DT	DT	_	12	det	_	_
12	donor	donor	NN	NN	_	10	pobj	_	_
13	.	.	.	.	_	3	punct	_	_

1	Human	human	JJ	JJ	_	2	amod	_	_
2	islets	islet	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	cultured	culture	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	sem=LOC	4	prep	_	_
6	RPMI	rpmi	NN	NN	_	5	pobj	_	_
7	-	-	HYPH	HYPH	_	6	punct	_	_
8	1640	0	CD	CD	_	6	nummod	_	_
9	(	(	-LRB-	-LRB-	_	12	punct	_	_
10	10	0	CD	CD	_	11	nummod	_	_
11	mM	mm	NNS	NNS	_	12	compound	_	_
12	glucose	glucose	NN	NN	_	6	parataxis	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	at	at	IN	IN	_	4	prep	_	_
15	37	0	CD	CD	_	17	nummod	_	_
16	°	°	SYM	SYM	_	15	punct	_	_
17	C	c	NNP	NNP	_	14	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	5	0	CD	CD	_	20	nummod	_	_
20	%	%	NN	NN	_	21	compound	_	_
21	CO2	co0	NN	NN	_	17	conj	_	_
22	,	,	,	,	_	4	punct	_	_
23	and	and	CC	CC	_	4	cc	_	_
24	experiments	experiment	NNS	NNS	_	26	nsubjpass	_	_
25	were	be	VBD	VBD	_	26	auxpass	_	_
26	performed	performed	VBN	VBN	_	4	conj	_	_
27	within	within	IN	IN	sem=TMP	26	prep	_	_
28	48	0	CD	CD	_	29	nummod	_	_
29	h	h	NNS	NNS	_	27	pobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	isolation	isolation	NN	NN	_	30	pobj	_	_
32	.	.	.	.	_	26	punct	_	_

1	Intracellular	intracellular	JJ	JJ	_	3	amod	_	_
2	Ca2+	ca0+	NN	NN	_	3	compound	_	_
3	measurements	measurement	NNS	NNS	_	0	root	_	_
4	.	.	.	.	_	3	punct	_	_

1	Intact	intact	JJ	JJ	_	2	amod	_	_
2	islets	islet	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	loaded	load	VBN	VBN	_	0	root	_	_
5	with	with	IN	IN	sem=MNR	4	prep	_	_
6	fluo	fluo	NN	NN	_	10	nmod	_	_
7	-	-	HYPH	HYPH	_	10	punct	_	_
8	4	0	CD	CD	_	10	nummod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	AM	am	NN	NN	_	5	pobj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	1	0	CD	CD	_	13	nummod	_	_
13	μM	μm	NN	NN	_	10	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	fura	fura	NN	NN	_	17	compound	_	_
17	red	red	NN	NN	_	10	conj	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	5	0	CD	CD	_	20	nummod	_	_
20	μM	μm	NNS	NNS	_	17	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	in	in	IN	IN	_	4	prep	_	_
23	0.5	0	CD	CD	_	24	nummod	_	_
24	mM	mm	NNS	NNS	_	26	compound	_	_
25	glucose	glucose	NN	NN	_	26	compound	_	_
26	buffer	buffer	NN	NN	_	22	pobj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	see	see	VB	VB	_	26	parataxis	_	_
29	below	below	RB	RB	_	28	advmod	_	_
30	)	)	-RRB-	-RRB-	_	28	punct	_	_
31	with	with	IN	IN	_	26	prep	_	_
32	0.01	0	CD	CD	_	33	nummod	_	_
33	%	%	NN	NN	_	35	nmod	_	_
34	pluronic	pluronic	JJ	JJ	_	35	amod	_	_
35	acid	acid	NN	NN	_	31	pobj	_	_
36	for	for	IN	IN	sem=TMP	4	prep	_	_
37	30	0	CD	CD	_	38	nummod	_	_
38	min	min	NNS	NNS	_	36	pobj	_	_
39	at	at	IN	IN	_	4	prep	_	_
40	37	0	CD	CD	_	41	nummod	_	_
41	°C	°c	NN	NN	_	39	pobj	_	_
42	.	.	.	.	_	4	punct	_	_

1	Islets	islet	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	fixed	fix	VBN	VBN	_	0	root	_	_
4	with	with	IN	IN	sem=MNR	3	prep	_	_
5	a	a	DT	DT	_	10	det	_	_
6	wide	wide	JJ	JJ	_	8	amod	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	bore	bore	NN	NN	_	10	compound	_	_
9	holding	holding	NN	NN	_	10	compound	_	_
10	pipette	pipette	NN	NN	_	4	pobj	_	_
11	within	within	IN	IN	sem=LOC	3	prep	_	_
12	a	a	DT	DT	_	23	det	_	_
13	continuously	continuously	RB	RB	_	14	advmod	_	_
14	superfused	superfused	VBN	VBN	_	23	amod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	temperature	temperature	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	controlled	control	VBN	VBN	_	14	conj	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	37	0	CD	CD	_	21	nummod	_	_
21	°C	°c	NN	NN	_	23	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	bath	bath	NN	NN	_	11	pobj	_	_
24	on	on	IN	IN	sem=LOC	3	prep	_	_
25	an	an	DT	DT	_	31	det	_	_
26	Axioskop	axioskop	NN	NN	_	31	nmod	_	_
27	2	0	CD	CD	_	31	nummod	_	_
28	FS	fs	NN	NN	_	30	compound	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	mot	mot	NN	NN	_	31	compound	_	_
31	microscope	microscope	NN	NN	_	24	pobj	_	_
32	(	(	-LRB-	-LRB-	_	34	punct	_	_
33	Carl	carl	NNP	NNP	_	34	compound	_	_
34	Zeiss	zeiss	NNP	NNP	_	24	parataxis	_	_
35	,	,	,	,	_	34	punct	_	_
36	http://www.zeiss.com	#hlink#	NN	NN	syn=ADV	34	npadvmod	_	_
37	)	)	-RRB-	-RRB-	_	34	punct	_	_
38	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	perfusion	perfusion	NN	NN	_	3	compound	_	_
3	buffer	buffer	NN	NN	_	4	nsubj	_	_
4	contained	contain	VBD	VBD	_	0	root	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	in	in	IN	IN	_	4	parataxis	_	_
7	mM	mm	NNS	NNS	_	6	pobj	_	_
8	)	)	-RRB-	-RRB-	_	6	punct	_	_
9	:	:	:	:	_	4	punct	_	_
10	140	0	CD	CD	_	11	nummod	_	_
11	NaCl	nacl	NN	NN	_	4	dobj	_	_
12	;	;	:	:	_	11	punct	_	_
13	3.6	0	CD	CD	_	14	nummod	_	_
14	KCl	kcl	NN	NN	_	11	appos	_	_
15	;	;	:	:	_	11	punct	_	_
16	2	0	CD	CD	_	17	nummod	_	_
17	NaHCO3	nahco0	NN	NN	_	11	appos	_	_
18	;	;	:	:	_	11	punct	_	_
19	0.5	0	CD	CD	_	20	nummod	_	_
20	NaH2PO4	nah0po0	NN	NN	_	11	appos	_	_
21	;	;	:	:	_	11	punct	_	_
22	0.5	0	CD	CD	_	23	nummod	_	_
23	MgSO4	mgso0	NN	NN	_	11	appos	_	_
24	;	;	:	:	_	11	punct	_	_
25	5	0	CD	CD	_	26	nummod	_	_
26	HEPES	hep	NNS	NNS	_	11	appos	_	_
27	;	;	:	:	_	11	punct	_	_
28	2.5	0	CD	CD	_	29	nummod	_	_
29	CaCl2	cacl0	NN	NN	_	11	appos	_	_
30	;	;	:	:	_	11	punct	_	_
31	0.5	0	CD	CD	_	37	nummod	_	_
32	,	,	,	,	_	31	punct	_	_
33	3	0	CD	CD	_	31	conj	_	_
34	,	,	,	,	_	33	punct	_	_
35	or	or	CC	CC	_	33	cc	_	_
36	11	0	CD	CD	_	33	conj	_	_
37	glucose	glucose	NN	NN	_	11	appos	_	_
38	;	;	:	:	_	11	punct	_	_
39	(	(	-LRB-	-LRB-	_	40	punct	_	_
40	pH	ph	NN	NN	_	11	parataxis	_	_
41	7.4	0	CD	CD	_	40	nummod	_	_
42	with	with	IN	IN	_	40	prep	_	_
43	NaOH	naoh	NN	NN	_	42	pobj	_	_
44	)	)	-RRB-	-RRB-	_	40	punct	_	_
45	.	.	.	.	_	4	punct	_	_

1	Laser	laser	NN	NN	_	2	npadvmod	_	_
2	scanning	scan	VBG	VBG	_	4	amod	_	_
3	confocal	confocal	JJ	JJ	_	4	amod	_	_
4	microscopy	microscopy	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	performed	performed	VBN	VBN	_	0	root	_	_
7	using	use	VBG	VBG	sem=MNR	6	advcl	_	_
8	an	an	DT	DT	_	11	det	_	_
9	LSM	lsm	NN	NN	_	11	compound	_	_
10	510meta	0meta	NN	NN	_	11	compound	_	_
11	system	system	NN	NN	_	7	dobj	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	Zeiss	zeiss	NNP	NNP	_	11	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	.	.	.	.	_	6	punct	_	_

1	Excitation	excitation	NN	NN	_	2	nsubj	_	_
2	was	be	VBD	VBD	_	0	root	_	_
3	with	with	IN	IN	syn=PRD	2	prep	_	_
4	a	a	DT	DT	_	9	det	_	_
5	488	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	nm	nm	NN	NN	_	9	compound	_	_
8	argon	argon	NN	NN	_	9	compound	_	_
9	laser	laser	NN	NN	_	3	pobj	_	_
10	,	,	,	,	_	2	punct	_	_
11	and	and	CC	CC	_	2	cc	_	_
12	emitted	emit	VBN	VBN	_	13	amod	_	_
13	fluorescence	fluorescence	NN	NN	_	15	nsubjpass	_	_
14	was	be	VBD	VBD	_	15	auxpass	_	_
15	collected	collect	VBN	VBN	_	2	conj	_	_
16	through	through	IN	IN	sem=MNR	15	prep	_	_
17	500	0	CD	CD	_	19	quantmod	_	_
18	–	-	SYM	SYM	_	19	punct	_	_
19	550	0	CD	CD	_	21	nummod	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	nm	nm	NN	NN	_	31	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	650	0	CD	CD	_	25	quantmod	_	_
24	–	-	SYM	SYM	_	25	punct	_	_
25	710	0	CD	CD	_	27	nummod	_	_
26	-	-	HYPH	HYPH	_	27	punct	_	_
27	nm	nm	NN	NN	_	21	conj	_	_
28	band	band	NN	NN	_	30	compound	_	_
29	-	-	HYPH	HYPH	_	30	punct	_	_
30	pass	pass	NN	NN	_	31	compound	_	_
31	filters	filter	NNS	NNS	_	16	pobj	_	_
32	for	for	IN	IN	_	15	prep	_	_
33	the	the	DT	DT	_	43	det	_	_
34	fluo	fluo	NN	NN	_	43	nmod	_	_
35	-	-	HYPH	HYPH	_	34	punct	_	_
36	4	0	CD	CD	_	34	nummod	_	_
37	and	and	CC	CC	_	34	cc	_	_
38	fura	fura	NN	NN	_	39	compound	_	_
39	red	red	NN	NN	_	34	conj	_	_
40	(	(	-LRB-	-LRB-	_	39	punct	_	_
41	FuraR	furar	NN	NN	_	39	appos	_	_
42	)	)	-RRB-	-RRB-	_	43	punct	_	_
43	signals	signal	NNS	NNS	_	32	pobj	_	_
44	,	,	,	,	_	15	punct	_	_
45	respectively	respectively	RB	RB	_	15	advmod	_	_
46	.	.	.	.	_	15	punct	_	_

1	Increases	increase	NNS	NNS	_	6	nsubjpass	_	_
2	in	in	IN	IN	_	1	prep	_	_
3	intracellular	intracellular	JJ	JJ	_	4	amod	_	_
4	Ca2+	ca0+	NN	NN	_	2	pobj	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	displayed	display	VBN	VBN	_	0	root	_	_
7	as	as	IN	IN	_	6	prep	_	_
8	upward	upward	JJ	JJ	_	9	amod	_	_
9	deflections	deflection	NNS	NNS	_	7	pobj	_	_
10	.	.	.	.	_	6	punct	_	_

1	Images	image	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	acquired	acquire	VBN	VBN	_	0	root	_	_
4	at	at	IN	IN	_	3	prep	_	_
5	1.5	0	CD	CD	_	7	nummod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	s	s	NN	NN	_	8	compound	_	_
8	intervals	interval	NNS	NNS	_	4	pobj	_	_
9	.	.	.	.	_	3	punct	_	_

1	Individual	individual	JJ	JJ	_	2	amod	_	_
2	cells	cell	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	selected	select	VBN	VBN	_	0	root	_	_
5	as	as	IN	IN	_	4	prep	_	_
6	regions	region	NNS	NNS	_	5	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	interest	interest	NN	NN	_	7	pobj	_	_
9	,	,	,	,	_	4	punct	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	the	the	DT	DT	_	14	det	_	_
12	average	average	JJ	JJ	_	14	amod	_	_
13	ratio	ratio	NN	NN	_	14	compound	_	_
14	intensity	intensity	NN	NN	_	37	nsubjpass	_	_
15	(	(	-LRB-	-LRB-	_	19	punct	_	_
16	RI	ri	NN	NN	_	19	nsubj	_	_
17	=	=	SYM	SYM	_	19	punct	_	_
18	[	[	-LRB-	-LRB-	_	19	punct	_	_
19	Fluo	fluo	NN	NN	_	14	parataxis	_	_
20	+	+	SYM	SYM	_	19	punct	_	_
21	1	0	CD	CD	_	19	nummod	_	_
22	]	]	-RRB-	-RRB-	_	19	punct	_	_
23	/	/	SYM	SYM	_	19	punct	_	_
24	[	[	-LRB-	-LRB-	_	25	punct	_	_
25	FuraR	furar	NN	NN	_	19	appos	_	_
26	+	+	SYM	SYM	_	25	punct	_	_
27	20	0	CD	CD	_	25	nummod	_	_
28	]	]	-RRB-	-RRB-	_	25	punct	_	_
29	×	×	SYM	SYM	_	19	punct	_	_
30	128	0	CD	CD	_	19	appos	_	_
31	+	+	SYM	SYM	_	19	punct	_	_
32	1	0	CD	CD	_	19	appos	_	_
33	)	)	-RRB-	-RRB-	_	19	punct	_	_
34	of	of	IN	IN	_	14	prep	_	_
35	these	these	DT	DT	_	34	pobj	_	_
36	were	be	VBD	VBD	_	37	auxpass	_	_
37	analysed	analyse	VBN	VBN	_	4	conj	_	_
38	over	over	IN	IN	sem=TMP	37	prep	_	_
39	time	time	NN	NN	_	38	pobj	_	_
40	with	with	IN	IN	sem=MNR	37	prep	_	_
41	Origin	origin	NN	NN	_	42	compound	_	_
42	v7.0220	v0	NN	NN	_	40	pobj	_	_
43	(	(	-LRB-	-LRB-	_	45	punct	_	_
44	OriginLab	originlab	NNP	NNP	_	45	compound	_	_
45	Corporation	corporation	NNP	NNP	_	40	parataxis	_	_
46	,	,	,	,	_	45	punct	_	_
47	http://www.originlab.com	#hlink#	NN	NN	syn=ADV	45	npadvmod	_	_
48	)	)	-RRB-	-RRB-	_	45	punct	_	_
49	.	.	.	.	_	37	punct	_	_

1	Prior	prior	IN	IN	sem=TMP	8	prep	_	_
2	to	to	IN	IN	_	1	prep	_	_
3	experimental	experimental	JJ	JJ	_	4	amod	_	_
4	recordings	recording	NNS	NNS	_	2	pobj	_	_
5	,	,	,	,	_	8	punct	_	_
6	islets	islet	NNS	NNS	_	8	nsubjpass	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	perfused	perfuse	VBN	VBN	_	0	root	_	_
9	for	for	IN	IN	sem=TMP	8	prep	_	_
10	10	0	CD	CD	_	11	nummod	_	_
11	min	min	NNS	NNS	_	9	pobj	_	_
12	with	with	IN	IN	_	8	prep	_	_
13	the	the	DT	DT	_	16	det	_	_
14	appropriate	appropriate	JJ	JJ	_	16	amod	_	_
15	control	control	NN	NN	_	16	compound	_	_
16	solution	solution	NN	NN	_	12	pobj	_	_
17	,	,	,	,	_	8	punct	_	_
18	and	and	CC	CC	_	8	cc	_	_
19	Ca2+	ca0+	NN	NN	_	20	compound	_	_
20	responses	response	NNS	NNS	_	22	nsubjpass	_	_
21	were	be	VBD	VBD	_	22	auxpass	_	_
22	monitored	monitor	VBN	VBN	_	8	conj	_	_
23	periodically	periodically	RB	RB	_	22	advmod	_	_
24	during	during	IN	IN	sem=TMP	22	prep	_	_
25	this	this	DT	DT	_	26	det	_	_
26	time	time	NN	NN	_	24	pobj	_	_
27	to	to	TO	TO	_	28	aux	_	_
28	ensure	ensure	VB	VB	sem=PRP	22	advcl	_	_
29	that	that	IN	IN	_	36	mark	_	_
30	responses	response	NNS	NNS	_	36	nsubj	_	_
31	(	(	-LRB-	-LRB-	_	30	punct	_	_
32	or	or	CC	CC	_	30	cc	_	_
33	lack	lack	NN	NN	_	30	conj	_	_
34	thereof	thereof	RB	RB	_	33	advmod	_	_
35	)	)	-RRB-	-RRB-	_	36	punct	_	_
36	were	be	VBD	VBD	_	28	ccomp	_	_
37	stable	stable	JJ	JJ	syn=PRD	36	acomp	_	_
38	prior	prior	IN	IN	sem=TMP	36	prep	_	_
39	to	to	IN	IN	_	38	prep	_	_
40	beginning	begin	VBG	VBG	syn=NOM	39	pcomp	_	_
41	the	the	DT	DT	_	43	det	_	_
42	experimental	experimental	JJ	JJ	_	43	amod	_	_
43	recording	recording	NN	NN	_	40	dobj	_	_
44	.	.	.	.	_	8	punct	_	_

1	Ca2+	ca0+	NN	NN	_	2	compound	_	_
2	responses	response	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	determined	determine	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	baseline	baseline	NN	NN	_	7	compound	_	_
7	subtraction	subtraction	NN	NN	_	5	pobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	calculation	calculation	NN	NN	_	7	conj	_	_
10	of	of	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	integrated	integrate	VBN	VBN	_	13	amod	_	_
13	response	response	NN	NN	_	10	pobj	_	_
14	(	(	-LRB-	-LRB-	_	18	punct	_	_
15	i.e.	i.e.	FW	FW	_	18	advmod	_	_
16	,	,	,	,	_	18	punct	_	_
17	the	the	DT	DT	_	18	det	_	_
18	area	area	NN	NN	_	13	parataxis	_	_
19	under	under	IN	IN	_	18	prep	_	_
20	the	the	DT	DT	_	21	det	_	_
21	curve	curve	NN	NN	_	19	pobj	_	_
22	)	)	-RRB-	-RRB-	_	18	punct	_	_
23	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	slope	slope	NN	NN	_	17	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	this	this	DT	DT	_	5	det	_	_
5	response	response	NN	NN	_	3	pobj	_	_
6	,	,	,	,	_	2	punct	_	_
7	reported	report	VBN	VBN	_	2	acl	_	_
8	here	here	RB	RB	_	7	advmod	_	_
9	as	as	IN	IN	_	7	prep	_	_
10	arbitrary	arbitrary	JJ	JJ	_	11	amod	_	_
11	units	unit	NNS	NNS	_	9	pobj	_	_
12	(	(	-LRB-	-LRB-	_	11	punct	_	_
13	AU	au	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	17	punct	_	_
15	,	,	,	,	_	17	punct	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	calculated	calculate	VBN	VBN	_	0	root	_	_
18	for	for	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	22	det	_	_
20	final	final	JJ	JJ	_	22	amod	_	_
21	60	0	CD	CD	_	22	nummod	_	_
22	%	%	NN	NN	_	18	pobj	_	_
23	–	-	SYM	SYM	_	25	punct	_	_
24	90	0	CD	CD	_	25	nummod	_	_
25	%	%	NN	NN	_	22	prep	_	_
26	of	of	IN	IN	_	22	prep	_	_
27	a	a	DT	DT	_	30	det	_	_
28	given	give	VBN	VBN	_	30	amod	_	_
29	treatment	treatment	NN	NN	_	30	compound	_	_
30	period	period	NN	NN	_	26	pobj	_	_
31	to	to	TO	TO	_	32	aux	_	_
32	allow	allow	VB	VB	sem=PRP	17	advcl	_	_
33	for	for	IN	IN	sem=PRP	32	prep	_	_
34	equilibration	equilibration	NN	NN	_	33	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	the	the	DT	DT	_	37	det	_	_
37	responses	response	NNS	NNS	_	35	pobj	_	_
38	.	.	.	.	_	17	punct	_	_

1	Hormone	hormone	NN	NN	_	2	compound	_	_
2	release	release	NN	NN	_	0	root	_	_
3	.	.	.	.	_	2	punct	_	_

1	Insulin	insulin	NN	NN	_	4	nmod	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	glucagon	glucagon	NN	NN	_	1	conj	_	_
4	secretion	secretion	NN	NN	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	measured	measure	VBN	VBN	_	0	root	_	_
7	as	as	IN	IN	_	8	mark	_	_
8	described	describe	VBN	VBN	syn=ADV	6	advcl	_	_
9	elsewhere	elsewhere	RB	RB	_	8	advmod	_	_
10	[	[	-LRB-	-LRB-	_	11	punct	_	_
11	45	0	CD	CD	_	6	parataxis	_	_
12	]	]	-RRB-	-RRB-	_	11	punct	_	_
13	.	.	.	.	_	6	punct	_	_

1	Briefly	briefly	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	batches	batch	NNS	NNS	_	10	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	ten	#crd#	CD	CD	_	8	nummod	_	_
6	freshly	freshly	RB	RB	_	7	advmod	_	_
7	isolated	isolate	VBN	VBN	_	8	amod	_	_
8	islets	islet	NNS	NNS	_	4	pobj	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	pre-incubated	pre-incubated	VBN	VBN	_	0	root	_	_
11	in	in	IN	IN	_	10	prep	_	_
12	1	0	CD	CD	_	13	nummod	_	_
13	ml	ml	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	Krebs	krebs	NNP	NNP	_	17	compound	_	_
16	–	-	HYPH	HYPH	_	17	punct	_	_
17	Ringer	ringer	NNP	NNP	_	18	compound	_	_
18	buffer	buffer	NN	NN	_	14	pobj	_	_
19	(	(	-LRB-	-LRB-	_	18	punct	_	_
20	KRB	krb	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	13	punct	_	_
22	supplemented	supplement	VBN	VBN	_	13	acl	_	_
23	with	with	IN	IN	_	22	prep	_	_
24	1	0	CD	CD	_	25	nummod	_	_
25	mM	mm	NN	NN	_	26	compound	_	_
26	glucose	glucose	NN	NN	_	23	pobj	_	_
27	for	for	IN	IN	sem=TMP	10	prep	_	_
28	30	0	CD	CD	_	29	nummod	_	_
29	min	min	NNS	NNS	_	27	pobj	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	rodent	rodent	NN	NN	_	29	parataxis	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	or	or	CC	CC	_	29	cc	_	_
34	1	0	CD	CD	_	35	nummod	_	_
35	h	h	NN	NN	_	29	conj	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	human	human	JJ	JJ	_	35	parataxis	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	followed	followed	VBN	VBN	syn=ADV	10	advcl	_	_
40	by	by	IN	IN	_	39	agent	_	_
41	1	0	CD	CD	_	43	nummod	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	h	h	NN	NN	_	44	compound	_	_
44	incubation	incubation	NN	NN	_	40	pobj	_	_
45	in	in	IN	IN	sem=LOC	44	prep	_	_
46	1	0	CD	CD	_	47	nummod	_	_
47	ml	ml	NN	NN	_	45	pobj	_	_
48	of	of	IN	IN	_	47	prep	_	_
49	test	test	NN	NN	_	51	compound	_	_
50	KRB	krb	NN	NN	_	51	compound	_	_
51	medium	medium	NN	NN	_	48	pobj	_	_
52	supplemented	supplement	VBN	VBN	_	47	acl	_	_
53	as	as	IN	IN	_	54	mark	_	_
54	indicated	indicate	VBN	VBN	syn=ADV	52	advcl	_	_
55	.	.	.	.	_	10	punct	_	_

1	For	for	IN	IN	sem=PRP	29	prep	_	_
2	experiments	experiment	NNS	NNS	_	1	pobj	_	_
3	in	in	IN	IN	_	7	prep	_	_
4	which	which	WDT	WDT	_	3	pobj	_	2:ref
5	Zn2+	zn0+	NN	NN	_	7	nsubjpass	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	chelated	chelate	VBN	VBN	_	2	relcl	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	GABAA	gabaa	NN	NN	_	10	compound	_	_
10	receptors	receptor	NNS	NNS	_	12	nsubjpass	_	_
11	were	be	VBD	VBD	_	12	auxpass	_	_
12	antagonised	antagonise	VBN	VBN	_	7	conj	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	Figure	figure	NN	NN	_	7	parataxis	_	_
15	1	0	CD	CD	_	14	nummod	_	_
16	)	)	-RRB-	-RRB-	_	14	punct	_	_
17	,	,	,	,	_	29	punct	_	_
18	the	the	DT	DT	_	21	det	_	_
19	Ca2+	ca0+	NN	NN	_	21	compound	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	EDTA	edta	NN	NN	_	29	nsubj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	SR	sr	NN	NN	_	21	conj	_	_
24	-	-	HYPH	HYPH	_	23	punct	_	_
25	95531	0	CD	CD	_	23	nummod	_	_
26	,	,	,	,	_	29	punct	_	_
27	respectively	respectively	RB	RB	_	29	advmod	_	_
28	,	,	,	,	_	29	punct	_	_
29	were	be	VBD	VBD	_	0	root	_	_
30	present	present	JJ	JJ	syn=PRD	29	acomp	_	_
31	in	in	IN	IN	_	29	prep	_	_
32	both	both	CC	CC	_	37	preconj	_	_
33	the	the	DT	DT	_	37	det	_	_
34	pre-incubation	pre-incubation	JJ	JJ	_	37	amod	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	test	test	NN	NN	_	34	conj	_	_
37	solutions	solution	NNS	NNS	_	31	pobj	_	_
38	.	.	.	.	_	29	punct	_	_

1	When	when	WRB	WRB	_	5	advmod	_	_
2	extracellular	extracellular	JJ	JJ	_	3	amod	_	_
3	KCl	kcl	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	increased	increase	VBN	VBN	sem=TMP	10	advcl	_	_
6	,	,	,	,	_	10	punct	_	_
7	NaCl	nacl	NN	NN	_	10	nsubjpass	_	_
8	was	be	VBD	VBD	_	10	auxpass	_	_
9	correspondingly	correspondingly	RB	RB	_	10	advmod	_	_
10	reduced	reduce	VBN	VBN	_	0	root	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	maintain	maintain	VB	VB	sem=PRP	10	advcl	_	_
13	iso	iso	NN	NN	_	15	compound	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	osmolarity	osmolarity	NN	NN	_	12	dobj	_	_
16	.	.	.	.	_	10	punct	_	_

1	Single	single	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	capacitance	capacitance	NN	NN	_	0	root	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	ion	ion	NN	NN	_	7	compound	_	_
7	current	current	NN	NN	_	8	compound	_	_
8	measurements	measurement	NNS	NNS	_	4	conj	_	_
9	.	.	.	.	_	8	punct	_	_

1	Whole	whole	JJ	JJ	_	3	amod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	currents	current	NNS	NNS	_	8	nsubjpass	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	exocytosis	exocytosis	NN	NN	_	4	conj	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	recorded	record	VBN	VBN	_	0	root	_	_
9	using	use	VBG	VBG	sem=MNR	8	advcl	_	_
10	an	an	DT	DT	_	17	det	_	_
11	EPC	epc	NN	NN	_	17	nmod	_	_
12	-	-	HYPH	HYPH	_	11	punct	_	_
13	9	0	CD	CD	_	11	nummod	_	_
14	patch	patch	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	clamp	clamp	NN	NN	_	17	compound	_	_
17	amplifier	amplifier	NN	NN	_	9	dobj	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	HEKA	heka	NNP	NNP	_	20	compound	_	_
20	Electronics	electronics	NNP	NNP	_	17	parataxis	_	_
21	,	,	,	,	_	20	punct	_	_
22	http://www.heka.com	#hlink#	NN	NN	syn=ADV	20	npadvmod	_	_
23	)	)	-RRB-	-RRB-	_	20	punct	_	_
24	and	and	CC	CC	_	17	cc	_	_
25	Pulse	pulse	NNP	NNP	_	26	compound	_	_
26	software	software	NN	NN	_	17	conj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	version	version	NN	NN	_	26	parataxis	_	_
29	8.50	0	CD	CD	_	28	nummod	_	_
30	)	)	-RRB-	-RRB-	_	28	punct	_	_
31	.	.	.	.	_	8	punct	_	_

1	Single	single	JJ	JJ	_	3	amod	_	_
2	α	α	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	identified	identify	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	their	their	PRP$	PRP$	_	9	poss	_	_
8	small	small	JJ	JJ	_	9	amod	_	_
9	size	size	NN	NN	_	6	pobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	Na+	na+	NN	NN	_	14	nmod	_	_
12	current	current	JJ	JJ	_	11	amod	_	_
13	inactivation	inactivation	NN	NN	_	14	compound	_	_
14	properties	property	NNS	NNS	_	9	conj	_	_
15	[	[	-LRB-	-LRB-	_	16	punct	_	_
16	58	0	CD	CD	_	5	parataxis	_	_
17	]	]	-RRB-	-RRB-	_	16	punct	_	_
18	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	method	method	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	validated	validate	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	combining	combine	VBG	VBG	syn=NOM	5	pcomp	_	_
7	the	the	DT	DT	_	9	det	_	_
8	electrophysiological	electrophysiological	JJ	JJ	_	9	amod	_	_
9	recordings	recording	NNS	NNS	_	6	dobj	_	_
10	with	with	IN	IN	_	6	prep	_	_
11	subsequent	subsequent	JJ	JJ	_	12	amod	_	_
12	immunostaining	immunostaining	NN	NN	_	10	pobj	_	_
13	for	for	IN	IN	_	12	prep	_	_
14	glucagon	glucagon	NN	NN	_	13	pobj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	insulin	insulin	NN	NN	_	14	conj	_	_
17	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	extracellular	extracellular	JJ	JJ	_	3	amod	_	_
3	medium	medium	NN	NN	_	4	nsubj	_	_
4	contained	contain	VBN	VBN	_	0	root	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	in	in	IN	IN	_	4	parataxis	_	_
7	mM	mm	NNS	NNS	_	6	pobj	_	_
8	)	)	-RRB-	-RRB-	_	6	punct	_	_
9	:	:	:	:	_	4	punct	_	_
10	118	0	CD	CD	_	11	nummod	_	_
11	NaCl	nacl	NN	NN	_	4	dobj	_	_
12	;	;	:	:	_	11	punct	_	_
13	20	0	CD	CD	_	16	nummod	_	_
14	TEA	tea	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	Cl	cl	NN	NN	_	11	conj	_	_
17	(	(	-LRB-	-LRB-	_	16	punct	_	_
18	tetraethylammonium	tetraethylammonium	NN	NN	_	19	compound	_	_
19	chloride	chloride	NN	NN	_	16	appos	_	_
20	)	)	-RRB-	-RRB-	_	16	punct	_	_
21	;	;	:	:	_	16	punct	_	_
22	5.6	0	CD	CD	_	23	nummod	_	_
23	KCl	kcl	NN	NN	_	16	conj	_	_
24	;	;	:	:	_	23	punct	_	_
25	2.6	0	CD	CD	_	26	nummod	_	_
26	CaCl2	cacl0	NN	NN	_	23	conj	_	_
27	;	;	:	:	_	26	punct	_	_
28	1.2	0	CD	CD	_	29	nummod	_	_
29	MgCl2	mgcl0	NN	NN	_	26	conj	_	_
30	;	;	:	:	_	29	punct	_	_
31	5	0	CD	CD	_	32	nummod	_	_
32	HEPES	hepes	NN	NN	_	29	conj	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	pH	ph	NN	NN	_	32	parataxis	_	_
35	7.4	0	CD	CD	_	34	nummod	_	_
36	with	with	IN	IN	_	34	prep	_	_
37	NaOH	naoh	NN	NN	_	36	pobj	_	_
38	)	)	-RRB-	-RRB-	_	34	punct	_	_
39	;	;	:	:	_	32	punct	_	_
40	and	and	CC	CC	_	32	cc	_	_
41	5	0	CD	CD	_	42	nummod	_	_
42	glucose	glucose	NN	NN	_	32	conj	_	_
43	.	.	.	.	_	4	punct	_	_

1	Except	except	IN	IN	_	23	prep	_	_
2	for	for	IN	IN	_	1	prep	_	_
3	Figure	figure	NN	NN	_	4	compound	_	_
4	8B	0b	NN	NN	_	2	pobj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	8C	0c	NN	NN	_	4	conj	_	_
7	,	,	,	,	_	4	punct	_	_
8	in	in	IN	IN	_	17	prep	_	_
9	which	which	WDT	WDT	_	8	pobj	_	4:ref
10	the	the	DT	DT	_	15	det	_	_
11	standard	standard	JJ	JJ	_	15	amod	_	_
12	whole	whole	JJ	JJ	_	14	amod	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	configuration	configuration	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	used	use	VBN	VBN	_	4	relcl	_	_
18	,	,	,	,	_	23	punct	_	_
19	the	the	DT	DT	_	21	det	_	_
20	electrophysiological	electrophysiological	JJ	JJ	_	21	amod	_	_
21	measurements	measurement	NNS	NNS	_	23	nsubjpass	_	_
22	were	be	VBD	VBD	_	23	auxpass	_	_
23	conducted	conduct	VBN	VBN	_	0	root	_	_
24	using	use	VBG	VBG	sem=MNR	23	advcl	_	_
25	the	the	DT	DT	_	28	det	_	_
26	perforated	perforate	VBN	VBN	_	28	amod	_	_
27	patch	patch	NN	NN	_	28	compound	_	_
28	technique	technique	NN	NN	_	24	dobj	_	_
29	,	,	,	,	_	23	punct	_	_
30	and	and	CC	CC	_	23	cc	_	_
31	the	the	DT	DT	_	33	det	_	_
32	pipette	pipette	NN	NN	_	33	compound	_	_
33	solution	solution	NN	NN	_	34	nsubj	_	_
34	contained	contain	VBD	VBD	_	23	conj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	in	in	IN	IN	_	34	parataxis	_	_
37	mM	mm	NNS	NNS	_	36	pobj	_	_
38	)	)	-RRB-	-RRB-	_	36	punct	_	_
39	:	:	:	:	_	34	punct	_	_
40	76	0	CD	CD	_	41	nummod	_	_
41	Cs2SO4	cs0so0	NN	NN	_	34	dobj	_	_
42	;	;	:	:	_	41	punct	_	_
43	10	0	CD	CD	_	44	nummod	_	_
44	NaCl	nacl	NN	NN	_	41	conj	_	_
45	;	;	:	:	_	44	punct	_	_
46	10	0	CD	CD	_	47	nummod	_	_
47	KCl	kcl	NN	NN	_	44	conj	_	_
48	;	;	:	:	_	47	punct	_	_
49	1	0	CD	CD	_	50	nummod	_	_
50	MgCl2	mgcl0	NN	NN	_	47	conj	_	_
51	;	;	:	:	_	50	punct	_	_
52	and	and	CC	CC	_	50	cc	_	_
53	5	0	CD	CD	_	54	nummod	_	_
54	HEPES	hepes	NN	NN	_	50	conj	_	_
55	(	(	-LRB-	-LRB-	_	56	punct	_	_
56	pH	ph	NN	NN	_	54	parataxis	_	_
57	7.35	0	CD	CD	_	56	nummod	_	_
58	with	with	IN	IN	_	56	prep	_	_
59	CsOH	csoh	NN	NN	_	58	pobj	_	_
60	)	)	-RRB-	-RRB-	_	56	punct	_	_
61	.	.	.	.	_	23	punct	_	_

1	Exocytosis	exocytosis	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	monitored	monitor	VBN	VBN	_	0	root	_	_
4	as	as	IN	IN	_	3	prep	_	_
5	changes	change	NNS	NNS	_	4	pobj	_	_
6	in	in	IN	IN	_	5	prep	_	_
7	α	α	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	cell	cell	NN	NN	_	10	compound	_	_
10	capacitance	capacitance	NN	NN	_	6	pobj	_	_
11	using	use	VBG	VBG	sem=MNR	3	advcl	_	_
12	the	the	DT	DT	_	19	det	_	_
13	software	software	NN	NN	_	15	npadvmod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	based	base	VBN	VBN	_	19	amod	_	_
16	lock	lock	VB	VB	_	19	amod	_	_
17	-	-	HYPH	HYPH	_	16	punct	_	_
18	in	in	RP	RP	_	16	prt	_	_
19	function	function	NN	NN	_	11	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	23	det	_	_
22	Pulse	pulse	NN	NN	_	23	compound	_	_
23	software	software	NN	NN	_	20	pobj	_	_
24	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	standard	standard	JJ	JJ	_	6	amod	_	_
3	whole	whole	JJ	JJ	_	5	amod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	cell	cell	NN	NN	_	6	compound	_	_
6	measurements	measurement	NNS	NNS	_	14	nsubjpass	_	_
7	(	(	-LRB-	-LRB-	_	9	punct	_	_
8	Figure	figure	NN	NN	_	9	compound	_	_
9	8B	0b	NN	NN	_	6	parataxis	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	8C	0c	NN	NN	_	9	conj	_	_
12	)	)	-RRB-	-RRB-	_	9	punct	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	conducted	conduct	VBN	VBN	_	0	root	_	_
15	using	use	VBG	VBG	sem=MNR	14	advcl	_	_
16	a	a	DT	DT	_	18	det	_	_
17	pipette	pipette	NN	NN	_	18	compound	_	_
18	solution	solution	NN	NN	_	15	dobj	_	_
19	(	(	-LRB-	-LRB-	_	18	punct	_	_
20	dialyzing	dialyze	VBG	VBG	_	18	acl	_	_
21	the	the	DT	DT	_	23	det	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	interior	interior	NN	NN	_	20	dobj	_	_
24	)	)	-RRB-	-RRB-	_	18	punct	_	_
25	consisted	consist	VBN	VBN	_	18	acl	_	_
26	of	of	IN	IN	_	25	prep	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	in	in	IN	IN	_	26	parataxis	_	_
29	mM	mm	NNS	NNS	_	28	pobj	_	_
30	)	)	-RRB-	-RRB-	_	28	punct	_	_
31	125	0	CD	CD	_	32	nummod	_	_
32	CsOH	csoh	NN	NN	_	26	pobj	_	_
33	;	;	:	:	_	32	punct	_	_
34	125	0	CD	CD	_	35	nummod	_	_
35	glutamate	glutamate	NN	NN	_	32	conj	_	_
36	;	;	:	:	_	35	punct	_	_
37	10	0	CD	CD	_	38	nummod	_	_
38	CsCl	cscl	NN	NN	_	35	conj	_	_
39	;	;	:	:	_	38	punct	_	_
40	10	0	CD	CD	_	41	nummod	_	_
41	NaCl	nacl	NN	NN	_	38	conj	_	_
42	;	;	:	:	_	41	punct	_	_
43	1	0	CD	CD	_	44	nummod	_	_
44	MgCl2	mgcl0	NN	NN	_	41	conj	_	_
45	;	;	:	:	_	44	punct	_	_
46	5	0	CD	CD	_	47	nummod	_	_
47	HEPES	hepes	NN	NN	_	44	conj	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	pH	ph	NN	NN	_	47	parataxis	_	_
50	7.15	0	CD	CD	_	49	nummod	_	_
51	with	with	IN	IN	_	49	prep	_	_
52	KOH	koh	NN	NN	_	51	pobj	_	_
53	)	)	-RRB-	-RRB-	_	49	punct	_	_
54	;	;	:	:	_	47	punct	_	_
55	3	0	CD	CD	_	58	nummod	_	_
56	Mg	mg	NNS	NNS	_	58	compound	_	_
57	-	-	HYPH	HYPH	_	58	punct	_	_
58	ATP	atp	NN	NN	_	47	conj	_	_
59	;	;	:	:	_	58	punct	_	_
60	and	and	CC	CC	_	58	cc	_	_
61	25	0	CD	CD	_	62	nummod	_	_
62	μmol	μmol	NNS	NNS	_	65	nmod	_	_
63	/	/	SYM	SYM	_	64	punct	_	_
64	l	l	NN	NN	_	62	prep	_	_
65	EGTA	egta	NN	NN	_	58	conj	_	_
66	(	(	-LRB-	-LRB-	_	74	punct	_	_
67	measured	measure	VBN	VBN	_	70	amod	_	_
68	resting	rest	VBG	VBG	_	70	amod	_	_
69	free	free	JJ	JJ	_	70	amod	_	_
70	Ca2+	ca0+	NN	NN	_	74	dep	_	_
71	,	,	,	,	_	74	punct	_	_
72	∼	∼	SYM	SYM	_	73	punct	_	_
73	0.2	0	CD	CD	_	74	nummod	_	_
74	μmol	μmol	NNS	NNS	_	65	parataxis	_	_
75	/	/	SYM	SYM	_	76	punct	_	_
76	l	l	NN	NN	_	74	prep	_	_
77	)	)	-RRB-	-RRB-	_	74	punct	_	_
78	.	.	.	.	_	14	punct	_	_

1	Pulses	pulse	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	applied	apply	VBN	VBN	_	0	root	_	_
4	at	at	IN	IN	_	3	prep	_	_
5	low	low	JJ	JJ	_	6	amod	_	_
6	frequency	frequency	NN	NN	_	4	pobj	_	_
7	(	(	-LRB-	-LRB-	_	6	punct	_	_
8	<	<	SYM	SYM	_	10	punct	_	_
9	0.05	0	CD	CD	_	10	nummod	_	_
10	Hz	hz	NN	NN	_	6	amod	_	_
11	)	)	-RRB-	-RRB-	_	6	punct	_	_
12	to	to	TO	TO	_	13	aux	_	_
13	allow	allow	VB	VB	sem=PRP	3	advcl	_	_
14	the	the	DT	DT	_	16	det	_	_
15	exocytotic	exocytotic	JJ	JJ	_	16	amod	_	_
16	capacity	capacity	NN	NN	_	18	nsubj	_	_
17	to	to	TO	TO	_	18	aux	_	_
18	recover	recover	VB	VB	_	13	ccomp	_	_
19	fully	fully	RB	RB	_	18	advmod	_	_
20	between	between	IN	IN	sem=TMP	18	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	pulses	pulse	NNS	NNS	_	20	pobj	_	_
23	.	.	.	.	_	3	punct	_	_

1	Statistical	statistical	JJ	JJ	_	2	amod	_	_
2	analysis	analysis	NN	NN	_	0	root	_	_
3	.	.	.	.	_	2	punct	_	_

1	Data	datum	NNS	NNS	_	3	nsubjpass	_	_
2	are	be	VBP	VBP	_	3	auxpass	_	_
3	presented	present	VBN	VBN	_	0	root	_	_
4	as	as	IN	IN	_	3	prep	_	_
5	means	mean	NNS	NNS	_	4	pobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	standard	standard	JJ	JJ	_	8	amod	_	_
8	errors	error	NNS	NNS	_	5	conj	_	_
9	.	.	.	.	_	3	punct	_	_

1	Significance	significance	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	examined	examine	VBN	VBN	_	0	root	_	_
4	by	by	IN	IN	sem=MNR	3	prep	_	_
5	either	either	CC	CC	_	4	preconj	_	_
6	the	the	DT	DT	_	10	det	_	_
7	unpaired	unpaired	JJ	JJ	_	10	amod	_	_
8	t	t	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	test	test	NN	NN	_	4	conj	_	_
11	or	or	CC	CC	_	4	cc	_	_
12	by	by	IN	IN	_	4	conj	_	_
13	multiple	multiple	JJ	JJ	_	15	amod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	comparisons	comparison	NNS	NNS	_	16	compound	_	_
16	analysis	analysis	NN	NN	_	12	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	variance	variance	NN	NN	_	17	pobj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	ANOVA	anova	NN	NN	_	16	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	and	and	CC	CC	_	16	cc	_	_
23	post-test	post-test	RB	RB	_	16	conj	_	_
24	,	,	,	,	_	3	punct	_	_
25	as	as	IN	IN	_	26	mark	_	_
26	appropriate	appropriate	JJ	JJ	syn=ADV	3	advcl	_	_
27	.	.	.	.	_	3	punct	_	_

1	Acknowledgements	acknowledgement	NNS	NNS	_	0	root	_	_

1	PEM	pem	NNP	NNP	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	supported	support	VBN	VBN	_	0	root	_	_
4	initially	initially	RB	RB	_	3	advmod	_	_
5	the	the	DT	DT	_	7	det	_	_
6	European	european	JJ	JJ	_	7	amod	_	_
7	Foundation	foundation	NN	NN	syn=ADV	3	npadvmod	_	_
8	for	for	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	Study	study	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	Diabetes	diabetes	NN	NN	_	11	pobj	_	_
13	(	(	-LRB-	-LRB-	_	7	punct	_	_
14	EFSD	efsd	NN	NN	_	7	appos	_	_
15	)	)	-RRB-	-RRB-	_	7	punct	_	_
16	/	/	HYPH	HYPH	_	7	punct	_	_
17	AstraZeneca	astrazeneca	NNP	NNP	_	18	compound	_	_
18	Fellowship	fellowship	NNP	NNP	_	7	appos	_	_
19	in	in	IN	IN	_	18	prep	_	_
20	Islet	islet	NNP	NNP	_	21	compound	_	_
21	Biology	biology	NNP	NNP	_	19	pobj	_	_
22	and	and	CC	CC	_	3	cc	_	_
23	is	be	VBZ	VBZ	_	3	conj	_	_
24	currently	currently	RB	RB	_	23	advmod	_	_
25	an	an	DT	DT	_	32	det	_	_
26	Alberta	alberta	NNP	NNP	_	28	nmod	_	_
27	Heritage	heritage	NNP	NNP	_	28	nmod	_	_
28	Foundation	foundation	NNP	NNP	_	32	nmod	_	_
29	for	for	IN	IN	_	28	prep	_	_
30	Medical	medical	NNP	NNP	_	31	compound	_	_
31	Research	research	NNP	NNP	_	29	pobj	_	_
32	Scholar	scholar	NNP	NNP	syn=PRD	23	attr	_	_
33	,	,	,	,	_	32	punct	_	_
34	Canadian	canadian	NNP	NNP	_	37	compound	_	_
35	Diabetes	diabetes	NNP	NNP	_	36	compound	_	_
36	Association	association	NNP	NNP	_	37	compound	_	_
37	Scholar	scholar	NNP	NNP	_	32	conj	_	_
38	,	,	,	,	_	37	punct	_	_
39	and	and	CC	CC	_	37	cc	_	_
40	the	the	DT	DT	_	43	det	_	_
41	Canada	canada	NNP	NNP	_	43	compound	_	_
42	Research	research	NNP	NNP	_	43	compound	_	_
43	Chair	chair	NNP	NNP	_	37	conj	_	_
44	in	in	IN	IN	_	43	prep	_	_
45	Islet	islet	NNP	NNP	_	46	compound	_	_
46	Biology	biology	NNP	NNP	_	44	pobj	_	_
47	.	.	.	.	_	3	punct	_	_

1	PR	pr	NNP	NNP	_	2	nsubj	_	_
2	is	be	VBZ	VBZ	_	0	root	_	_
3	a	a	DT	DT	_	10	det	_	_
4	Wolfson	wolfson	NNP	NNP	_	10	compound	_	_
5	Royal	royal	NNP	NNP	_	6	compound	_	_
6	Society	society	NNP	NNP	_	10	compound	_	_
7	Merit	merit	NNP	NNP	_	8	compound	_	_
8	Award	award	NNP	NNP	_	10	compound	_	_
9	Research	research	NNP	NNP	_	10	compound	_	_
10	Fellow	fellow	NNP	NNP	syn=PRD	2	attr	_	_
11	.	.	.	.	_	2	punct	_	_

1	Abbreviations	abbreviation	NNS	NNS	_	0	root	_	_

1	[	[	-LRB-	-LRB-	_	4	punct	_	_
2	Ca2+	ca0+	NN	NN	_	4	nmod	_	_
3	]	]	-RRB-	-RRB-	_	4	punct	_	_
4	i	i	NN	NN	_	0	root	_	_
5	-	-	:	:	_	4	punct	_	_
6	intracellular	intracellular	JJ	JJ	_	7	amod	_	_
7	Ca2+	ca0+	NN	NN	_	4	appos	_	_

1	FuraR	furar	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	fura	fura	NN	NN	_	1	appos	_	_
4	red	red	JJ	JJ	_	3	amod	_	_

1	GABA	gaba	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	γ	γ	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	aminobutyric	aminobutyric	JJ	JJ	_	6	amod	_	_
6	acid	acid	NN	NN	_	1	appos	_	_

1	KATP	katp	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	ATP	atp	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	dependent	dependent	JJ	JJ	_	6	amod	_	_
6	K+	k+	NN	NN	_	1	appos	_	_
7	,	,	,	,	_	1	punct	_	_
8	TTX	ttx	NN	NN	_	10	nmod	_	_
9	,	,	,	,	_	10	punct	_	_
10	tetrodotoxin	tetrodotoxin	NN	NN	_	1	appos	_	_

1	VDCC	vdcc	NN	NN	_	0	root	_	_
2	-	-	:	:	_	1	punct	_	_
3	voltage	voltage	NN	NN	_	5	npadvmod	_	_
4	-	-	HYPH	HYPH	_	5	punct	_	_
5	dependent	dependent	JJ	JJ	_	7	amod	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	channel	channel	NN	NN	_	1	appos	_	_

1	Figures	figure	NNS	NNS	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Tables	table	NNS	NNS	_	1	conj	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	1	0	CD	CD	_	1	nummod	_	_

1	Glucose	glucose	NN	NN	_	2	nsubj	_	_
2	Suppresses	suppress	VBZ	VBZ	_	0	root	_	_
3	Glucagon	glucagon	NN	NN	_	4	compound	_	_
4	Release	release	NN	NN	_	2	dobj	_	_
5	Independently	independently	RB	RB	_	2	advmod	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	Paracrine	paracrine	NN	NN	_	8	compound	_	_
8	Signals	signal	NNS	NNS	_	6	pobj	_	_
9	Mediated	mediate	VBN	VBN	_	8	acl	_	_
10	by	by	IN	IN	sem=MNR	9	prep	_	_
11	Zn2+	zn0+	NN	NN	_	10	pobj	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	GABA	gaba	NN	NN	_	11	conj	_	_
14	.	.	.	.	_	2	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	11	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	5	compound	_	_
5	release	release	NN	NN	_	11	nsubjpass	_	_
6	from	from	IN	IN	sem=LOC	5	prep	_	_
7	isolated	isolate	VBN	VBN	_	9	amod	_	_
8	mouse	mouse	NN	NN	_	9	compound	_	_
9	islets	islet	NNS	NNS	_	6	pobj	_	_
10	was	be	VBD	VBD	_	11	auxpass	_	_
11	suppressed	suppress	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	sem=EXT	11	prep	_	_
13	60	0	CD	CD	_	14	nummod	_	_
14	%	%	NN	NN	_	12	pobj	_	_
15	at	at	IN	IN	_	11	prep	_	_
16	7	0	CD	CD	_	17	nummod	_	_
17	mM	mm	NNS	NNS	_	18	compound	_	_
18	glucose	glucose	NN	NN	_	15	pobj	_	_
19	compared	compare	VBN	VBN	_	11	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	1	0	CD	CD	_	22	nummod	_	_
22	mM	mm	NN	NN	_	20	pobj	_	_
23	(	(	-LRB-	-LRB-	_	25	punct	_	_
24	filled	fill	VBN	VBN	_	25	amod	_	_
25	bars	bar	NNS	NNS	_	11	parataxis	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	.	.	.	.	_	11	punct	_	_

1	Glucose	glucose	NN	NN	_	2	nsubj	_	_
2	retained	retain	VBD	VBD	_	0	root	_	_
3	its	its	PRP$	PRP$	_	5	poss	_	_
4	suppressive	suppressive	JJ	JJ	_	5	amod	_	_
5	effect	effect	NN	NN	_	2	dobj	_	_
6	on	on	IN	IN	_	5	prep	_	_
7	glucagon	glucagon	NN	NN	_	8	compound	_	_
8	release	release	NN	NN	_	6	pobj	_	_
9	under	under	IN	IN	_	2	prep	_	_
10	conditions	condition	NNS	NNS	_	9	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	Zn2+	zn0+	NN	NN	_	13	compound	_	_
13	chelation	chelation	NN	NN	_	11	pobj	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	Ca2+	ca0+	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	EDTA	edta	NN	NN	_	13	parataxis	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	open	open	JJ	JJ	_	21	amod	_	_
21	bars	bar	NNS	NNS	_	13	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	and	and	CC	CC	_	13	cc	_	_
24	antagonism	antagonism	NN	NN	_	13	conj	_	_
25	of	of	IN	IN	_	24	prep	_	_
26	GABAA	gabaa	NN	NN	_	27	compound	_	_
27	receptors	receptor	NNS	NNS	_	25	pobj	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	SR	sr	NN	NN	_	24	parataxis	_	_
30	-	-	HYPH	HYPH	_	29	punct	_	_
31	95531	0	CD	CD	_	29	nummod	_	_
32	)	)	-RRB-	-RRB-	_	29	punct	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	shaded	shade	VBN	VBN	_	35	amod	_	_
35	bars	bar	NNS	NNS	_	24	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	2	punct	_	_

1	Antagonism	antagonism	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	GABAA	gabaa	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	2	pobj	_	_
5	increased	increase	VBD	VBD	_	0	root	_	_
6	both	both	CC	CC	_	7	preconj	_	_
7	basal	basal	JJ	JJ	_	13	amod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	glucose	glucose	NN	NN	_	11	npadvmod	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	suppressed	suppress	VBN	VBN	_	7	conj	_	_
12	glucagon	glucagon	NN	NN	_	13	compound	_	_
13	secretion	secretion	NN	NN	_	5	dobj	_	_
14	,	,	,	,	_	5	punct	_	_
15	suggesting	suggest	VBG	VBG	syn=ADV	5	advcl	_	_
16	a	a	DT	DT	_	18	det	_	_
17	paracrine	paracrine	JJ	JJ	_	18	amod	_	_
18	role	role	NN	NN	_	15	dobj	_	_
19	for	for	IN	IN	_	18	prep	_	_
20	GABA	gaba	NN	NN	_	19	pobj	_	_
21	independent	independent	JJ	JJ	_	18	amod	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	the	the	DT	DT	_	25	det	_	_
24	glucose	glucose	NN	NN	_	25	compound	_	_
25	effect	effect	NN	NN	_	22	pobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	5	punct	_	_
7	A	a	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	4	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	using	use	VBG	VBG	sem=MNR	4	conj	_	_
12	rat	rat	NN	NN	_	13	compound	_	_
13	islets	islet	NNS	NNS	_	11	dobj	_	_
14	.	.	.	.	_	11	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	syn=ADV	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	1	0	CD	CD	_	22	nummod	_	_
22	mM	mm	NN	NN	_	23	compound	_	_
23	glucose	glucose	NN	NN	_	20	pobj	_	_
24	,	,	,	,	_	19	punct	_	_
25	or	or	CC	CC	_	19	cc	_	_
26	as	as	IN	IN	_	27	mark	_	_
27	indicated	indicate	VBN	VBN	_	19	conj	_	_
28	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	2	0	CD	CD	_	1	nummod	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	Release	release	NN	NN	_	10	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	Isolated	isolate	VBN	VBN	_	8	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	Intact	intact	JJ	JJ	_	4	conj	_	_
7	Mouse	mouse	NN	NN	_	8	compound	_	_
8	Islets	islet	NNS	NNS	_	3	pobj	_	_
9	Is	be	VBZ	VBZ	_	10	auxpass	_	_
10	Regulated	regulate	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	_	10	agent	_	_
12	a	a	DT	DT	_	17	det	_	_
13	KATP	katp	NN	NN	_	17	nmod	_	_
14	Channel	channel	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	Dependent	dependent	JJ	JJ	_	17	amod	_	_
17	Pathway	pathway	NN	NN	_	11	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	15	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	15	nmod	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	filled	fill	VBN	VBN	_	7	amod	_	_
7	circles	circle	NNS	NNS	_	4	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	insulin	insulin	NN	NN	_	4	conj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	open	open	JJ	JJ	_	13	amod	_	_
13	circles	circle	NNS	NNS	_	10	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	secretion	secretion	NN	NN	_	0	root	_	_
16	measured	measure	VBN	VBN	_	15	acl	_	_
17	from	from	IN	IN	_	16	prep	_	_
18	mouse	mouse	NN	NN	_	19	compound	_	_
19	islets	islet	NNS	NNS	_	17	pobj	_	_
20	in	in	IN	IN	_	16	prep	_	_
21	the	the	DT	DT	_	22	det	_	_
22	presence	presence	NN	NN	_	20	pobj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	8.3	0	CD	CD	_	25	nummod	_	_
25	mM	mm	NNS	NNS	_	26	compound	_	_
26	glucose	glucose	NN	NN	_	23	pobj	_	_
27	at	at	IN	IN	_	16	prep	_	_
28	increasing	increase	VBG	VBG	_	29	amod	_	_
29	concentrations	concentration	NNS	NNS	_	27	pobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	diazoxide	diazoxide	NN	NN	_	30	pobj	_	_
32	.	.	.	.	_	15	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	5	punct	_	_
7	A	a	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	4	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	using	use	VBG	VBG	sem=MNR	4	conj	_	_
12	rat	rat	NN	NN	_	13	compound	_	_
13	islets	islet	NNS	NNS	_	11	dobj	_	_
14	.	.	.	.	_	11	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	glucagon	glucagon	NN	NN	_	3	compound	_	_
3	responses	response	NNS	NNS	_	21	nsubjpass	_	_
4	to	to	IN	IN	_	3	prep	_	_
5	1	0	CD	CD	_	6	nummod	_	_
6	mM	mm	NN	NN	_	7	compound	_	_
7	glucose	glucose	NN	NN	_	4	pobj	_	_
8	(	(	-LRB-	-LRB-	_	10	punct	_	_
9	filled	fill	VBN	VBN	_	10	amod	_	_
10	square	square	NN	NN	_	7	parataxis	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	100	0	CD	CD	_	14	nummod	_	_
14	μM	μm	NNS	NNS	_	15	compound	_	_
15	tolbutamide	tolbutamide	NN	NN	_	7	conj	_	_
16	(	(	-LRB-	-LRB-	_	18	punct	_	_
17	filled	fill	VBN	VBN	_	18	amod	_	_
18	triangle	triangle	NN	NN	_	15	parataxis	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	indicated	indicate	VBN	VBN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	5	punct	_	_
7	A	a	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	4	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	in	in	IN	IN	_	4	conj	_	_
12	the	the	DT	DT	_	13	det	_	_
13	presence	presence	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	1	0	CD	CD	_	16	nummod	_	_
16	mM	mm	NN	NN	_	17	compound	_	_
17	glucose	glucose	NN	NN	_	14	pobj	_	_
18	and	and	CC	CC	_	11	cc	_	_
19	only	only	RB	RB	_	20	advmod	_	_
20	measuring	measure	VBG	VBG	syn=ADV	11	conj	_	_
21	glucagon	glucagon	NN	NN	_	22	compound	_	_
22	secretion	secretion	NN	NN	_	20	dobj	_	_
23	.	.	.	.	_	11	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	5	punct	_	_
7	A	a	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	4	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	examining	examine	VBG	VBG	syn=ADV	4	conj	_	_
12	the	the	DT	DT	_	13	det	_	_
13	effect	effect	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	tolbutamide	tolbutamide	NN	NN	_	14	pobj	_	_
16	in	in	IN	IN	_	11	prep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	absence	absence	NN	NN	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	glucose	glucose	NN	NN	_	19	pobj	_	_
21	.	.	.	.	_	11	punct	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	secretion	secretion	NN	NN	_	10	nsubjpass	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	response	response	NN	NN	_	3	pobj	_	_
5	to	to	IN	IN	_	4	prep	_	_
6	20	0	CD	CD	_	7	nummod	_	_
7	mM	mm	NNS	NNS	_	8	compound	_	_
8	glucose	glucose	NN	NN	_	5	pobj	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	indicated	indicate	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	sem=MNR	10	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	filled	fill	VBN	VBN	_	14	amod	_	_
14	square	square	NN	NN	_	11	pobj	_	_
15	.	.	.	.	_	10	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	zero	#crd#	CD	CD	_	22	nummod	_	_
22	diazoxide	diazoxide	NN	NN	_	20	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	A	a	NN	NN	_	22	parataxis	_	_
25	–	-	SYM	SYM	_	26	punct	_	_
26	C	c	NN	NN	_	24	prep	_	_
27	)	)	-RRB-	-RRB-	_	24	punct	_	_
28	or	or	CC	CC	_	22	cc	_	_
29	zero	#crd#	CD	CD	_	30	nummod	_	_
30	tolbutamide	tolbutamide	NN	NN	_	22	conj	_	_
31	(	(	-LRB-	-LRB-	_	32	punct	_	_
32	D	d	NN	NN	_	30	parataxis	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	3	0	CD	CD	_	1	nummod	_	_

1	Tolbutamide	tolbutamide	NN	NN	_	4	nmod	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Glucose	glucose	NN	NN	_	1	conj	_	_
4	Effects	effect	NNS	NNS	_	5	nsubj	_	_
5	Are	be	VBP	VBP	_	0	root	_	_
6	Non-Additive	non-additive	JJ	JJ	syn=PRD	5	acomp	_	_
7	and	and	CC	CC	_	5	cc	_	_
8	Glucagon	glucagon	NN	NN	_	9	compound	_	_
9	Response	response	NN	NN	_	11	nsubjpass	_	_
10	Is	be	VBZ	VBZ	_	11	auxpass	_	_
11	Altered	alter	VBN	VBN	_	5	conj	_	_
12	in	in	IN	IN	sem=LOC	11	prep	_	_
13	Kir6.2Y12X	kir0y0x	NN	NN	_	14	compound	_	_
14	Islets	islet	NNS	NNS	_	12	pobj	_	_
15	That	that	WDT	WDT	_	16	dep	_	14:ref
16	Express	express	VBP	VBP	_	14	relcl	_	_
17	a	a	DT	DT	_	20	det	_	_
18	Truncated	truncate	VBN	VBN	_	20	amod	_	_
19	Kir6.2	kir0	NN	NN	_	20	compound	_	_
20	Subunit	subunit	NN	NN	_	16	dobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	5	compound	_	_
5	release	release	NN	NN	_	0	root	_	_
6	from	from	IN	IN	_	5	prep	_	_
7	isolated	isolate	VBN	VBN	_	9	amod	_	_
8	mouse	mouse	NN	NN	_	9	compound	_	_
9	islets	islet	NNS	NNS	_	6	pobj	_	_
10	at	at	IN	IN	_	5	prep	_	_
11	1	0	CD	CD	_	18	nummod	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	open	open	JJ	JJ	_	14	amod	_	_
14	bars	bar	NNS	NNS	_	11	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	and	and	CC	CC	_	11	cc	_	_
17	20	0	CD	CD	_	11	conj	_	_
18	mM	mm	NNS	NNS	_	19	compound	_	_
19	glucose	glucose	NN	NN	_	10	pobj	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	filled	fill	VBN	VBN	_	22	amod	_	_
22	bars	bar	NNS	NNS	_	19	parataxis	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	under	under	IN	IN	_	5	prep	_	_
25	control	control	NN	NN	_	26	compound	_	_
26	conditions	condition	NNS	NNS	_	24	pobj	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	presence	presence	NN	NN	_	26	conj	_	_
29	of	of	IN	IN	_	28	prep	_	_
30	0.5	0	CD	CD	_	31	nummod	_	_
31	mM	mm	NNS	NNS	_	32	compound	_	_
32	tolbutamide	tolbutamide	NN	NN	_	29	pobj	_	_
33	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	8	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	A	a	DT	DT	_	8	det	_	_
5	glucose	glucose	NN	NN	_	8	compound	_	_
6	dose	dose	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	response	response	NN	NN	_	0	root	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	release	release	NN	NN	_	9	pobj	_	_
12	from	from	IN	IN	_	8	prep	_	_
13	control	control	NN	NN	_	15	compound	_	_
14	C3HB	c0hb	NN	NN	_	15	compound	_	_
15	islets	islet	NNS	NNS	_	12	pobj	_	_
16	(	(	-LRB-	-LRB-	_	18	punct	_	_
17	filled	fill	VBN	VBN	_	18	amod	_	_
18	circles	circle	NNS	NNS	_	15	parataxis	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	and	and	CC	CC	_	15	cc	_	_
21	Kir6.2Y12X	kir0y0x	NN	NN	_	22	compound	_	_
22	islets	islet	NNS	NNS	_	15	conj	_	_
23	(	(	-LRB-	-LRB-	_	25	punct	_	_
24	open	open	JJ	JJ	_	25	amod	_	_
25	circles	circle	NNS	NNS	_	22	parataxis	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	.	.	.	.	_	8	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	5	punct	_	_
7	B	b	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	4	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	insulin	insulin	NN	NN	_	13	nsubjpass	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	measured	measure	VBN	VBN	_	4	conj	_	_
14	.	.	.	.	_	13	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	control	control	NN	NN	_	20	pobj	_	_
22	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	4	0	CD	CD	_	1	nummod	_	_

1	The	the	DT	DT	_	4	det	_	_
2	Intracellular	intracellular	JJ	JJ	_	4	amod	_	_
3	Ca2+	ca0+	NN	NN	_	4	compound	_	_
4	Response	response	NN	NN	_	14	nsubjpass	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	Single	single	JJ	JJ	_	8	amod	_	_
7	α	α	NN	NN	_	8	compound	_	_
8	Cells	cell	NNS	NNS	_	5	pobj	_	_
9	within	within	IN	IN	sem=LOC	4	prep	_	_
10	Intact	intact	JJ	JJ	_	11	amod	_	_
11	Islets	islet	NNS	NNS	_	9	pobj	_	_
12	Can	can	MD	MD	_	14	aux	_	_
13	Be	be	VB	VB	_	14	auxpass	_	_
14	Re-Activated	re-activated	VBN	VBN	_	0	root	_	_
15	by	by	IN	IN	sem=MNR	14	prep	_	_
16	Low	low	JJ	JJ	_	17	amod	_	_
17	Concentrations	concentration	NNS	NNS	_	15	pobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	Diazoxide	diazoxide	NN	NN	_	18	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	7	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Representative	representative	JJ	JJ	_	7	amod	_	_
5	intracellular	intracellular	JJ	JJ	_	7	amod	_	_
6	Ca2+	ca0+	NN	NN	_	7	compound	_	_
7	responses	response	NNS	NNS	_	0	root	_	_
8	from	from	IN	IN	_	7	prep	_	_
9	α	α	NN	NN	_	12	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	β	β	NN	NN	_	9	conj	_	_
12	cells	cell	NNS	NNS	_	8	pobj	_	_
13	within	within	IN	IN	sem=LOC	7	prep	_	_
14	an	an	DT	DT	_	17	det	_	_
15	intact	intact	JJ	JJ	_	17	amod	_	_
16	mouse	mouse	NN	NN	_	17	compound	_	_
17	islet	islet	NN	NN	_	13	pobj	_	_
18	exposed	expose	VBN	VBN	_	17	acl	_	_
19	to	to	IN	IN	_	18	prep	_	_
20	0.5	0	CD	CD	_	21	nummod	_	_
21	mM	mm	NNS	NNS	_	22	compound	_	_
22	glucose	glucose	NN	NN	_	19	pobj	_	_
23	,	,	,	,	_	22	punct	_	_
24	11	0	CD	CD	_	25	nummod	_	_
25	mM	mm	NNS	NNS	_	26	compound	_	_
26	glucose	glucose	NN	NN	_	22	conj	_	_
27	,	,	,	,	_	26	punct	_	_
28	and	and	CC	CC	_	26	cc	_	_
29	11	0	CD	CD	_	30	nummod	_	_
30	mM	mm	NNS	NNS	_	31	compound	_	_
31	glucose	glucose	NN	NN	_	26	conj	_	_
32	plus	plus	CC	CC	_	22	cc	_	_
33	2	0	CD	CD	_	34	nummod	_	_
34	μM	μm	NNS	NNS	_	35	compound	_	_
35	diazoxide	diazoxide	NN	NN	_	22	conj	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	diaz	diaz	NN	NN	_	35	parataxis	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	as	as	IN	IN	_	40	mark	_	_
40	indicated	indicate	VBN	VBN	syn=ADV	18	advcl	_	_
41	above	above	IN	IN	_	40	prep	_	_
42	the	the	DT	DT	_	43	det	_	_
43	traces	trace	NNS	NNS	_	41	pobj	_	_
44	.	.	.	.	_	7	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	11	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	6	det	_	_
5	Ca2+	ca0+	NN	NN	_	6	compound	_	_
6	response	response	NN	NN	_	11	nsubjpass	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	α	α	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	7	pobj	_	_
10	was	be	VBD	VBD	_	11	auxpass	_	_
11	suppressed	suppress	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	sem=MNR	11	prep	_	_
13	11	0	CD	CD	_	14	nummod	_	_
14	mM	mm	NNS	NNS	_	15	compound	_	_
15	glucose	glucose	NN	NN	_	12	pobj	_	_
16	,	,	,	,	_	11	punct	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	could	could	MD	MD	_	20	aux	_	_
19	be	be	VB	VB	_	20	auxpass	_	_
20	reactivated	reactivate	VBN	VBN	_	11	conj	_	_
21	with	with	IN	IN	sem=MNR	20	prep	_	_
22	low	low	JJ	JJ	_	23	amod	_	_
23	concentrations	concentration	NNS	NNS	_	21	pobj	_	_
24	of	of	IN	IN	_	23	prep	_	_
25	the	the	DT	DT	_	28	det	_	_
26	KATP	katp	NN	NN	_	27	compound	_	_
27	channel	channel	NN	NN	_	28	compound	_	_
28	agonist	agonist	NN	NN	_	24	pobj	_	_
29	diazoxide	diazoxide	NN	NN	_	28	appos	_	_
30	.	.	.	.	_	11	punct	_	_

1	***	**	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.001	0	CD	CD	_	0	root	_	_
6	,	,	,	,	_	5	punct	_	_
7	compared	compare	VBN	VBN	syn=ADV	5	prep	_	_
8	with	with	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	13	det	_	_
10	low	low	JJ	JJ	_	12	amod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	glucose	glucose	NN	NN	_	13	compound	_	_
13	condition	condition	NN	NN	_	8	pobj	_	_
14	,	,	,	,	_	7	punct	_	_
15	or	or	CC	CC	_	7	cc	_	_
16	as	as	IN	IN	_	17	mark	_	_
17	indicated	indicate	VBN	VBN	_	7	conj	_	_
18	.	.	.	.	_	5	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	5	0	CD	CD	_	1	nummod	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	Release	release	NN	NN	_	10	nsubjpass	_	_
3	from	from	IN	IN	_	2	prep	_	_
4	Isolated	isolate	VBN	VBN	_	8	amod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	Intact	intact	JJ	JJ	_	4	conj	_	_
7	Human	human	JJ	JJ	_	8	amod	_	_
8	Islets	islet	NNS	NNS	_	3	pobj	_	_
9	Is	be	VBZ	VBZ	_	10	auxpass	_	_
10	Regulated	regulate	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	sem=MNR	10	prep	_	_
12	a	a	DT	DT	_	17	det	_	_
13	KATP	katp	NN	NN	_	14	compound	_	_
14	Channel	channel	NN	NN	_	16	npadvmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	Dependent	dependent	JJ	JJ	_	17	amod	_	_
17	Pathway	pathway	NN	NN	_	11	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	17	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	15	nmod	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	open	open	JJ	JJ	_	7	amod	_	_
7	bars	bar	NNS	NNS	_	4	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	insulin	insulin	NN	NN	_	4	conj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	filled	fill	VBN	VBN	_	13	amod	_	_
13	bars	bar	NNS	NNS	_	10	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	release	release	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	measured	measure	VBN	VBN	_	0	root	_	_
18	from	from	IN	IN	_	17	prep	_	_
19	isolated	isolate	VBN	VBN	_	21	amod	_	_
20	human	human	JJ	JJ	_	21	amod	_	_
21	islets	islet	NNS	NNS	_	18	pobj	_	_
22	under	under	IN	IN	_	17	prep	_	_
23	control	control	NN	NN	_	24	compound	_	_
24	conditions	condition	NNS	NNS	_	22	pobj	_	_
25	and	and	CC	CC	_	22	cc	_	_
26	following	follow	VBG	VBG	_	22	conj	_	_
27	addition	addition	NN	NN	_	26	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	10	0	CD	CD	_	30	nummod	_	_
30	mM	mm	NNS	NNS	_	31	compound	_	_
31	glucose	glucose	NN	NN	_	28	pobj	_	_
32	or	or	CC	CC	_	31	cc	_	_
33	200	0	CD	CD	_	34	nummod	_	_
34	μM	μm	NNS	NNS	_	35	compound	_	_
35	tolbutamide	tolbutamide	NN	NN	_	31	conj	_	_
36	.	.	.	.	_	17	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	11	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	11	nmod	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	open	open	JJ	JJ	_	7	amod	_	_
7	bars	bar	NNS	NNS	_	4	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	insulin	insulin	NN	NN	_	4	conj	_	_
11	secretion	secretion	NN	NN	_	0	root	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	filled	fill	VBN	VBN	_	14	amod	_	_
14	bars	bar	NNS	NNS	_	11	parataxis	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	measured	measure	VBN	VBN	_	11	acl	_	_
17	in	in	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	19	det	_	_
19	presence	presence	NN	NN	_	17	pobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	10	0	CD	CD	_	22	nummod	_	_
22	mM	mm	NNS	NNS	_	23	compound	_	_
23	glucose	glucose	NN	NN	_	20	pobj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	increasing	increase	VBG	VBG	_	26	amod	_	_
26	concentrations	concentration	NNS	NNS	_	23	conj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	diazoxide	diazoxide	NN	NN	_	27	pobj	_	_
29	(	(	-LRB-	-LRB-	_	33	punct	_	_
30	0	0	CD	CD	_	32	quantmod	_	_
31	–	-	SYM	SYM	_	32	punct	_	_
32	200	0	CD	CD	_	33	nummod	_	_
33	μM	μm	NNS	NNS	_	28	parataxis	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	.	.	.	.	_	11	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	controls	control	NNS	NNS	_	20	pobj	_	_
22	,	,	,	,	_	17	punct	_	_
23	unless	unless	IN	IN	_	25	mark	_	_
24	otherwise	otherwise	RB	RB	_	25	advmod	_	_
25	indicated	indicate	VBN	VBN	syn=ADV	17	advcl	_	_
26	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	6	0	CD	CD	_	1	nummod	_	_

1	Intracellular	intracellular	JJ	JJ	_	3	amod	_	_
2	Ca2+	ca0+	NN	NN	_	3	compound	_	_
3	Responses	response	NNS	NNS	_	12	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	α	α	NN	NN	_	6	compound	_	_
6	Cells	cell	NNS	NNS	_	4	pobj	_	_
7	within	within	IN	IN	sem=LOC	3	prep	_	_
8	Intact	intact	JJ	JJ	_	10	amod	_	_
9	Human	human	JJ	JJ	_	10	amod	_	_
10	Islets	islet	NNS	NNS	_	7	pobj	_	_
11	Are	be	VBP	VBP	_	12	auxpass	_	_
12	Regulated	regulate	VBN	VBN	_	0	root	_	_
13	by	by	IN	IN	sem=MNR	12	prep	_	_
14	a	a	DT	DT	_	19	det	_	_
15	KATP	katp	NN	NN	_	16	compound	_	_
16	Channel	channel	NN	NN	_	18	npadvmod	_	_
17	-	-	HYPH	HYPH	_	18	punct	_	_
18	Dependent	dependent	JJ	JJ	_	19	amod	_	_
19	Mechanism	mechanism	NN	NN	_	13	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Ca2+	ca0+	NN	NN	_	5	compound	_	_
5	responses	response	NNS	NNS	_	0	root	_	_
6	measured	measure	VBN	VBN	_	5	acl	_	_
7	in	in	IN	IN	sem=LOC	6	prep	_	_
8	two	#crd#	CD	CD	_	11	nummod	_	_
9	human	human	JJ	JJ	_	11	amod	_	_
10	α	α	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	7	pobj	_	_
12	within	within	IN	IN	sem=LOC	11	prep	_	_
13	the	the	DT	DT	_	15	det	_	_
14	same	same	JJ	JJ	_	15	amod	_	_
15	islet	islet	NN	NN	_	12	pobj	_	_
16	at	at	IN	IN	_	6	prep	_	_
17	0.5	0	CD	CD	_	18	nummod	_	_
18	mM	mm	NNS	NNS	_	22	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	11	0	CD	CD	_	21	nummod	_	_
21	mM	mm	NNS	NNS	_	18	conj	_	_
22	glucose	glucose	NN	NN	_	16	pobj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	glu	glu	NN	NN	_	22	parataxis	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	,	,	,	,	_	6	punct	_	_
27	in	in	IN	IN	_	6	prep	_	_
28	the	the	DT	DT	_	29	det	_	_
29	presence	presence	NN	NN	_	27	pobj	_	_
30	of	of	IN	IN	_	29	prep	_	_
31	2	0	CD	CD	_	32	nummod	_	_
32	μM	μm	NNS	NNS	_	33	compound	_	_
33	diazoxide	diazoxide	NN	NN	_	30	pobj	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	diaz	diaz	NN	NN	_	33	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Summary	summary	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	Ca2+	ca0+	NN	NN	_	8	compound	_	_
8	responses	response	NNS	NNS	_	5	pobj	_	_
9	at	at	IN	IN	_	4	prep	_	_
10	0.5	0	CD	CD	_	11	nummod	_	_
11	mM	mm	NNS	NNS	_	12	compound	_	_
12	glucose	glucose	NN	NN	_	9	pobj	_	_
13	,	,	,	,	_	9	punct	_	_
14	at	at	IN	IN	_	9	conj	_	_
15	11	0	CD	CD	_	16	nummod	_	_
16	mM	mm	NNS	NNS	_	17	compound	_	_
17	glucose	glucose	NN	NN	_	14	pobj	_	_
18	,	,	,	,	_	14	punct	_	_
19	in	in	IN	IN	_	14	conj	_	_
20	the	the	DT	DT	_	21	det	_	_
21	presence	presence	NN	NN	_	19	pobj	_	_
22	of	of	IN	IN	_	21	prep	_	_
23	glucose	glucose	NN	NN	_	22	pobj	_	_
24	(	(	-LRB-	-LRB-	_	26	punct	_	_
25	11	0	CD	CD	_	26	nummod	_	_
26	mM	mm	NNS	NNS	_	23	parataxis	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	and	and	CC	CC	_	23	cc	_	_
29	diazoxide	diazoxide	NN	NN	_	23	conj	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	2	0	CD	CD	_	32	nummod	_	_
32	μM	μm	NNS	NNS	_	29	parataxis	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	,	,	,	,	_	19	punct	_	_
35	and	and	CC	CC	_	19	cc	_	_
36	following	following	IN	IN	sem=TMP	19	conj	_	_
37	the	the	DT	DT	_	38	det	_	_
38	removal	removal	NN	NN	_	36	pobj	_	_
39	of	of	IN	IN	_	38	prep	_	_
40	diazoxide	diazoxide	NN	NN	_	39	pobj	_	_
41	,	,	,	,	_	36	punct	_	_
42	but	but	CC	CC	_	36	cc	_	_
43	in	in	IN	IN	_	36	conj	_	_
44	the	the	DT	DT	_	46	det	_	_
45	continued	continue	VBN	VBN	_	46	amod	_	_
46	presence	presence	NN	NN	_	43	pobj	_	_
47	of	of	IN	IN	_	46	prep	_	_
48	11	0	CD	CD	_	49	nummod	_	_
49	mM	mm	NNS	NNS	_	50	compound	_	_
50	glucose	glucose	NN	NN	_	47	pobj	_	_
51	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	18	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	5	det	_	_
5	re-activation	re-activation	NN	NN	_	18	nsubjpass	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	human	human	JJ	JJ	_	12	amod	_	_
8	α	α	NN	NN	_	10	compound	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	cell	cell	NN	NN	_	12	compound	_	_
11	Ca2+	ca0+	NN	NN	_	12	compound	_	_
12	responses	response	NNS	NNS	_	6	pobj	_	_
13	by	by	IN	IN	_	5	prep	_	_
14	2	0	CD	CD	_	15	nummod	_	_
15	μM	μm	NNS	NNS	_	16	compound	_	_
16	diazoxide	diazoxide	NN	NN	_	13	pobj	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	reversed	reverse	VBN	VBN	_	0	root	_	_
19	upon	upon	IN	IN	sem=TMP	18	prep	_	_
20	application	application	NN	NN	_	19	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	25	det	_	_
23	KATP	katp	NN	NN	_	24	compound	_	_
24	channel	channel	NN	NN	_	25	compound	_	_
25	antagonist	antagonist	NN	NN	_	21	pobj	_	_
26	tolbutamide	tolbutamide	NN	NN	_	25	appos	_	_
27	(	(	-LRB-	-LRB-	_	29	punct	_	_
28	100	0	CD	CD	_	29	nummod	_	_
29	μM	μm	NNS	NNS	_	25	parataxis	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	18	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	5	det	_	_
5	effects	effect	NNS	NNS	_	0	root	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	increasing	increase	VBG	VBG	_	8	amod	_	_
8	concentrations	concentration	NNS	NNS	_	6	pobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	diazoxide	diazoxide	NN	NN	_	9	pobj	_	_
11	on	on	IN	IN	_	5	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	Ca2+	ca0+	NN	NN	_	14	compound	_	_
14	response	response	NN	NN	_	11	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	a	a	DT	DT	_	19	det	_	_
17	human	human	JJ	JJ	_	19	amod	_	_
18	α	α	NN	NN	_	19	compound	_	_
19	cell	cell	NN	NN	_	15	pobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	β	β	NN	NN	_	22	compound	_	_
22	cell	cell	NN	NN	_	19	conj	_	_
23	within	within	IN	IN	sem=LOC	5	prep	_	_
24	the	the	DT	DT	_	26	det	_	_
25	same	same	JJ	JJ	_	26	amod	_	_
26	islet	islet	NN	NN	_	23	pobj	_	_
27	exposed	expose	VBN	VBN	_	26	acl	_	_
28	to	to	IN	IN	_	27	prep	_	_
29	11	0	CD	CD	_	30	nummod	_	_
30	mM	mm	NNS	NNS	_	31	compound	_	_
31	glucose	glucose	NN	NN	_	28	pobj	_	_
32	.	.	.	.	_	5	punct	_	_

1	At	at	IN	IN	sem=TMP	10	prep	_	_
2	the	the	DT	DT	_	3	det	_	_
3	end	end	NN	NN	_	1	pobj	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	6	det	_	_
6	experiment	experiment	NN	NN	_	4	pobj	_	_
7	,	,	,	,	_	10	punct	_	_
8	diazoxide	diazoxide	NN	NN	_	10	nsubjpass	_	8:gap
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	withdrawn	withdraw	VBN	VBN	_	0	root	_	10:gap
11	and	and	CC	CC	_	10	cc	_	_
12	glucose	glucose	NN	NN	_	13	nsubj	_	8:gap
13	lowered	lower	VBN	VBN	_	10	conj	_	10:gap
14	to	to	IN	IN	_	13	prep	_	_
15	0.5	0	CD	CD	_	16	nummod	_	_
16	mM	mm	NNS	NNS	_	14	pobj	_	_
17	.	.	.	.	_	10	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	E	e	LS	LS	_	7	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Dose	dose	NN	NN	_	7	nmod	_	_
5	-	-	HYPH	HYPH	_	4	punct	_	_
6	response	response	JJ	JJ	_	4	amod	_	_
7	curve	curve	NN	NN	_	0	root	_	_
8	for	for	IN	IN	_	7	prep	_	_
9	the	the	DT	DT	_	10	det	_	_
10	effect	effect	NN	NN	_	8	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	diazoxide	diazoxide	NN	NN	_	11	pobj	_	_
13	on	on	IN	IN	_	10	prep	_	_
14	α	α	NN	NN	_	16	compound	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	cell	cell	NN	NN	_	18	compound	_	_
17	Ca2+	ca0+	NN	NN	_	18	compound	_	_
18	responses	response	NNS	NNS	_	13	pobj	_	_
19	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	grey	grey	JJ	JJ	_	4	amod	_	_
3	horizontal	horizontal	JJ	JJ	_	4	amod	_	_
4	line	line	NN	NN	_	5	nsubj	_	_
5	indicates	indicate	VBZ	VBZ	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	response	response	NN	NN	_	5	dobj	_	_
8	with	with	IN	IN	_	7	prep	_	_
9	11	0	CD	CD	_	10	nummod	_	_
10	mM	mm	NNS	NNS	_	11	compound	_	_
11	glucose	glucose	NN	NN	_	8	pobj	_	_
12	alone	alone	RB	RB	_	11	advmod	_	_
13	.	.	.	.	_	5	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	controls	control	NNS	NNS	_	20	pobj	_	_
22	,	,	,	,	_	17	punct	_	_
23	unless	unless	IN	IN	_	25	mark	_	_
24	otherwise	otherwise	RB	RB	_	25	advmod	_	_
25	indicated	indicate	VBN	VBN	syn=ADV	17	advcl	_	_
26	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	7	0	CD	CD	_	1	nummod	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	Secretion	secretion	NN	NN	_	9	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	α	α	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	Cell	cell	NN	NN	_	8	compound	_	_
7	Ca2+	ca0+	NN	NN	_	8	compound	_	_
8	Responses	response	NNS	NNS	_	2	conj	_	_
9	Are	be	VBP	VBP	_	0	root	_	_
10	Dependent	dependent	JJ	JJ	syn=PRD	9	acomp	_	_
11	upon	upon	IN	IN	_	10	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	Activity	activity	NN	NN	_	11	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	Voltage	voltage	NN	NN	_	17	npadvmod	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	Dependent	dependent	JJ	JJ	_	19	amod	_	_
18	Na+	na+	NN	NN	_	19	compound	_	_
19	Channels	channel	NNS	NNS	_	14	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	15	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	15	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	open	open	JJ	JJ	_	7	amod	_	_
7	bars	bar	NNS	NNS	_	4	parataxis	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	insulin	insulin	NN	NN	_	4	conj	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	filled	fill	VBN	VBN	_	13	amod	_	_
13	bars	bar	NNS	NNS	_	10	parataxis	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	release	release	VBP	VBP	_	0	root	_	_
16	from	from	IN	IN	_	15	prep	_	_
17	isolated	isolate	VBN	VBN	_	19	amod	_	_
18	mouse	mouse	NN	NN	_	19	compound	_	_
19	islets	islet	NNS	NNS	_	16	pobj	_	_
20	at	at	IN	IN	_	15	prep	_	_
21	1	0	CD	CD	_	22	nummod	_	_
22	mM	mm	NN	NN	_	26	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	20	0	CD	CD	_	25	nummod	_	_
25	mM	mm	NNS	NNS	_	22	conj	_	_
26	glucose	glucose	NN	NN	_	20	pobj	_	_
27	,	,	,	,	_	15	punct	_	_
28	under	under	IN	IN	_	15	prep	_	_
29	control	control	NN	NN	_	30	compound	_	_
30	conditions	condition	NNS	NNS	_	28	pobj	_	_
31	and	and	CC	CC	_	28	cc	_	_
32	in	in	IN	IN	_	28	conj	_	_
33	the	the	DT	DT	_	34	det	_	_
34	presence	presence	NN	NN	_	32	pobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	the	the	DT	DT	_	39	det	_	_
37	Na+	na+	NN	NN	_	38	compound	_	_
38	channel	channel	NN	NN	_	39	compound	_	_
39	antagonist	antagonist	NN	NN	_	35	pobj	_	_
40	TTX	ttx	NN	NN	_	39	appos	_	_
41	(	(	-LRB-	-LRB-	_	43	punct	_	_
42	0.1	0	CD	CD	_	43	nummod	_	_
43	μg	μg	NNS	NNS	_	39	parataxis	_	_
44	/	/	SYM	SYM	_	45	punct	_	_
45	ml	ml	NN	NN	_	43	prep	_	_
46	)	)	-RRB-	-RRB-	_	43	punct	_	_
47	.	.	.	.	_	15	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	6	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Intracellular	intracellular	JJ	JJ	_	6	amod	_	_
5	Ca2+	ca0+	NN	NN	_	6	compound	_	_
6	response	response	NN	NN	_	0	root	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	single	single	JJ	JJ	_	10	amod	_	_
9	α	α	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	7	pobj	_	_
11	to	to	IN	IN	_	6	prep	_	_
12	0.5	0	CD	CD	_	13	nummod	_	_
13	mM	mm	NNS	NNS	_	14	compound	_	_
14	glucose	glucose	NN	NN	_	11	pobj	_	_
15	.	.	.	.	_	6	punct	_	_

1	TTX	ttx	NN	NN	_	9	nsubjpass	_	_
2	(	(	-LRB-	-LRB-	_	4	punct	_	_
3	0.1	0	CD	CD	_	4	nummod	_	_
4	μg	μg	NNS	NNS	_	1	parataxis	_	_
5	/	/	SYM	SYM	_	6	punct	_	_
6	ml	ml	NN	NN	_	4	prep	_	_
7	)	)	-RRB-	-RRB-	_	4	punct	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	included	include	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	13	det	_	_
12	perfusion	perfusion	NN	NN	_	13	compound	_	_
13	medium	medium	NN	NN	_	10	pobj	_	_
14	during	during	IN	IN	sem=TMP	9	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	indicated	indicate	VBN	VBN	_	17	amod	_	_
17	period	period	NN	NN	_	14	pobj	_	_
18	.	.	.	.	_	9	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	5	det	_	_
5	effects	effect	NNS	NNS	_	0	root	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	TTX	ttx	NN	NN	_	6	pobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	glucose	glucose	NN	NN	_	7	conj	_	_
10	on	on	IN	IN	_	5	prep	_	_
11	α	α	NN	NN	_	13	compound	_	_
12	-	-	HYPH	HYPH	_	13	punct	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	Ca2+	ca0+	NN	NN	_	15	compound	_	_
15	responses	response	NNS	NNS	_	10	pobj	_	_
16	.	.	.	.	_	5	punct	_	_

1	Note	note	VB	VB	_	0	root	_	_
2	that	that	IN	IN	_	4	mark	_	_
3	TTX	ttx	NN	NN	_	4	nsubj	_	_
4	inhibits	inhibit	VBZ	VBZ	_	1	advcl	_	_
5	Ca2+	ca0+	NN	NN	_	6	compound	_	_
6	responses	response	NNS	NNS	_	4	dobj	_	_
7	as	as	RB	RB	_	8	advmod	_	_
8	effectively	effectively	RB	RB	_	4	advmod	_	_
9	as	as	IN	IN	_	8	prep	_	_
10	glucose	glucose	NN	NN	_	9	pobj	_	_
11	and	and	CC	CC	_	4	cc	_	_
12	that	that	IN	IN	_	15	mark	_	_
13	the	the	DT	DT	_	14	det	_	_
14	action	action	NN	NN	_	15	nsubj	_	_
15	is	be	VBZ	VBZ	_	4	conj	_	_
16	at	at	RB	RB	_	17	advmod	_	_
17	least	least	RB	RB	_	18	advmod	_	_
18	partially	partially	RB	RB	_	19	advmod	_	_
19	reversible	reversible	JJ	JJ	syn=PRD	15	acomp	_	_
20	.	.	.	.	_	1	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	controls	control	NNS	NNS	_	20	pobj	_	_
22	,	,	,	,	_	17	punct	_	_
23	unless	unless	IN	IN	_	25	mark	_	_
24	otherwise	otherwise	RB	RB	_	25	advmod	_	_
25	indicated	indicate	VBN	VBN	syn=ADV	17	advcl	_	_
26	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	8	0	CD	CD	_	1	nummod	_	_

1	Glucagon	glucagon	NN	NN	_	2	compound	_	_
2	Secretion	secretion	NN	NN	_	4	nsubjpass	_	_
3	Is	be	VBZ	VBZ	_	4	auxpass	_	_
4	Regulated	regulate	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	sem=MNR	4	prep	_	_
6	N	n	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	Type	type	NN	NN	_	10	compound	_	_
9	Ca2+	ca0+	NN	NN	_	10	compound	_	_
10	Channels	channel	NNS	NNS	_	5	pobj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	5	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Glucagon	glucagon	NN	NN	_	5	compound	_	_
5	release	release	NN	NN	_	0	root	_	_
6	measured	measure	VBN	VBN	_	5	acl	_	_
7	at	at	IN	IN	_	6	prep	_	_
8	1	0	CD	CD	_	15	nummod	_	_
9	(	(	-LRB-	-LRB-	_	11	punct	_	_
10	open	open	JJ	JJ	_	11	amod	_	_
11	bars	bar	NNS	NNS	_	8	parataxis	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	and	and	CC	CC	_	8	cc	_	_
14	20	0	CD	CD	_	8	conj	_	_
15	mM	mm	NNS	NNS	_	16	compound	_	_
16	glucose	glucose	NN	NN	_	7	pobj	_	_
17	(	(	-LRB-	-LRB-	_	19	punct	_	_
18	filled	fill	VBN	VBN	_	19	amod	_	_
19	bars	bar	NNS	NNS	_	16	parataxis	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	under	under	IN	IN	_	6	prep	_	_
22	control	control	NN	NN	_	23	compound	_	_
23	conditions	condition	NNS	NNS	_	21	pobj	_	_
24	and	and	CC	CC	_	21	cc	_	_
25	in	in	IN	IN	_	21	conj	_	_
26	the	the	DT	DT	_	27	det	_	_
27	presence	presence	NN	NN	_	25	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	100	0	CD	CD	_	30	nummod	_	_
30	nM	nm	NNS	NNS	_	33	compound	_	_
31	ω	ω	NN	NN	_	33	compound	_	_
32	-	-	HYPH	HYPH	_	33	punct	_	_
33	conotoxin	conotoxin	NN	NN	_	28	pobj	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	middle	middle	JJ	JJ	_	33	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	or	or	CC	CC	_	33	cc	_	_
38	20	0	CD	CD	_	39	nummod	_	_
39	μM	μm	NNS	NNS	_	40	compound	_	_
40	nifedipine	nifedipine	NN	NN	_	33	conj	_	_
41	(	(	-LRB-	-LRB-	_	42	punct	_	_
42	right	right	JJ	JJ	_	40	parataxis	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	6	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Exocytosis	exocytosis	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	elicited	elicit	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	sem=MNR	6	prep	_	_
8	500	0	CD	CD	_	10	nummod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	ms	m	NNS	NNS	_	11	compound	_	_
11	depolarisations	depolarisation	NNS	NNS	_	7	pobj	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	−	−	SYM	SYM	_	14	punct	_	_
14	70	0	CD	CD	_	12	pobj	_	_
15	to	to	IN	IN	_	12	prep	_	_
16	0	0	CD	CD	_	15	pobj	_	_
17	mV	mv	NN	NN	_	11	appos	_	_
18	under	under	IN	IN	_	6	prep	_	_
19	control	control	NN	NN	_	20	compound	_	_
20	conditions	condition	NNS	NNS	_	18	pobj	_	_
21	(	(	-LRB-	-LRB-	_	20	punct	_	_
22	Ctrl	ctrl	NN	NN	_	20	appos	_	_
23	)	)	-RRB-	-RRB-	_	18	punct	_	_
24	and	and	CC	CC	_	18	cc	_	_
25	in	in	IN	IN	_	18	conj	_	_
26	the	the	DT	DT	_	27	det	_	_
27	presence	presence	NN	NN	_	25	pobj	_	_
28	of	of	IN	IN	_	27	prep	_	_
29	either	either	CC	CC	_	30	preconj	_	_
30	nifedipine	nifedipine	NN	NN	_	28	pobj	_	_
31	(	(	-LRB-	-LRB-	_	35	punct	_	_
32	50	0	CD	CD	_	33	nummod	_	_
33	μM	μm	NNS	NNS	_	35	dep	_	_
34	;	;	:	:	_	35	punct	_	_
35	nif	nif	NN	NN	_	30	parataxis	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	or	or	CC	CC	_	30	cc	_	_
38	ω	ω	NN	NN	_	40	compound	_	_
39	-	-	HYPH	HYPH	_	40	punct	_	_
40	conotoxin	conotoxin	NN	NN	_	30	conj	_	_
41	(	(	-LRB-	-LRB-	_	47	punct	_	_
42	1	0	CD	CD	_	43	nummod	_	_
43	μM	μm	NN	NN	_	47	dep	_	_
44	;	;	:	:	_	47	punct	_	_
45	ω	ω	SYM	SYM	_	47	punct	_	_
46	-	-	HYPH	HYPH	_	47	punct	_	_
47	con	con	NN	NN	_	40	parataxis	_	_
48	)	)	-RRB-	-RRB-	_	47	punct	_	_
49	.	.	.	.	_	6	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Summary	summary	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	8	det	_	_
7	exocytotic	exocytotic	JJ	JJ	_	8	amod	_	_
8	response	response	NN	NN	_	5	pobj	_	_
9	under	under	IN	IN	_	4	prep	_	_
10	control	control	NN	NN	_	11	compound	_	_
11	conditions	condition	NNS	NNS	_	9	pobj	_	_
12	and	and	CC	CC	_	9	cc	_	_
13	in	in	IN	IN	_	9	conj	_	_
14	the	the	DT	DT	_	15	det	_	_
15	presence	presence	NN	NN	_	13	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	nifedipine	nifedipine	NN	NN	_	16	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	ω	ω	NN	NN	_	21	compound	_	_
20	-	-	HYPH	HYPH	_	21	punct	_	_
21	conotoxin	conotoxin	NN	NN	_	17	conj	_	_
22	.	.	.	.	_	4	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	11	ccomp	_	_
6	;	;	:	:	_	11	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	0	root	_	_
12	,	,	,	,	_	11	punct	_	_
13	compared	compare	VBN	VBN	_	11	prep	_	_
14	with	with	IN	IN	_	13	prep	_	_
15	1	0	CD	CD	_	16	nummod	_	_
16	mM	mm	NN	NN	_	17	compound	_	_
17	glucose	glucose	NN	NN	_	14	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	the	the	DT	DT	_	22	det	_	_
20	control	control	NN	NN	_	22	compound	_	_
21	capacitance	capacitance	NN	NN	_	22	compound	_	_
22	response	response	NN	NN	_	17	conj	_	_
23	,	,	,	,	_	11	punct	_	_
24	unless	unless	IN	IN	_	25	mark	_	_
25	indicated	indicate	VBN	VBN	syn=ADV	11	advcl	_	_
26	otherwise	otherwise	RB	RB	_	25	advmod	_	_
27	.	.	.	.	_	11	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	9	0	CD	CD	_	1	nummod	_	_

1	Voltage	voltage	NN	NN	_	3	npadvmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	Dependent	dependent	JJ	JJ	_	4	amod	_	_
4	Inactivation	inactivation	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	α	α	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	Cell	cell	NN	NN	_	13	compound	_	_
9	N	n	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	Type	type	NN	NN	_	13	compound	_	_
12	Ca2+	ca0+	NN	NN	_	13	compound	_	_
13	Currents	current	NNS	NNS	_	5	pobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	Exocytosis	exocytosis	NN	NN	_	13	conj	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	10	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	N	n	NN	NN	_	6	compound	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	type	type	NN	NN	_	8	compound	_	_
7	Ca2+	ca0+	NN	NN	_	8	compound	_	_
8	currents	current	NNS	NNS	_	10	nsubjpass	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	evaluated	evaluate	VBN	VBN	_	0	root	_	_
11	during	during	IN	IN	sem=TMP	10	prep	_	_
12	blockade	blockade	NN	NN	_	11	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	18	det	_	_
15	L	l	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	type	type	NN	NN	_	18	compound	_	_
18	channels	channel	NNS	NNS	_	13	pobj	_	_
19	with	with	IN	IN	sem=MNR	10	prep	_	_
20	isradipine	isradipine	NN	NN	_	19	pobj	_	_
21	(	(	-LRB-	-LRB-	_	23	punct	_	_
22	2	0	CD	CD	_	23	nummod	_	_
23	μM	μm	NNS	NNS	_	20	parataxis	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	N	n	NN	NN	_	4	compound	_	_
3	-	-	HYPH	HYPH	_	4	punct	_	_
4	type	type	NN	NN	_	5	compound	_	_
5	channel	channel	NN	NN	_	6	compound	_	_
6	antagonist	antagonist	NN	NN	_	17	nsubj	_	_
7	ω	ω	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	conotoxin	conotoxin	NN	NN	_	6	appos	_	_
10	(	(	-LRB-	-LRB-	_	15	punct	_	_
11	1	0	CD	CD	_	12	nummod	_	_
12	μM	μm	NN	NN	_	15	dep	_	_
13	;	;	:	:	_	15	punct	_	_
14	red	red	JJ	JJ	_	15	amod	_	_
15	traces	trace	NNS	NNS	_	6	parataxis	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	reduced	reduce	VBD	VBD	_	0	root	_	_
18	the	the	DT	DT	_	20	det	_	_
19	Ca2+	ca0+	NN	NN	_	20	compound	_	_
20	current	current	NN	NN	_	17	dobj	_	_
21	elicited	elicit	VBN	VBN	_	20	acl	_	_
22	by	by	IN	IN	sem=MNR	21	prep	_	_
23	a	a	DT	DT	_	25	det	_	_
24	step	step	NN	NN	_	25	compound	_	_
25	depolarisation	depolarisation	NN	NN	_	22	pobj	_	_
26	from	from	IN	IN	_	17	prep	_	_
27	−	−	SYM	SYM	_	28	punct	_	_
28	70	0	CD	CD	_	26	pobj	_	_
29	to	to	IN	IN	_	26	prep	_	_
30	0	0	CD	CD	_	29	pobj	_	_
31	mV	mv	NNS	NNS	_	26	pobj	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	right	right	JJ	JJ	_	17	parataxis	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	.	.	.	.	_	17	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	As	as	IN	IN	_	0	root	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	A	a	NN	NN	_	5	pobj	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	,	,	,	,	_	4	punct	_	_
10	but	but	CC	CC	_	4	cc	_	_
11	the	the	DT	DT	_	12	det	_	_
12	pulse	pulse	NN	NN	_	17	nsubjpass	_	_
13	to	to	IN	IN	_	12	prep	_	_
14	0	0	CD	CD	_	15	nummod	_	_
15	mV	mv	NNS	NNS	_	13	pobj	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	preceded	precede	VBN	VBN	_	4	conj	_	_
18	by	by	IN	IN	_	17	agent	_	_
19	a	a	DT	DT	_	24	det	_	_
20	200	0	CD	CD	_	22	nummod	_	_
21	-	-	HYPH	HYPH	_	22	punct	_	_
22	ms	m	NNS	NNS	_	24	compound	_	_
23	conditioning	conditioning	NN	NN	_	24	compound	_	_
24	depolarization	depolarization	NN	NN	_	18	pobj	_	_
25	to	to	IN	IN	_	24	prep	_	_
26	+	+	SYM	SYM	_	27	punct	_	_
27	10	0	CD	CD	_	28	nummod	_	_
28	mV	mv	NNS	NNS	_	25	pobj	_	_
29	.	.	.	.	_	17	punct	_	_

1	ω	ω	NN	NN	_	3	compound	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	Conotoxin	conotoxin	NN	NN	_	4	nsubj	_	_
4	was	be	VBD	VBD	_	0	root	_	_
5	without	without	IN	IN	syn=PRD	4	prep	_	_
6	effect	effect	NN	NN	_	5	pobj	_	_
7	on	on	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	9	det	_	_
9	current	current	JJ	JJ	_	7	pobj	_	_
10	measured	measure	VBN	VBN	_	9	acl	_	_
11	during	during	IN	IN	sem=TMP	10	prep	_	_
12	the	the	DT	DT	_	13	det	_	_
13	depolarization	depolarization	NN	NN	_	11	pobj	_	_
14	to	to	IN	IN	_	13	prep	_	_
15	0	0	CD	CD	_	16	nummod	_	_
16	mV	mv	NNS	NNS	_	14	pobj	_	_
17	under	under	IN	IN	_	10	prep	_	_
18	these	these	DT	DT	_	19	det	_	_
19	conditions	condition	NNS	NNS	_	17	pobj	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	right	right	JJ	JJ	_	19	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	8	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Top	top	JJ	JJ	_	8	amod	_	_
5	:	:	:	:	_	8	punct	_	_
6	peak	peak	JJ	JJ	_	8	amod	_	_
7	Ca2+	ca0+	NN	NN	_	8	compound	_	_
8	currents	current	NNS	NNS	_	0	root	_	_
9	measured	measure	VBN	VBN	_	8	acl	_	_
10	in	in	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	12	det	_	_
12	presence	presence	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	2	0	CD	CD	_	15	nummod	_	_
15	μM	μm	NNS	NNS	_	16	compound	_	_
16	isradipine	isradipine	NN	NN	_	13	pobj	_	_
17	alone	alone	RB	RB	_	16	advmod	_	_
18	(	(	-LRB-	-LRB-	_	20	punct	_	_
19	open	open	JJ	JJ	_	20	amod	_	_
20	squares	square	NNS	NNS	_	16	parataxis	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	or	or	CC	CC	_	10	cc	_	_
23	together	together	RB	RB	_	24	advmod	_	_
24	with	with	IN	IN	_	10	conj	_	_
25	1	0	CD	CD	_	26	nummod	_	_
26	μM	μm	NN	NN	_	29	compound	_	_
27	ω	ω	NN	NN	_	29	compound	_	_
28	-	-	HYPH	HYPH	_	29	punct	_	_
29	conotoxin	conotoxin	NN	NN	_	24	pobj	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	red	red	JJ	JJ	_	32	amod	_	_
32	circles	circle	NNS	NNS	_	29	parataxis	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	during	during	IN	IN	sem=TMP	9	prep	_	_
35	a	a	DT	DT	_	36	det	_	_
36	depolarization	depolarization	NN	NN	_	34	pobj	_	_
37	to	to	IN	IN	_	36	prep	_	_
38	0	0	CD	CD	_	39	nummod	_	_
39	mV	mv	NNS	NNS	_	37	pobj	_	_
40	following	following	IN	IN	sem=TMP	36	prep	_	_
41	200	0	CD	CD	_	43	nummod	_	_
42	-	-	HYPH	HYPH	_	43	punct	_	_
43	ms	m	NNS	NNS	_	45	compound	_	_
44	conditioning	conditioning	NN	NN	_	45	compound	_	_
45	pulses	pulse	NNS	NNS	_	40	pobj	_	_
46	to	to	IN	IN	_	45	prep	_	_
47	between	between	IN	IN	_	49	quantmod	_	_
48	−	−	SYM	SYM	_	49	punct	_	_
49	70	0	CD	CD	_	53	nummod	_	_
50	and	and	CC	CC	_	49	cc	_	_
51	+	+	SYM	SYM	_	52	punct	_	_
52	70	0	CD	CD	_	49	conj	_	_
53	mV	mv	NNS	NNS	_	46	pobj	_	_
54	.	.	.	.	_	8	punct	_	_

1	Lower	low	JJR	JJR	_	3	amod	_	_
2	:	:	:	:	_	3	punct	_	_
3	inactivation	inactivation	NN	NN	_	0	root	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	the	the	DT	DT	_	11	det	_	_
6	ω	ω	NN	NN	_	8	compound	_	_
7	-	-	HYPH	HYPH	_	8	punct	_	_
8	conotoxin	conotoxin	NN	NN	_	10	npadvmod	_	_
9	–	-	HYPH	HYPH	_	10	punct	_	_
10	sensitive	sensitive	JJ	JJ	_	11	amod	_	_
11	component	component	NN	NN	_	4	pobj	_	_
12	.	.	.	.	_	3	punct	_	_

1	Half	half	RB	RB	_	3	advmod	_	_
2	-	-	HYPH	HYPH	_	3	punct	_	_
3	maximal	maximal	JJ	JJ	_	4	amod	_	_
4	inactivation	inactivation	NN	NN	_	11	nsubj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	10	det	_	_
7	N	n	NN	NN	_	9	compound	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	type	type	NN	NN	_	10	compound	_	_
10	current	current	NN	NN	_	5	pobj	_	_
11	was	be	VBD	VBD	_	0	root	_	_
12	at	at	IN	IN	syn=PRD	11	prep	_	_
13	−	−	SYM	SYM	_	14	punct	_	_
14	31	0	CD	CD	_	16	quantmod	_	_
15	±	±	SYM	SYM	_	16	punct	_	_
16	6	0	CD	CD	_	17	nummod	_	_
17	mV	mv	NNS	NNS	_	12	pobj	_	_
18	(	(	-LRB-	-LRB-	_	21	punct	_	_
19	n	n	NN	NN	_	21	nsubj	_	_
20	=	=	SYM	SYM	_	21	punct	_	_
21	5	0	CD	CD	_	17	parataxis	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	.	.	.	.	_	11	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	6	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Exocytosis	exocytosis	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	elicited	elicit	VBN	VBN	_	0	root	_	_
7	with	with	IN	IN	sem=MNR	6	prep	_	_
8	500	0	CD	CD	_	10	nummod	_	_
9	-	-	HYPH	HYPH	_	10	punct	_	_
10	ms	m	NNS	NNS	_	11	compound	_	_
11	depolarisations	depolarisation	NNS	NNS	_	7	pobj	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	−	−	SYM	SYM	_	14	punct	_	_
14	70	0	CD	CD	_	15	nummod	_	_
15	mV	mv	NNS	NNS	_	12	pobj	_	_
16	to	to	IN	IN	_	12	prep	_	_
17	between	between	IN	IN	_	19	quantmod	_	_
18	−	−	SYM	SYM	_	19	punct	_	_
19	50	0	CD	CD	_	22	nummod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	20	0	CD	CD	_	19	conj	_	_
22	mV	mv	NNS	NNS	_	16	pobj	_	_
23	.	.	.	.	_	6	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	E	e	LS	LS	_	6	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	6	det	_	_
5	voltage	voltage	NN	NN	_	6	compound	_	_
6	dependence	dependence	NN	NN	_	0	root	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	10	det	_	_
9	exocytotic	exocytotic	JJ	JJ	_	10	amod	_	_
10	response	response	NN	NN	_	7	pobj	_	_
11	.	.	.	.	_	6	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	F	f	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Exocytosis	exocytosis	NN	NN	_	0	root	_	_
5	elicited	elicit	VBN	VBN	_	4	acl	_	_
6	by	by	IN	IN	sem=MNR	5	prep	_	_
7	500	0	CD	CD	_	9	nummod	_	_
8	-	-	HYPH	HYPH	_	9	punct	_	_
9	ms	m	NNS	NNS	_	10	compound	_	_
10	depolarisations	depolarisation	NNS	NNS	_	6	pobj	_	_
11	to	to	IN	IN	_	10	prep	_	_
12	0	0	CD	CD	_	13	nummod	_	_
13	mV	mv	NNS	NNS	_	11	pobj	_	_
14	from	from	IN	IN	_	5	prep	_	_
15	holding	hold	VBG	VBG	_	16	amod	_	_
16	potentials	potential	NNS	NNS	_	14	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	between	between	IN	IN	_	20	quantmod	_	_
19	−	−	SYM	SYM	_	20	punct	_	_
20	70	0	CD	CD	_	24	nummod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	−	−	SYM	SYM	_	23	punct	_	_
23	30	0	CD	CD	_	20	conj	_	_
24	mV	mv	NNS	NNS	_	17	pobj	_	_
25	.	.	.	.	_	4	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	G	g	LS	LS	_	4	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Summary	summary	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	effects	effect	NNS	NNS	_	5	pobj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	holding	holding	NN	NN	_	9	compound	_	_
9	potential	potential	NN	NN	_	7	pobj	_	_
10	on	on	IN	IN	_	6	prep	_	_
11	exocytotic	exocytotic	JJ	JJ	_	12	amod	_	_
12	responses	response	NNS	NNS	_	10	pobj	_	_
13	elicited	elicit	VBN	VBN	_	12	acl	_	_
14	by	by	IN	IN	_	13	agent	_	_
15	depolarisations	depolarisation	NNS	NNS	_	14	pobj	_	_
16	to	to	IN	IN	_	15	prep	_	_
17	0	0	CD	CD	_	18	nummod	_	_
18	mV	mv	NNS	NNS	_	16	pobj	_	_
19	.	.	.	.	_	4	punct	_	_

1	Data	datum	NNS	NNS	_	4	nsubjpass	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	been	be	VBN	VBN	_	4	auxpass	_	_
4	normalized	normalize	VBN	VBN	_	0	root	_	_
5	to	to	IN	IN	_	4	prep	_	_
6	responses	response	NNS	NNS	_	5	pobj	_	_
7	obtained	obtain	VBN	VBN	_	6	acl	_	_
8	using	use	VBG	VBG	sem=MNR	7	advcl	_	_
9	a	a	DT	DT	_	11	det	_	_
10	holding	holding	NN	NN	_	11	compound	_	_
11	potential	potential	NN	NN	_	8	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	−	−	SYM	SYM	_	14	punct	_	_
14	70	0	CD	CD	_	15	nummod	_	_
15	mV	mv	NNS	NNS	_	12	pobj	_	_
16	.	.	.	.	_	4	punct	_	_

1	*	*	SYM	SYM	_	5	punct	_	_
2	,	,	,	,	_	5	punct	_	_
3	p	p	NN	NN	_	5	nsubj	_	_
4	<	<	SYM	SYM	_	5	punct	_	_
5	0.05	0	CD	CD	_	17	ccomp	_	_
6	;	;	:	:	_	17	punct	_	_
7	**	**	SYM	SYM	_	11	punct	_	_
8	,	,	,	,	_	11	punct	_	_
9	p	p	NN	NN	_	11	nsubj	_	_
10	<	<	SYM	SYM	_	11	punct	_	_
11	0.01	0	CD	CD	_	17	ccomp	_	_
12	;	;	:	:	_	17	punct	_	_
13	***	**	SYM	SYM	_	17	punct	_	_
14	,	,	,	,	_	17	punct	_	_
15	p	p	NN	NN	_	17	nsubj	_	_
16	<	<	SYM	SYM	_	17	punct	_	_
17	0.001	0	CD	CD	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	compared	compare	VBN	VBN	_	17	prep	_	_
20	with	with	IN	IN	_	19	prep	_	_
21	ω	ω	NN	NN	_	23	compound	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	conotoxin	conotoxin	NN	NN	_	20	pobj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	C	c	NN	NN	_	23	parataxis	_	_
26	,	,	,	,	_	25	punct	_	_
27	top	top	JJ	JJ	_	25	amod	_	_
28	)	)	-RRB-	-RRB-	_	25	punct	_	_
29	or	or	CC	CC	_	20	cc	_	_
30	with	with	IN	IN	_	20	conj	_	_
31	the	the	DT	DT	_	33	det	_	_
32	initial	initial	JJ	JJ	_	33	amod	_	_
33	response	response	NN	NN	_	30	pobj	_	_
34	.	.	.	.	_	17	punct	_	_

1	Figure	figure	NN	NN	_	0	root	_	_
2	10	0	CD	CD	_	1	nummod	_	_

1	A	a	DT	DT	_	2	det	_	_
2	Model	model	NN	NN	_	0	root	_	_
3	for	for	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	Suppression	suppression	NN	NN	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	Glucagon	glucagon	NN	NN	_	8	compound	_	_
8	Secretion	secretion	NN	NN	_	6	pobj	_	_
9	by	by	IN	IN	_	5	prep	_	_
10	an	an	DT	DT	_	15	det	_	_
11	Intrinsic	intrinsic	JJ	JJ	_	15	amod	_	_
12	α	α	NN	NN	_	14	compound	_	_
13	-	-	HYPH	HYPH	_	14	punct	_	_
14	Cell	cell	NN	NN	_	15	compound	_	_
15	Pathway	pathway	NN	NN	_	9	pobj	_	_

1	Schematic	schematic	JJ	JJ	_	2	amod	_	_
2	representation	representation	NN	NN	_	35	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	effects	effect	NNS	NNS	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	glucose	glucose	NN	NN	_	6	pobj	_	_
8	,	,	,	,	_	7	punct	_	_
9	tolbutamide	tolbutamide	NN	NN	_	7	conj	_	_
10	,	,	,	,	_	9	punct	_	_
11	and	and	CC	CC	_	9	cc	_	_
12	diazoxide	diazoxide	NN	NN	_	9	conj	_	_
13	on	on	IN	IN	_	5	prep	_	_
14	α	α	NN	NN	_	16	nmod	_	_
15	-	-	HYPH	HYPH	_	16	punct	_	_
16	cell	cell	NN	NN	_	17	nmod	_	_
17	KATP	katp	NN	NN	_	29	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	Na+	na+	NN	NN	_	17	conj	_	_
20	,	,	,	,	_	19	punct	_	_
21	and	and	CC	CC	_	19	cc	_	_
22	N	n	NN	NN	_	24	compound	_	_
23	-	-	HYPH	HYPH	_	24	punct	_	_
24	type	type	NN	NN	_	25	compound	_	_
25	Ca2+	ca0+	NN	NN	_	19	conj	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	VDCC	vdcc	NN	NN	_	25	parataxis	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	channel	channel	NN	NN	_	30	compound	_	_
30	activities	activity	NNS	NNS	_	13	pobj	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	glucagon	glucagon	NN	NN	_	33	compound	_	_
33	secretion	secretion	NN	NN	_	30	conj	_	_
34	is	be	VBZ	VBZ	_	35	auxpass	_	_
35	shown	show	VBN	VBN	_	0	root	_	_
36	.	.	.	.	_	35	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	insulin	insulin	NN	NN	_	3	compound	_	_
3	response	response	NN	NN	_	6	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	6	auxpass	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	shown	show	VBN	VBN	_	0	root	_	_
7	for	for	IN	IN	sem=PRP	6	prep	_	_
8	comparison	comparison	NN	NN	_	7	pobj	_	_
9	with	with	IN	IN	_	8	prep	_	_
10	our	our	PRP$	PRP$	_	12	poss	_	_
11	experimental	experimental	JJ	JJ	_	12	amod	_	_
12	results	result	NNS	NNS	_	9	pobj	_	_
13	(	(	-LRB-	-LRB-	_	18	punct	_	_
14	dashed	dashed	JJ	JJ	_	15	amod	_	_
15	lines	line	NNS	NNS	_	18	dep	_	_
16	,	,	,	,	_	18	punct	_	_
17	lower	low	JJR	JJR	_	18	amod	_	_
18	panels	panel	NNS	NNS	_	6	parataxis	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	grey	grey	JJ	JJ	_	3	amod	_	_
3	gradient	gradient	NN	NN	_	4	nsubj	_	_
4	represents	represent	VBZ	VBZ	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	“	"	``	``	_	7	punct	_	_
7	window	window	NN	NN	_	4	dobj	_	_
8	”	"	''	''	_	7	punct	_	_
9	of	of	IN	IN	_	7	prep	_	_
10	α	α	NN	NN	_	12	compound	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	KATP	katp	NN	NN	_	14	compound	_	_
14	channel	channel	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	9	pobj	_	_
16	that	that	WDT	WDT	_	17	dep	_	7:ref
17	supports	support	VBZ	VBZ	_	7	relcl	_	_
18	the	the	DT	DT	_	19	det	_	_
19	activation	activation	NN	NN	_	17	dobj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	Ca2+	ca0+	NN	NN	_	24	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	Na+	na+	NN	NN	_	21	conj	_	_
24	channels	channel	NNS	NNS	_	20	pobj	_	_
25	.	.	.	.	_	4	punct	_	_

1	Above	above	IN	IN	_	8	prep	_	_
2	this	this	DT	DT	_	3	det	_	_
3	window	window	NN	NN	_	1	pobj	_	_
4	,	,	,	,	_	8	punct	_	_
5	the	the	DT	DT	_	6	det	_	_
6	cell	cell	NN	NN	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	hyperpolarized	hyperpolarized	VBN	VBN	_	0	root	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	Ca2+	ca0+	NN	NN	_	13	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	Na+	na+	NN	NN	_	10	conj	_	_
13	channel	channel	NN	NN	_	14	compound	_	_
14	activation	activation	NN	NN	_	16	nsubjpass	_	_
15	is	be	VBZ	VBZ	_	16	auxpass	_	_
16	prevented	prevent	VBN	VBN	_	8	conj	_	_
17	,	,	,	,	_	8	punct	_	_
18	whereas	whereas	IN	IN	_	25	mark	_	_
19	KATP	katp	NN	NN	_	20	compound	_	_
20	channel	channel	NN	NN	_	21	compound	_	_
21	activity	activity	NN	NN	_	25	nsubj	_	_
22	below	below	IN	IN	_	21	prep	_	_
23	this	this	DT	DT	_	24	det	_	_
24	window	window	NN	NN	_	22	pobj	_	_
25	depolarizes	depolarize	VBZ	VBZ	syn=ADV	8	advcl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	cell	cell	NN	NN	_	25	dobj	_	_
28	and	and	CC	CC	_	25	cc	_	_
29	causes	cause	VBZ	VBZ	_	25	conj	_	_
30	voltage	voltage	NN	NN	_	32	npadvmod	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	dependent	dependent	JJ	JJ	_	33	amod	_	_
33	inactivation	inactivation	NN	NN	_	29	dobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	Ca2+	ca0+	NN	NN	_	38	nmod	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	Na+	na+	NN	NN	_	35	conj	_	_
38	channels	channel	NNS	NNS	_	34	pobj	_	_
39	.	.	.	.	_	8	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	A	a	LS	LS	_	8	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	High	high	JJ	JJ	_	6	amod	_	_
5	-	-	HYPH	HYPH	_	6	punct	_	_
6	glucose	glucose	NN	NN	_	7	compound	_	_
7	concentration	concentration	NN	NN	_	8	nsubj	_	_
8	reduces	reduce	VBZ	VBZ	_	0	root	_	_
9	α	α	NN	NN	_	11	compound	_	_
10	-	-	HYPH	HYPH	_	11	punct	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	KATP	katp	NN	NN	_	13	compound	_	_
13	channel	channel	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	8	dobj	_	_
15	,	,	,	,	_	8	punct	_	_
16	reducing	reduce	VBG	VBG	syn=ADV	8	advcl	_	_
17	glucagon	glucagon	NN	NN	_	18	compound	_	_
18	secretion	secretion	NN	NN	_	16	dobj	_	_
19	.	.	.	.	_	8	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	B	b	LS	LS	_	14	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	Graded	grade	VBN	VBN	_	5	amod	_	_
5	application	application	NN	NN	_	14	nsubj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	tolbutamide	tolbutamide	NN	NN	_	6	pobj	_	_
8	(	(	-LRB-	-LRB-	_	5	punct	_	_
9	in	in	IN	IN	_	5	prep	_	_
10	zero	#crd#	CD	CD	_	11	nummod	_	_
11	glucose	glucose	NN	NN	_	9	pobj	_	_
12	)	)	-RRB-	-RRB-	_	5	punct	_	_
13	transiently	transiently	RB	RB	_	14	advmod	_	_
14	increases	increase	VBZ	VBZ	_	0	root	_	_
15	glucagon	glucagon	NN	NN	_	16	compound	_	_
16	secretion	secretion	NN	NN	_	14	dobj	_	_
17	as	as	IN	IN	_	22	mark	_	_
18	KATP	katp	NN	NN	_	19	compound	_	_
19	channel	channel	NN	NN	_	20	compound	_	_
20	activity	activity	NN	NN	_	22	nsubjpass	_	_
21	is	be	VBZ	VBZ	_	22	auxpass	_	_
22	reduced	reduce	VBN	VBN	syn=ADV	14	advcl	_	_
23	through	through	IN	IN	_	22	prep	_	_
24	,	,	,	,	_	23	punct	_	_
25	and	and	CC	CC	_	23	cc	_	_
26	eventually	eventually	RB	RB	sem=TMP	27	advmod	_	_
27	below	below	IN	IN	_	23	conj	_	_
28	,	,	,	,	_	27	punct	_	_
29	the	the	DT	DT	_	30	det	_	_
30	window	window	NN	NN	_	27	conj	_	_
31	supporting	support	VBG	VBG	_	30	acl	_	_
32	glucagon	glucagon	NN	NN	_	33	compound	_	_
33	release	release	NN	NN	_	31	dobj	_	_
34	.	.	.	.	_	14	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	C	c	LS	LS	_	14	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	The	the	DT	DT	_	6	det	_	_
5	graded	grade	VBN	VBN	_	6	amod	_	_
6	application	application	NN	NN	_	14	nsubj	_	_
7	of	of	IN	IN	_	6	prep	_	_
8	diazoxide	diazoxide	NN	NN	_	7	pobj	_	_
9	in	in	IN	IN	_	6	prep	_	_
10	high	high	JJ	JJ	_	12	amod	_	_
11	-	-	HYPH	HYPH	_	12	punct	_	_
12	glucose	glucose	NN	NN	_	13	compound	_	_
13	conditions	condition	NNS	NNS	_	9	pobj	_	_
14	increases	increase	VBZ	VBZ	_	0	root	_	_
15	α	α	NN	NN	_	17	compound	_	_
16	-	-	HYPH	HYPH	_	17	punct	_	_
17	cell	cell	NN	NN	_	20	compound	_	_
18	KATP	katp	NN	NN	_	19	compound	_	_
19	channel	channel	NN	NN	_	20	compound	_	_
20	activity	activity	NN	NN	_	14	dobj	_	_
21	into	into	IN	IN	_	14	prep	_	_
22	,	,	,	,	_	21	punct	_	_
23	and	and	CC	CC	_	21	cc	_	_
24	then	then	RB	RB	sem=TMP	25	advmod	_	_
25	above	above	IN	IN	_	21	conj	_	_
26	the	the	DT	DT	_	27	det	_	_
27	window	window	NN	NN	_	25	pobj	_	_
28	supporting	support	VBG	VBG	_	27	acl	_	_
29	glucagon	glucagon	NN	NN	_	30	compound	_	_
30	secretion	secretion	NN	NN	_	28	dobj	_	_
31	.	.	.	.	_	14	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	result	result	NN	NN	_	3	nsubj	_	_
3	is	be	VBZ	VBZ	_	0	root	_	_
4	a	a	DT	DT	_	7	det	_	_
5	transient	transient	JJ	JJ	_	7	amod	_	_
6	“	"	``	``	_	7	punct	_	_
7	re-activation	re-activation	NN	NN	syn=PRD	3	attr	_	_
8	”	"	''	''	_	7	punct	_	_
9	of	of	IN	IN	_	7	prep	_	_
10	glucagon	glucagon	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	9	pobj	_	_
12	at	at	IN	IN	_	7	prep	_	_
13	low	low	JJ	JJ	_	15	amod	_	_
14	-	-	HYPH	HYPH	_	15	punct	_	_
15	diazoxide	diazoxide	NN	NN	_	16	compound	_	_
16	concentrations	concentration	NNS	NNS	_	12	pobj	_	_
17	.	.	.	.	_	3	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	D	d	LS	LS	_	20	meta	_	_
3	)	)	-RRB-	-RRB-	_	2	punct	_	_
4	In	in	IN	IN	_	20	prep	_	_
5	low	low	JJ	JJ	_	7	amod	_	_
6	-	-	HYPH	HYPH	_	7	punct	_	_
7	glucose	glucose	NN	NN	_	14	nmod	_	_
8	(	(	-LRB-	-LRB-	_	12	punct	_	_
9	1	0	CD	CD	_	11	quantmod	_	_
10	–	-	SYM	SYM	_	11	punct	_	_
11	2	0	CD	CD	_	12	nummod	_	_
12	mM	mm	NNS	NNS	_	14	parataxis	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	conditions	condition	NNS	NNS	_	4	pobj	_	_
15	,	,	,	,	_	20	punct	_	_
16	graded	grade	VBN	VBN	_	17	amod	_	_
17	application	application	NN	NN	_	20	nsubj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	diazoxide	diazoxide	NN	NN	_	18	pobj	_	_
20	increases	increase	VBZ	VBZ	_	0	root	_	_
21	KATP	katp	NN	NN	_	22	compound	_	_
22	channel	channel	NN	NN	_	23	compound	_	_
23	activity	activity	NN	NN	_	20	dobj	_	_
24	above	above	IN	IN	_	20	prep	_	_
25	the	the	DT	DT	_	26	det	_	_
26	window	window	NN	NN	_	24	pobj	_	_
27	supporting	support	VBG	VBG	_	26	acl	_	_
28	glucagon	glucagon	NN	NN	_	29	compound	_	_
29	secretion	secretion	NN	NN	_	27	dobj	_	_
30	,	,	,	,	_	20	punct	_	_
31	causing	cause	VBG	VBG	syn=ADV	20	advcl	_	_
32	a	a	DT	DT	_	34	det	_	_
33	monotonic	monotonic	JJ	JJ	_	34	amod	_	_
34	inhibition	inhibition	NN	NN	_	31	dobj	_	_
35	of	of	IN	IN	_	34	prep	_	_
36	glucagon	glucagon	NN	NN	_	37	compound	_	_
37	release	release	NN	NN	_	35	pobj	_	_
38	.	.	.	.	_	20	punct	_	_

1	Footnotes	footnote	NNS	NNS	_	0	root	_	_

1	Competing	competing	JJ	JJ	_	2	amod	_	_
2	interests	interest	NNS	NNS	_	0	root	_	_
3	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	authors	author	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	declared	declare	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	no	no	DT	DT	_	8	det	_	_
7	competing	compete	VBG	VBG	_	8	amod	_	_
8	interests	interest	NNS	NNS	_	9	nsubj	_	_
9	exist	exist	VBP	VBP	_	4	ccomp	_	_
10	.	.	.	.	_	4	punct	_	_

1	Author	author	NN	NN	_	2	compound	_	_
2	contributions	contribution	NNS	NNS	_	0	root	_	_
3	.	.	.	.	_	2	punct	_	_

1	PEM	pem	NNP	NNP	_	7	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	LE	le	NNP	NNP	_	1	conj	_	_
4	,	,	,	,	_	3	punct	_	_
5	and	and	CC	CC	_	3	cc	_	_
6	PR	pr	NNP	NNP	_	3	conj	_	_
7	conceived	conceive	VBD	VBD	_	0	root	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	designed	design	VBD	VBD	_	7	conj	_	_
10	the	the	DT	DT	_	11	det	_	_
11	experiments	experiment	NNS	NNS	_	9	dobj	_	_
12	.	.	.	.	_	7	punct	_	_

1	PEM	pem	NNP	NNP	_	13	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	YZDM	yzdm	NNP	NNP	_	1	conj	_	_
4	,	,	,	,	_	3	punct	_	_
5	RR	rr	NNP	NNP	_	3	conj	_	_
6	,	,	,	,	_	5	punct	_	_
7	AS	as	NNP	NNP	_	5	conj	_	_
8	,	,	,	,	_	7	punct	_	_
9	XM	xm	NNP	NNP	_	7	conj	_	_
10	,	,	,	,	_	9	punct	_	_
11	and	and	CC	CC	_	9	cc	_	_
12	LE	le	NNP	NNP	_	9	conj	_	_
13	performed	performed	VBD	VBD	_	0	root	_	_
14	the	the	DT	DT	_	15	det	_	_
15	experiments	experiment	NNS	NNS	_	13	dobj	_	_
16	.	.	.	.	_	13	punct	_	_

1	PEM	pem	NNP	NNP	_	13	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	YZDM	yzdm	NNP	NNP	_	1	conj	_	_
4	,	,	,	,	_	3	punct	_	_
5	RR	rr	NNP	NNP	_	3	conj	_	_
6	,	,	,	,	_	5	punct	_	_
7	AS	as	NNP	NNP	_	5	conj	_	_
8	,	,	,	,	_	7	punct	_	_
9	LE	le	NNP	NNP	_	7	conj	_	_
10	,	,	,	,	_	9	punct	_	_
11	and	and	CC	CC	_	9	cc	_	_
12	PR	pr	NNP	NNP	_	9	conj	_	_
13	analyzed	analyze	VBD	VBD	_	0	root	_	_
14	the	the	DT	DT	_	15	det	_	_
15	data	datum	NNS	NNS	_	13	dobj	_	_
16	.	.	.	.	_	13	punct	_	_

1	PRVJ	prvj	NNP	NNP	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	RC	rc	NNP	NNP	_	1	conj	_	_
4	contributed	contribute	VBD	VBD	_	0	root	_	_
5	reagents	reagent	NNS	NNS	_	4	dobj	_	_
6	/	/	HYPH	HYPH	_	5	punct	_	_
7	materials	material	NNS	NNS	_	5	appos	_	_
8	/	/	HYPH	HYPH	_	5	punct	_	_
9	analysis	analysis	NN	NN	_	10	compound	_	_
10	tools	tool	NNS	NNS	_	5	appos	_	_
11	.	.	.	.	_	4	punct	_	_

1	PEM	pem	NNP	NNP	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	PR	pr	NNP	NNP	_	1	conj	_	_
4	wrote	write	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	paper	paper	NN	NN	_	4	dobj	_	_
7	.	.	.	.	_	4	punct	_	_

1	Funding	funding	NN	NN	_	0	root	_	_
2	.	.	.	.	_	1	punct	_	_

1	Work	work	NN	NN	_	6	nsubjpass	_	_
2	in	in	IN	IN	sem=LOC	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	UK	uk	NNP	NNP	_	2	pobj	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	supported	support	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	6	agent	_	_
8	grants	grant	NNS	NNS	_	7	pobj	_	_
9	to	to	IN	IN	_	8	prep	_	_
10	PR	pr	NN	NN	_	9	pobj	_	_
11	from	from	IN	IN	_	8	prep	_	_
12	the	the	DT	DT	_	14	det	_	_
13	Wellcome	wellcome	NNP	NNP	_	14	compound	_	_
14	Trust	trust	NNP	NNP	_	11	pobj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	the	the	DT	DT	_	18	det	_	_
17	European	european	NNP	NNP	_	18	compound	_	_
18	Union	union	NNP	NNP	_	14	conj	_	_
19	(	(	-LRB-	-LRB-	_	23	punct	_	_
20	Eurodia	eurodia	NNP	NNP	_	23	compound	_	_
21	LSHM	lshm	NN	NN	_	23	compound	_	_
22	-	-	HYPH	HYPH	_	23	punct	_	_
23	CT	ct	NN	NN	_	8	parataxis	_	_
24	-	-	HYPH	HYPH	_	23	punct	_	_
25	2006	0	CD	CD	_	23	nummod	_	_
26	–	-	HYPH	HYPH	_	23	punct	_	_
27	518153	0	CD	CD	_	23	nummod	_	_
28	and	and	CC	CC	_	23	cc	_	_
29	BioSim	biosim	NNP	NNP	_	32	compound	_	_
30	LSHB	lshb	NN	NN	_	32	compound	_	_
31	-	-	HYPH	HYPH	_	32	punct	_	_
32	CT	ct	NN	NN	_	23	conj	_	_
33	-	-	HYPH	HYPH	_	32	punct	_	_
34	2004	0	CD	CD	_	32	nummod	_	_
35	–	-	HYPH	HYPH	_	32	punct	_	_
36	005137	0	CD	CD	_	32	nummod	_	_
37	)	)	-RRB-	-RRB-	_	23	punct	_	_
38	.	.	.	.	_	6	punct	_	_

1	Work	work	NN	NN	_	6	nsubjpass	_	_
2	conducted	conduct	VBN	VBN	_	1	acl	_	_
3	in	in	IN	IN	sem=LOC	2	prep	_	_
4	Sweden	sweden	NNP	NNP	_	3	pobj	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	supported	support	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	6	agent	_	_
8	the	the	DT	DT	_	11	det	_	_
9	Swedish	swedish	NNP	NNP	_	11	compound	_	_
10	Strategic	strategic	NNP	NNP	_	11	compound	_	_
11	Foundation	foundation	NNP	NNP	_	7	pobj	_	_
12	,	,	,	,	_	11	punct	_	_
13	the	the	DT	DT	_	16	det	_	_
14	Göran	göran	NNP	NNP	_	16	compound	_	_
15	Gustafsson	gustafsson	NNP	NNP	_	16	compound	_	_
16	Stiftelse	stiftelse	NNP	NNP	_	11	conj	_	_
17	,	,	,	,	_	16	punct	_	_
18	the	the	DT	DT	_	21	det	_	_
19	Swedish	swedish	NNP	NNP	_	21	compound	_	_
20	Research	research	NNP	NNP	_	21	compound	_	_
21	Council	council	NNP	NNP	_	16	conj	_	_
22	,	,	,	,	_	21	punct	_	_
23	the	the	DT	DT	_	26	det	_	_
24	Swedish	swedish	NNP	NNP	_	26	compound	_	_
25	Diabetes	diabetes	NNP	NNP	_	26	compound	_	_
26	Association	association	NNP	NNP	_	21	conj	_	_
27	,	,	,	,	_	26	punct	_	_
28	and	and	CC	CC	_	26	cc	_	_
29	the	the	DT	DT	_	32	det	_	_
30	Novo	novo	NNP	NNP	_	32	compound	_	_
31	Nordisk	nordisk	NNP	NNP	_	32	compound	_	_
32	Foundation	foundation	NNP	NNP	_	26	conj	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	LE	le	NNP	NNP	_	6	parataxis	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	6	punct	_	_

